>UU001 dnaA chromosomal replication initiator protein
MANNYQTLYDSAIKRIPYDLISDQAYAILQNAKTHKVCDGVLYIIVANAFEKSIINGNFI
NIISKYLSEEFKKENIVNFEFIIDNEKLLINSNFLIKETNIKNRFNFSDELLRYNFNNLV
ISNFNQKAIKAIENLFSNNYDNSSMCNPLFLFGKVGVGKTHIVAAAGNRFANSNPNLKIY
YYEGQDFFRKFCSASLKGTSYVEEFKKEIASADLLIFEDIQNIQSRDSTAELFFNIFNDI
KLNGGKIILTSDRTPNELNGFHNRIISRLASGLQCKISQPDKNEAIKIINNWFEFKKKYQ
ITDEAKEYIAEGFHTDIRQMIGNLKQICFWADNDTNKDLIITKDYVIECSVENEIPLNIV
VKKQFKPEQIIEIVAKELNIKTDLIKSSIRKNNIVWARDIVCYILKNKLNLTLTDIGKLL
NGREHTTISHSISKVQKILDDENSQEALQINLIINKF
>UU002 rpL31 ribosomal protein L31
MRDIHPVSKPCVYNCVTCKKEFIIDSAAKNTEVAIEVCSNCHTFFIGKQNATTTLRGRAE
KLNNRFEAGLNNINKKPEKKKIQGKSEPRKSLNEL
>UU003 prfA peptide chain release factor 1
MEYNKKLYEAIERVAIKNDALKKELETVVTDFKKIKEINIQLKKTTKIAEAFAKYKQKLD
TGIAAEKILNTEKDLELIELAQMDLDEAKINIPIIENDLKIMLLPTDPNDDKNVIVEMRP
AAGGDESSIFVGNLFDTYRAYAENNNWKMKIIEMTPNAVGFSFISFMISGEEVYSRMKFE
SGVHRVQRVPATESKGRVHTSTITVAVLPEQDEVDVVINPTELRIDTYRASGAGGQHVNR
TESAVRITHIPTGVVAACQEGKSQIENRETAMKMLRAKLWEAAQEQQNAEFANLRKNQVG
TGDRSEKIRTYNYPQNRVTDHRINLTLNKLDQIMMGELDEIIDALIADEQTGLMANLDI
>UU004 hemK protoporphyrinogen oxidase N-term
MTYHQLIFQAYSLLEKKLRNPQVAFQLLYGLDNKINDSYSFSNNRLTIVNSNLEYTYFKL
LDEFINGKPLVRILGYGYFCAKRFYVDKNVFAFRVETELLIDVVNKVIQQSTYKIKNVID
VCCGSGVLGLSTKMNFNQLNVSLLDISIDAINNCKKNAKYHNLTDVNFIHKSMQEYFLNT
KKRFDLIICNPPYIKSNYELNREVLDYDPINALIDFDHKDGISFYLFIINNIKSIANEKF
TIIFEIGFDQKEILEKVIKKNEFPLFYYFINDYNNLCRILIISNIKYENL
>UU005 hemK protoporphyrinogen oxidase C-term
VILNMKIYRITNLNVIYDALMANKCVLIPTDTIIGLLAKNQDVIYEIKQRDRNKKIIRFV
ADYKLLGDLTVEQKQFLDLFWPGSVTIIKNGISYRMPNSPYILKLIQKLGPLYCSSANIS
GEEPIKNHNEAIFKFGANSKLIYVEAQQQIGVPSTIVDIDKWEYIRRGANVEMVDMFIKE
LKDNKTGK
>UU006 lacA galactoside O-acetyltransferase
MIKKIYFGNDHAAYEIKDQIITHLKQKGYQIIDEGAQAALGSVDYSTYALKVANDVVNDT
KNDSIGILLCGTGIGMNIAASKVHGTRVALVYNESSAKLAKEHNNANIITIGARENSLNQ
ILKMIDDFLTSKFLGERHQKRLDIIAKYEKEQNS
>UU007 unique hypothetical unique hypothetical
MLNILNNVSNSSLYSAASNATAQTGSNLINDLVPETLTASGISIAISVFSVIGTIVIALS
VLPQTIKTLREKDTASLSLLLFLLNGIATAFLTLYGIGLVTVHPNSFSFLVDIKNGMFIY
NREEWVAGYLICGIFLIMGEALCSVTSFIVLFCKVNNMIKAKKMGMSEEEYYEKQIKPFL
KVKGAN
>UU008 unique hypothetical unique hypothetical
MNFTSLLQDGIYEVGNGAIVTDQSPYLGITPDYQGAYGFPTHPWGIFFQVVGAILVFGAY
LPAVIKVLISKRTENLAIGMWIISIAGLGLLAIFAWLGVSVNPGGFILVALSETLSCIAS
IIVFALKIANKAKAKAAGMTELEYCNLHYPIVKKLPKR
>UU009 mgtE Mg2+ ion transporter
MENKQSTLNLNNNTNINQNFLTQNILKTYEHKDITGLKKLLKSKRIDKIVESLETINDTQ
IILFVLVATKDGICGDIFKYLNTELKSKIINDASLQQLRIILFELYNDDVIILKNDFPMY
TKKILLSLDSQQRAAIKQLSEFDEDEAGSIINSDFFTINQNLSIKEALIEIKRMYNDFEQ
SNIIYVVDNYNRLKGYVTIHSLLFADSFELKISNVIQEDVFYVRSDEDIDAVLDIFRKYQ
IEQLAVVDKDNQLIGYISDNDILPVINAETTTDIYKMYGISELDFPYIKSSVFVLFKSRL
LWLAVLMISATCTGFLIDKFQDVGQLVTAGLSTLVIVPIIPAMTGTSGNAGSQAAASVIR
ALSVGEITLKEYNKVLAKEFLVGALIGLVLAIINFARLIIYFAIIKPDLQQYNVLYENIT
NNPHTKMIVGAIVSAGSSVALFFAIVISKLLGGTLPLLATKLKIDPTIMSTPILSTLLDM
VTTIILFGFGIIFLLIIVDKVKVEQLNNIREHIHAIKNVNSWLPNQNFLLNNLNYSKHFA
>UU010 rpL10 ribosomal protein L10
MANVRPSVVFKQQEVNHMADILKNSKSFIVFEYHGLTAANILALRNVLHSSNSKLYVLKN
NITARAFEKAGVSGFENQLTGPNAVAVAMDDEIAAIKAVNDVAKEFDFVKIKGAYLENKF
ADTHKIDQLAAIPGREGLYSMLLSCFTAPLRNVMYGLKAVAEQKGE
>UU011 rpL7/L12 ribosomal protein L7/L12
MSKLTIEQFIAAIKEMSMLELNDLVKAIETEFGVSAAAPVAAAAAPVAAEAPTEVTIKLV
EAGTNKVGVIKLIREITGLGLMEAKTAAETAGSVIKEDVKTEEANEIKKKFDELGAKVQL
V
>UU012 unique hypothetical unique hypothetical membrane lipoprotein
MKKLNKKVLFLAIGSVFALGTIITVATSCTQKSTLNYSQFYWTSPTSDDDEGFQTKYKSM
ASDGKRALLMPGYQHPERLQNALVNDKFDPNLIALILDGVYNNDNKAEFYKGADRVADVY
FKVDEAAFLGGIAAAYMLNSNQAVFGADNKLTWGGYVGINAKNTTNYLAGFDLGVKWANE
KLKDKNIKQEGTQETKKWINVEQVYASESSAGGFQSDSANAKKIIQELITKGADLILPVA
IPQVGIAVTEAIATTSHNVGVIGVDVEIENDQAINKKTDKFINTHLSGNKNGVIRFSITK
RLDTATIKLLENAIKGESLSKKSDQIVIGSEIDPKDKYKLGVNTVGNLSDGVVGISPSAY
HYVIDAFNLAQTNQSDKVSTYDELVNKITNDDLFKTLDKKPVVDGYLDVKKETDNEASLL
NNKTIDPRVNGGTFYKSAKGTYYFYPVAKSTYISNTSSKKFKEIWDNTKSNDEKQALIGL
LLSYAGAKVKDGGYSENTYNGLKEFYAKHGIKIPQL
>UU013 rbsC-2 ribose/galactose ABC transporter
MPSLSLINDASIYAAILILGALSGFFCERVGIANISINGQMIIGALVFTLFSTIIYKYMG
TKTETEYTFIVCLIIAGILTIPTSLLFGFLTIKLKTNQIIAGTAINLLASGVATFVTYPL
GDKIADKTSLSSDYLGLMKIGDGINTIYIGSILILIAVVLITIGLMIMMKKTPFGLRLYA
IGENPNAADAQGINVYKYQWIAVSISGFIAGIGGGLYMYASRSPFAGEVGGIGFLALAIL
IAGAWRIPLIAVVSIAFAVITKTFSQIDKIPQEIGKLIPYVITLIALISFSKYSVAPKNV
GIPFDKTKR
>UU014 rbsC-1 ribose/galactose ABC transporter (N-term domain)
MLKFKTLLSYDSFLKGQERKTITKKFLSTVFAIFVAIVVSAILVGILGYNIRDFFIRLFT
KWIGSPDIYLTKVAILGIAALSFIFAFKAGLFNIGISGQMLGSGLIMLLVVKNMQIANIN
MPNVLGQFFLLIIAMLAGAMFAVFIGILKVFLKINEVVSSILLNWIMFYITRYVVFTAQS
KMYNPTPDQVGSRSIPFADNYSLFHLASGYGYLFALLIFISLSIIIWVILKYTVFGHKVL
SVGKSFDAAKYAGYRTKIISLATFAISGALAGALAMVNYTSTTTNAIVISQAADALPTQG
YDGIAMGLISLAHPLATIPVSFLMGLLQQSADNLGGSFPQDLSGIIISFVMLGAAMFILF
ERISPVYWIYHLIYTYKGKDYYRDYENKNNNIISEYKAIYSEINKKRNQYLQELKKLRKE
LDQFKNHEQYNKVNQQYEYTISYIKTTYNAWLKVEYDKYLKQLKNNAMQLKKHLIIERAT
LVYYPEINTTRKIKNKLKHFENISAKKLSRIKDKIHNEDFLIKNLVAKEISKYAQSKSFD
YNKLKYLLQEYENNNSVLTTELVNELSLVLKDEQAQLMFSEFKQASFENNLDHMIDLKNQ
IMTYINSLLDSRLEQLSITLKSKNLVHDEQMDKIILLLNPNDKILNKIIISRNKHLENYT
KEITKLELRNISQDDEIKKNTKQRSSSYLTKHYEKTKQHINKINLDQEQKLLLEDWLTTA
YQKAIINQQNMKEVIS
>UU015 mglA methylgalactoside permease ATP-binding protein
MEIKTNQCPYAIEMHEITKTFLNGTVIANKDVNLFVKKNEIHAIIGENGAGKSTLMSILF
GIYKQDSGSIKINGRIVNFSSAKDASKTGIGMVHQHFKLIDTLSVLDNVILGSEGATQLG
IINRKKITKELKKIIQEYGLNINLKSKISKITVGQQQKTEILKLLYRDIDILIFDEPTAV
LSEDEIQAFLQMLKDFKAAGKTIIIITHKLNEIKEVADSATVIRRGHYIDSFDVKQKTIA
EMAELMVGRKLVEVKNIDPITSNEKVFEVQNLDIQSIVKKQKDIVKVKSSPKGDDVSLLS
TKNNNFINFSIRKGEIFAIAGVEGNGQSELAQIISGLLKGNKEAKIMLDNQEIEHASIRK
RYQLGLSHVPEDRHKHGLVLDDTIAMNAILQQVDDKPYSNLGFFNNNEISKHAINIIKKY
DVRGTTRGTSDARGLSGGNQQKLIIGREFERSHKLILLVQPTRGLDLGAIEFIHEQTLEE
KRKGNAILLISYELDEILSLADTIAVIHNGYFISVGDRFSMTRQKIGELMAGEKI
>UU016 conserved hypothetical hypothetical membrane lipoprotein
MKKSKINKKILFASLAGVVTLTSVAAIAASCNDSNKDDGKTNKDGNYISKLSLEDFYAKP
AGDDSLGYHRTYNSLYDDGARMLGLISFSHSIPIKEYFGSSSDKKDLSAVLIDDKFSGTV
GKDRIASVSYRVDQAAFLTGIAAAYYLNANQKTFAADGKLTWGGYVGLHFTSTSTFIQGF
KLGVQWANEKLKDKEINQEDANGSKKKWMNVEQVFASKYVAGSFKPDEEGATNIINDLIT
KKADVILPVAGPQTNLATSIVSNATDPSVIIGVDTAQELDDVTNRKRITNKTVNDGKTIL
FSIVKRVDLAMKGAIENASKGAQLTNDINKDAYKLGTHTEASLDKSTYVDDTPLVELSNA
GRVYLEQAAKLAGLKAITYAQIVNVIQNEELFKLLSTKGTTKLEDLATKTSDGWVLKDSE
KNKSFSELQKLLGGEVYINESDKKLYPYSLTGSSYLEEDPKKRSASQEFKKYWDAATTPE
AKEKLAKVVLGQNNAVLKDKSFSESAYNGLAAFYKSKKIIIPKI
>UU017 conserved hypothetical hypothetical
MLEKIKIIDTHTHPNIEPLIEEFDDIIFKCYEQGIGLNIVGVDLKTSQTAIQQAKKFKFL
TCSVAIHPNDLHNIENDFVALEKLIAENIDYISCIGECGLDYYHEQNYDHDFQKHWFKKH
IELAKKYHKPLMLHIRNAHDDAIAILKELAVQDVIIHCFTDKKEYAQQYIEMGYYISYPG
VITFKPTKNNQLHELYEAIKITPLDKILVETDAPYLTPVPKRGQTNYPYYVLYTSAFIAN
LLGITHEKMQKILLENSLRILNFKK
>UU018 thdF GTP-binding protein in thiophene and furan oxidation
MSTIVALATAPMNCAIHIIRVSGPKAFEIINKISTIKIKKETFKIWYTILKDDNQILDEV
LINTFVAPKTFTGEDLVEINCHGGIVVANLIIKTLIKYGCQPAQRGEFSRRALLNKKMDL
SKIEAINNLVNAKNELSVKGVIGALLGRVSQSIAEFRHELFMIIGQIEVNIDYPEYDDVE
QVDAIILKQRLLSLDKKITKIIDQSKKFLPINKGIRVLIIGKPNVGKSTLLNALCNEQKA
IVTDIPGTTRDVIESSINIDNITLNILDTAGIHLTNDFVENLGINKAKALIDKVDLILYL
IPANEQQDLELYDLIKKQKHLLVYTKKDLVDQYDDKQIYINAKNNDIQSLIDEIKKLFYV
QEFDNANIDVLQSQRQIGILENVHYLINNAILNLEKGDTLDLIVADLEFCNLRLNELLGI
SSEYDFLDDLFKNFCIGK
>UU019 dnaH DNA polymerase III delta subunit
MKYSFANLLIQSPKTSLESGIEEIMLAFIYEKNHKEQSFYVTKVKNKQYFDLKIYDGLSM
KKSDVIDLQNTFLCDGVEDINLKFYLIKNIDLASKYVLNALLKFIEEPPKNTIAIFSTKN
LNQVLKTIKSRCQLFYLPTNHDLYKKLINQINQPIDLVECDLMFDDLDELKILLENKEIN
DVLTYYGKLSDLRSFEILNDLKEIFKNLSTLQIHYLLKLIFIRINNVNSKEIILDLMRAN
LKININKNNLFTIIYTIINKNKGD
>UU020 tmk thymidylate kinase
MITMILTKNSNEKKPLKKGLFIVFEGIDGAGKTSILKQLLEVLKEPKLVNKIFLTREPGG
KNNNAAEMIREFFLKNLEVFDPLTLAYLYASSRAEHVKKTINPHLEKDHIVISDRFVHSS
YIYQGIVQNQSLDVIYQINQQAIGELEIDYVFYFDVNVNNALNRMKNRFDNTNAFDSQNK
QFYEKLLKQYPSVFKVYNQPKKIIFIDANKNENEVLCEVKEQLLKIFKEHKYI
>UU021 lip3 triacylglycerol lipase
MIMELIKTNTLNFYFEPSKSELKKGSIVFIHGLDASPHYFFLINKDLSDYDCYFVGLPAH
GLTPINNKKDLNIKVFAELFINWINEIDLKEFHLLGHSLGAGIASLVSFIIPQRIEKLIL
VCPYHYQYLNPFLNKKLFNAWVLFPNPFLKFKTDVVLKKLYIDYRNNYKTLIETRWESIS
REYPRIARDVLFLCLSLLNIKINHELKMAQRNLIMPTLIMVSRHDQLIDFNLAIKVFKNN
NKVNQYIFNNSGHIPFIEEPKLFTNILLSFLEDRFVEQEENDNNDINEK
>UU022 fatC ferrichrome ABC transporter
MSIKIKHDQNLKHQFEQKLFFRFKKNKFFLSLSLLIITIILTLIAVAGASRFINVFSYLS
DWKIITQLLFSGIALGISGYILQRLTKNRLADSSLLGMGNINLVILTILFLIFDFGQLQI
QKRMEYVLPFIYLIGSTMICFFIHFLCNSSTGYIFKRIIVSGIIINLITIVIAQSLRILM
SKESSMYLKTILLGNIESRSDFCFYFCFGMLTISVIWLMLNATKFKIMVTNQQISGQLGI
NNKSLTIQTFICISLLVSVSYSLSGNVIFVGIVAANFSFNYVKNNISNGIINAGLIGGIV
LLISYIFVVLILNLSTDQTILLVPIISGPYFLYQVILLKN
>UU023 fatD ferrichrome ABC transporter
MKIKLKFENKLNFKKYLIYKWSVFVVLVLLTSFIFIFNIIYTNKTFIWESFYFQNASFEE
VFLLFFYSPIVLLVCGAGLVCSGFSLQSTTRNGLAGPSTLGIFPLAALGNILSQLITKSF
SNIFIGYVFGIIFSLFALGINFLFIRISPHKKTFKPIIFGFSLGAIITAVNILIANFNSS
IVASPIQLLGSIGVYNSIERFYIGTPIVFISTIILLCYAKKIQILDTDHYLAKSLGIDVN
KVFWITSTCSIFIAISTTFLIGGLSLIAIVMPHLVRLLFKRTNYLFQMIIAIFLTTFLLE
LLGIIVEFFSKFNIVFLVATVFAIPMIVLLKWELGWKVNKN
>UU024 ABC sbp putative ABC substrate-binding protein - iron
MVLIMKISFKFRLINVISMLGLSIIFTTLSSCKNLQQQKPYDTNWLFKNKNWRLNNFFRD
PYKIHLEFARQLDNVLNFNELKKRLPKPMQNVHSFTEWSLKIARLLKNDINNVAMLDSIQ
KMRNHKATVLVIENRNELVNNKENYNKFSILTPSDFPLIYSNPYTEVPGLGLNFPKPINN
DISDIIDRYQSIGYNALRTNPLESVLKQTSSFYKTADYVFYMYDSNLFTNNKYKTDGQKR
EDLFKEILSNKNFYAHKFLRNSRSKIIFIDRSLFWWGSFTMVGQSLIIKELLKIFTNKKT
IKKQWSYLPFNKEELINLFDHKPTIKERNLIIKPHYINKNFKLTYGYKIVGTWADSIDHL
ISFGLKPDAIVDYESFNNINLKTQGVGNYLKELINYDKLEKINKAPNDSEKAEFVDKNFA
IYMGPSHLLNSMNKLIMIKNTGSWIISSTQGINDPKTQFKTRINTAKSDF
>UU025 fecC ferrichrome ABC transporter
MQNYTFRFKLFKQIKNQQVKKLKPLILIGATVFLIIAIFSIWVWNISYANFYDQQLNKYV
YFPLHESLKLIFNGHFLDPTNIKYLNLQATFWASISSILSGISLAIAGCVTQALTKNPLA
DSSTLGIVQSSVFMIVIAFSYNMISFGELFGFAIIGGIIASIILLILVFATRSRLSYIKI
TLAGLAIGVFFNTISYFIRIQSAKGSSINFKYVLGGSENIYTTHIDPFLTLWVSAILILI
GVILACFLAYKLTLLEIGDEKAKNLGSSIIIIKILAIISTIFLVSPTILLVGNIAFVGLF
GPHIVRKIFSIRDYRYVMPLSGLLGAMITSLGLILYRETIYINSSIWMSFIGAPVLAYLG
WKHWNRA
>UU026 rpS2 ribosomal protein S2
MSQMENSTKKVESVANVEVVTTENAKVEQKPTSPADAIQLKVNANSTIKNLKTLVSIVKL
TESGAHIGLNPKKWNPKMASYIHAKRSNNHVIDILKTILFLDRAYKFLQEVSQNGGTVMF
VGTRGRVVKELIKAEAERTNSFYVTQRWLGGTLTNFTNISRSLKKFNSNLALLESEEINK
YSKKEQIAINKETAKLEKFYGGIKNMKQRPDVLILVDPVNDVNAIKEARKLNIPVIALAN
TNADPQLIDYIIPVNNYSVKSITLILGVLADSIAELHGEPTKIVGRPDSEIVLPETKSNW
KQNNYDPSKRGYNPKYVNHKSTFNKFNNKKPVDSTTNEIKTNVIKAETK
>UU027 ABC sbp putative ABC substrate-binding protein - iron
MNKKIKTVFISSLIVGLLGLITTSGVACSSSIKSKQENEIYPTIKGYDQHDFSKILASEF
IKIIKTNIQFLAPNKDIKYELYDARLNELDEDVIDLIIRYHFKGQTHTYKKILKGFKNAK
QYRLFLENKKYLEDEKNHNTLYLMPIVNSSINISKTTVDEALKWQNSYLNINNSNNDLKY
EILKITKSKTANSIDIEIKISKGNGENLASITYNKTLNGFISEADKKIYLANLEAIKQDK
NQLEPQLIDEKTKQKTIKEVIENYKTLFKLPFQTGFIYEIQSVEPDVNNKTAVVFKILIK
KGNGSQEAVLEYLKTIKGFNQNK
>UU028 ABC sbp putative ABC substrate-binding protein - iron
MKIKLKKIIMSFLGLPILAIPLIVSACSQFKINQDVILTYRPTVSLAKEFANDNNTIDDV
LKKVKINKDGSNNLLVYDLSRNPKNVQYKIVDIKKDSEQILKVTINAKIQKYKESINYDF
YFQPFLTPKQKEDKTILQQNLNIIKSAWDYDQKQKIGFFNLRIKPEYQKRSLVEIKTLGE
KAFNFGEDLIPQLKVDSKFKDINIKIIDINYFEPLDERQRELVVEIMISKGKNEQQAQLF
KKIKINLD
>UU029 conserved hypothetical hypothetical
MIDLIIKTLVQKLKIEAKYITNVLNLLADNNTIAFIARYRKHLTNNMDEFQIQAIAHEYE
YLTKLNKRKEVIIKNLEQKGLLTNDLLELINNCQRLVDLENLYEPYASNKKTKASIAIEK
GLEPLALLILKNNPNSNIKEVAKQYLNEQVLSVDEAIAGACDIIAQKVANDTTLREMLYE
TINKHAKLITRINKITNDPTKNFALYYEFSCPIKYLKAYQLMAIDRANELKIIAFKLDFK
KEFLIDFAVNKYTRKIKSNSYDYIKSAVNDGFDRLLIPSVSNAVYKEKLEEAHQQSAQIF
SNNLQQLLLQKPLKSHVVLGFDPGYVHGCKLAIVNKNNQLLHTDIIYPHKPQILITQAKN
TLISLINKYEVNTIAIGNGTASNESVIFISDLIKEFKLNLNYCVISEDGASIYSASSIAS
EEFPNLSVEKRSAISIARRIIDPLSELIKIDPKSIGVGQYQHDINKNILQQKVDFCIDYC
VNQVGVDVNTASIPLLSKVSGLNKRSAKKIFEYVKKHQFIENREQLKTIPYITDKVFEQA
AGFLRINNANNFLDRTSIHPEAYLVVNELCKYLQLPINKLINNYQVLNQLNPNELTTILK
TDIYTIENIINNLKNPLQDVRDDYDIPILRSQMVDINNLKIGMLVQGTIRNQTEFGSFID
IGLKNDALLHISNYCEEDNLHVNKNINVYIDKIDTITQKISLKLKL
>UU030 unique hypothetical unique hypothetical
MNLKTKFFLKVISVIAPIVIIPTILANCAHINSNELDNAKTNLKGSVEVVNINPYKTKQM
LASNINKEQINSYFIFIFNLIKTNQKIEEKILDKNDYEILNWAANDNDGTLGINIYIKTT
KQSYLINTKPVFLTDKQNNYLQELKYKTPAVYSIDEILKFSNNPYNLIHNNPYYREQLLR
AKIYFNQNEANVDDSKLYMNKIGYSEFGSDVQKRLENAFKIRYDEQNIYQINSPQILAKE
TKTLTSYIDKKTNNNYSINIELIKKLIQINPFGKLPKNFAQLINLIKKEEYPKFLTITKN
ESVDNIVVKDIYYRIIDRYAKLEFILEIYNKKTKQTVYLSANFNQKNSGLLKNEDYFQYI
FDRTISLDLLTTKDGKNVELNSGTGWIVDRIIDDSLPKNKIKLLIATNNHVMGWSNLAIS
KDNRMKSRWFNKQEYINYLENNAGFISSNIYEDKDRYQYLLWGTAPLKSPVSNKYNSLSG
ISFSNLAKVYNITNQNFINRAWYIPQLSANGIKINENLRTWYQINQEDIKSIKNGTLDFV
LVPMVFDIEDIKEKLPNYYKVLNTKDEANWYIGLGNSKKYLPQLQLFSGGYPGDVNPNSS
AIVSWRGSKSYGSLIQAFDREIKNESILDYYGPKQINNIDGYQKVGEGYLNKLFNVGTRV
ITSDEIGDLGSGSSGSMIIDSNFNLVGIHFASLNSRAYGAPNDSMIGNLFVAQSQDLSGD
IDVRAAVIKKLKAENIYTYKLNPKVSS
>UU031 unique hypothetical unique hypothetical membrane lipoprotein
MAIVAKINGNASEWYHAPIALAFFLRFSLINKIFAIILSCIFCVSIYRFRKKLVQYENFN
EIKSIKNNAILTVIFSVVAILSLTLFINLMIVFINQNYYYIKRIHNLLIPIRIDEIKILE
YSYIYLLRCGFYILLTVFIAKFIHDKRSMIKVLSLYLFVNFILMIIGTSFTFLEHTNFYN
GMLTYWTTFSCGLLYPEIINDNFQWISSFNYNLKNTIYENNFIAYLPYFCSFIVLIILIK
KVSWKSITISSNSY
>UU032 unique hypothetical unique hypothetical
MSKKINNNKTPRNKVKNNNVSKDNDDIVISLRYENWVKEERVNSLTTYTKDENQFLKNII
YILNTLFPYVYKNWKNKGINDHCHPIKQNNVFSKYIKLIKKLHPNLLKNDNEELELYQLG
LGRSVRVICSKIDNILFPLLIDHHHLGYESQSYNDKDTKKYDYCPLRKYNKNQDN
>UU033 conserved hypothetical hypothetical
MKEITPLIVANWFLTKESMTPKKVQKLVYYAYSWYLTLMNEKVDDLKNKLFDEKIKAWVH
EPAIPMLYNEFKEHKYNSIPKINDFNELEYFNLDTIDILNQVWDEYGHYSANQLESITHQ
EDPWIKARKGFGPLDSCNAVISDKEIFSYYIKQMKNN
>UU034 unique hypothetical unique hypothetical
MLISKHEERVKSILSARMENGNLRSRENTQVEFKQSFNKGNIAIYAKTMAAFSNNSGGYI
IFGIKDSPRSIIGLQNSNFENIQQEDLTDSINNLFSPSINWELGSFILKEKEINSNGDVI
IVQKIIGWIYTEESNIKPVIAQKNNSSEKIVNGDIFYRYRARTEKIKYAEMEQIINCRMK
QERDSLFKVFEFIRNNGATNLGIVDYNNGKLSTPYGVDVVLEKNLIAKLLKKAKFIKEGS
FSENEGIPVIKVTGNINLAEEVPVPLENLDETYPYIQKQLAEKLNITPQKLYALIWYFKM
KESKKYHLEITTSKTNKTHKFSKFALLFLKEKIIELDENKNELNNIISKFNNRKK
>UU035 unique hypothetical unique hypothetical
MRKFNKMLSNKKFLDLDIIKESFDNYLSVGTSRSTKKLKTLHGSIAKDLEELLGKEYNIK
SQGYRDDKEECIDGRYYNKKVDITIKNNGKSIAGLAIKFVMSNYSQNSNNYFENMLGETA
NLRSNSVPYFQIFIIFDKVPYYKSDGVLQKYDNISNHNLEKYLKLSDDDPKVYFHTPDKT
LFILLSLKEISEEIKNKKDYIRCYKEIMNDEDLLSYSNKIDDLFGNSIILNNYEDFIKRM
CALIIGYQKIKT
>UU036 conserved hypothetical hypothetical
MKINIYDSKMDFVIGNPPYVRIHNLIKEPNLIKNYLFSNKGMTDLYIIFYEIGIKMLNKN
GILCYITPSSFFTSLAGLNMRLFLSEYKLIESVCDLKHFQAFNATVYTTIICLNKSKKNE
CVEYYEFDEKKLKPCFIEKISHNDYFIKNNYYFGPKQKLIFLKKVLLSNKTTNILVKNGY
ATLSDKIFINDFDFESKFIIPVIKASKGELKKIFYPYDKENFLIDELVLKKDLKMYNYLK
FNKNNLLKKIMILVQKIVDMHLVEVKELKILIRIKLQ
>UU037 unique hypothetical unique hypothetical
MKELLRLTKVKRYGKVYTPDYLVNIILDKGHYINGNINKKHVIDNSCGDGQFLTYIVDRY
CKDYLINNNDLIELKKTIRNIYTWYRNW
>UU038 conserved hypothetical hypothetical
MLNLKQYLGETNFYDKKEKLEKKKIKSWLKSVCTFANGQGGKLIFGVNENNNVLGLENYL
NDSEFISETIKTKIDNIPEFDIEINEYENKIILILTIFPGRNPPYFLVDNGSKTPYKRVG
NQSVIASINDLLNWCLRSQNRTYDSLVSNKLLKDVSFLMLKNEYQKHTENLWEDKFLKSF
ELIDNNNYLTNAGALFADGYQVYQSGVFCTRWNGKTKTNGLIEALDDAEFEGNLLFLLNS
SINFIKRNSKNMWRKGVLYRIQYPEYPIKAVQEVIVNALIHRDYSIIGSEVHIDMYDDRL
EVYSPGGMFDGNFVQNIDLYNVWSIRRNPILADLFARMNLMERRGSGLKNILEIYASKEN
YREDLKPEFRSTESAFFVVLKNLNYQEQNISKNENQKISPSQRRKKIIEFIGQNPKTTAY
ELTKIFFVSINTIERDLAKLVHDGYVEFVGSSKNGEWKIKTNQ
>UU039 gidA glucose inhibited division protein
MKKYDVIVIGAGHAGLEAAFATSNLNLQTALITLDEKGIGMMPCNPSIGGPAKGIVTREI
DALGGIQGKAADATTMQMKILNSSKGPGVWAIRAQIDKIAYQRWFKQQIKQQKNLDLIIA
EVSDLLVENNIVKGVVLSDQKIIQADYVIITTGTYLKSITHRGSVCVDEGADGTKNAKFL
SDALVKLGFELIRLKTGTPARIKKDSIDFTNMILEPGTNQKIAFSHYHPVYKPYDEQLPC
HIIYTNEQTHQIIRENLNKSAMYGGMISGIGPRYCPSIEDKIVKFSEKPRHQIFVEPESY
ELDSMYLGGFSTSMPIDVQEKMIRSLPGLENCEILKYAYAIEYDAIDPTQLYPSLESKLV
NNLFFAGQINGTSGYEEAAAQGLMAAINVNQKYQNKEPVILGRDQAYIGVMIDDIVTKGV
VEPYRLLTSRAEHRLALRNDNADDRLMKIGFEIGLLKPEVYDQYLNNLKQIKEILNWLKT
TTVGQIDDLKFTTLKTNSYLIDYLKRPEIKLNDLLIYCPIKIEDEQIINKVQIQVKFEGY
IKNQEENLKQLKRLNNIKLHAIVDYKEVPNISLETIDKLNKIKPLDLEQASRISGVNLTD
IAMIKYYLERIKND
>UU040 gidB glucose inhibited division protein B
MSFEKYKTIIQKYNQIFNLTRLDSDDKIYQNFFLDSLAPYKELDFFTQNTNLKLIDIGSG
SGIPGVVLKIIFKNLNLTLLEANQKRCEFLKILTQELGLNDVLIWNMRAEDLTQSMRESF
DIATSRAVASLDKILEISAAFVKVNGYLIQPKSIKFYEEELKAKNIIKTLYLERIALKDF
WENDYHHLVGVYLKKQITPLQFPRPWNLILKKPL
>UU041 conserved hypothetical hypothetical
MSSLPVIILVIGIFGSIFLVIGYIPQVIKVIKTKRTDGISLTFLISLNIACFLFVIYSIL
VMIFNKHNGIPTALPLCLANTIVGILGLVILIYKVKNIKKAKLYLMDEKTYYEKYVLNNL
>UU042 unique hypothetical unique hypothetical
MSPISIELIIQISIGLSASLILLFAFLPQTLLTIKTKNTAALTISMFIICFIARLCFSLS
AILTIIVYIHNQNYGLSLYALTLPVLICHGINMLLNLIIAFIKINNVYKAKIHKMNENEY
IIFAYAQKLKEKVSIKNK
>UU043 conserved hypothetical hypothetical membrane lipoprotein
MKKLKLITLSLSPIPIVAIMATACSTTKKEKEVDHKQDELTTINNNLQLEYPQNKDIETS
AAIKEEIKPLNLPSGVVFSIKEISPKANDESTLIVKYTLKKGNITKEFKKEINGFKKIRK
DQNIANLKDMHDDFKTIFNNIKLKDTFDFKLKGLFNSNFGEYDKLLPSQIINNFAQGVET
RINTNQDRLGIEVIDVSYPNKNFGSANREGNLKMSLLVTDKKTKQVFIKSIIAYGFKTNA
MGLDENGSIPGGGADLVKPKVDENNYFNKTQLERYEIDNQAYLNGLKGQHMGKTWQQVRP
ELGDNEQKINEFDQKAKGVSQDAYASAAYKGFTLPVYDKNGDFKGLSINESSYGQARSWV
DTRGRDEWKTTGLPRTLPNEKYRDEALQTLGISSLTLKDGKKDTWDKSSGTTWILDYQKT
NDNKYPTKWYFATNLHVADTITDKTTSIDLMKLMDSVKTKTTLRLSNLDENIYRFGFASK
NNKFLLNHGLKKIYDGRNFLKTKPTEYLTEQQKEKYKDAGSFVDFAVFELDFEQLKLLNV
WNNQLNSNGGVITKYDHSSAQDLAKIITSDYANHSDKQIKFLSKSYLNDYSKIDVPLRST
SYKFEGKDELFALGWPNSTRDGFFERYVDDDQTKYRTTDNFSLWTNSDYRFFGKLTEQEG
GQPAFPTERTERGNYLSYAIGYRSFIDKPGVLDAFISAPHTGNDLYKSLDGKKYINMGLE
YMPRHYAPAGGASGSSVRNQNNEIVGIYHVSNEFASTGLATAFRSEGYDYKGLYGDKYKE
LPQYDLIYGGGKDQATGQSYREKMKEIYKNNNNIKTALFPNGFDQYDEKFKFNNNQSK
>UU044 unique hypothetical unique hypothetical
MKFIKRKTKLLTITIGAVAVSSILLGGIFYGTSQKSPSSFGIASIDQKENFINKDNLDYQ
KARPSIKDSNLKEIPKPKPQPKPKPQPTPFPDPIPTPPKKEELKKPDIKPEEPKKPEIKP
EPKPEPIPQPAPPIETKPKEELLPPNPPPPKEEPKPEPNPQPQPQQVPNNSNSRIIEING
VRVEAEVEVPPPRDIAEYDKQNNLVNPNPYINDSVGKIKNVKVTDELRKATGKLVQGNLG
RWDYKHLINDLLTLKPEEIEKYVKNDKSGYYAKVWYRFSRLFESENVVNFLTEQGKKEYP
EMKSKFVSKDHKYAWLYQHLDLTKFTQLSNESESYLKEGYTPDPDNAYVDENGKISSHAY
SPAKGYNSVTSRMENDNWNRRVFGYKSWYGRTPGNLVEGNYPGWKKTNVTQEFHQYGVSD
GDGITVNKLTREKTEDGRLNEGYVIDIDADNPQGYEKTKKLIQTLKEKNINITGYRIHNM
GKSDSSQKFVDILKTLPNQLPLLELFFSAGSHNTSSLIALKDKKIKELGLFTLGNSLLDE
WSINPNALRNVEWINSNDYNVSFNYKQGADIATRITFDTLAFDESDYNDNASDIKSKLKQ
INDGLRMVYWTRNNEPIFQGSFGPGLDPDHKESGNSYPQGLDFSRVPQIRSLRGLIFKDE
QKTSNNKDRKLRRINFYNNSTTYKMSIEDLNEAGFNEHIVSGEPGEKSKITFSNGSGTTK
IQIDGDQELSANGISNLSAMFNFAESLQRTIVVNNTNSPLANQLRNAGYSVESTTNAGLI
DI
>UU045 conserved hypothetical hypothetical membrane lipoprotein
MKKNKLTTLALILPITILTPIVIASCTNKTKVKKSSSLDKIASNLKLEYFNNKANTKASS
VQKDEIKKPLNLPNDVVFSVKDVFVSHKDQSVLIVKYTLKKGNEIQEYTYEIKGFKSVYE
KDKIVNDLSQANEDFKKIVNNIRLKDTFDFKLAAFPNQNYDQLLPSQIYKNYYQGIEIQQ
HKYQNELDIKIINFLYPDGDFGSANKNGTLKLSLMLTDKKNNQVYYKLLEVSGFKSNPYG
VDENGTIPGIGTERLKPKNQDDYFSKTQLQRYEIDNEGYLQILKRQNNDKNWKELRPDLN
ATVSDIKHFDEKAKNVGQDSYESAAYKGFTLPVYESDGKISGLALAGKDTPKGPSWVDAI
GRNQWQIGGLPRTLPNEKYRQEAMQTFSLGILNNDSHKNNTYNKTAGTTWILDYQKTSDN
KYPTKWYFATNLHVADAINENTLSINLMRLMDSAQIKTTFRLSNLDENIYNFGFRSKEHG
KNLLNHGLKKIFDGRDFLKTKPAEYLINSQKEKYKDVGNFTDFAVFELDFEKLELVNVWK
NFLGENNGLVTKYNNYNPQELAKVITSNYANNKNNQIKFLSKSYLSDYSKIDVPLKYRQE
DAKTWFKKYDELFALGWPNSTEDFFFKAYVDDDQLKYRTRDNFSLWTNSDYRFFNNLTQQ
EGGQPAFPPERTERGNYLSYAIGFRSFIQKPGIVDAFIAVPQIGNNLYTSSDNKKYINMG
LEYLPKHFAPAGGASGTSVRNQKNELVAIYHAKYDSSKTGLAAAFRSEGYDYQGLYGNYN
LPQYDLIYGGGKDQTEKKSYREAMKDIYQNNNIKTALFPDGFDKIPDEFKFNNN
>UU046 unique hypothetical unique hypothetical
MKFIKRKTKLLTITIGAVAVSSILLGGIFYGTSQKSPSSFGIASIDQKENFINKDNLDYQ
KARPSIKDNNLKEIPKPKPQPKPEPQPTPFPDPIPTPPKKEELKKPEIKPEEPKKPEIKP
EPIPKPKPQPIPQPTPPVETKPKEELLPPSPPPPKEEPKPEPDPQPQPQQIPNQSTVRKI
ELNGVLVDAEVEVPPPRQTFKYDQDNGLSNLNPYTNISVGKIKKVFVTDELRHKSADLVR
GNLKRGDYQSLVKDLLDPNIKPEEIDSYIAMVDKSGYHAKLWSKFKKLFDTDNVVNFLNE
QGKKEYPNMKTKFVSDAHKYAWLYAHLDFSKFTKLSANSEKYLQEGLTPDPDNSYVNENG
ELDSYAYSPAKEYNTVTSRLANDNANRRVFGYNEWYNRSPNGLANGDYPGWNKSDATAEF
KQYGIKDGDGIKVYKLERQKPQEGKLNTGYIVDIDADNPDGYQKTKELIQKLNNQNKKIT
GYRIRNMGKSDSGQKFSDILKALPNELPLLELFFSAGSHNTSALSALETKHIKELGLYTL
GNSLLDEWSINPNALRKVEWINSNDYNVSSEYKQGSDIATRITFDTLSFDKNDFNDNAND
LRTKLKRINDGLRMVYWTRNNEPFFQGGFGPGLDPDHKEVGNSYPQGLDFSRVPQIRSLR
GLIFKDEQKASNNRERKLRRVNFFNDKENYEMSINDLNEAGFSEHIVTNEPMPPKSKITF
SNGNATKRIYIKGNGSLTASGIQNLATLFNLAESLDSKSVVVDSNNSELKSQLEGLGYKV
SDASDANYIDI
>UU047 conserved hypothetical hypothetical ATP/GTP-binding protein
MKIKKLIASVSIITPIVFVSALAASCVNNKHEDKNIVHNSSDHGNNKKNNFTNDLNQNLT
THEFKSNLISTSQLDNIAKLINFTYENKANTYLKNILINQLKHSPIQNQDFKLEIIGLYP
KQNSLQDLIIYYKLTNQKTKEIKGYYFELNGFKKPDNTIFSNQLTPELKKIIDTIQFKKT
FDLVINNQQVLNYENVLPSQIKNQLLMGLKVIQKEYTDKIKLSVLDVLFINEGGQINANK
LGAFSLLLEVLDLKSKKTYQILIPVDKFKTNPYGADEYDLLPTQVNNGFAPTSLAQINQY
NNADQQTRYLYDNENYLKSLKAYQRNVNWYQIRQDLINNKQKINEFDQKAPQVFQDSYES
AARKGFTLPVYDEDGKYQGLSFNETEIGKSVSWVDAIGKDQWKINGLARTLPNDMYKQIA
LQTFGIQIQTPNGKPRESDVVAGTMWIMDYQKRNDNKYPTKWYFGTNLHVAEALKSTTTV
FGINKIMPTVKTKTTLGLANADDNIYRFSLVSKDNQPNMDKPISNGIKTIYDGRDFLKLN
PSDLLTSKLKNKYHNLQEFVDFAVFEIDFEKIKLGSITKNFYSGSDWSVDKYNNLDPSEL
AKLITNDYAQKPNEQIKFLSKSYLNDYARINVPLDSKYNQAFDTNKYDELYAVGWPSSAS
DYFLDPIKDQKQFESRRESYSLWINSNYQFYNKLNHNPPLFPLTQINRGDFLSYNIGYRS
FTNKPGLLDAFIASPITGKTVHKSTDNQNYIGFGLNYLPMHYSPIGGSSGTSLRNQKNEL
VGIWHVGNGFAQTGLAAAFRSEGYDYHGLYGSYNLPQYDLIYGGGKDQKTSYRQAMMALY
KNKNIATALFPNGFGEDQIPSAFKFKN
>UU048 unique hypothetical unique hypothetical
MMNTKTFTSVNRVIYDDNYSLKQQQKSSFINQFLKGLLSAITLLFFILLLIFAENTLFGL
GFGDENKSMMISKSLNAFFDLHSPKYLQLNFLIVFRFFILSFTLFYTLIKNFTNLYWHRA
TIKKYLPWFVLYLVIATISFLLFFTFFSVWPKEVFNLVFLLLVLFLLNLSYEIFNYFISK
KTNPLLYDNYKNLIIAMVFQALLLLFVIITPLVWINTGKSPNFLFVDNRFYTRIVDIFTV
QSGKNFIILIAFFFFLITFIVLANTNFFALVINKRYDRNYVKNNLWFILLLFSAIFIWLL
RVFAYKHENENLPVGNNHLLWVYILQSFFAIIILILYMVFTLKKRLSVKSSLNTLLNLVV
TQTILSLSLFLVTLFNSKSVVSLINVFITITVQMSVFGIYIFQNKNISTKLLVLLKVIMI
LIILTAAIVGFDYLLTSDHHNNYLFSNIQPKMNLVQIMLLLNFSLNFTLISYLTIKFAMV
IFKINKLNKELNNEKK
>UU049 unique hypothetical unique hypothetical
MKKNKSNLTPTTNYFDVFNTYKEKKASVDLITYEELMASVLFDNKLGFESEVYLDFVKKF
TLAFEKKLDIWFENFIINFNLNLKFSTTIMIPILVTKANSTTDAINFRNDQNPVYNNFLI
SYNQKIKKLLLQNHPVQILPHLILFKSNLNGSLVLVFSEKIIASIEQKSGN
>UU050 unique hypothetical unique hypothetical
MQLKDLINKKKNLNNINLKVSNERNIFLINIMKLNQRLTFFSKNAFEIKESILSLKRIYN
IKHDMLRHEERKIFKFLNKINDRVLWIYLTEEQKYSTDSYSRYEQKILKTIKSNRDDFIL
IGQGAIEFGKNHNLNVLQTFNDSNIKNLTTQLTKMIMILYTFDNYKKVNFVINSNKNYDG
HFTILPMNEFSFDKFINLQKCDSNIIDFQKVKIYPNLNEFINVQINVFLVNIINTLITES
SFYKTKNGLVATNNILKELDDNLSKIQRKITRVKTELQIEEINLLARQNMNEDDNDNDGG
VYES
>UU051 unique hypothetical unique hypothetical
MKMIMITMVVFMNHNYNIQITLLENKKFNIDNGLLYVNVNEENTWQKIENNTVLAYEIIL
LKIVDDDYKKTFYLFLKNTHISVLNNIVKIQALNDLHFFIKDGLNKKNNHKKELVDKYKN
ITNNILELEAKQQLGLTLSEFLDLDNLKQEQYITNMQIRLNLVEYKKDEK
>UU052 unique hypothetical unique hypothetical
MRNKLKIKLKFLASLATIPIVASPLIFSVAANEDGKQENNNGNNHDPNQQKKPKIPKNDP
NFNTFKTDADKTVKDSLEKGINAAIVYVKSRQEEILENKEIEFKKKIQQLIYLKNLQSYL
EKNKENILKNPNDYGFYLNTPQILGTLKNYDIKDIEFNGETYKQIKVGKTDPLNYQKAVA
PKGKISDVQSDQINDVEETKYKDTLKKYESEFLKEINKLIYDENDVPQINKDVELTRDEK
GQFNTTLPKGYNDWNAYFISKIKDRVTAFDLKQNQQTNEDKQEEQPNEQKDPDTPPPLPP
PLVEGDHNEIDLPPTQANAIISSLPLLLPYISPIYSNESLSGLKSKFDSLKPELKQTLFY
FNNPINTRYLYSVLDFGVNGSSMINIKVKIIDQVNPKLQRTYIINKYDPILDINFNSLKL
NEVNAIKQIFVNLYKHLGLDEKIDYKKLRNFYIRNALFTMIEAAQKLILRFNQIDKDNKI
IGQKTFATLQNEYLEKYKQKLVNNTDDKERLLNEFNNLTKENFFRYLNNTLINNDYYWYQ
LVGAYKQVSLQFSEVLRLNKDKIKANIASIKGDENTIANLYKLNNQLIYQLSAIVAQRSF
NSQQWYQSYLNVLQPIKENFDLMSILTNQTDIKTNKDKAKDFKNAYDSALKSLERQKQVN
KQIRRKIGIAFIVISLLVLIINLIIYGLIKKLKNKKVILIINSVIMVLTIIVLIMGIILI
I
>UU053 atpA ATP synthase alpha chain
MQNTKANPRIKSIFNYIVTVSGIYDYQHHQIFVLKNDPTVKLFVISAKEDLAYLLISNEH
ANINIGDEIIETNREENVVTDLNYFGKIIDINNNFIWPKPLNNLPSAKIAQTNPAFGLAH
NLMTVKTLNEQLNTGIVAIDLLIPIGKGQRELIIGDRQTGKTHIALNTIINQSRAGTKCI
YVAIGQKRESLTTVYETLKAHDALKNTIIIDAPLTAYEQYLAPYIGMAHAENLSYQDDVL
IVFDDLTKHANIIREMALLTNKPVGKEAMPSDVFFSHSSLLERAGSFKNRKTITALPILQ
TVDGDITSLISSNIISITDGQIVTSTDLFAAGKVPAINIDLSVSRTGSSVQSRMITKVAG
EINKIFRQYKRHLKLAMLDYEFNKETSLLLHKGKLIDKMFLQKGFSLFSYRFIVLSTKLI
AWGILKGVKDEQKAFMLLDYAINNYEDAQKAFNTISTTQNYDDKIMKNYFAFILKQYSDY
LNLNWEVELEHSFIPLQNEFLMNVAKFLGDK
>UU054 atpD ATP synthase beta chain
MNNGRVIKIWSDIVEIEFKNSLPALNHLLTTHDGNTFLLVKRLVDATHARAIVVYASKDL
AINDIVINTNKSFMVPVGNDSKNNIYNFWGHPLLETNKTPKYVEMNSTILNERYVDKSIE
IVETGIKAIDFFMPILKGYKLGIFGGAGVGKTVLMKEIIFNLNRHKQANSNIFIGSGERS
REAIELYNELTASNLMPNSVMFISKMNEAPGARTSIVPIGITAAEYLRDQNKENVLLFID
NIYRFIQAENEVSTALGKKPSVGGYQSTLESDVTHIQNRLFRNKNGSITSFQTIFLPMDD
LSDPSAVAVFNHLDGKLVLSRAQAAKNIFPAFDPLASSTNAIDPKIIGERHYNAIIETKK
VLKAYKDLEDVILILGFDELDAESKIIVKKALQLEMFFTQNFFMTEHFTKAPGQFVPLKE
TVESVIRILEGKYLKQSPDVFAYIGSNKDISQDH
>UU055 mnuA membrane nuclease A - hypothetical
MVCKKNKLKMFGFIAIGTVLTSAIIPFLVTCAKEKKIKQEVIKPKQISNLNLEAKNIDIV
LKNNVFNKETAKFTLDFDINKELNLQMVAVFDVFDKKNNWLKTIKTAKTNLVDKKFVFDS
LDENVKYLLKQIDFYDPKAPNQIIYTKNNQTFSFDTKMDDSIARTVELIIISGFNGFVDE
QIVPDYNKQTTYLKAPGLIRLLNEVNKIKKERGANNVAVVMGGNNYYENNISSLTRAQYT
TAALKFLNPVATSIANTDLNWGYDLIDEKTKHFKEYVKALYGNDGILSVNSYLKDGDKNI
QMTNNSKIINFGGFKLGLIGAMSNLINFESNLNLTKNIQWFSNEQTANLINDEADKLKDQ
GVKNIVLLSSFLADKAKENDTLTNDEKSFYKEASRMSKLIDNNVNLMSVINPYKALNVIA
NNKNNQPLNVVQSKPNSGFVRYMITLNPYNRILKTEIKLVDKLSTSGDNAGYHYITQQDL
LNPQKNPDFNQNLITLNNFLNNYKDHEYEQLREKILIKNDKKVNLYSSTYSLSSLGAFIS
DILAKYYQAPFYNKQTHTFEFKQTQAILLAPHAIRSLVSAKPIKLENLNQILPFNDTLVS
GEISVKNLKEFLINKNKSQNYNEPYQFSNTLKIEYENLQETKTKKKSRKKQSEQSYSDNE
KKDGLILSHQKRVIKVFLKNSDGTYTELNDNQKIIVSVMNSILKFNKKFSEALLNKTYAD
QTNIRDLLRTYLPKETQIDQKYDQSVFSKNDARFYKKKETDQNKSLIYNHINESINNKQA
DHLRIGHWNVLHQTGLNDPKNYALAKTILFNKYDIIGLTEIWPAENNNQEQNNLPLIGII
KYLNQLSGSDDYDFLISDNLKGSENDKLATNEHTSTERIGIIYNKKKVKPIPFANNKIGY
IYSNPLQPGKYEKAETDYSRPPFAIKFASIGQIKNDFTLVFGHLDSPGTYPSNTEYQKKE
HLLKRTELVNKKVISTNQMINKYEQGSREVDDAERLVKVMEEIKKIDNNKDDDYFFLGDT
NIRLHNQQWVFRTLIQNGYSSVFSDNDLFKSSLSVNPGEFSNPYDKIFSQVNGLTISNPS
IYNLWNVYEDQIVDQEWLKKVRSLYPNEYHDKLFYIRNDISDHAPTFFDLGLNKNDTK
>UU056 unique hypothetical unique hypothetical
MALTIVLILFSVLALIIGLLLSRTSPSGGLSSLNGQDLEIFKKTKDRGWIKGLQVFMFLL
TIVMILIIIFYRVS
>UU057 vacB virulence associated protein - Exoribonucleases
MSDFTKQTITEVISKEERPIPAAILAKKVLEKIPTLNKTDVYKLIDLLIQENTIKKLENN
RLVIGYLDYEFDHEIKQGIITINSKGDGFIKEDNTEIEYYVNKKYLNGALKKDSVKFVKL
KKEPKNNLQDAAVIEIVGHAKDHYVGQFITLPNGGYYIFVDDPLFYLNINLKDTTGLVNG
HKILFKIISQTTKDAIAELVHIIGHKNDVGSDVLSIVYDNGIDPTFDPQVVDLASKLEFY
VDEHQNKIRRSIIDREIISIDPVGSKDIDDAVYVKKLNDQRYFLGISIADVSFYVQPNTI
LDADAFKRGTSTYLVDRVIPMLPHNISNNICSLNEGEFRMCITCDMVIDKDGKICWKDVY
PAIMKNYRQMSYDEVNDFYEGKSRFESATLTMKEMLLEAKELHHILRNKKIKDGYVDFDI
KEPKIILDETGVPIDIKIYERKTAQMMVEDFMIAANEAVTMFAEEHMDKTLKEFNLEMPF
IYRVHDKPSIINLQKFEIEAKKLSFNISHDFENIQPNTISNWLKMNDNHVNLPLISKLLL
RSMAKASYEIINTGHFGLASDNYTHFTSPIRRYPDLIVHRLLWMFIFDSQSYTDKQRVEL
VNKLKLITEESNKNEIIAVKTERDVNAAKFAEYMNLHIGKEFIGVVTTVSSFGVFVELEN
TIEGLIRIKNLKDDFYDFIPENMTLVGQKRKKIITVGNKVRVRVIEANKLTRKIDFELVA
Q
>UU058 smpB small protein B
MIVSNKHARRNYELLDFFECGIVLKGTEVKSISRANCSINEAYVQIIKNQALILNMHVAN
FFEGNNFNQDPYRNRKLLLHKKEIIRLQHLVKTQHMTIVPTKIYWKNNKLKIEIALGKGK
QLHDKREDIKKRDLARETRLF
>UU059 msbA transport ATP-binding protein
MKRVYFNIKGGIIMKSVWKILLIKHKFLFFFILFLNLVQVLLVIGSPLLLSILNNGNYAS
TTADAFIYGGVLIAMAIGWAIFSIFTNYISTVFQIIVESRLQKKIFEKTMFLTYADKQKF
NQSILLTTSIKDVEELSKTIIFLTRPVIMGIFYFIGAIILLFIISGNLWQIPLTVVLMAL
STIIIFMIISKFNAKNWNKMRVANDELAKVSLENVSGVKVIRSFLLDAFFLTKLDFKWKD
NVSKSIIANRISKVSIAIVTFIIYVITPVILIIGICTNSMKATNILSIMQSTNLLVLGIA
LIGFGSEQYFRSIVSIKRINDLIFYKNQIVYNGTKEINNNNIEFKNVSFRYHNSKKWAVK
NISFSIKDTDRVGIIGTTGAGKTTLIKLLMHQLEPNSGEIFIDNIPLKDIKKTSLQAAFS
LNEQVPLLFYGTIRDNVLFGLEDIDENKINEVIEIAQAKDFIESKNEKLESLIAQRAQNL
SGGQKQRLAMARALLRDARTLVLDDSTSALDMITEKKFLTALKQQIKFKNSIIIAQRINI
ILDCDKIIVMDKGKIVGIGNNETLLKTCAVYKNIYQHQINKGAEYEPTTTNQ
>UU060 msbA transport ATP-binding protein
MSQQLQTNKPVSKLYLIYYYFKDFKKVFIGLSIAIIFWLSTTIAATFLLQETVDKYAIAN
GIVDTVVKMCAGLIGIYFFSFIFLLIINEFAIRISFKIESHLSMMVINRIRYLPMKYFDI
NKSGEIFTKTLSDPTSVQDGIVNFYIELNKAIFGAIGFGTALLITSPYIALIGIVIYVLV
MLFNILIFKKSHQLMRIKRQNFGEMNGYIEEMIYGQNVVANFNEQVFFIKKLDNMIKKLY
KNWIKAQYSSQIIFPWSIFSMRLMNAVLIVSYLLISIKGIHLPGLINNIDPTTNIISFGG
LVSISLFGNFFCDNFSQLSNTIPIFIVARTSLAKIDEIVKTPNEINWNEKLIIDASQGIE
VRFENVNFNYLKNTPTLKNINFVAKRNQRIAIIGPTGAGKTTITNLINKFYDINNGFIYF
NDVDITNKSRESVREHISIVLQDPFLFSESIYENIKKGKMNATKEEIIAAAKKAQVHDLI
LSFPKDYATVIDEKQNLSQGQKQLITIARAIISDAKIIILDEATSSVDTQTEHKLQLAIN
NLLKGRTSFIIAHRLSTIINSDLILVIKDGEIIAQGNHDYLIKNSPFYQELYYANFNE
>UU061 conserved hypothetical hypothetical
MTSLDITTLVISILSLIATLSISFNIYFIELRKQRERKIERLQQEAKQFIINNLDEKDFI
VLCQFIYKLYKHDKHTRKIHYEFVLLNEPVQKEVFKQLEILNIVDFKDNEWIANKFSILK
EIVNDYQLGNWDDYKFYENFNFAYTLFREEKCDAVFEEIKQNKFGGKNLSFHEYLNEYAH
RSKESDMLAPIDYFIDQNNLNNVFDRQKHAIYKLYLLDLILNELCRSMNNDHRINNEFKY
FDCEVIYVEDLYLKILYKLYFQLN
>UU062 lysS lysyl-tRNA synthetase
MERKFSDQELIRRTHLQELKNQNKNPFLITKVDRSMFLKDFAEKYKNFSKEELHNMDLEK
LTLAGRLIGIRQTFGIIQDFSAKLQIYINKKNVAPEVFSTFKSLDIGDIIELEGVAMKTN
SDEITLNVTNIRLVAKSLKVLPEKYHGLVDEEIKARQRYLDLIVNDETKNTFIKRSLIIR
EMRNWLDNKGFFEVETPVLQDILSGAAARPFITHHNTLNKEYYLRIATEIALKKCIIGGF
EKVYEIGRIFRNEGMDSTHNPEFTSVELYIAYVDLWYIMQLTEDLIRHIATKLNLLNPTF
RGFSIDLNKPFKKAHMVDLINEYVGVNFFEVKSDEQAIELAKKHHVKLLDHQKNFGHIVN
AFFETFVEEKLVEPTFVYGHPLQVSPLTKKNQSDPRFVDRFELFICQKEFANAYSEINDP
IDQYERFIAQLEEAKLGNDEASELDMEFIEALEYGMPPTGGLGIGVDRLVMLLTSNDSIR
NVLLFPHMKDKTK
>UU063 unique hypothetical unique hypothetical
MSKKIKIYLAGPLFTLAEINDRKQQASLIRKTFKDELPNYELDLFNPIEVNDELGANAHK
PNIFFYESDIKFIDQTDIAIIDIDNTDDGTMAEMGYFVALQKHVKPTLKIYILNTDWRVH
KHRNEVLNKFLDGMILSHCQYFTNFTDLLNHLLIELKK
>UU064 unique hypothetical unique hypothetical
MSDEQKTKLIELKQKVNDLEFELDKIKNEFMMKIIIAVILIFFLTIVGLFYLIINLSRII
SLNQKRKSLELKTKELNHEINKIEISLL
>UU065 pepF oligoendopeptidase F - zinc metalloprotease
MENKKYEWDLDDLLNNKSLDDLYAEFEEKKAKYIKAFPTFLDSKQNFAQWQILEEEFTIV
ANRFYNYVSNNLNTNVVDPKWNSWSQKLSASFYELETALSNYNSVVLANEAKIKEYLTDS
QLNVYTRKYNEIFRYQPHTLNNEQSKLFSTLIRADEGFSTIFSTYTNNDMKFSDAIDAKG
KKHPIKNEAEAFVHLKSKDRVLRKSAYLSMYRAYYDSRESITKMLYYNYLSLNQQAKAKN
FDDYIAKAAFDDVVDKSLITLIYDQVKLYKDTNEDYKKVRNTYLKKLIKVSKIEPWDNGL
PLISKKIDIPIEEAKQMAIDSLSILGDEYVSNIKRAFDEKWVSWLPQKGKRGGAYSIGGT
KGISKYYILMNYTNSLRDVQTIVHELGHSMHSLYSNRTQKIYSDYKIFYAEIASISNEVY
LNYYLLEKYKNDLEMKLMILDEMISGFFATTTRQVIFSNFEWIANELINSGAPFTADVVM
KEYQKLELEYTNKPIVEDLNSIYSLSSITPLRIPHFYVGNFYVYKYAVGQVAAIISGHRV
FTKVTGAKQKVFDFLSSGGSKDPLDTIKLLGVDLTKPQAWQEALEIVKLWIKDYKQTIAL
LNKKRSKK
>UU066 pta phosphotransacetylase
MLSSINKLKNKLKNLAKKPIKVLFIEQSLEIDKAKKMLSQDTLINIVDLSSFKTPEIINE
CEEIWYELRKLKGESRNDAQIAVNDNLNFAVCLSYLKKIDVLIVGANLSSKTCFSSILKI
LKNPNGSIAYSTMVMINKRELIFMSDCALNLNLNKQQMIDAAKYSCTISRNYFDVLNNHV
GYISYLSQNDVIYQNKNFDFIGPIQFDAVVDLKVRNKKVPNIHQYHINHYVFDNISIANT
VFKIYQTKLNYLTVGTYISNILTKVSVISRSASSDEIIATTYLLCVAFLTDLT
>UU067 unique hypothetical unique hypothetical
MDQYKINELIPSEYKLASYFNCGRITIHNAYEVLKVLGIVTTIKGSGYYVYSSIDHFTNK
AFANLYKTIDNIKYEQFLIDFEYHGNKFNSITKFSLIKNKKIIAVSYYITPNNMDLEQFD
TNNINISKQLILSGFDDFFNVKTQINYENINLLKSILEDENIKFNTPIILNKLTSSSLKV
ELLILTHISKEYFDYEETNKLIIN
>UU068 conserved hypothetical hypothetical
MNFKSTIVNKKPIDWKHTIVLEELNVDPKALEMHKERINTVFAKQTEEQRSQQLHNIIVR
ENLFNKAMTYLADFYEIDVNEEDIKDLAPRIKQAFGVEDEKLAYEIAQKIIAKALIFQDL
QKEFTIEIKDEELTKILESYYEETNLSIRDFKENKAQWEAAKSTLLEEKTTAFIVDKFDR
DLSILEANIRKKIAEQMELDKKIKEIQDNNKSKQNADK
>UU069 fecE iron(III) dicitrate transport ATP-binding protein
MFKIFAKYFCNHQLDRNQIINASKNDALIINNLSYRYHKKLPEVLKNLSFSIKKNSFTTI
LGPNGCGKSTTAKAIVKLLKLKKNIIKVFDRNINELSFKQLAQLISYIPQSIEIPQGTRV
IDFITFGRNPYLGFSGILGKEDKLIIDLVINEMQLHDLKEKFMQELSGGQRQKVILALCL
VQDTPIILLDEPTTYLDIKNQYELLESLKKLQILRQKTIIAILHDINQAIQYSDEVFVLK
NGQIYANGNPNEVITKELLKNVYNIDAQIDIVDNQKIVHKIKVKDYLSNSE
>UU070 hmuU hemin transport system permease
MKINQKTNLKQKHFYLIKNLNYKQSVIIKMAGLILIAICFVFLTLAIYFDTTNGFEASIN
QFNFNIRGPKTLMAFFSGGAIAVAGLLLQKVTRNHLADTSVLGIGSLNIILMTVYLILIK
DKTSSYLNPEMRILPLVMFLSSIFGTSIVYTLSKLGRANNEKFIIIGIALNFLFEAISVV
LINPANNSLFSNQDKNLMIAFENIKNYTLGIIPNSQYIDLSLVISCSVLIALTLIPIWFL
RKKIDLYETSAALASTTGINIERLKISIYLLVALLAGLEIVLVGYIALLGVIGASVARQL
FGNRTGITMFAAFLIGATLVCFALLISVNFNTQVPVGFLSTTIITPYFMYLIVRGK
>UU071 ABC sbp putative ABC substrate-binding protein - iron
MHKKTKKYLISMLATISIVIGTTTIISSCTKKTSANVQEQIKYDIMPTYTSQADNLLALG
ITPDYYPQQMYWKKNSPYDYLNPQKPNYQKWFYEKDDFANKFKEKLINLEKNIKQYGTTW
WSFSGNTYGEGVSEEYWNKNKGKLVYYDRYLIDNSHFERAKKTLVAHGGPISNQKTAIPV
DFKMSRDFYLTLNKNDILNFKNDPNSLLRKSLLLGLEYKDKEKGELNELYNYSYFADKLN
KNYFNAETFDGINFNNSAFKKRILEGNDIPIFYTETKWKDPKSLNSKIYEAFKTVVLTKK
VRESGLNKLNYDPFLSTTKQDSYVTSILQHHPIYEQNMRWDGGTQVYLGTMRDSLLYLYD
IAYATTKYAYSEEAKIDFKDNLAKLEPLKKALFNANQIANNLINRLNKMRLYFQAIGVVD
KNYNPNIKQFDNTNSKTLGLLTTSQNSGSSTLQTQSKYGFLYYDLGFKAPKPILKKDEWT
ELLEDVNGKQLLCHRHGNGQIHCFGGDNQDGTQIDKNIVGSLFNMDDNGWWWNLGEGSLS
ASNFAKFNSEFDYLIKISYQNLEDFHSNNLSRPQKELIMSLIKSDYDDPAKRIFDDNYEL
WNDGIKSPIGYNMILDSVIKIINKTIDPQLIQQNKQLLKEANDWGSYWKTFVNQK
>UU072 hlyC hemolysin
MIEDSQETISTQANFSVGILVILAIITLILICFSVFFSAAETAITSVTTVKWKTESNKIK
SKTITNVVYKMINNYTITLATILIGNTLVNTASSTIAGLFFAGIMKSFSTTSNAEAIGTG
IATGIITLIVLIFGEFIPKNFAKKNPIKVLKLVAYPLNCFYILFWPLTWSLNRIFNKKSQ
NIITATEEELKSLIEVIRHEGTLDSQEALIINKAILFDDILIKQKMVPWTQVVKINENKT
VLQSFEIFNSTGFSRLVVVNKNDEVVGIIYLKKIIKYLLNEPNKIIRTIMQTPLLINQKD
TLYDGLRTMQFQRIHLGIVVDNITEKNPIGIITLENITEELTGNVYDETDNENEIKEIQI
VNETTWRVDAKTNAKLFLHQYIDKDIEVNDDISMGKYISKINKNRAFKNRQLINTPNMYI
ETFKDVRTNQFAFLIEKKINQS
>UU073 conserved hypothetical hypothetical
MPKSTLQEIIDNDSNKFTFSEFVKEDIYTNTDYSSTDYKVILYSFFRNNLTIKIGQKLTW
IIKSQNLQIIEFILNGLDYFNNLNIEYEIMFEPDHLNKTRTNYSLLLWGDLDKLDEILKL
FDDANNENFHKDRYCSNFLIGAMLSGGSIAHPLENYHLEIRCDSNNYIPLLTKALARYGL
EYKIIYRNKKTIVYFKKSEIISDFLKAIRTQNSLFEFENIRIQRDFNNQQQRLNNLDISN
LSKSSKAGVLTKEMILEIKKNHDEFCKQSTKFLKYCELRVQNPDCSLNELSCLLKQMFNI
EISKSGLNHFNSRIKEMYEELKLKKLVFKN
>UU074 trxB thioredoxin reductase
MNQEVYDLVIIGAGPAGLAAAVYAKRSGLNVIIVEKQFPGGKIALTSNVENYLGINSIPG
PELAYKMYEQVLNLNVSIIYEAADEISLKEKYKKIKLTTQTLITKTVIIATGTENRRLNI
LGELEFENKGISYCAICDGPLYKNKAVSVIGSGNSAVEEAIYLATIAKEVHLIANKPQFK
AEQQLVQIANNTPNIKIYYNKQTFEFFGHQFLEGLKFRDLITNEVTTLNIEANFTFIGLL
PSRINTNNLCIFNEVNGFITTDKNMQTSVCGIFAAGDIVDKNVRQIATATNDGVIAALYA
KEYITRNNW
>UU075 lgt prolipoprotein diacylglyceryl transferase
MQLEIINPESTLVNDVVAHRVAFSIGSNFNIYWYGIIFVCGFLIAILTYSLRLKFHYKVP
YDPGFYYIFLAIPMTIIGARLWSLAIGDAKDFFDFRSGGLAIQGGVIAGVLSAAVYFPLI
LRMPKYHIRDIDADGNVVIRQPSMWIYADAIIPTILIGQALGRWGNFINGEIFGAESTVN
DLQWLKKAMPAVFEGMKHYFIEGNKTLFTIYQPLFLYESFFNVIVFVFIYFGLSYIKQLK
IGFISMSYFFFYGVTRFSTESARAPQFSFEGTYIINSLLLIFGVLGALYVQFIAPLLRKK
FLLDAIIEMFYKKKDQIHKFGELRKPEEFLFYCHK
>UU076 hprK hpr serine/threonine protein kinase
MEIRGKLFVSQVVRKFNLNVVANSDYIDREISTTGITRVGFELAGEILFKEIWNIVYFGS
KESNYFNKFSETIISKKLGKILDLNPPLIIFGKNFKHAGILLKLAERYKIPIVEVKYSFY
ELNFTINSYISQKLSHQSLVHGTLLSVFGIGVILMGESGVGKSELAIELVKKGHIFVGDD
AILVNRIGGNLYGRAEDSTKDFIEIRGLGIMNFSRSFGIERMIESTKIEIVIELIKPAKH
EKIKFERFGREIQHKEFLETKIAHYYIPVIEGRSISDIIETAITDYKLKTSGYNSAEEFI
LQINKKGI
>UU077 conserved hypothetical hypothetical
MKILIKLWTNLINRISNKKYLAAVSGGPDSMAMLNMYKRNIRVVCHVNYHKRESSDRDQQ
IVVDFCRKNNLIIEILDVDEKVYERYGHIDNFQTKARLIRYDFFKEIGKKYNIENLYIAH
NFDDFLETAYMQRARQSKALFYGIKESNVINGIIVKRPVLFVRKQTLQRYCDENKIKYGI
DETNELDIYERNRVRKIISSWSLNEVYDFKKFVIKYNKEHSSFANFIDLSYIEFKKNKYK
YDYFIRQDDMVQYYLIYYFLIDHKIINPSENKIISLIKFFGKQINKEKAYRVQENIYMHV
NDDELISLISYNKSDNISNSNVDIIDDHNVIEK
>UU078 pth peptidyl-tRNA hydrolase
MEKYLIVGLGNPGSNYAKTRHNVGFMVINEICNKLNLSLDSSKFNGIFTKTIYNNSIVFF
CQPTTYMNLSGEFVIKMLNFYNIPIKNLIVIYDDVDTKLGTIKLRKKGSSGGQNGIKNII
NILKTDEIKRIRIGIDKDPHIKLDQYVLSNFKIDELVIIKPAIIKGALATLAAIGEDFDK
VMNKFN
>UU079 dnaN DNA pol III beta chain
MEVFISIKKLIEAIKFSTTIANTNNANALLLGVLIEVSQNKISFKTTNNQVSGYKEITEG
FEYFNSGKVLVTAKIILGLISKLKDKSVLLKQIDTNILLIKTENFETQINTMNIEGFPNL
NFSLEDYVKISLPHQIMQEINTKVLPNVLNSQGIEKIQPISGILIDTQTLENKLIAIGTD
KIKASCLIREYMGEKFKFIVSYSTMKLIIEILKNVEYSNNQTVDFYVRSRSLIFKINDAI
LQTRMIDGVYPNIYSIFDETNEENTYVFDRRLLIEIIERGMNIVMQEQNPKISIRIDKNE
AEISLTTFEIGNMKEKMSIVNLNNKSAEFILNPSLLAHVLKNFDNNDVTFKVKDEILRPI
IFIDTKDVGFKQILSRIKN
>UU080 conserved hypothetical hypothetical
MKKIFISTEYVTLNQFLKIAGLINNGGQAKFWLLENKVMVDEKIENRRGRKLYDQMIIKI
KNQLYQIVKTNE
>UU081 gyrB DNA topoisomerase - DNA gyrase subunit B
MNDSNKEKKYTAESIKVLEGLEAVRKRPGMYIGSTQSEGLHHMIWEIVDNSIDEAMGGFA
TIVRVILKKDGSVRVEDDGRGIPIEIHEKTGLSGVETVLTVLHAGGKFDNDSYKVSGGLH
GVGASVVNALSKNFKVWVNKNHVQYYVEFINGGHAIEPLKPINNKDVKEKGTTIEFIPDF
EIMEENEWDELKIMARLKQLAYLNKGVNIEFESELTNRKEKWHYEGGLKEYITDLNAEKE
PLFDLIVYGEEEKEVRVPGHNEQTYNIKCEVAFQYNNSYNNSTHSFCNNINTTEGGTHEE
GFKLAITRLLNKYAVDKKYLKDTDDKITKEDVSEGLTAIISVKHPNPQYEGQTKKKLGNS
EVRPYVNEITSIIFEKFLNENPEESKKIVAKVMQAAEARRRSHEAREATRRKSPFESNSL
PGKLADCSNRDSSVTEIYIVEGDSAGGSAKTGREREFQAILPLRGKIINVEKAKIDKIFA
NEEIQNMITAFGAGIGPEFNIEKLRYSKIIIMTDADVDGSHIRILLLTFFYRYMLPLIQN
GNVYIAQPPLYKVSYAKTIKYAYSDQELERIKSTISNIKYNIQRYKGLGEMNPDQLWETT
MDPKNRLLLKVNIEDAAIADKTFSLLMGDDVAPRKEFIEKNAKYVKNIDA
>UU082 gyrA DNA topoisomerase chain A - DNA gyrase A subunit
MALKKPKKSRLTTEEIKQQLEGSTIKEQSITKEVETSFLDYSMSVIVARALPDVRDGFKP
VHRRALFAAFENGMTHDKPYKKSARWVGDVIGKYHPHGDQAVYQTIVRMAQDFSMRYLLV
DGHGNFGSIDGDSAAAMRYTEARLSKISYELLKYIDKETVDFVPNYDASEQEPSVLPSGF
PNLLTNGTTGIAVGMATNIPPHNLTEVCQAIKAYAKNHNVTISEIMEYLKGPDFPTGAEI
YGDSGIIKYFNTGRGSVTIRSKYEIEDIGQGRVAIVVTEIPYMVNKANLIEKIVELVTNK
QIEGISDLRDESSRDGIRIVIEVKRDVIPEVLLNKLFKTTPLQTNFSVNNLALVNGVPMV
LNIKEMIKYYFEHQIEILVRRTNFDLKKAKERIHIVEGLVIAVNNIDEVIKIIKASGDDD
IASKSLIQRFDLTELQTKAILEMRLRALTGLNIDKLKKEYEDLILVIKDLEDVLNNYNRQ
VNIICENLDYLIEKFGDERRTEIMYGVSSHIDDEDLIPVEDIVVTMSKRGYFKRLPIDTY
KNQRRGGVGVQGLKTYEDDDVEKILVANTHTDLLFFSDLGRVYRLRGHEVPLGSRQSKGI
PAINFLPIEKSESILTILPIDNYDQGSLFFTTSKGIIKRANLSDFESIRANGKIAITLKD
GDKLFSVMQTLGNDEVFIGASNGNVIRFNENDAREMGRIATGVKGINLENDEYVVGTGLS
SHGEYVLAVGSKGLGKLTDINDYRLTKRGAKGVNTLKVNDKTGNLVSIKVVNREEEALII
TTSGKVIRLSIKDISVIGRNTSGVKLISLENKEEVKSIAIFKKEEINDEQLLQENDYNLK
>UU083 conserved hypothetical hypothetical
MNVALELINLLKERRLRLSVCESASCGALSSSIGEVAGASSVFAGGFISYSNEVKIKLVG
VSEKTIFKYGAVSEQTAKEMCLQTNQKFNTDIAISITGNAGPQGSENKEVGLFYIGIAIK
DFAIVKKVTLNSNERTFNRFSIAWEAISYLIELIKK
>UU084 recA recombination protein
MKENNNLEKLDPIATLETKFAKSSYFIADEIKDEKINAISTGSIHIDQITGINGIPVGKI
TEIYGNESSGKTTIALQTIAECQKTGGTVVLLDLEGSFDINYAKSLKVDLTKLIITQPQT
GEQAFDMIETLIKTNSIDLIVIDSVAAMLPESEYQANMNEALMGAHARLMSKGLRKIQPL
INKSKTAIIFINQLREKINTFFGNPEMTTGGKALKFYASLRIETKKADLIKEGINKIGIK
TKVTTVKNKLAPPLQTCFIDIFFGSGFDYNNEIIDFAIQYGVLKKNGSWFYFNDNKIGQG
REQLKNTLSKNNELFIQISEKTLEFVNNEKSNWQ
>UU085 conserved hypothetical hypothetical
MGYLIAFIILLILFVLLITIVPVVMVVYLKKKQLKLTFVPKSQTSFKKIVQKTKDLEEEC
EDLNNKNNELKKAISDQNLQIDLLKKNNENFLLNATSLTAEQAKKELFNLLKIKFKKELA
QEYAKIKHEFNEAQEIYAQNILVETMEQIAEPLIVERSLFNIDIIDENLKGKIIGRDGRN
KAVFENEGGVDLIVDRQQPIVGISTPNPIRREIARIVMQKLIDSKNIDINRIELLFKEER
EKFEKKVFEIGKNVVEQTLGFFDLPEGIYSYIGRMKFRNSYGQNILSHSLEVAEYAERIA
KLINIDPIKAKKAAFFHDIGKTIDFESDLDHVEAGLLIAKKFNLDDYIYNAIESHHNKVI
PTTIYGALVKIVDTLSAARPGARVNSYDEYYSRVKELETICMRFEGVKSAYVIKSGRQLR
VIVDSNLVSDEQLELLGHEIKVAIEENDLLTNYKIKIVLIKEKRISIDTNIIG
>UU086 dgk deoxyguanosine kinase
MSDKKLDFLTPSFKKNRVSNSIAIGGMIAFGKSTLAQALHEKYQPSNVVYEMVEGDKLMD
LLLAKMYERENNVLFGSLFQLYFVLNRFANYKNNCNRKSLTIFDRSIFEDWLFAHANIDK
PSVFSYYDGLWQGVCKELIYEHGVPKLYVILDGDWELFKERIFKRNRKVEIDNFSINETY
FKRLLEMYKNYMVNVCKDFGINYVVLDANNSVEQNVDEVTKILQKLENEQDK
>UU087 dnaX DNA polymerase III gamma-tau subunits
MSESTLYRKYRPHKFKNVIGQDLIKQALMNACLNNKITHAYIFSGPRGIGKTSIARIFAS
SINCLNPNKGDCCGKCSVCESILKEQSVDLIELDAASNNGVDQIRIITDNINYLPTFFKY
KVYIIDEAHMLSTSAWNALLKTVEEPPQHVIFIFATTEYQKIPLTIISRCQRYDFKRLNN
SELQELIDSILTKEDIKIDNNAIDKLIQLADGSGRDCLSILDQLTTVKKNIDLDLINKTF
GLVDNFKVISLIELIQKNDILLLREFIYELYNQGVNLEAFCVQIINVLIDYLIYLKTNDI
NNLKKVSVDELKKMLLINFNGNYLLNNFISLFNNLKKSLNQVFEFEIYLYKIINANNDKL
ENKKIELSINPEENKINNSQIITTKKIDCFEEINKNTVDFDKLYKTKIFYHKKINNQNDK
ESGINQKEELSTELVNDNKLICNSNDILDNYELAKQAFFNKDIKLSKEMSQKFKDFKNEE
TIENSYIDIIKQADLVLWCSPNALVLGVEFLGLINRINKVTHSFEFIKEFVKKFDSIKLV
IAISKKQALNIINIKKQGLKTNIINDVLIDDIKMLLKQEEQRKQEQTALLNEIEDEE
>UU088 conserved hypothetical hypothetical
MDFQKLAQELKKMQNTLSKKQKEFEEKVFDFDYKGYVLVKIKGDLNIEAIEIKTEIVDPE
DKETLQDILRAAINEAISITCKERDAIMNATIPKGTGLF
>UU089 recR recombinational DNA repair protein
MSKPVEFEMLVDALKSLPGVGTKNANKWAFFLLQQDQKYIDDLIKRIKEAKTNILKCKYC
ANFTNKDECDICLNEYRDFTKLMIVTTNEDLERIESANIYNGLYHITNGEISLRKNVVIE
HTNIKTIKERVLNGSFKEIIIATSYTHDGEVTADYIIRMLEDIKDLQIYRIGFGIPLNSS
IDYADDETLKQSLINKRKIRN
>UU089.1 conserved hypothetical hypothetical
MYNYKEVKHMGYGKGYLAMFKNKKVRFKVVNSFPDLKVQFVTSFPDYKVKISNSSSFCEE
TIKIQVVTSFPDVKLQKVTSFGDFEAYID
>UU090 conserved hypothetical hypothetical
MLAHFFNIFNLRRGELIMANEYYNMCALDALKFVKNRNMLLPDIQREYVWDTTDIEKLFE
SIVDDYPVGSCIFWKTNKKVLNDEKPNLYYFISKYKQGVTKNEKAPEFVSDETDYYIVLD
GQQRITSLNIALFGSFTSKKKGKGYSVKNSKSWVERELYYNLSFYDSNELDDENPIKRFV
FLSEEEAKNGNYYKVKQIVKSDNLTDYVDTISNFNKNVKTDLMCLYRRIMEASATSVIHY
YCIAENTYDEALDIFVRVNSTGRKLSKSDLLFSTLIDGWKEGKENIDTLLSDLNSAGDGF
SFTRDYLMRLALVLVDANTNLKIDSLTSKTIKEIRDNWQKIKKALEKLSELLVSIGMCDE
NMTSYNATIPLAYYFYKGGKIDTAESKKEARKFLAVSMSKGLFGVASNDSLNQSRTALKS
VNEKTPFSLTLFSSITLTGNRTFTASKDDIEYWLTKFEKGKNTFIILSLLYPNLKLSQVE
FHQDHCHPYTSFDDKNIKKLGLTEDKIKEWQFKRNLIPNLQFLAGKENESKNKRPLSNWV
KDGNTFEYRPENVSLELSNFDKFFNERKSLIKNKLLDIFGLKAN
>UU091 ffh signal recognition particle
MFKAMIGSIVSKQMSKKLKNATIVEEDIKELLSEIRIALLDADVNLLVVKKFIKNIKEKT
IGLYVEANQKPADLVLKIIKDELVEILGKENKPVNTAKSQLKIMMVGLQGSGKTTTTGKL
ANYFKNKYNKKPLLVAADIYRPAAIDQLRTLAKQVRVDFWEEGTQRPDLIVKNALNKADE
NENNLIIVDTAGRLQTNEELMQELVNVKKTLNPDEVFLVVDAMAGQDIINVATEFNNWLK
LTGIIVTKLDSDARAGAVLSLTSLLNIPIKFTGTGEKIGSIDSFYPERMADRILGLGDIM
TLAEKAADVIDEKQVRGSMQRMMAGKMDLEDLMRQMSQISKLGSFSGIAKMIPGLNNISE
NQIGDAESKMKIWTILLSSMTLKERRDPRVFKKEPSRRIRVLKGSGRSPDELNKLLKQWE
VSRDKMAELGKMLQKGKNPFSKSGGLFS
>UU092 unique hypothetical unique hypothetical membrane lipoprotein
MNKKINLNSSLAYIGFLTRLIIVKKTTYLLPIITLLITLIIGIVVGCVVKQKTQFLIISY
VMIMFNLLMTTIFASLKALNIFKDFSEDGIDILVISKPISRKNIVWSKIFFFVLTGIVWS
LVSFLGLLIFYLISFNFAKNVNYYWILSYISPFICYLIFGLITSLLALKLNAKISILIPF
VSFIPLLTIGIIANLVSQVQSQAFLRLLKQKSTNNIEAFYLNNNLDQYYLINTGFFNHKF
NENQNLEIMNAYLKTRSLATFWQVSSWILPVYQLADVFNKSDYEPFSDFIKNQVDQILYA
NNLASKQFNYQLEKNSNSLINFSINNDKSFLIPSLLKNDSQNLINNNLNQEVIYAIDNWK
DQTIEYQKNSYTQLSSDDIVGSLKWMIIKEVLNVRSFNTYANNLFKTLDQKANQKQILDL
ISNSVQKFDFNKWNDENADLFKKDFNKLLIKSKTEQQIYLAVSLIYYLYFNPHYTNLLKI
LLVDHQNNLQYKTQLKINLNNKNYLIGGFKSYLLHQILPQENDDGIDELKKDKKIRYRYS
LEQGGNYLFDYVQQNYSFKRKQQIVYKEAYCVIWLILIFSLLIGTYYGYKRKDYR
>UU093 bcrA ABC transporter
MNNEFILEVKNLTKIYKKSNQGVFDLSFNVKRGEIHAFIGENGSGKTTTIKSIINAYTNY
KGSILIDGFDNKTPKSHEKIGYVPEIALFPSELTTFQYLYSFARLSNLNKKQAIERIHNF
LEKFRISDLKNKKPINFSSGQKKKVILIQALLHDPELIILDEPTANLDPSARHEFNNILK
ELHEQNKTIFICSHILKEMDTYVDSLTLIHKGKLVYSGHKYDALEKIYYDSVLKNK
>UU094 unique hypothetical unique hypothetical membrane lipoprotein
MFKKRSSSRKWFIICTSLSISSIAVVSLSACANTNNKIVNAGFIYNGSTTNDAITGFDVN
DYIIKAPENDTNLNQQILRNNNYEQKPILWNDYLKEYDSVKKQHDQQIKNFYEYIWINEA
SKYKNLNKVIDINDPYFINWFLKLTPNTLKNDLYNFINNIRKDNTKPSLVFSSSEPQIKV
WKDLGNNQKQVLNPNQAIFEPLTEQDIKNNINLLEKNKALRVSISFWYALTNQSSANILI
NDPFYKKPSGIASNTSEKYFIRIEASPIALDFSQTDRLERDKYSAQTTSIKNTYKMRYYF
NNIRVEKQVTKVKNNAKRGDQNAEENFPKEFYFGANSNEKFSFGTHSYTLNNEITQASYE
QDIFSLDHKIKNELKKLNEQQILKDIEYAFTSGYDVAIDSIGSIFNILKGVANDLNLKEL
FLQSSQDFRNLTYNITQQNNLTNLITLITSNQSLGMVIDGFKPILKEIIYNNPSIDQSVK
NTIWSKIDSMDFKNNLIAEIGQIRTLLDSISLTEIKTYKPIINKLLELISLIEARSKKDP
KNYGFIDGLDELFSFFLNLKQNDLPSSINFKIGDQNYTLYDLITEVKKIANNLIPHENQY
DPKDQQIISTNYFLTKIKILDLISLNKNDQLDYHKGVEMIFSLLKKFQIAIPEFIYKIID
ELLIQNTNWNKENIKKLLDAILYPKITSNDPSINDLKSYFKYGISKPEITSKELEYDQNN
LLIKKLNIKYRYKVLANAEFDIKPLFDLLPQKPLSFIDLGGLWEQIKKEFPYKIVLAKND
YVDHTISISQPQELTTLIFKDRSDHDKYKIGYVFYPTHTVQTHMPNSMKAIIENISLRND
RLLPNKYVAQLLNWLFYKKWVFINPLAIYETFEGDKKIPNDKNVKYLIKDNLNKYLKNYD
SNTYCEGFDFKHFSNNLENKVGNQTIRNLILAKIKTIKTDGQELYQDALGRKIIATSAYD
QINLTLQELIDYKLLGFGKKVDLKKDVYLSAVAFNFGLNTNDSDQTNVLNNNDEIKYNLN
ILKKVVITLHFTKPMLDLSDPNRTKLVNSYTFVV
>UU095 hsdR type I restriction enzyme R protein
MENKVLLAEHENSTVVAEFKSIKVHSNKFESEAELEETFIKLLIAQGYEYLPIKNNNDLK
NNLRKQIEKLNNYQFTNNEWESFLSTYLLNPNDGIEARSKKIHEDYSYPLKKDKDSITKN
IKIIDKNNIHNNSIQVINQYQNNNLDNQQKTRYDVSILINGLPLVHIELKRRGTNLKEAF
NQIKRYANHSFTDLYLYTQIYVISNGTQTKYYSNTTRETSIKERNNTNSKKTSNSFEFTS
YWADSKNNQILDLIDFCQTFFAKHTILNILTKYCVFTSDNTLMVLRPYQIVATERIINRI
KISLNDKKLLGTTGAGGYIWHTTGSGKTLTSFKTAALAKEIEGVDKVLFVVDRKDLDYQT
TKEYEKYSKGCVSANTNVNELAKQIGNQENKIIITTIQKLGIFISKNPKHPIYSKNVVLV
FDECHRSQFGDLHKKITKKSFKKYMIFGFTGTPILEENSNVKNKNIFFTTEHLFGACLHK
YTIDKAIRDGNVLGFRTEYYKTLSEKDDIDDETSSTGIDKKEALENPIRISEIVDFILKN
YNRLTKRNEEFFEHNKIANINEVITSRNKLSENKVLTTLNGFNSILACSSINAAKIYYSE
FKKQQQKFPQEEKLKIGLIYSYLPSEQESNDNELSNFELLDENNENTNQLDLDSRNFLDE
AIKDYNEMFGTSYSTDNANFNNYYKDFSLRLKDRSLDIAIVVNMFLTGFDATTLNTLWLD
KKLKYHSLIQAMSRTNRILNGVKSNGNIVFFINLEDEVNEALRLFSSESNINSSIAILRS
FKEYYEGYYNEDNQYIQGYRNLVEELKSNFKIPFNGTKEEERIFIKLFGDILKYKNLLSQ
FSEFEQNDDLIGTEMQDYQSIYIGLRDKYQDKKRMETDSIVSDLDFKIELISQQDIGVDY
ILKLMNEKLKKDLKEVKYHDLERDILSSLKARKKKDLIIEFVNEINKLPNKDEIDIFNEW
SKFIKNKKESELIKIINENKLDNKKTFEFMKKAFENNEFNENGVDIVNLMPPTSFFKKSN
QNSNRSKIKENATEKLLEYFEKFRG
>UU096 hsdS type I restriction enzyme S protein (fragment)
MSFKHISANELKRYEKCNFGNVKLLSTGLYDGYIKYNENDNNINYGEIIALPSGGSPIIK
YYNGYFIDSLNIIFSQKNKKECNLKFIYYFLIANKMLIEENYRGASVKHPNMIEIIELLI
PIPHISIQNKIVEILDKLEAYTKDIGVGLPFEIKQRKKQYEYYRNKLLDFKKY
>UU097 hsdS type I restriction enzyme S protein (fragment)
MSNVMQEIIIPIPPISIQNKIVEILDKLETYTKDINTGLPLEIEQRKKQYEYYRNKLLDF
DNIARERES
>UU098 hsdM type I restriction enzyme M protein (fragment)
MFGDAYEYLMSMYAANAGKSGGEFFTPQEVSELLVELTLIDFNNENKDVRRKIGKVYDPC
CGSGSLLLKYAKLNEGVKFYGQEINLTTYNLARINMFLHNIGYDKFDIKLGDTLLDPKHN
DDKPFDAIVSNPPYSTKWEGKSNPLLANDERFHVTQLAPKGKADFAFVLHILHNLSSSGT
AAIVMFPGTLYRDHAEQDIRKYLVDNVNVVDSVIQLPDNLFFGTSISTCIIVLRKNKNNN
DNANGILFVDASKEFVKSGIKNKLTNANIKKIVDTIRFKKEVTYFSKLVSREEVKNKNYN
LSVNTYVEKEDTSEKIDIKLLNMQIKEIVAKIEKLRKEIDEIVLELEE
>UU099 hsdS type I restriction enzyme S protein (fragment)
MNKIEKLINEFCPNGVEFKKLKNIITVAPKSPFGVTKLLKMEKGNYLTITSGKKSFYVDN
FLVDGEYIFVNDGGQADIKYNFGKTMYSDHIFAFKVNEYNTKYLYFYLLNISNFINKKLF
IGSTLKNLNKKEFLNLAIPIPPISIQNKIVEILDKYTELETELETELETELELRNKQYIY
YRNELLNFNKNQTLLKKIMDSDDIKSIDHKIEFKKIEYVCEIKRGQVYSKEFINSNKGNY
PVYSSQSLNDGVLGNINKYDFDGEYVTWTTDGAYAGTVFYRKGKFSITNVCGILKVFDNS
N
>UU100 hsdM type I restriction enzyme M protein (fragment)
MDNKKEIERNNLHATIWKIADELRGAIDGWDFKQYVLGILFYRYISENLTKYINDNEHKI
GDHDFNYETCNDDDVDEEMKITLIKEKGFYIKPSFLFANIVKNAEKNENLNETLETVFNN
IEGSSSGYDSEKNLKGLFNDIDVNNSRLGSTTQERNKRLARILIRIIYKNMDLLILKPYI
NKKEIPN
>UU101 unique hypothetical unique hypothetical
MAKYIKTGVSYINLDNARTINILPEDIDSYLELGGDEAYKTSDLGSELYINYADFESTNI
LFDLKKEELQAKIDAFLISNDTVLDLSEVFLDIHFSEDDDYEEDCCCEDECCSDEENEAC
CNSEVKVEEECCGGAKDDCCGGHEHEHEVCCDSETKTSETQEECCGGTKDDCCGGHEHEH
HHHHSHQH
>UU102 uvrA excinuclease ABC sununit A
MDKIIIKGARENNLKNIDLEIPKNKLVVITGVSGSGKSSLAFDTIFAEGKRRYFESLSSY
ARQFLGGNDKADVESIEGLSPTIAVDQKSTNQNPRSIVGTITEIYDYLRVLFARVGTPFC
PNGHGQIKSQTPKQIADFLFSLSPKSKIQILAPIEIKKGYKINDVLNNLRNQGYLRVLVN
NEVYQLDENLPQFLDNKKTDVAIIVDRLILNIDHQTKTRALDAIEFALNYSGGEIAFKVN
DDIHYFTQNDVCQVCGFKIKEIEPTLFSFNSPIGACEQCKGLGYNYVPDERKMIPNPNLS
INEGGLDYFKNTVNTTNLDWQRFNSIIKHYKIDKTKPLKELDRKEIDLLLYGSDEAIEID
ITSANNKKYSSIDYVEGVLELVNRRYQETSSELAREHYNKYMSEKVCKSCKGKKLSSQAL
SVLINKINIIDFIEKNIDEAIDFLLHLDLNEAQTKIANPILKEVLDRLGFLKNVGLEYLT
LARPASSLSGGEAQRIRLATQIGSKLTGILYVLDEPSIGLHQRDNDKLINTLKEMRDLGN
TVIVVEHDEETMLAADYLIDIGPQAGVNGGYVIAAGTPQEVMQNPNSLTGQYLSKQKDIL
VPKTRRSGNGHKVILKGAKHNNLKNVDLTIPLGKFICVTGVSGSGKSSLILETLVKAIEY
TNFNPFVIPGEYKDLIGASNVDKIVVVNQDAIGRTTRSNPATYVGVFDDIRTVFENTIEA
KARGYSKSRFSFNIKGGRCERCWGDGTIRIEMHFLPDVYISCEECHGKRYNDETLQVKFK
GKSIYDVLKMPIDEALVFFENYPGIHRKLQLLVDVGLGYLELGASSTSLSGGEAQRIKLA
KFLQRKPTGKTLFVLDEPTTGLHIDDVAKLIKILDKIVDGGDTVLVIEHNLDLIKVADYI
IDIGPEGGNKGGKIIATGTPEQLLSKKDISYTAQYLEKYLKKN
>UU103 unique hypothetical unique hypothetical membrane lipoprotein
MKHKTKKITLLIAGITLTSLCTIFAITACSKQKSQPNPKIKPNKIIEKIDQAFFNEFKTK
IEQKRTLPNIKITSTFKIPFEKNENTLKSPLFKIGEKSVFDLKQNEIPITWVQDLKDYFL
SQKTILTYYSLANLKLTGNDAKDAYFLEFIQYIQNMQQKGIISEDFYQQLWYLISEISDY
DMQNGILRSVYRIANPKLAIKDFYLDGSLYGFKKEKSKYMNFTSLFQWPNAEEKATFDVV
FKNKNSAQSYTKKIELIYSKEKKFILDSLINYSEFTPGEYELVSIKKHDDMNAKNLINPN
NPNIAKIFKIKVFKENEKFKPITLTSINQQEADEYDRQRNQIIHKNNSEIGILDDSNKIK
ELGTFLYFKKPLSEITINDFDRYFRTYFICPEQDFNDFSRQYKITKIDKQKQIIELSILH
INNKTNEIYSSPINFKFYYKKIYDINKNTDARLDLSFDESKKEQKQKLQELVNKLNFDKL
TYNDLSELAVVMFEDVDLENTKIYVEMIKNKDRSITLKAFVDKAFKNGKLKVSNKPDILI
KEFKINYFMPNYFK
>UU104 hpt hypoxanthine-guanine phosphoribosyltransferase
MIKNQKTRNDGIKMKDIDPRIKEVLITEEQIDQKITEAANWINKEYEGKEPIIIGILKGC
IPFIGKLLPKIKIDMKLDFLAISSFKGATSAQTEPEIITDLKFEVKDRDLILVEDIVDTG
RTIKKVYDLLKIRGARSIKLVTLVDKKDGRLVDLQADFVCCDIPLVFIVGFGLDYKEIMR
NLPYIGVLKEEVYQNDLNNKNEGDGE
>UU105 ftsH ATP-dependent zinc metallopeptidase - cell division protein
MYFLKKIVNLFSSKIESEDNNVKKDDLTQPRKQSPEARKRRNRRIIFWLIILLIIGTIIG
VIIYFSVRKEYDNVIVKSAQTEVVNNKKVLYLNTIRPNSTQITRYTIDEDQLLTARVNIL
NNTNFQIISNASSLGLSRISFNIVREGVEKFKLGETNIYAPISGNTNNQWNWLTSIITQN
AGIPSSGFNPQVIISPLISIIFFIIFLYIILRVSKAQSDSLLGTNKANAKLTKSGVRFSD
VAGIAEVKEELIEIVDFLKEPKKYVAAGARIPKGVMLYGPPGTGKTLIAKAVAGEANVPF
FQTTGSSFEDTFVGVGARRVRELFEKARKSAPAIIFIDEIDSVAKKRGNSLTAVQDQTIN
QLLSELDGFDTSSGVIVMAATNRLDTLDDAILRPGRFDRQISVNLPDILEREQILRIHSR
NKNLSAKVSLEDIARRTAGFSGAQLENVLNEAALLSVRDKATSIHMNHLDEAIDRVIAGP
SRPNKVISEREREQVSYHEAGHALIGLYSPGADVVQKITIVARGRAAGYTLQTPERNENI
LQNKTELISRVRTALGGRAAEELIYGPNEITTGAANDFYKITNIVRAMVASFGMTDVGLT
QYIATEGVDNPYRNSYSEQTALAIDIEIEKIIQREYKIVKEMINEHREELELIVQTLLEL
ETILKPQIDYIHQYKQLPPEVIANKNKREASQKQANSSVEEAKVVDDEESIKDKEKDQKS
N
>UU106 serS seryl-tRNA synthetase
MFDINLIRKDIATTKEKMLNKKVPSNLFDQIFDLDVLVRSLMQQEQNLNAKKNQLSKEIG
ILAKNKDPKLQQTLDLVNNIKNELQDISLTLSNKQDELNKLLLVIPNMPDDSVPIGNDEN
DNVEIKKVFKPKKFDFLPLAHWDLAVKNKLIDFDKSTKITGSRFIIYTNFGARLYRALQQ
FCLDMNVKAGFSEIWAPVIVNQESLIGSGNLPKFADDLFKLENSNYYLSPTAEVQLTNLH
RNEILKASDLPLYYTALTPCFRSEAGSAGRDVRGVIRQHQFHKVELVKLCKPEDSFKELE
SMTRQAESILEALELPYRRIVLCTGDLGFSSAKTYDLEVWLPSYNAYKEISSCSNCTNFQ
ARRAKIRYKETIDATTELVHTLNGSSLAIDRLWAAIVENYQQEDGSINIPKVLKKYIY
>UU107 potA spermidine/putrescine transport ATP-binding protein
MEKTLLHLRDITKIYDDGFAAVNKFDLKIKKGEFVTLLGPSGCGKTTMLKIIAGFEQPTN
GKILYNGIDIKDMPIRLRPTSTVFQDYALFPNMTVKQNIKYGLKLMRKPKDNVDQSIYLQ
ADKVYNSASKKANEKIKELKKQRRGLLAEIKKMDLKYQKNKNIFEIKEMRKNQYLGTLDE
LYQKQGINKNGKPGFLNYFKSWFSHEKLNLNDPIDREIFNLKKAYKEKSGLDKRYDKITY
KYNDLDYWESYWATYPQLKKEQFENKNITRLLTKEEVEKEANRVINLVGLSARKDSYPSD
LSGGMQQRVALARSLVIQPEIILLDEPLSALDAKVRKQLQDELKKLHKNLGITFILVTHD
QEEALSLSDKVVVMSNGQIEQVGKPSDIYDSPNSLWVANFIGKTNIFEGHYIAKGEVEFD
GITSKTDVINGFSENEACYIMIRPEDFDVVKKDEGSINARVESVLYKGLMWDIKCKYNDM
IISVEGVNKVNEGDEIGLDWDDIDVHVIKKDYLNNEQAI
>UU108 potB spermidine/putrescine transport system permease
MNKQFNFNFAPSKLSDINKKNETVFFLKEVKVIKKNNRKHYKQTLFDKLKMNKALILTIP
YFLVTIFLLIIPLVSIIVKTFINNTDSTGVTTNIIDNWSVITPTIGMKIFNSLWIAAVAT
IFCLIIGYPFAYFLSIGKSKFLKAIAIALITSPIWMSMLVKLIGIKTFFDVVNGEINSTH
GHIFTILGLVYINLPLMILPIYTSLSTMPKNLVNASYDLGRGFFYTFFHIVIPYTKNALI
SGVWIVYLAAFTSVVVSGFLNNDNAGGLIGGEIFAQGQDGISSGVQLSRSSTITLVISLI
LLGIYLIIVIIPKIVQLIYYKRKNLKKGVKNNEAD
>UU109 potC spermidine/putrescine transport system permease
MKQINWLSWLRNFYIWIILAIIYIPLIIIVLLSFTTPSIKGNITSAFNWNDGSNYLTLTT
NQFTDALINTIIISVIAVPISTIIATITCFGVWHAKIFYKKLMTASSQTNIMIPDVISGI
SLSLLFAATFIPIGFSFGFGTIILAHISSCTPYAIMIIYPRMLKMKKNLILASYDLGYTK
IATFFRIILPYLLPSIISATIIVFAMSFDDFIITKLVGGKVNTIGTEMYSMAKGIKAWAV
CFGALMVLLTILIAALISANKIIKLKLINKQTNKRKLKIWNRQV
>UU110 conserved hypothetical hypothetical membrane lipoprotein
MKINKKLLKIFAGITSLLVFIPIITACSQKSKLVVGNFDSYMDPDVANEQAKRFRKNNLS
YSFYDNNEILSSLIKAKISDVQVASAYEVAKLAKNGLIKKINWAKFNLKDENNQTITSIE
GLKKIFTKQVWAISNAYSSYLGDLDKDGKNDQLLEYMIPYFYQDLIFAYRGKKIPNLDDN
KKDVYWSDVFKELTRNDGTPNRFLYEQKANLGFGVDKRTPITIAKNKTKIIAIDDARTIY
DIAKIMQLEGDNKNNIIKIINHEILGIDNSISQILHILKNPNIKEDIKEENIKKLKRLQK
QLEDRQKELKTNVFLPDSSSVSYIEDKLNNISNMFKNLHPNSMYLKANSNDVLNDLAMAN
VAGAIAYSGDIAFAANGGEYTTEADSNYANMKPTSDNFHVVRPKDTMSVLDGFTISNSIN
KQNEQAAYEYLNELCFAGLNEKNTDGESKILDYGLKIHRNKTPKEIADYENSLDDQNEVG
DVLEDSGYLYTPMRNFDYVQYSPTLNTIADYVLDENNGFYGKTGFESDLLRQKMVEIFEI
DTKYKTKKERQRKHKYISLLNEIINHIYNTYQKDKKFIFNPTLINDIYEQKPIKNLIYEC
LNNLNIKIESHVFNNYLLLKLEAIFNNINEEVEEHAALNATLRKIFNVRLNINTLEFPTN
DLSISNLKLAYLAFREKI
>UU111 unique hypothetical unique hypothetical
MNYKYSAEEKQIIYNYILREYGQVDHIIFLSNEHIRVPIEYDILVIKKQNLQILMTFGLG
AFKSHNHEENTQERAEIFLELPVDWDFNKHENMWPVHFLINIVKYSYSNHLTLKWLQTFI
NPSYFNKSNKIAGFLDLSWYGENSLECKINNDFFVSFYQILIIDDEELFYAKTNGIRALS
KFFDDGKSRIVDLNRKSFVK
>UU112 unique hypothetical unique hypothetical
MKICDNISEINDDQDLVFIDIEATDSKGEQRIIQFSGYRLNIKKNKIFNFNKKFNPEQEI
NSRIKTLLNFNKNFNNIEQMPKLDKQAAREIYCFVKNAIVITFTDFDIKKMHELFTYYNF
DFEKIVYFDVYKFFEKKLQTKSVPSLFSLGILSGIKINFFKLHNALYDAFILKEIFMCIR
HKTNEELYEMYRYYEFLPKIISSSYFVTNEQEKNRGIIKKEIKYVMYIKEFDFSNKFNLD
FVVYKKDHHFYSKPIYDSSLELQTISSLTSKSNFMKVKLANIFFNYLSKSAVFSIKKLSI
KQSEKFLKFYKTQTNKRKVIKVLNLNLKKEIKPENFVIKAQIICEILFKNPIIHHFVHEY
LKIFQNIFSQEEKDN
>UU113 sfhB pseudouridine synthase (uracil hydrolase)
MNLKEIKIKINDANQRLDRFLLKNFPNLSRIAVYKIIRTKDVKVNHKKVDHNYLLKENDV
VSIYAKENFLEKKVDLSFANAKDELDIIYEDKNILVVHKPIGLIVHEDNRYKNDTLQNRI
KKYLVKKDEYHPFDESAFVPSLCHRLDLNTSGLIVAAKTANALRVITEMFKNNDVIRIYK
CLTYNQLPKNNDVIYNFMYKADDNTMIVQNFKTKFNKTAITKYTYIDKYKKYFIYDIELL
TGRTHQIRAVLNFLHAPIVGEQKYITKDIDKNQNYMYQCLVSYKIKFINLKKYQCEELNY
LENKEFRIKNIWFLK
>UU114 folA dihyrofolate reductase
MLKLIWCQTLNGGISKNNKLPWYIKEELDHFYKTTKNHKIIMGKNTFDSLDQKPLNNRTN
IIFSSIMQTPEDESYFVTNDFQQVLNDAKKEDIFIIGGKELFDIFLAYADVLIVSVLKDY
YDCDLYMKVDYNNFNLDKQDVYDNFIVNYYSNKKEK
>UU115 gph phosphoglycolate phosphatase
MFMIILLLIIIQIRRKNKRFMTKKLIVFDFDGTIMHTHTTMSLSIIGVLEFYNHHIPSLK
EMNDLLGNLSMVNIFKKYAKHDLLNIEIEMMISKYYEIYESSLFMIHSYFFDGILDLIKK
LKSLNNNVKLAILSNKRSSLLATMVDYYNLRPYFDYIFGAEDVEQMKPDPSGLLKIMNNC
NVDHKNTLLIGDSIADLKAAINANCHFILVNWEPQYQKHMETIINLKPLIVKTIDELETQ
INHFLY
>UU116 upp uracil phosphoribosyltransferase
MHKIINHPLIKDKLTRMRKVSTVSTVFRTNLEELTQLMVYEATKDLELNEIEIETPVVKV
AKGYKLKNKICLIPILRAGIGMVDGVKSLIPTATIGHIGLYRNEQTLKPVEYFKKFPKNI
SESDVIILDPMLATGGSVVEAVNIIKKYNPKSIKFVCIVAAPEGLKYVQEVHPEVDVYIA
ALDDKLNENGYITPGLGDAGDRIFGTK
>UU117 tyrS tyrosyl tRNA synthetase
MHSLIKDLKARNLINNITNEEKLIKALEKNKGIYVGFDPSADSLHLGNYIMIMLLKRFRL
YNIKTLALVGGATGMIGDPSGKSAERNLLDKTILEKNIAKIKFQLEKFTNSQVINNYVFY
ENMTFLDFLRDVGKLININYLLEKEIINSRLSVGISYTEFSYNLLQGYDFLQLYKNDNIA
IQAGGSDQWGNITTGIEMIRKNLGDDNIACGLTINLLTNSEGKKFGKSEKGAIYLDENKS
TVYEMYQFLINQSDADVEKLLNFLTLIDVEEIKKIMQAHKNNPALRVAQKALAKAVVVDI
HGQQKYEQALHISEVLFNGSISTLNQEELEIAIKSLPATKLDKDEIKIIDLLNLANISSS
NRIARDFLNTGSILINDIKINDENFLVKKQDAINQKFSIIRKGKRNYFLILWNKD
>UU118 ABC ABC Transporter
MRNKKENDNVINPLSNPDENKKINIKDLSKDERKELKKRIKEVEKLNRNHKGDIDMPSRD
PNNIIELRDVKKIFTNGYLINETLKGVNLDIRKGEFVIILGPSGSGKTTLMNIMSGLDRA
TDGDVRVCDKQLINMNQNKLTDFRKEYIGFVFQQYGLLPTLSVEENVEIGADLQVDKKRR
IKPQDALKAVGMLDYAKKFPHELSGGQQQRVSIARALAKNPIILFGDEPTGAVDETMSKI
ILKEFVKVNQELKTTVIIVTHNPIFAELGTLVIKVKDGNINELIRNDHPKSVDELKWDEQ
>UU119 secA preprotein translocase
MNLISKISPQNRILNRARLIAEEVLKKEEEYEHFSDQELINKSDDIIEYLANNNPLDDKL
VEALCIIREVIYRVHNKRAFKVQIIGAIIVYFGDFAEMMTGEGKTLTLVLVAYLNALYKK
GVHMVTVNEYLVKVGAEFATPVLNFLNMSVGQITANMNEYEKRNNYNCDITYTTNSELGF
DYLRDNMVTNYANKVQRGLWFAIVDEGDSVLIDEARTPLIISGEPQEEIGNYVKADRFVK
TLYPQDFTLDPESQSVALTESGVEKAQKFFNTKNYYNFENSDIIHKVTNALRANFTFFNG
REYIVKKDDDGEDIIALVDQSTGRIMEGRSYSAGLQQAIQAKEQIKIEPENLTVATITYQ
SLFRLYKKLAAVSGTAITEAEEFLNIYNMVVVTIPTNKPIKRIDHPDYVFDNKRTKWKYV
IADVIRRHENGQPILIGTASVEDSEILHQLLERVNIPHEVLNAKNHAREAEIIACAGEYK
AVTIATNMAGRGTDIKLSPESLEAGGLCVIGTERSDSRRIDNQLRGRAGRQGDIGESRFF
ISMEDTLFSRFATDNLAKADDKLSEDVISTKFFTRLLNNTQKKVESLNYDTRKNLIDYDH
VLSNQRELIYKQRDKILISSDNKDILYRMLDSVIDDLIYQSHNKPNEDIIDIKKLIDLAT
QNIFYDNYLNQDEYYGLKFEQIKTKLKKDCINFFEQKEQLMTPTIFNQILSEIMISNIDE
EWTKHLDITSKIREGVNLRAYEQKAPLNIYVEDSDKLFEKLKHNVAWKTVCSIGKINYVH
QDYSDLNSEFIVNDNEINENNNSIDFENFNESIPTDQTIQESFDDNQSDNEDDKNNN
>UU120 uvrB excinuclease ABC subunit B
MDDFKKFELISDYKPAGDQQKAIDEMVNNINQGIQRQVLLGATGTGKTFSVANVIAKTQL
KTLVLAHNKTLAAQLFAELKEMFPHNKVEYFVSYFDYYQPEAYKPITDTYIEKDSVTNAE
IEMMRLSTINSLATRNDVIVVASVACIYASVSPIEFTKKNLYLHVGELIEFEQIKYKLVQ
LGYERKDYDLVPGTFRIRGDLIEIMSGYSDKFKIRISMFGNEVESIDLCDPITNNIISKE
QRFILRSASEYIFDDSRLAIAIENIKNELDERVKFFLKNNQLIEAQRIEQRTKQDLESIV
EFGFCSGVENYYRHLEHREPFQTPWTIFDFFSYNNQDWLLIVDESHISLPQVKGMHNTDR
SRKQTLVEYGFRLPSALDNRPLNYDEFNKKLSKTIYVSATPNDEEIALSDNHIVSQIVRP
TGLLDPIIEIRKTEHQIDDLINELMLLKNKNQRAFITVMTIRMAEDLTNYLNNTKIKAAY
LHNELKTLERSVIINKLRKGIYDCVVGINLLREGLDVPEVAGVFIFDADKPGFFRSDKSL
IQIIGRAARNADGKVIMYADVITQAMQTAINETKRRREIQLAFNLKHNIIPKTIIKPIHE
DLSGHDYKQNAELYAAKASKNEYNQKIKELKKKMEEAAKKREYEVAAQYRDMIVELEAIK
QSVKSK
>UU121 lig DNA ligase
MDKIKAKIDELKQKLDQWNYEYYVLDDPSVPDHVYDQTMRELIELENNYPQFKTNNSPSV
KVGGFVSEKFNKVKHKRPMLSLSNAFNDDDLKKFDQDNQNASVDLKGYVVEPKIDGLSIS
IIYKNAKLHQAITRGDGINGEDVTSNILTIKDIPHYIDQKYKDYEIEVRGEVYMAFHDFY
EMNDNLEESDKKFANPRNAAAGTLRSLDNSIVAERKLSAFMYYLVNAQELGIKTHYESIQ
FLRDNKFKVSDLIVKVDTINEVINQIDCYTKVRDKLSYMIDGIVIKINNLEVYDEIGYTS
KFPKWAIAYKFPANVVSSQLLEIINDVGRTGKISYVAKIKPILLDGSMVEYATLHNFDFI
KEKDIRINDEIKIYKAGDVIPYVDGVDLSKRLANSVPYEPIINCPSCQSVLVRENDEVDQ
RCLNIYGCKKINIEKIVYFVSRNCMNIEGMSDAIINKFYDANLIKNIADLYYLQKHKEFI
LTSDFKIKEKSFSNLINSINNSKKCSLEFLLTAFGIRHVGPNLAKKIAKQFKTMTALMHA
NFDELTNVDACGEKAALSLINWFNDEHNVSLVNQLQQVGVNMEYIDDFIYDDNINIIDEY
KNKTFVITGSFSISRDEIKTILEKYYHAKVKNSVSKKTDYVLVGTEAGTKLEKAKLLGVK
IIENEFWKKDNNF
>UU122 conserved hypothetical hypothetical
MLGLGILVAYLSHFIRFNFLAFDFSLFTLVYLIYKVKYRFVYLVTILLSLANLLHGSPSW
IGTMVLSLNNLFFVTMVILFKKLFIPKRPKFYLNLWVLVLSSFLTTVFNVIMNGILYTPL
YWYTFKITPTLNFLEVQKIYEKHPTLFLLNIKSYWLGIIALYTSFNLIKNIIISFISLTI
LKIFADKKTIITY
>UU123 cysS cysteinyl-tRNA synthetase
MKLYDSYSNQLVEINDELISIYNCGPTVYNHIHIGNARPLITMDVLYRFLKKHNIKTKYV
LNITDIDDKIINYALANNLKELEVSEYYFNEYLKIKKALNTLEMINPKVSTHMDKIIDYI
QKLIDKQAGYFIGDDVYFDTKKALNYGQLSKRDLENDIVGMRIESAANKHNPNDFILWKK
TNKGIMWNTPWGIGRPGWHSECSCLINTYIGEQVSIHGGGIDLKFPHHENENAQNQVLYN
KNLAKVWMHFGLVNINNEKMSKSLNNFILVKDLLAEYDYQVVRWFFYQADYKQPIKFSHE
IMKQNEKEILKIKNAIYNAKNYLYFNNQLKSLTQIDHFELFDERINDDLDFVGIVDLIHI
SVKKINILIKENKDMNELKLNLTQLLYMLDILGINFVDLHNDENLALLNTWKNYVDKKDY
VKADELRKQLINIGIL
>UU124 spoU rRNA methylase
MNYNFGKKALLDAIGNKQSISKVYLLSKNYELINLINKNKITYEIVNEAWFKQFDHSLNH
QNIAFKLVKKNFQKTSLESFLKLIKDKKNALVLILDEIEDPRNFGAIIRTANGFGVDAII
YKKHHQASINDLVIKTSMGAINYIYMIEVNNLSNTIKNLQDEGFWVYATSLLKSQPYEKV
DYANKTVFIVGNENKGVSPLILKNADQSIRIDMFGDVQSLNVGVATGIILAHYRTKIKP
>UU125 conserved hypothetical hypothetical membrane lipoprotein
MKKNKYKLLIKSLVITSFLVTTSSVIVACTNKEKEQHLTELKKLSQHAKQIYNEIKTNEL
FKKEASVLNDQINKVLKINEQNNLDVITKNYNDLKKLLDEIQEKISKEKEKEKQQNAYLN
KEINIKLENLNQIVNHNLLKGNKESFFNQIINFTPITTEIQTIINQNQNLLDFKNEELEL
KLKNLDLFIKELDHKFKNIIDQLFNIEDSYINKFLKFINNQDFIKDQKYQEREKFNPQEY
LELTKSIQSSFNKLKNVTINSNLDQYLNSLNLVLLSLTNETKAFFTKFEDQIKKYFKWIV
YGRDDTLTKAFNRIVEEQKRNEFIEQTEKALLTFPMEINQKFKMFVDFFTLKNDKNETEY
QKIWKSKHNEVNKVWFGIAECFATGKCTDKNKPS
>UU126 unique hypothetical unique hypothetical
MQKKILKNLSIGVVSTIILGSITISLSNCSYNKKTFSSSTITNQDTKNLDIIAKNIKFKY
DIFENEDEQIIKINKIKVVGDLGQAKIIIKKVIIEQKSNNFFVQYQLSLHNQTKEYTQNL
EINKKQSVIETKYINDELINNDYRPFALKQLLSSPQNIKKTSDLSLITMQKNNQEFNNYF
NFIQNEDNFKQLPFNQATLLTKQNQLTDHHTNFKFEKIEIDKQNQIATVSFSHDSDSQTI
QKILNATNKRLLIKNFDWTNPFSKIISYEKINNNQLRFSLKDFPKSLTKFIITHIQYDDV
VESLGRDLKNLFLYNQIEEELTLKKLNFYLQENEVYGSAFFDFNEQTLKLYKNKIFLFEF
TLDENYSEAKKNQSLIAKYTPPIQYVRVPFKSLWKFKIPHLYNGYLYKLNRISVRDNNSL
TPFAFVKVKELNTSTFFVKNIIYNDRKIIDLYYNNNQFFSTKYQTLKNKNLTLNDLYKLW
ASNQNNLYLDYSLRNFISLVQYENTYLFYQNKTNEGFYDFITKKADFILVNNNEIKNLHK
TTLKDNPDLIFKKDKDNYFQLTKKINKIKNLNLVNEKNLVFNITFGLDPNLIKETNLWKN
LMLRSQISLAVPYKTLKNKKVIEDAEFVLNYGIGNQEYEYELYKKIKQDFRFQISYINDE
LKIKIISKNNISVFDNIWEHNSSIDSSYFLTKANFNIYYLNNTTIDIMEDDKSNNQYTTR
IYKNNEQNFLPIKNARDRVISLSLIQDGTWNVLGKVKPNDDDDYRYYLISCAHVLNSTQA
FKSINKTGNKDLFESSNSSNGDFDPLVPQIIHENETLNDKKNPYYNALEKNGKLEANQNQ
FQFLNFPEKISIESIINFDHQVKNKLSPHVNALGFFNPNASLDFSLITINLKPFFQKYGQ
LENSPAFNDLTKEQQSVIRHIINFKDLKPLKLSNQTKYFDDNQNVKWYLSTFPRTETINE
FNAGKLPRYREYEINKYDKIQENIITTNNYLSTVGTTKISNQYFDVGSGSSGSVVYDENG
DLVGMISFGAHENAKFTAGGMIVFDSLISGFFGDKNNFANRTSLIQQIKQLAYLYPEKYE
DIYK
>UU127 unique hypothetical unique hypothetical
MKIIGSAFLGIVFCILLAFAIIFGIEIDYYHQGDYLKYLNFLDKLHQYNKIDNSFEYSNH
YESALIGVIVLTIICFLIFITPIIIIVITKIKEKKVINKKI
>UU128 atpC ATP synthase epsilon chain
MANLTKLKIVTPYAQILEKDVYSVELKTSEGRITVLPDHNPLMSTIENHVAYIRELPNTP
RKPLLLLDGIVYIEQHQVRVFSDYFKFLDEIQIDEINSSLNQLKHDLNNEEDDKKKLQLK
SKIKLNESILIAYKDR
>UU129 atpD ATP synthase beta chain
MTEVKKGKINQILGPVVDVRFPSEWLPEINTALELNNHGSKLVLEVSQLVGDNIARCIAM
DTTDGLVRGQEVINTQKPITMPVGKQVLGRMFNVTGDPIDEQPAPTGKRMPIHRPAPSFA
EQAESIEILETGIKVVDLLVPFAKGGKIGLFGGAGVGKTVLMQELIHNIAKNHGGLSVFA
GVGERTREGNDLYYEMAESDVLDKTALVFGQMNEPPGARMRVALSGLTMAEEFRDAFGQD
VLLFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLAFEMGQLQERITSTKKGSITSVQAV
YVPADDLTDPAPATTFSHLDAKVVLDRAIASLGLYPAISPLQSTSRLLDPLVVGVKHYSV
ARRVIEILQRFMELQDIIAILGMDELSEEDRQLVMRARKVRNYLSQPSHVAEKFSGQPGL
SVKLEDTIEGFRKILDGECDDIHEQHFLYVGKIDDVFEKAAKNK
>UU130 atpG ATP synthase gamma chain
MSLDAMKRKINSVQTTAKITNAMKLVATAKLKRQRDRLAAIKEYCHDYYDVIGLLLSVVD
DVEFLKIPNAKDRTLYITINSTMGLAGSYNYNVNKLISKIVNETDITFTIGKKGHDFMRL
SGRVDQVNTYLNLNDNDLTFDMSLQIAREALELYSQGEVNKICIIYTKFINAITFEVSVI
DVLPFDKTALIKDHLAETIELAKDNIIFKPNKFELVKKILPTYIATVLYGSLIESKISEN
ASRRNAMDAATKNAKALAENYKLIYNTLRQGKITREITEIVAGSDD
>UU131 unique hypothetical unique hypothetical
MNQIKMNKSFAEFSKLPKIKQVFTPWFIAALVIFIVGLTIAFTMVGLLNEGFENARALVN
DQGQIIGKVADVSGDNHSLMSWLGYDQHANYQELYKTIHDQLINGKTMESLINNTNKNND
PKLYEALHYHAHSKFINHNGTWGFVTKVLSDWENSWFYKYNQLFSQLANSQNPVLAAQGI
KSLAKLSTIIQYQNPNYIAYNWVFIVFMMPQMITFIIIVVKLATVFSPKKSAEEKQAYKL
AKLEVKNQKKAKKLNNSLQQINLNLEAN
>UU132 atpA ATP synthase alpha chain
MTDNKNHSLISDIKSQIKKFSEKALTLEVGNVISLGDGIVLVDGLDNVMLNEIVRFENGV
EGMALNLEEDAVGVVLLGDYSNIKEGDRVYRTKRIVEVPVGDVMLGRVVDALGKAVDNKG
NIVANKFSVIEKIAPGVMDRKSVHQPLETGILSIDAMFPIGKGQRELIIGDRQTGKTTIA
IDAIINQKGRNVNCVYVAIGQKNSTIANVVRELEAHGAMEYTTVVTANASELPALQYIAP
FTGVTIAEEWMHQGKDVLIVYDDLSKHAIAYRTLSLLLRRPPGREAYPGDVFYLHSRLLE
RACKLKDELGAGSITALPIIETQAGDISAYIPTNVISITDGQIFMMTSLFNAGQRPAIDA
GQSVSRVGSAAQIKSVKQTGASLKLELANYRELEAFSQFGSDLDDETKRILKLGKAVMAV
IKQAPNKPYNQTDEAIILFTVKEKLIPQVPVERIQDFKEYLLNYFKGTKLRADLEDKKAF
DKENTPAFRCAIQKAINSFLNNSQDFKPCEEAEQTAFDKFFNENESIVVDGENDFNFINE
EVSLKPTTETSEAVQIEEKVQDFVEPQEILETNKMEENHIFEEVEPEKIICEHHEFEIAE
NQEKIEGQQVLEDTNHEYSIYETVEQSGEVDNDESKDDDLEVLVPVAEIEHDEAILDERE
NRNWVFSDSAVSEVEKQTIMISISSNEAEQLFDNAKSVVFFKVTPKYPVEKVLVYVTSPV
QKVVGEFDLLKIDVNSVNTSWNKYRSSSVISSRKEYLEYFNSHKEAHALLASKVYKYRKP
KDLASFNMNKGPSGFTYLK
>UU133 atpH ATP synthase delta chain C-term
MQSNTKLAKYSKIIANRLKAYSNQTRFIEIKTAFELNDEQKQRIKKTVISRFGDERPIKF
IVDPSLIGGISLKINLEIIDSSLKTKLNQIINTKEKEGA
>UU134 atpH ATP synthase delta chain N-term
MKSSLKPVEKYAYSIFEIAKEEKKLDLYKHNLETINSIIEEVPAFFEAVGDPARDRNERK
QIVIKNLEGEIDIYLISLIDLLIDVKSVKLLKKIVLKALDFVNEALSVKKVLITTAYELT
KNQIDRLLQSLKKKYVCEKIEPIVVVDKSIIGGLSINFESQVLDNSLKTKLFNIVKKVN
>UU135 atpF ATP synthase B chain
MKLNKKHLVAILSVLSLSIIVVPLLTSCTGDIPELNPAEIINTLFPNVWVFIAQVIAMCV
VFSLVLWLVWKPTNKMLDKRREYIAKEITDAENAKQEALQYLENAKSEHLAAQAQTLEII
AKAKSESLTLRESLEKEAREAADKIISSAKISIANERRENLERLQSEAREAAYIAAEALM
KKELSREDNDKLVDQFIKELENNEK
>UU136 atpE ATP synthase C chain
MSSFIDITNVISSHIEANLPAIASENVGSLANGAGIAYLGKYIGTGITMLAAGAVGLMQG
FSTANAVQAVARNPEAQPKILSTMIVGLALAEAVAIYALIVSILIIFVA
>UU137 atpB ATP synthase A chain
MENYSPLDIMIALPHIAAIIMVTLIIGTVSLIYFSMVKKLTVHDVPNRFVIIIGMIVDYF
RGLVVDTMGAKHVKLAPYVLFTFCYIFTANLVSLFGFKEATTASAVPLAMALGTVIGGQI
VALKYQKASFFLKFAFKIKGFPIMINPLEIVSKLTPIISLTFRLWGNISAAAILLNITYW
AFAGFTNVVPWVGVSLIAAVVILPILIGYFTCFAGTIQAFVFTLLTSINWGLEIKEGEEH
HAHLAHKKAEKLAAKKLAELDTQNQIQNNEAQVVL
>UU138 conserved hypothetical hypothetical - cytochrome b
MNLKRMINSYLIIFLPFLSVSFVVFVFLGILLEASWSFFYSYLLVIPFGFGITLLRIFII
SKLLNKRLKMNNLGVNPKKYRRLPANFFAFGTIYILFNFLILVPLIIGNLVNLYQSIFET
ISLFVLTFFMFFIQMGMQIYLGIKKDKGEKK
>UU139 unique hypothetical unique hypothetical
MDEQIFIQLLENNLTNSKSYVTQPIILEFKTDVFLIINQILKQYKKGKIIKNNTNEIILE
IDNKLISITNLDINKFHSYQIVNINENKNIYNERNSLILFDLVNYIIEKNQNSIRHINFW
TIQMSVVNWIYFITYNFNNSYLIDPNWKKYVFKIKKDESKGVISTNLLHNYGFVDFVVQS
KSQNFLKAYRVQDEILKSVLNLGDNLNNEFLEEIMRKYDTYKIIDRDHKYLVINIE
>UU140 p115 p115 protein
MIFLKKIEAHGFKSFGEPVVIEFKHPMTGIIGANGTGKSNIIDALKWVIGDQSLKSMRAH
KNDLLFSGGRYAPKAHIARVNLYFNNVNNVLYTQHKEIKISRVLNIKTNENTYYINDEVA
LLKDITDMFLDSGLSKGSLGIISQGAVSWFAEAKPNERRKMFEEASGIGRYSKRKQEALN
SLSRANENLARLNDIVANLKKELAKLQKQAMRFNEYKQIKDELTKLDLVIIVRDIIHWQK
QLNDIQENLKEYKKEYNKQKPLIQSKKNEIESLRVISDRYAKEYTNLEFEYKKLEDTIND
LNLKLSLTKNTLETTAFNATNTQERIDAFATLIKTTEIELNNNKKNINEKKDQLKDIQKQ
KLELESLKTKQKNNLDTIIWEIASKNLKKEMLEEQFKRQTENERGVKTIIDSQKALVGVY
GTVAQNISTKTEHELAISTALAKGINNIIVKNNQAAENCINFLKKNNAGVATFLPIENLQ
AKSIKPEFYDVLKELEGFVGVANELVKINVNYKISIDYLLGNTIIANNLKNAIILSEYTY
KNYKVVSLEGDIVFGGGAISGGSNSKKNIILNLEEKIKELDLKIKKLNEEQIELNNLHNQ
TKKQWQEYYNSEQIINGILNNLITTNNSLSDNLNNYKSQYEALSATKLSKEEIESKISDN
WNEYNKKKNELINLKQKIQTLKANLNTANLNKNELEITYNKELEDFYNLDKNITSCESNI
DNLNYSIQNVQTRLVDNYKLSVENAIETYQNQEIDMSESAARLRIESLKIDLEKYNDINL
NALEEYEEKQAEYDSNFLEYENCKQAVDQISSSIQELDKKAKADFMRVIRETNKLMPEIF
EYLFGGGSCAISLNDPNNILESGVEIIANPPGKRDVPLSALSGGEKTMVVLAVLFALLKI
AKFPLVILDEAEAALDASNVAKFGAIIAKYSDETQFLVITHREGTMKSCGYLLGTTMMNN
GVTTLLEVDLNDTKIKYESEL
>UU141 ftsY SRP family of GTP-binding proteins - cell division protein
MGFFKKIFNKILGKKDTEQISQEISQKNEENRILKLEDNSINKFNEGLRKSSSALTDAIN
ELAVKYIDIDERWYEHLEEVLISYDVGYVATNKIIESIRNEMIYQKVNDPDLIKSIIIDK
IFIYYIQDTEINTAINLKENQTNVVLVVGVNGVGKTTSIAKITKKFIDENKKVLLVAGDT
FRAGAVEQLKVWAQRLGVDIELPNKEGQDPASVIYAGVKKGYEQKYDLVICDTSGRLQNK
INLMNELKKIHDVIHKFDEYAPHETLLVLDATQGQSGINQAKAFNEVTKISGIILTKMDS
TSRGGIVLAIKDAFNIPVKLIGLGEKLEDLSVFDLEMYVDSIVLGMKLDVK
>UU142 conserved hypothetical hypothetical
MLNKNKRWYLIALYDIYQGLLTTKQCEYFNLHYFKDLSFSEIAELKEISKSAISDCLNKV
CDQLLKYEQALLIYEKNKKRNDLYTLINDSELVKKLKDI
>UU143 conserved hypothetical hypothetical
MKRIKNRKWWKFGGVLFLLPLASFLIMCKNQEAPKTNQEAPKTNKENVLDDFDANIINIE
NISKPKFINQNKTIINLKLKKFNFKSPNTTITLTYKDNNGHKFTSDPLSINDEQNYDFIF
SNLTPNRKYQIQNLTFNNQKRTDIYLKTNLNNAIFSIKPIPIKTNNFKIKVFNQNALISF
SIPKNSDVRVNEKIALEFENLSSNLVPNNEIISRIDKNFNVEFKLDNLKLNNKYRIVNLR
FLDTNPPNVSPNIFEKLSNYESSFIIPGIKTNMHNHKDLNSNDKKYIDSPYNTKIELNDK
NNFNDKVLPDAFEQQNINIQEVENLNQDILNQNELELQKYFSFISDQANLKDKDFQNYSF
NDINKNSKQEIKFKIKHINIDSSNKKAIIELDSSSSNDNTKLLEANNKQLLIKSYDYNNP
WSKIVSYEKKDNNKMIFDLHDFPKDLKTFIITHIRFDDNITSLGKIKENSFEYYQNDKEY
LLKSLKYYFDIKENQLYGSACFNFNNDDFKILKNKTFVFKYEIDTKNNILNKYIPLNKYI
NVDFKNLAQFKIVNVFDGLNYKLESIKIVNKNSLLPYNDHVNIQNANNTNFSVWHKVYPK
QNIINEFFDDSLIKDEFNLSKIDFNHLWKNNTDQKNIPYSLRNLISLTLHEREYAIYKHN
ATNGFYLYNTITSNKDFNLIKNNKESYHLNSLIAHLAIKDEGLKKDESAGFFLEKDLNDF
DNLNNFKDEDIVFNVDLELDPNLIYESQLVDKNMRRSHVIIPISYKVIKKQHILEDVEFS
LNYALGSEAYENHIYQQIKSQLKFNVFLNGSKIKVEVKPRNDNIKLYDYVWKHNNSNQPS
YFIGRYDFIVNWLTNNNEVIIDKKLEEFKKKSYTARILKDNENEMSKAAIKQVRERTITF
SLTSDGTWNFLGKVKPNDPNDYRYYMLTDHHVIGSGGSWYNPQINWAGKMEYESINLNKK
TIYDDDGNEKYTYSNFADYTVVIPQTISQNDLNKDKYQPYYNYSSVNNQDTPGKNQLQYF
AFPFKLKFEKVMDFCLQKNNIYKHYNALGRYDDKISELDWSVVSIDLKPIFEAFKNQDLN
KPFIYNNKTLSPEETSVIKYFLSLKNIKPLEVSPQTRYVRSNQDVDWYIGTFPRYTNTNQ
NSMGVGELRYREYNIQKIDSVNTNFVTGGKGVLYKSDIPYTTISTDYIDAAGGSSGTSLY
DEQGRFVGSIATGRTPSKNGHPTWETIGWSLIDSQISGFFGDRENRANNSSIIQQIKQLA
YLYPEKYEDIYK
>UU144 unique hypothetical unique hypothetical
MSLHKTIYIKFNNRDYDVKLTNVKIANIALNNDNVNNIEQNHISFRHLSTNDIKNSNDKV
EAKFSIGLGFDISEKLKNIAFKKLDTNTNKLIDISDPTILRLTFYEYNKDQKVENNLAAP
TDKTKISVVEIKKSQLMNSSIVSFVKKLNKNAKYHMANIAFNQQLLPYLNKQFNVNADFP
IDLEQNPIDFNDNKQANDEKIKKTKESAIKVATAIAKQIVGIDYKGRDIIKNFIELDNVV
NKK
>UU145 ripX integrase-recombinase protein
MERQSMINKFLQSIKKRNLSKNTYLTYESHLRKFKVQEQSFKQIIKQLLNNNYKPKSLKL
AKSILSEYWKFSKQYQYVQELEQIKLSKEQKSYKKVFSLDDIKKCLKINKQDTKQIKFYK
TILLFYATTGIRAMEIYQLKQINNDLFVISGKGNKNRQICYIEHLWNNIKNKKLPSTKTL
RKYLKVFFDNKNVSLHTLRRSFITNFLTSNENYKRGDMLKIVQDLVGHENIQTTLQYVQI
TKEQVDDVYKEFFKEFENDK
>UU146 unique hypothetical unique hypothetical
MINNIFNKKLLVYNEKDQRWYNKFDRTKPLFSPSRLLSFKNYIFEKIPAKNLEYPIEFGT
SLMQIIQYYFENQSKLDVILNSINEEKLKEVFLLFLDYLKTNDYSLIAVELHLFSPKLNH
YWHGFADVVVKTKDDKYKVLEIKTHNEIQSVPSWKFQAGVYDYIISQELSNYEPSAILAF
SRKQAKLSVYENDSLDLSFINKINELYS
>UU147 unique hypothetical unique hypothetical
MNYILNKNKKVSLTELMNQQPHWYLEELQEHLIKYLDTNGLNDTKKLIKQTIKEWKK
>UU148 unique hypothetical unique hypothetical
MDKIKNYLEKLQAFYKLYSLNLTQGTEILIIQIIDKGNLIFDSIEKGKTFNESKIIEPLL
FIFKKINTILAILKLTFTKDDLIGILQSLEEHISEFIIANYKYDFEIEEDDED
>UU149 unique hypothetical unique hypothetical
MEKIVGFIVNIINVQKQMIKDLKELKNHKDIMVKDHEKLNDMLNSMIDEAVKNYKIALKN
ITEILNVHLNCVLYNHNLKCGVKDEKLLLPLFKRKKAS
>UU150 unique hypothetical unique hypothetical
MAMLCMCDECQAIINYYVVQIEQLCNEIVKTRKRVEPYKKLGKLFFEIIQNDLFEAIAEE
VFRIDEKPKRKTNKRVCK
>UU151 unique hypothetical unique hypothetical
MKNQNEKQIKEYVNKFKDLRNQLTKNNDVKKVCDLINDLFFEVYKNNLIDEVIKEINKHD
>UU152 unique hypothetical unique hypothetical
MKLSRRLTNMTNWDKEHALSEELRQLKDEFEDLMDDLARINKDLDFNIWERKDLEYRKAS
YETDIESIRLRINQKQNEMMEIIKNDK
>UU153 unique hypothetical unique hypothetical
MTNSIKREILSALNDETKKVISKLQQTNNLIKQLSDEKKTLEQYLKDNVNNHEIVDLDSD
LKIKIYDLTSKDSIVLDYDKIITDYKVDTKKYETIKKGTTSTRITWSGADK
>UU154 unique hypothetical unique hypothetical
MVKDDKLVPSIRLLTPNELSEQWANPNSEINQITRAVLTIQGIDLKAIDLNQAAQIIYFC
QANNLNPLNKEVYLIQMGNRLAPIVGIHTMTERAYRTERLVGIVQSYNDVNKSAKTILTI
RSPGLKGLGTVEAEVFLSEYSTNKNLWLTKPITMLKKVSLAHALRLSGLLAFKGDTPYIY
EEMQQGEAVPNKKMFTPPVAEVIEPAVENIKKVDFNEF
>UU155 unique hypothetical unique hypothetical
MSSNNFDNNMPRIEFKKMPLTFIRLNTKKSNNAPFVSGSFWLADKVNANVYFSEYLMERI
VPFENNKTNIVILENVSCYINFNWEEKRIIMRVVSFDNIFYKHQLSEQQTIDFVSAEKEY
NYQTQTVNSYSNSDDEIEIINWLESDEQKAYFDSQLMFIDYKNQGFFKNKTMPDKLKNNA
NALELYKQIIKLDLEAFSGLYNGLKPFEAANKLIEKGYITLNDFFKYAI
>UU156 unique hypothetical unique hypothetical
MRSKQWHLSTQDANLANKKYDYIYFRGVNQLYLKRLKKSSNKFFVYKKCKIVPRMISKHL
NNDHLINVNDYVPLTKEFIKKSVEKEVKHYLRFISYENKTKQMPELINFLEKSLEDKLFI
VAKDYDPLFSVFLRYYIQSLIEKYINELWINEW
>UU157 unique hypothetical unique hypothetical
MNKWVIGIDLSTTITGVAILRNEQIIKTFAVAFDNFNEKNLYNNVIRLIKEINLNVWLLA
DDDYYIGIEVANFSNPKLTQRFSIYAGMIIALMSQVLRDFNAEFKMFNANAWQLKIPQIQ
YNTLRKDRKLITKNLMIKTFNIKSNLNEDEYDALAIAYFYDSINSTLEQEEITKAKKIVK
MNKVKQQLSISKKINKLLEKKSKLKKATAISKVDEQIEELKKLNK
>UU158 unique hypothetical unique hypothetical
MTKQEFKAITKELFFFNKKRLMLWIAILIFVIAFAMIIVFVPFFNFNDKIKSLFDKLKHI
NWQDPTALFGLVFSVLGYLITALSIPLKVFELMLMLRFRLMLAKLIKDGILDPKAFIDDI
RHSYLSRRKQRKLEEEIEYLKRIKSDY
>UU159 unique hypothetical unique hypothetical
MMNNKNKFKNKEWKFSKKQVQLIYLTSSIISGLFLGLALLSTYLIAGLPNDNAFVLFVKE
QKFYFPFFMTIGFINLIISMLTLLPTLKTLWRTVAKMHQYGDLSKEEFEALDILVEQIRN
RYISVENIKAVISSNNYKTLDEELKKLEQQEKQLKIQEQEQKVKRLEQEIIKDDKTRVQS
DY
>UU160 unique hypothetical unique hypothetical membrane lipoprotein
MKEYINRRILWLWILTTLWTIFLICSFFIKIGETSFVFFGKESEYTDKATLWDWMISKFP
KLGSTKKWQLFLVVLFAYIICGCVDFFAISPFFWRFTTEGKNWHLKTRIEQDKLKSEWKA
INEQKRSIKKAQNDLYKQNKESILNDEQ
>UU161 unique hypothetical unique hypothetical
MANHEVIFKWYLSLNFNNSSVDWSDKDYSLTFSFDRNTDRNNMLSDSGETQQQILLWNQY
QPQFLVVRVNAEKSGVNVDLWLIDIVNKTFATNFEVGLNYEWSVRTIYVGE
>UU162 unique hypothetical unique hypothetical
MNNRLLLSVEEYLSLFPLIVRNENLEDNQLQLERKKQALTTFILRAQSMIDDCVASNGGA
GFIYSWFDDLKTTDYQKTKFKEAIATLTNYLWLQGHFIDKDYTSAIGDGLSLSFKSENAD
FEKKRLDIINKLRVCGLYKKSKFANFNDDGIYVNYDELKINAINNVHEELRDHYISKNNP
VVNNNFDLNHHNINNVSSINASGNLATLNGFILNDCTLPNDLTTDKSNKVYDNAIANYVD
IHDVKNLAWYGQNNNNAITRQELYEYCNKINSKMYWDAIYDYKAGELVYDLDEKTNTIKV
YKALVNNGVSTHNIVDPSKQINENVWELINIQQIDLNKIKEGVQDAVDNKVNEVKKAIDT
KENTFTKNLENKVNEAKQAVLSSYEQDKASGVFKGEKGEPGIQGPIGPKGETGPKGEKGD
SANVDALTSNLESFKNTALNRNVRFPWKIMDNLNKII
>UU163 unique hypothetical unique hypothetical ATP/GTP-binding protein
MGILILILRFVGRLLLSKIKSLISTLINLFSRMLKMFKFDFFKMFKNKTGAFMKKGKTVF
HDFNLKPDDILKKFFDNSSLEKIFNSKELKIIQDNKDLAKKLKDAINEAIKDIAKQTSKY
TTKQKDSIIKHLTDTLDNASKTEKKNFEKVRKENQFKDVDNVDIDFNKHWIDYGTWYASD
GVGKIGYLTLKLMKPSKRNPLARYTWRNIPKRIATMLKFAPTGTTFWNIFYHANRKNLIH
LQKESIYWFDASRKYFEGVK
>UU164 unique hypothetical unique hypothetical
MADNQNTWKRPDPNAKYTITQYLDVVNANNERVVAGGFEKYMLENQFNAEFLGSATMTPT
KIMDDMRTAIYEVGVIGQVEEYRDDFTQKQVPAIDRLTLHLSNDYQKEVSISVFDKKTGA
QWNDFLAKTLANLEVVKQDQINLINIDAIYQSCLATGNYIIIPELSPDRVESLTDDERLK
IVEKIYRKAKQVTKSRTKFNLGADPNKLRFVLSDDAALVVLTAKTYKIRDGQAYSDYSTK
GLGSSSQYMGDYLGMPIYSSAYLGEDYLKSTDQKYTSNLIRDYKFSKLSGIITMPETTIC
LKQELMLTTFQSPTSKSHQLIHNSWSMNSAVFPQFAHLNFVILNDKPTKDEINKARSNLY
SQFPSLYAEFKTPISEDSKITEVNKANWRGLSTYK
>UU165 unique hypothetical unique hypothetical
MVDELEKNQVQPQETEENKENALYDEIDKRIQKQFENYLKTNEQLDNANKLVEAKLKEIK
DLENTFKQREQELLNKIATLEQNQQFVNIHQEKPVVEDANSHFLKFFN
>UU165.2 unique hypothetical unique hypothetical
MNKIIKFHNERIKWLWILTAILAISFFVICFNNVKWIYTENTAKYELLTSSLEKIVKFYS
FSLVDKPFARGVPNSIDVFSRAIIGVAFGLGFVGTMLIDYFIISKVAYIVKQKIKQSKKV
GM
>UU166 unique hypothetical unique hypothetical
MESLKMSNIYLDELEGYSQKNIEDSIDSLIEPNQKPIHLCPFRILKGFIKITNTGEQSLL
VNDKDFSTVWNIKASNEPIIAYWDKSFTYNFKGSLNYISKDYARIDPSNTTLKNNFKPYY
FQAWVQNYSQANNVSTIVFNDKEHTVIKTITTVTLIVKYPSVYEDEIYQNEQGNLVSHKA
KFKQWTTDMLKEYLFIIPDEHAQANQWLMVNEVIPFYSTTSKRYEGAQITLTNVNDLLTS
SGNDILATIQPCQPGDGYLWPVIQNGKLTYDERKEKPLGVKSIQLLTNGPYALNSMLITG
RTYNNDTRELSANKRLLLYKAKIPVASKFFNVSAPTSNYVYLYNAFFEIEKIYKDQYEKQ
KDFTFDHNANIKLNGGLLLNHKWDASNNALSYEDNRYPFKLWDEGFKIHASFFNFKLGGT
GAQKGGSLTENAEQKKPLADAVVTGQVAGEVVSTVFESIGRNVSQGFNLNNLGLWSFNMG
FAKTKAEQIKEATKIGLNNITMPPGTNLHTFLNHNAFMYDLIKYLPYSYKETIRQNLGEL
IDNTPLSLGKVRRGIVDILYPGWTKVEDATGYNMSNIWLNTRGFNFIAPCLPLELEVSNK
LKADLINLDIFTNKPAKTFSPLGIPAIACCYHFDITDRFAKFVDDELKVFDTELIGQTTY
RDGTYIRKDKKPLYWDSFCEALPPNTPLSYEPAVINIASGKREDVNRVKYPYVIDTIDIK
GLGKCDIKLTAFSGFYSPDARLKDEFKNVYEAIFESNGKYTDDMSQWSNYINFSTLDEIN
SVGTKLSYPKPPVETDFLKNTKTNSDDGVNASLQTINETLYKVGDNSLLSATQYRKPRFY
FYEPDSSKLANLFGYGSYTNKLNYLFGGSNLSDVIVANKVIAYSFVFKWDFNYREWLNLG
SVNKTKRNLKLTFEIESNWIQKGWTNQFNVDNSFNQLITLLVLN
>UU167 unique hypothetical unique hypothetical
MKVELYTNDWIDFFKNIAIAWFKTKRYGNKRLSSIEQKQVNKLIRQEFDQYVEFKIISNL
IKDYNDNMEKVISLYGANLMPLNLAVQKLYPELTPTEQDELVKELEHKQKLENGEFENE
>UU168 unique hypothetical unique hypothetical
MALKTNTIIKSKWNPSNFDINIDIKEMIARTAQESTVNDVILKTKDNVPLEWMEFIDNIN
ENNEILKLIKGDCRIKSLYGINYVGFEIYNNDILIFNADINNAMNKSIRINQQQEYSSTI
YRKIALMKDSEYLSLKELHTPYEIKRLIYNSTGVYKIIFNEFEVSTPMYFKDIFKNKNVV
HNYGVLCTKEFLNRSFIDFENKINEKLPDWYPVNDLINDTNALLNFIKKERELNKTRIVG
SIINHNDAQTYRNQWIDEIQYMSSDLILNTNTPDKNAFEIMQSTFNESIHLQAITEKLNL
IFKGCGYVWNMGDSLSYQNSETATNLNKATFETQKWK
>UU169 unique hypothetical unique hypothetical ATP/GTP-binding protein
MRIKLDFIECFGFYSDLVEFVAKKLPIPFNEINLLGGRSSGKTFATLDFLSSLVAIKQQN
AIYVFRQNISDAKKIFSDYLNFLDQKQLLKFAKINHSERTVIINGWTVMFEALNETRNNI
NKGAKVGFRLWTQARYVFAFFEEASQLDFNLVKNSQQSLRGTKDTQVVSIFASNPWTSEH
WYIENFNNHLAENEFSIQQKPYYEYSVVDKKLFLRSTYRANKFTSQQEIEQFEWWKDIDY
SKYRVISLGLSGSVEGAIYARSLSVMHEPYGEYDNYAMQFFGGMDWGDGTSSSSSDTACL
FGSISKENGIEILDEMVYNNNVNPLTSEQQIELVVRWFIKKQQEVNVKIVIYIDNAHLRY
FYETFNATFKRIAFQYNMYGSELVFAPAIKHAIWDRVVLVNYMLASGKLRFSKNACPKLY
KDLKNCYVVLPKTIKEDTKKERSHEHTHTINALEYLMCAFHLYFYAQAPAINEKGAIRYG
T
>UU170 unique hypothetical unique hypothetical
MMKRNELKQLQELQLKINDFYTLVMTTKNLDLCNLSALLEFLGINWGVWVNLSTQRDEFN
KKRYEYITKANYGLRMALNELLGRNASYDKEINNQGLRKFRTQEYFKRLDFELANEQKST
DIEDTTITFEKVDDNNKLTIKKLINVI
>UU171 unique hypothetical unique hypothetical
MIANKITINKIQNGTATIEVTFSKFKLADANKKDFVLEVKDSANDDASAISATELVFDAN
KKILTGKLNGLASNINYKISKFTLNNNEIKFDFKQEDQQELLNQYIQQAELNTIIDKANK
KINIKLQNFSILNSFQDNQPVLTFDIEINKKDGITQVVHKSLTKNQLLNPNGLEIDLKDK
MKNNIDYWTLAYVVWFLAI
>UU172 MBA paralog MBA N-terminal paralog
MKLLKNKKFWAMSLSAIAISTSIVAFAASCSNTNIKSKLSKQLAQTKDQKNHFAVYEIEN
YTKLTDEEKKSLENLEFGVSILDKDGKNPINIKVKGVQKEGKIYVKLPRKPEVNEKLLVV
PTKNILKTEALVLNNDNLNYQTVTFEQVPDQKLEPKEEKQTKAVDYEKAIKDEDYVKQIT
LSNLEKYISNEYQYLNPNNKTLDYKNHSFVQKFLDEIDLLAQKLESNDLNLEDKQIYEKI
ILGLRWLLAEDNNETKNKALELFKDYFTTIMKATKVNDKVHYDPSFINEFYGSISNLFEE
HDLEPSVEIESNKIRIVKEDKDVIKDKTVTATFNLYNGFDWSTLLKDVVFKEYKKDSNGK
PVIDEKTKMPIETDKIVEDPVVMRLEIAEYPKDWNTSKENPKNFSYINFKKSEVLKSPKL
VFTKVFNLDKEQKYHINNVMFSHKLIPNLLKALDIKNNTTNAELIKKIKENMTAIDEKTQ
TNLNTNYIPLSLTETNNKK
>UU173 conserved hypothetical hypothetical
MRTGKYITKYDYIGYYTKQKAMWFFTNAEIKAKIDLLLKNVSSYDFEDLDDEEEHDYEID
AYEIYKEQTDFLSQLEINKNIDVDNPKIAEGILLDKASQEDIKKTYHYIKKIINFETDPL
FKNKSLEELANLTLELIDKNDKIIFFQPVFINDKLITKPDCFIKKNDEFIVIETKGTSSI
KKHHILDVFYQAQVISKHPYFINKCISYQMCIVDYVKLKKNQVNFTISPYYNYQKSVVLS
LPPSAANQFNKFEINELKRKRKRGEAIYLKKDENKKYYEDIDAYDHCKGILIDDLIDGTY
SSINDYKEAKKIYDYKTEDLKDDVRFNKTMDELIKGIEKLHNDFDEVISELLVHKQNLLA
LPIEQRIPNYFIPSYNDKGDYKDNDFWLELRNLYAYSGYDVIKYSGKILTIKKFGLDNVT
KDILGIDILKTYANQTFFNLYKNNQIKIYQAAVDLFAKLKSKKVYFDFESINSAIRAVDN
SFPFTQTVTQNSIIIDDGSCDIKNLKCTNMIIDPREINNEWFKAIIDKIHQGLEYSYIVY
NKSFEASRLKEMAEFINEEIYELKVSEIIKNMYDLADFFIVSMGKQLIVIPELKGFYSIK
KVLPIIEKEFPQIYHDVNCLNYKELSVGNGLVCQTKTTKRFFNTITDLEWEQFVHDARIY
CENDVRAMIAVEYFIKKLIDEAKMKNLILS
>UU174 conserved hypothetical hypothetical
MGKNNKYLIACDLDGTLLNNDSDISEKTIEGIKKIINQGHIFCIVTGRPLRGSIHIYEKL
GLTTLMANYNGSYISNPSDKKFAPINMTFSKDIVSAILKNRFIAKNIVNAVVEADNVATI
LNSNMDLNIWKSFIDIFHVPIRDMNEKNKLTKENDINNLIRDANALLLNVNDKALFDSMV
YHIKQIAPTLAVRSWSARVDDQFEVIEINSSFADKAMAMRYLSSYYGIPLDRCIAFGDGE
NDLTMLNHAGYGFAMKNGTRPAKLLARHITKHTNVENGVVWELEYVLNENK
>UU175 trpS tryptophanyl-tRNA synthetase
MKRLISGIQPTNNLTLGNYLGAIKNFVDLQDDYEVFLFVADLHSLTPNIFDNTDFSTTKR
QIIATYLAAGIDPKKTCLFYQSDILSIPLLAHILLCSTSIGELTRMTQFKDKSIKATKMA
NNTEMIPSGLLTYPTLMAADILTFNADVVPVGQDQKQHLELTRTLADRFNKRYGNTFKLP
QVYIPKIGAKIMDLLDPNIKMSKSSKNLKGVIFLNDSKDIIFKKIKGALTDNLNKVKYDL
TLQPGVSNLMTIYACLTNLSFKEIELKYQQQNYGVFKNDLANIVADFLEKLQQKISYWLN
SPELDIMIDNSCERANDIAYQNVQLVLKHMQLK
>UU176 conserved hypothetical hypothetical
MIYVLYSPNCAVCKKVVRFFRNNQIEITKIIIGEDKIERSMLLDILSLCEDGFGTIISFK
TESSKRLNITSKTFLDLSTKELLNLIQNDLNLIRRPLIYQTKNNRPYRLQIGYDSEEIEI
FKRAVHEK
>UU177 conserved hypothetical hypothetical
MKNNKPICFYDIYCFKPQECFKRNDINLLEDKLKRYSKITFLRNKENPEIIFLLGGDGSF
INFINQQWKKNVKIVGINYGQLGFYSSYDSIKTINLDEIIDENMYYNPLLLKVSINNQNF
FYCLNELSLFSNELVSFDISINDYPYEKFRGSGLLFVTPSGSTGKNKTAFGPIIFNNHEN
FIMTEIFPVNHLKYSSLNAPVVFRKDYKISLTNIKFKKSFSVAIDGNIINFSDKINDIKV
ETIQASSKIHGLNNFKKYIDKLNKSFIKGE
>UU178 conserved hypothetical hypothetical
MQNLNNKQKTLIIFLGIITFGIFIIYFFTKAKKVSQIRNTHLIVSSNIPFSLNDFYNCIG
SKNNLVNVDATINTLKIELKEINALNNEKLKVLGAKGIMCNQTKISIIFGDFCLELKELI
KKDLFS
>UU179 unique hypothetical unique hypothetical
MLIKPAKRSEKIYTIIAIKDSVVTLKNDYQDEKNIQIYEFDLQNIIPEVGKFINLIKYDQ
QGCSVFEEYDKNI
>UU180 conserved hypothetical hypothetical
MMIKIISVGKLKQKAFVDLINDYLKRINHYLKCQEIVVSDEPEPVQISNKSLEQIKSKEA
SKIFKNINQNDFVIALIIESNIISSETLAKKIQQWLNTFSHDICFIIGGSNGLHESIYER
ANYHLSMSKMTFAHGLAKVMLCEQIYRALSILNNGKYHK
>UU181 tpiA triosephosphate isomerase
MKYIIANFKMNATQELINHFLNNLTLFDEQKIIIGLAPGDLYLKTFVNLAEIKKVNLYAQ
NPSLHNKGPYTGQISCLQLLDINIKNALVGHSEIRIDFSQSIIDQKIKISMDLLEQVIIC
VGETFDAYKQNKSLNFVLNQLANIINYKGLKKIIIAYEPIWAIGTDLELDFKHINYMIEG
IKTYLYNCTGINIPILYGGSVNDNNINELCNQKLIDGFLIGNASLDVNVFNKIIDKCK
>UU182 pgm phosphoglycerate mutase
MKLNKKIGLIIIDGLGIGKEDNTNAVHLANPPTLNYLINNFPTLQISAAQQNIGLLENQA
GNSEIGHLTIGAGRIILNDNANINNYMKSVDYESAVLSNIKNEIVHIVGMYSNGLVHSNY
EHIHWIIKQIIKNNNQVVLHLISDGRDDYPYGFAQFIEQINALKKQYNIIVKSLSGRYFA
MDRDQRWERTQKAFNAMFVKQDKICEKTFLEVAQSIANSYKSDEFVQPVVFNDDEKYNLK
PHQKVILANYRSDRMRQLAHLLKPNKKFHYNNPFLVQDVNLITLVPFPDVDAIALFEKQN
LNNTLGDVFNKHQIKEARIAETEKYAHISFFFDGGVNKYYSTKTQYLIPSQKVATYDLCP
QMSAHLITKTIIDHYFDHDVFIVNYANPDMVGHSGNMQQTIEAILSVDHEIRKLYDFFEK
NNGVLMITGDHGNAEMMLDDQKQVITSHSVNDVWFIITDNKVILNSTQKFSLANIAPTIL
EYLNIAQPIQMTATSMIKKICE
>UU183 unique hypothetical unique hypothetical
MDKKAKIYTWSHIILIVFSLVCLHWFFILSITIPNQTGFLINRVGQWINSSSTYAYKIDP
RSLFYLNYTLNFNIALNASGIASIVLFICYILTFIFNLIMIGIIRSWRPSLLHLIIAILI
WLAILYLFIIIMIKPNFNQIINNSYYTWLKNVIFNDQTLTLNKKNVILNTYINHYHLPII
NDPQVALLDISKHQINNENLTFNPSYNYNANLYFTKAKLIYCTYTIIGIIFIISFIYYLS
EIIKRCLLVNDNWKIKQHERKDGLNIKKRKNKQEIVAPDPILEEIFKELDL
>UU184 eno enolase
MKIINLLAYQILDSRGQPTVAVKLFLENDQSVIAMVPSGASTGAKEALELRDGDVNYFFN
KSVKLAIQNINNIIRPHLINKNVLNFFELDNLLINLDGTENKSKLGANALLGVSIAIVKA
GAIAASKPLYQYIKEDLMHNYDVNYYAPIPLMNFINGGAHADNDLDIQEFMIVPLNAISF
SQAIQIGSEIFHQLDKLLKSNHLSTTKGDEGGFAPMLKNNYVTLELLVHAIKKAHYLPSK
TQGVCLALDVAASELYENGKYFFKKSSSHNITLEQTSFSSDEWIKYWSKLVSMFPIISIE
DCFEENDWNSFALFLKNNPHIQVVGDDLYCTNLKYLQKGIDFKATNAILIKPNQIGTISE
TLDVIKFAQKNNINTIISHRSGETEDTFIADLAIGVGAGQIKTGSLSRSERIAKYNRILE
IEQELKDKLIYEPSKFFKFR
>UU185 pfkA 6-phosphofructokinase
MNQVNFLNLDKNILIITSGGDAPGMNASLISLIHRLMNNNFNVFIGIEGLLGLYNNLIEP
IKDKRVFDVYFNEQGTVIKTSRFIKLDINDKKTQIIKDNLLSHNIQKIIILGGQGSMQAG
LVLTKMGFEVFGILHTIDNDFSETQMCIGALSAASFNQKLLKCLNYTAKAHCAFNLVELM
GRECSWLVNNSVGKLKPILMLTNQDNKYTVDEVIDLIKDKINSIKEYDPLIIVQELIYDQ
KWYELLVKTFEQKLHKSLRITILNYLQRGAPVSDFDLQLAKDSANVLVDFIVNQNDIKNT
NNMYVVINKFDNKLEVIKFNK
>UU186 pyk pyruvate kinase
MFSKTRIIATVGPATTKLFSNWLEFNDLNNINDAQQVCINIKDLILSGVNIFRMNLSHGD
QKIHLFRTQLIKKIADELKIKVEILFDTKGPEIRVCEMSDNNFIIKNSEVIIHCKEKVLG
SFNEFSVTDATGQYNMISDVKINHRILIDDGKLILIVKKIDFLKNIIYTTAKNSYSLKTN
KRLNLPDANYSLPFLSKKDIDDINLAVKLKIPYLALSFISNIKQINEVKQLLKKSSFIPK
LIAKIETQEAIDNLEEIIKNTDGIMVARGDLGLEVPFYKIPIYQNKIVELCHKYNKYCII
ATQMLDSLERNIIPTRAEVTDVYYAVKQKVNATMLSGETAAGIDPINAVQVMKSIILETE
NNNIENEITFKKNELLIPKEVKLKILSFHKLKINKHKLLVVNLISKNSKHLVYDILKYDF
NFNILFVIDKNQEHDLLLKNANFIISENKMLKQEELLKSFNIDFNNHEFLFISI
>UU187 rpoB DNA-directed RNA polymerase beta subunit
MQNNKNYTEKFITDKVMRRDYSKIKSNFEGPNLLEIQVESFKRFMEKDLKEVISSIFPLK
SPQGKYTLAFKGLKIKQPTKDESACRDEGKTFETPIYIDLELTDNYTGEVKRAQRNTKTG
EDGIYLGAIPKMTEKGTFVINGIEKFVISQIVRSPGIYVLGKSSIKLNGSRKRLFEGKIC
EIYPSKGTLMLGYIPKDRHNIQIVARDSSGDNAQTFSVTTLLKAFGLTSAEILKIFNNEK
EIRESLEIEKYAPEYIFENSQENEIIFKIYSDAHDIHEKADRRESNNKLKEEYIEQGSPL
LSKLKQLIFNYVEKNDEIDALLHENKDVEDASFIKNNKKLYDEREEIINCIISEKAAKDI
VELLGINIKNIETLRHLGKASYQIALQQHFFNKRLYDISSAGRYKFEKKLLLSERLYQKV
IANDIIDKKNNILIPKDTLITKEHIELIKKESRDKNIKWTKKINLLPTALESEIEQFLEY
ESIAVYKDNDLRDETTEIVGLASGCKLQTLTVADLVATTSYIYNLNYEIGEFDDIDHLGN
KRLKLIHELLRARIATSMARIEKFINEKLAISDGSSNNITNVNDKGIDTELDREIEESDM
SDEEKKKAISVKSIINTKQFQSLVKDFFNSHQLIQFIDQQNPLAELTNKRRISAMGPGGI
SREDPNLDIRDVHHSHSSRICPIETPEGMNIGLIMSLASLAKVDENGFIVAPYYVVEDGV
VKEDYKYLTAHEDDNYIIAESSVQLDENKRILDEQVVARYRGSTGLFSPNEVDFIDIVPK
QVVSIAASAIPFIENDDGARALMGSNMQRQATPLIKPYAPIVGTGTEFKIAHDSGMAVVA
KNDGVVEFVDSQKIIIRNDNDKLDDYKLIKYRKSNQDTCNNQIPIVKVGQRVHKSETIGD
GPAMQNGELALGRNILVGYTTWRGYNFEDAIIISERLVDQDVFTSIHIDEHTIQCMKTKN
GDEEITRDMPNVSDTAKRFLDNQGIVLVGAEVHEGDVLVGKTTPRGNVETAPEDRLLQTI
FGDKSKTVKDSSLKVKHGQEGIVAAVKRIKSSDENGSELPDDVIEIIKVYIVQKRKIQVG
DKMAGRHGNKGIVSKVVPIQDMPFLKDGTPLDIMLNPLGVPSRMNIGQILELHLGYAAAE
IGKKQLIQIAIDQLGYEKYISLFGINEIIAKKLYENISNLIKHKQAKQAKDIDLIDVTII
LKELGLSYDDIGIKISTPVFDGANHDDIVSIMNEANIDIENNKGKQVLYDGRTGEPFDGL
ISVGLTYMLKLDHMVDDKIHSRSVGPYSKITQQPLGGKSQNGGQRFGEMEVWALEAYGAA
YNLLEILTIKSDDVQGRNQAYNAIIKGHDVVADGMPESFKLLTKQMQGLGLCITVETKDD
RMVDINEYTLNQNRLNNDDDEVILDENLKEINDSNEEIFNTNFNNNDYDDEENF
>UU188 rpoC DNA-directed RNA polymerase beta' chain
MSQKGIKSLTISIASPEQILNWSKGEITKPETINYKSLKPEPNGLFDESIFGPSKDYECY
CGKYRKVKHKGKICERCHVEITESIVRRERMGHIELAAPVAHIWFTKELPSPSKISLLLD
ITYKEVDQVVYFVNYIVLDEGNNVYDGKSIFNKKEVLDLTSPKNSIRSRNKLRRTLRNIQ
ERIEDELNHEREALIQDFDYRLAVTYDQMLKDSNIPFSVKDVMAFIEKHTGVRFGIGAEA
IRELLEKLNLEEEHEKIKQAIQNSPNAYDQKTKRLLRRLECVRWIKDSGSKPEWMVMTRI
PVTPSETRPIISLDGGRFTTSDTNNFYRKIIIRNERLKQMQATDAPEILLDNEKRLLQEA
VDSLFDNNSRKKPVVGKDKRPLKSLSNHLKGKQGLFRQNLLGKRVDYSGRSVIVVGPELK
MYEVGIPALMILKLFRPYIISELIRKRDELGNEIQPICANIKLAEQKILAQDNEIWPVVE
KVIKQRPVILNRAPTLHRLGIQAFEPKMVDGKAIRLHPLVTTAFNADFDGDQMAVHIPLS
KEAVAEARSILLASWHILGPKDGKPIITPTQDMILGIYYLTKEKFPQVIEEMMAKDPTQA
RVEFINNFHIFSTQDEAIRAYKLKTIRINDVIGITTKAFNNKTFSKEGILVTTVGKIIFN
QAFPVNFPYINDVKNLYGENQFEIIGMHESILDYLKAYNLKEPLTKKTLSTVIDYLYKVS
EIEVVPQTMDKIKALGFKYSMISATSISAFDIPSYDQKYEYFKETDELVSKLREFYLDGK
LTDDERYTKVVQAWSQTKDKVTHDIEKLINSNEYKDNPIVIMAKSGARGNTSNFTQLAGM
RGLMSKSYNYDQKNNNGVIKDTIEIPIKHSFIEGLSVSEYFNSSFGARKGMTDTAMKTAK
SGYMTRKLVDSTQAVVIKDHDCGTKEGIIVREIRNTKDNTSIESLKDRIVGRYSINTIYD
TKNKLIIESDKLITSEIANIIQNSGIREVEVRSPLHCASLYGVCQKCFGLDLSTNKLIET
GTAIGVIAAQSIGEPGTQLTMRTFHTGGVAGDTNITQGFERIKQLFDCIQPQENEKAVIS
QVKGTVERIEKDSNTNGYNVVIKYNKDNYVNYPTRSNAVLRVKTGDEIIAGQKITEGSID
VNDLLKYAGIENVRHYIIKEVQKVYRMQGIEISDKYIEVIISQLTNKITITNPGDSGLFV
GETISINEFTEVAQNMLVNKKKPPSAINQVFGLDHAPSKSGSFLSAASFQDTKKILTDAA
ARSQKDMLIGLKENVILGNLIPAGTGLKDVEEVIAYGEEMYKKQY
>UU189 MBA paralog MBA N-terminal paralog
MKLLKNKKIWVLTISSVLIGVSVITSIASCSSSNIESKLSDKLVEDEDNNYYVAYQISNY
EKLKDFEKKQLEKVTFSTSITPTDKTKNSQVFNAKVNEGILFNQQAKTFYIKLVRKPEVG
ESIIILPNNSILKTHGFVVTNENLNFIKINKKGELQRSNTAITKKNNLTNEYK
>UU190 conserved hypothetical hypothetical
MLWKNLDELFLKYDRVVILTLSSGLSSYFESLSIIKEDYKDKHLVCIDSRSVSIGILWLV
DEINLLLKNNPSDEELISLVKQRSQKIIGGVIVNNLDQLIAGGRVKKTKGIIAKALRLKL
IVRWNGQLDFMDKTPNLSTAIDKLLDIIDNQNHWRTNGIKNIAILTDLENESQINSLKTS
LQEKIRQTIEIKISYLPGCIYAHVGLNNFAILIEAK
>UU191 unique hypothetical unique hypothetical
MKTAILIDTGANVLDIKDDNVYFVPIQLIIREQQIWKRIKRCYWR
>UU192 conserved hypothetical hypothetical
MYIYYNKTSLNDTLIFLKNNQQYDHQVFLNDDLLLFYHGDELIGLNLFNASEYLKNLNEG
YLYPTTQLIQKLSDLIKIKLSLDNAFKGFVVGKILEVNLIPNTHLHICLVDIGDQQIQII
CGAQNVRIGLKTVVATPNLLMPNGNEIKKSKLMNYDSFGMLCSQKELNINNFNSQGIVEL
NDEYQVGQLFTKVYSNL
>UU193 prsA phosphoribosylpyrophosphate synthetase
MSKNDDILLFSLSNSHQLANKIANLLKIELSPIRIDKFADGELIVAPQVPVRGRRVIIIQ
STSKPVNDSLMELLIAIDSIKRASAKAISVVIPYYGYARQDRKAKPREPITARLVAKMIE
SAGATSVLTWDIHSLQTQGFFDIPFDSLEAVWVLMKHYFSAYKDSSNITIVSPDYGGVKR
AREISIATGATLAIVDKRRSGKNQVEINNVLGDVKDRDCVIVDDMIDTGGTILGAAKIVR
EKGAKSITIIATHGLFNNNARQHFQQAIKDRIINKICIADTIENEPFDGLEIVSIAPAIA
KCIEIYSEGTGSMSFVHDENSKVLFAKKIY
>UU194 conserved hypothetical hypothetical
MNKPIIKEVIIVEGKTDAQKIDQLVNAQIITTNGSEINKKTLALIKQAQLSKGIILFLDP
DYQGERIRKIITNYLKDGIIKQCFISKDNMKNNSKKIGIAEANNDALLKALKSQGTFVIN
SIESITWLEYLSLNLNNKKIRLMLCDYLNISYCNHKQLFKRLNMMQKTFKEIKIIIEGF
>UU195 conserved hypothetical hypothetical
MKLCDKEYILSVIATPIGNLEEVSERVIKCLNEAYVILCEDTRVTAKLLHLLNIYDYKKL
ISYHNFNEIQKLNEAINYIKKYPTALVSDAGYPTISDPGYKLINECHQQNIGIQVINGPS
SLMHALVASGMCSQDFMFLGFLGKTQKQRVEKLKLYKNLQTTFVIYEAVHRIEKTLMDIY
EIWGDILIFIGRELTKKNESHYYGYLSQLPPITEKGEFVIVIDNKINQDVIKNNNINECL
IKIRDLMKQNFKLKDACKEVSKSSNFDSKELYKLIINQK
>UU196 conserved hypothetical hypothetical ATP/GTP-binding protein
MLDKLIKTLKNPHSIDDIVGQKYLLDEIGIIRRMVNHHQVFNLIFYGPPGVGKSSLAKVL
AQDLKVPFAFFNPVVDSKKQLMQIIEQALDLNNFIIIIDEIHRLNKDKQDILLPIIEANK
IKLFATTTENPFFVINPALRSRCQLLSLKPLTSSQISERIKTLINVEEVFEPQAFNLLIN
KTNGDLRAVINTLEIIYLLYKEHKVDYVLLKRIMQESYALGSSDGDEIHDLKSAFHKSMR
GSDCDAALYYLARLIIIGDFEAIYRRVSVCVHEDIGLANPNLCLRVDQGINSCRFLGYPE
NQVILANLVLQICLSNKSNSVYLAYQKAFEDAANGKQYSIPNHVRDAHYASAIKLGVHGY
KYPHDFKNNYVNQQYLPRELTNKKYYVPQNNEQEFKLNQNQQKFKNNN
>UU197 metS methionyl-tRNA synthetase
MLKQKKFFISTPIYYSSGNPHIGHAYTTIIADVLARYKRLFGYDVFFLTGMDEHGQKIQQ
KAFEENISPKALVDRNSIIFLNLWKRLNISFSKFIRTTQMDHEESVQKVFSYLYKQGKIY
LGQWTGYYCVSCEENYNPAEIIKSQDNIMLCRMGHKLETKSEESYFYKMSDQAPFLKTYY
QNHPNFIIPNERANEMVNNFLNNLEDLSISRTTFDWGIPIAENPKHVIYVWLDALMNYLT
ATGYLSNNEELFQKYWCDNETEIVHLLSKEIARFHCIYWPIFLNDLQIRFPSTILSHGWI
ITKEGKMSKSLGNVIDPNVLIDTYGVDALRYYLMADLSLFRDAIFSEDNLIETYNTQLAN
SYGNMISRTLGMLKKYRNNIVPKYVGCVLKNDEKLENLINKNIELVQENINKYSIDKALN
CIQEILVEANKYIEDNKPWELAKNQQEQELDSLLVHLVKVIQVTTTLLSPILIEGSKKAV
EQLNFDESFLTLASLASYDIFNYHKVNDSKPIFARIIVEKQ
>UU198 conserved hypothetical hypothetical
MRLRYKILCASLGVVGVVGVIAAISIDYKQIPIVYANGSSSVLPLIQALSEKHHKQDIIS
NAGGSSLGIIEAVEQRTNIGVSSRSPNIDFEQQSVEKSHVVYDKWKQNQLKTYTIAWDGI
GIIYKLNKTNHELVLTKDNIIKLFKAFTGNEQVSYYDLDPQLPKTPILAYSRTGGANASG
TAEAFLTSNPLISKKEFKKKYHDIYKVIEAGTYGKLIRSTEESNTQAWTNISKDNVDGSI
TYLSTGFILKNYDQIIAKGYKIAYLQNKDLKNYLPFEINENKQEIVNVAKTYGWYRPFNL
VFSLNMQGIKNTKEFVWWLLTNKKVEKIIQESGFIPLTFEQKNSMFLKPYKDEQSFQEAI
NNQSAKNNFFVSDFELIESNRINILGAKSA
>UU199 pstA phosphate transport system permease
MSILNLNSQQTKKIIFNKKIKDKLAKTLVISFAWLFSICFIGLVVFIIIRSIPGFEAYGL
KNIFWSKNFNLADYAAGSSVWFPLAITLLVSFGAIIIAAPIGIKTATFIKFRIKNKRLQK
FFRVTILALAGIPSVIFGLFAIQSLGPAISFVFHIDTVQNITTSMFMLAFIIIPTIISLT
LSTYDGIDMRLIENGIGMGSSYTRSIYKIFKKEARGGIIIAIIIALGRAIGETMAISMIL
SDQGYQNIFGTGFLQIMHSALRPLGAVISANMFAENGGEGLRGLLYIYGIVLFVAIMILN
GLVTYLTRKRSKKTYAWFIKLEKSLAYIVCFIPDQLKILYEKITHRSQYKLHVNNLDNLN
NYITDRIQNRKLKRLYTVHKLFFESLAFMVAFAFLAWISLDILVNGIKAINLPTSTVVAY
TKNTTGQATINTLIIIIVAILIGLPFSLFVAIYINEYAKNKWPKKVLLFFIDSFGSTPSI
IFGMFGLVIFIEIFGFTSMGNIGKSLLAGALTITLVVLPTFTRSIQQSLKAVPMSIRENA
YGLGCSKWETIVKLVLPQAKKGIISAIVLTIGRIVAETAPLYLTAGLSSAQSITILNPGQ
TLTTRIYAQLYENNTNIAHNVMYESAFITLWLVIALIIIAHVIVPYFEFIKHDIKKWFKI
LKNYLRAPYMRDIKVFKPQIYQKHLYLTHNQAKIMGYNESVNKVAKIGLKLYEIRYVDDE
QIQKELLKVRG
>UU200 pstB phosphate transport ATP-binding protein B
MNDQKDNKEIQTIVPLNQKTNLNELDAKAIYDEFQKLNKYQRAFAWLKLPKQKKAELKQF
LNKKKTQVDLLKEDFNHANVFEIRNFNFWYMNRTKHVLHDLNLDIKRNKVTAFIGPSGCG
KSTFLRNLNQLNDLIEGTSHEGEIYFLGTNTRSKKISSLELRTRIGMVFQKPTPFEMSIF
DNVAYGPRNNGINDRKILEKIVEKSLKSAALWDEVKDDLDKAGNALSGGQQQRLCIARAI
ALEPEVLLMDEPTSALDPIATAKIEELILELKKKYSIIIVTHSMAQAQRISDETVFFYQG
WIEEAGETKTIFIHPKNKRTKDYISGKIG
>UU201 conserved hypothetical hypothetical
MATNYFLMKESQCDLLNDFKNFFQMVIDNQKLICDLLKNDQSSYKETYEKACFLEKKVNT
TYADMLEEIMWIIQRDQPRASYLRFFIAGINSIKDLERISDHSEIICEYFLETEFDEEQK
NFFLTSFEISNQILSDLYDFFDKNEFSVNTIEHIKDLRSKSIMKINKNLIQSLHDQSKLL
DENSNYIKLILMYRHIERNIEHGINIVQNFGNVHITSR
>UU202 unique hypothetical unique hypothetical
MTYMLLTSSDLHCGSCSSNLYNVLEKIGAQNISVNILNSEFAFEFEENKIADQDVIKEIN
KNGFKTNILEKYIY
>UU203 copA copper-transporting P-type ATPase
MLKNNLIKKFQLLPINKRRYLISLMKTSIALLISIPLMVFEMLFMFKSNLILSIDGYFIY
GWIVFVLSIFIVFGLGFSFFKGAFFEVFKWKKPGMSLLVVISTCVAFIYSTYSLISNTII
YEPKLHGFFETACMIIATMSVGQLVSDRIKLKANQDLQSLNNLQVKKYNSYDLNTKQVSE
KVVFQAKINEYALVKKGEIVPLDGVLYSQIAEVDESSLTGEARPILKTINNDIIAGSINV
GDNFIFKITKLYNDSTIKKIINGVNQIASSKPKIQVVADKISLWFTPFILLMAILAFLLQ
AFVPSIQELPIAFLNLHGSNNDSNLYEKAAYVAVSVLVISCPCAFGIAVPLAVLIGAGHG
AKSGITFNNSNIFEKIKKVNAIAFDKTGTLTYGKLQLKQVIGNDQFLDLIYQMELISLHP
LAKSFVTYAIINNIVMSTKLIDIKEVAGVGIIAKDVDGNIYELTSEHYANENQFDFSLIN
QKSSTSTNLLASNIIFSINKKVQSILVFEDEIRADAYETIKVLHENNIETYMITGDSFNV
AQKIAKELGIKHFYAQVKPEEKANIIKKIQNDQKTVMYVGDGINDLLALKQANVSISIGE
TNKATNAVADISLIKPDILNIYKVIKLTKITKMFIVSSLLWAFGYNLIFIPLALIGIIPP
FISVLIMTTSDIAVVLNSLIFRLLKMRLVNKKQIHKLNLKIINEAMLHK
>UU204 rps15 ribosomal protein S15
MAVSKQQKHDLTVKFGGSASNTGKTEVQVAILSAEIDSLTTHMIENKKDKASKRGLYKKV
AQRKKLLSYLQRVDIERYRALIKELNLRG
>UU205 rnc ribonuclease III
MDNKKFLDFLKQNRIEPKNLSIYLEALTHKSYANEHKLTKNYQRLEFLGDACVEWVISNF
IFNYKIKDNEKMRSLDEGEMTRARSNMVRSEILSYAAKDLGLTDFLMIGVGLEQDQSARM
EKIYEDIFEAFIGAVAQDQGIKKVSLILEKTLIKYFREGQINYQKDYKTIFQEQAQRINK
KPIMYKLVRNEGDKKEVHLVWNDLIYGIGIASTRKEAEILAAKNAILKLDDYTKKA
>UU206 plsX fatty acid/phospholipid synthesis protein
MEKIKILLDTMGYENDLEHVIKAAKDFYYQHEDDLEIILVGNEQLIKPLLDNDWRLFPIV
HTEVSIEQNDTILSARKKQNSSMHLALRYLKDKQADGMLTAGNSAVFVYNAYATIGLLEH
IKKPAFMPFVPTIDGGVTNLLDVGASIDVDGTDLFNFAIMANTIAKMRTPNPRVGVLNIG
TEDHKGLPYHQEANELLKTSNLNYVGFVEPKTILEREVDVLVADGFSGNIALKTMEGVGK
TISNFLKNEYKKPKNLFAALLSKPIFKKIKKAFDYKEHAGAFVLGLDGILVKTHGSADYQ
QFMSALKILYETIKADVLNEIKKDLNNYYGQ
>UU207 conserved hypothetical hypothetical
MKTIKLDLFQKMLYAGAKILEIECEYINDLNVFPVPDGDTGSNMKTTTAGAIIAIKEIEI
SNFSQLAKIFSRGLLMNARGNSGVILSQIFRGFMDALNNDAYEVSIEQLKQAFNGAKEKA
YASVSTPIEGTILTVIRVINERISERQNFDSVEDLFAFVTKEAQIILERTPEMLPSLKEA
NVVDSGGYGLVSFLKGMYQSLTNTFDEKLIIKNEEENIKSKTKPLDLEIIHKEKEEGFGY
CSEIILSLRKKIIPNSPSKSFFEFEKYKSELAKIGDSIVAIQDEDLVKVHLHTLTPYKFL
QLSQKYGEFDKIKIENMTNQFYESLERKGLTTKKENKLTLSMEQKIIATVPSEKFKKMFI
EEHGIDNVIVTETEGAPSIQRFVDEINSTNSSQIFIVTDDSNIVLAAEQASKIVAENNIL
VSVIGAYNVFETLLAISHFEQQNDYRTNFKTMNKIVKKARSGMITTSIKNVKYPHITVNK
DDYIGIINKKIIASEKNAYDVLLKTIEMLIESLKKPEICYIYYGINASQTDVHQIEKYIS
EKYGIICDLRYTGQSLYHYYIGIQ
>UU208 unique hypothetical unique hypothetical
MLKKTKFDTQLVKSLITSSILKVPGIFSVDINDKLSDFNRNYFVIKIDLHEDVVNVLSVA
NEARNLVYYELSKQLNDDNVVINIIINC
>UU209 unique hypothetical unique hypothetical
MNINWKSMYKEILIRNSDLNYIVSDPFENMIGGFPIILFENDNYIYYLSGQNAYLPSKMR
RWKNWDEILINKNDLLKENFIYKDIYINLFQIYVTKKNNLSRYLSNQFNFTLTKNDFKDE
LWNKLIYNTIKKLINNSNPQILLFEISRNKKQKYHSLLLFADKNVLKKFYLNSATKDNYE
DIIDLAFNKFENLQNLLKTTKVKNHLKNLKKY
>UU209.1 rpL28 ribosomal protein L28
MAKRDQLTGKGPLSGNTRSHAMNHSKRRWNVNLQKATIKTENGSQRVLVSAKTLKTLKKH
NLLA
>UU210 rpL27 ribosomal protein L27
MNKLYWLTDLQLFASKKGVGSSKNGRDSNPKYLGAKLGDGQSTKAGQIIYRQRGNKIYPG
LNVGQGKDHTLFAKTAGVVKYTKFMGDKTKVSVLPKEDNN
>UU211 conserved hypothetical hypothetical
MIKINHYPNALLVKGHANFDEHGKDIVCAGVSAIIMGALNWFDQQKTTIKVEQGFILIII
DNNNQLYRQYLELIIIQLKAIYFKYQSYIELHEYKQQYKRGL
>UU212 rpL21 ribosomal protein L21
MFAIFQTGGKQYKVQQGEKIYVEKLDLEVGSKISFDQVIMVEGSVGTPFVKNAVVNATVI
KQGKQKKINIIKFKSKKHHLKRQGHRQPYTQLVIDSISVK
>UU213 gmk guanylate kinase
MKRGKLIVFSGPSGVGKHTILSKIINRKDLNLAYSISMTTRKKREGEVNGVDYYFVNDEE
FKKAILNNELIEWAEFVGNKYGTPRTIVEKLRDEGKNVILEIEVVGALKVLDLYKNDDLI
SIFLLPPSIDELKKRLLKRNTETLETIKKRIQKATHEITIKDYYQYNIINDNPDHAANQL
AEIILNEIKQS
>UU214 conserved hypothetical hypothetical
MKLNNHNLKEIYSLSLNELKEELFKLGLKSFISKQIYSWIYQKRIFNFDKFSNIAKNNVI
ILKENFSNNLLKINSYQSNSDGSIKFEFLTDKNLIINCMIIKFKNGFLIKINPFGINFKK
EIINLSTNELVLQILLIQQFLDQRKLGNITNVIIKGLQDSLLNMDVVSNFINIINNENGL
NIGKRKIAVWTSGINVDLIKWGQLQNQIELIISMNASNSLIYQKIMLKKLNQNWSFLKLI
EQIKAYTKITNNRVVLEYLLIDKINDDLNYANELVELLKNILCYVLLIPYNLNNYRTSAN
LDDFFNILSVNKIRISKRIRKSNDLDISFKQLKIKE
>UU215 ptc1 protein phosphatase
MNFGFISDIGSQRKHNDDCALVIQNQYQQTLLIVCDGLGGYKGGAAASHITLETIKDNFL
TTDFSEYDKQQIQKWYIKVIKLAQVEIDRTVLLDKDVYNMGTTVVASIVVNDFSYTLNIG
DSRAYLLSNEQFLQISRDHNLLQVLQERKANPEVYKKHEKNLFSLTQFVGRTSNIFLSYD
LFVNKLNPNEIIVLTSDGFHNYFELNTLYEKLIKSTQETKNELLQQLIRQAIINGSNDNL
SLAFLIF
>UU216 pkn serine/threonine kinase
MREEIKTNSILNYKYKVVKHLADGGFSKVYLCCFLSDETKFIVIKVLDINDEKQQMVVYD
ELRISNLIKNSDSDKKNYIMEYYEYFETGSLENNDKRIYIVFEYIEGLTLREYLDEFKTI
TYVKAVEIIRQVALGVSFFHSCNPQIIHRDLKPENCMINKTLTKIKIIDYGAASVFYNRE
DLTKDQEIKCTIIYASPKLLSLGQKVKEQANKGLNKRALSLINDALGVSYDIHSLGVMLY
ELITGTNPFSEHTITDDRDYLEKWITYDVEPLSLINKTIPKGIDNILMRCFAWKKEDNKL
LYKDIYTLIDDLSNVMDPESNLNQEYIKPLNKLRIYRKNLAGLYEIKEKDRKWYLQKWFI
ILISCLSVILIILLIIILFFKKSGAI
>UU217 conserved hypothetical hypothetical ATP/GTP-binding protein
MVGDDVEVELIGNTYLITKIYERYNQLIRPKVANIDIVLIVVSIVQPDLNTLSLNKYLAF
YEARNIKNVLIGLSKYDLANNHLKQKINKLILDYKKNNYAVFILTKENDILLLKEKIKSK
TLCLAGNSGVGKSTLINKLDPSIQQRTQEISHFLNRGKHTTTSTKLISFANGFLVDTPGF
GNLEVNLTKNEMANAFNDFANYARFCKFSNCLHIEEPECAIKKAVDEKLIVNWRYDDYLK
IIKELPNDVLKIKTRAQNRKCK
>UU218 amt ammonium transporter
MRIVSTIITTSWGVDPNIYFSKHELTWVPATADANTLALTNFNPTSTLLVALAIAFVLLM
TPGLALFYGGLTRRKSTLTIINQCVASLGITTLIWIFGGFSLAFGPSVGKGIIGDISTYF
AFRNLLFADGWSGDVGIVFANFTNGVPLILFFAYQLAFAIITPPLMVGAFADRMKFKNYL
VFLVLWQYLIYIPFAHWIWGQGFLAAAGVIDFAGGIVIHTTAGFGALAASLVLGKRVLLK
NDKSRPHNIPMTIIGATLLFFGWFGFNVGGSGFVAGGNAATWSAATSAWINTIIALAIGM
VGWAVLETIFNKNHKATGVGLVTGAIAGLATITPAAGYVPIWASVPIGVAAVLVCYTSAK
TLHHFHKIDDTLEVWGVHGMGGVTGSLLIGAFASKSVNPSIMYEAIGPTTTGVLFGVQLG
AVLLAAVYGFVFTILLVYITRPRLSARQQLGHIDYINHGEDAYSFDIEIPSEKEMEQYEL
ADSTWHSSTGVKYSLLNNKNQQNHKVANDH
>UU219 amt ammonium transporter
MKIVSTWGLNKDIYFSTHELTWVPADASQSTLNAIGFNPTNTLLVALAIAFVLLMTPGLA
LFYGGLVRRKSALTIINQCVASLGITTLIWIFGGFSLAFGPSVGKGIIGDISTYFAFRNL
LFADGWSGGAVLVFANFTNGVPLILFFAYQLAFAIITPPLMVGAFADRMKFKNYLVFLVL
WQYLIYIPFAHWIWGQGFLAAAGVIDFAGGIVIHTTAGFGALAASFMLGKRTTLITDKKR
ANNLPMVVLGAALLFFGWFGFNVGGAGFVKENTNHISQAISSWLNTIIALAIGMIGWVTL
ETIVNKNHKPTTVGLVTGAVAGLATITPAAGFVPVWASVPIAIMGVLVCYSVSRLLDYFR
FDDSLEVLPVHGMGGVIGSLLIGAFATNTVAHGIKYDAVGLDNNGNPIYGILFGLQLGAV
LLAATWAFAFTCLIVYITKPRLSVRQQLGHIDYINHGEDAYKFDFIIPSESEMFEYESFD
QTWECKASGCKKSNLAAKKNPVFIENENDCTWQSKSRECTK
>UU220 unique hypothetical unique hypothetical membrane lipoprotein
MPRINTQVFNENNDKNRIKSNNNKICDDIEYTRLLETKEYNAGFSPNNDSQDILIKKQDN
ILKLKPTLNFDDSDQLISIVPTKNYENLRLKEIEIDKKNTVDYQLKKEIIDQDLTDDNHL
SISQKSNGFALKTKQFIPQNISEFIYHNEDDPKTYGSENNLTFSQLEEKVNQKNTPDFYL
KEIHAVRNKIIIWTILLAIGVGLIFYLIYEVIINHFNPWIFLPISIYCVLMIFFLALSCS
NFINFKKEMDYQKNHFDCTKATNFIVGIYRKLIVVHINVNWITAYIYLTSLFMIFGVFVV
SYFMNLYYNAAIGSRFGDLIIKIPVVINNHLSQKISFNKNPLWAMIGLGAILGLTFIIHL
WLVFNAHHRINRIHSYYVNEIITSEEIISLKKQANRRGLVIFLVLTVILGLIFYLMYTIL
KRKYTIKK
>UU221 fthS formate-tetrahydrofolate ligase
MAKIIEEMINKKGLLIDDYELYGNEIAKIKSIKKLNKKDSKLIVITSMNPNPAGEGKTTT
AIGLVDALNKHGYKAIGALREPSMGPVFGMKGTGSGGGLSFLKPFDKINLHFSGDFHAIT
AANNLIVAVIENEIHNRSSMQIDSQKILIKRCLDVNDRSLRNIEYDINHQQTKSGFNITA
ASDLMALFCLAHDHKDFEDKLAQTIVAYNIVNQPIRICDLELTKAIMAILEDALYANLVR
TNEDNPVFVHGGPFANIAHGCNSIIATKNALALGDYVVTECGFGSDLGLEKFMNIKMASL
NLKPDLIGLVISLKSIAYHAQTNEKDYVKQGFANVLCHINHIKKYNVSFIVYINVNTNTD
SEEDLLTLEKLLDEHQIEHARSYAYSYGSKKSEEITKKTITLTNQINDHELKLIYDIKDH
LSYKLKKICENVYGADGYELSYEAKEQLNRYEHLDFYLCIAKTPYSISDDAKLLNNPKNF
KIHIERFEINYAAKLIIAITTTIYRMPGLNKEPAAKNFVMK
>UU222 xerC integrase-recombinase protein
MKDFIRYTKKRNLSLNTIRTYESVLKHYEPVLDSWIKIRNKIINSNFKPRTIHLHKNVLL
SFFEFKKLKRYLQNLKLLKLPQIEMKYFDVISKNNLYKKTDILDDDSLEIKKYKTIIRFL
FETGIRAHELFFLESINNRLYVLGKGNKKRQIFFVKQTFEQLQKFYENLKGFETTKTLRL
YIKKIIGKNFTPHSLRRSFATFMLIKGANPKTVMLQMGHANIQTTFSYLNLNEQTNRRIY
NKIMYQNDAE
>UU223 xasA amino acid antiporter
MGFVLLTASAIIAFYTFPSLSTAGWIAIIFAFITAMCWFIPIGIAAAEMATIKGWAEGGI
FTWVRNLLGPRNGFIVTWLQFQVTFGFVAMILFVLSSFSFAFAGADGYNYFNTLKLGTTL
NQATSVNFSKNFSNGALYGIGIVVVAGLIFMSLLGQKRTHQFGQVALIIGILLPFFIILG
FQIYTVATMPDPLYFIGKHFQKEPHLDPSVTGTSYELNKTFMSSVVMASFMAFSFSLHGV
EVSAIAANRMDNPSKKYPQAMMIVVISALVCIIIGSIMISMTVPTSTLSFNGGLVQTIMF
NLSVGGIDVKLPDGTVAHYKTLAHAYSVIETQYGTAAANQVMYQFVYGHPINTGSDLARS
DLLTLTSEVNDPLKNPSLFISVMNIETNKMAMQGLQAITFFIGIGVFVEVSVWMSNLSTG
LNYAMRKAHFPAWVTYRLKNGSALTVAILWIVLLMCIFAIYMFGYNSLMQYKGQTISDIL
ANEIRINQDQKEPMALLSNQNLDEIKLMARSIYEHSHAPGAQANVLHFDFNKHANSEVKA
IYDKIKDYIGINAVASGTPASITNISFISNVVSQISMYYIGYNIFLIGYLRYVFKANWLR
REFRVKWSWLQISLALLAMGVNTFAVVATYLPAAPELYPGQEAYYVFISIALPMFICTLL
LGLFIYLINYAWNKKRGINLSEHSNLTNVDQNVLDVINNWHLYKDQKEFAKFERHVQLLQ
QKQVIVRTTKDKAQRELVANEMQYLAAEIATRFAPEEEH
>UU224 unique hypothetical unique hypothetical membrane lipoprotein
MKKNHKKWLLMTTPILLIGGLSTLALTSCKDGKKSNPKPDKPSTIEEYKLSLSSVETGFN
EAKLIFDNNDSFKTLDNFKVILKNTQNTNEVIEASNLSATIENQKLVLKLNNLQDGQTYK
INKILYQTNKEVILSNNQVFTTKTKPKIEYEVQEKILKLDDKTYYVVLKVKDPQNLNEPT
KEILKSVTFTSKISNVANLKNAILENQRPYVKEDYSEIQIKLPRVPVISEKIEITANNSL
FKSFTITVGEKHIKNVEKIIDITKKVFGNQELKSISITKQNSSSANITLSLKLNGNSIIV
GANKLINKKDKAIKFSFFVKNKATNTVKEFNFNEKSKPIGSYQFTLNGLDANSDFVIEDI
RYDDKSIKITEELLASLSFSTK
>UU225 unique hypothetical unique hypothetical membrane lipoprotein
MKKWQKILTIALPTSLLVAIPIVVASCSTKSEAQKEFEKTYKEYLSWLDKLASKMPALKE
AFSTLKEEINKQINKSEKLSDEAYKALTASLKVSIDGMKKTLGQN
>UU225.1 unique hypothetical unique hypothetical membrane lipoprotein
MHLGIYYMVYSYYGSPYLTQDIATTNVVNAWAMYNAGVAFLVIFALIEIASFALFVTTTV
NVGLNLKRQENFVLPFVFGILGCLGIIPIIGSIIIYVQLNKFYKQQNESSLI
>UU226 conserved hypothetical hypothetical membrane lipoprotein
MRICLEKIMRKIKLNKKIILASVIGIMGVALVPIALVACSQNKTKSDSRNLTLNNFYGRP
SSDGDDAYQAIYASKIQDGARMLGLISFRHKNPISKYFNSPKDNQQVSAVLIDEIYDLQT
GKDRIASITYRADQAAFLAGIAAAYYLNSNQNVFGKDNKLTWGGFVGIHLPSTTRFIQGF
KFGIQWANEKLKNKKVKQTENNEEKEWINVEQVFATNYQSGDFSPTSDKAKAIVNQLVSN
NVDLILPVAGPQIDYATTAAAESSKPIVVVGVDTEQELDDNTNKARISENNKSLANGKTI
IFSIVKRLDLAFKGALLKASEGAQLTNDINKDAYKLGTHTEASFNKNTYVDNTALVELSK
AGHQYLIDAIKLSGLKEVNDYKTIVEIIQEDPLFKLLSQIGTKKLDEVATKSQQGDWVLK
SEYQDLPFIQLQKMLGGLVYVDQKNELYPYELSNSFYLEKDPNKRQASRAFYNYWNAKDA
NQINLVKIFLGQSVDVLKDKSFSESIYKGLEEFYKSKNIIIPKLY
>UU227 infC translation initiation factor IF3
MSSNNDARKNQPLINDQIRFRTMVVIDDHGNNLGEMNRIDALNLAASKNLDLVVIAKKGN
IPVTKILDYGKYKYEQKRRQKESRKNQTIIKVKEIKIKPMIGEHDLKVRAENAKRWLEDK
DNVKFVIEARGRMCTKDEFIVQAYEKFIDLIKDYGTVVQANKKVSNYRYETIIEPIKK
>UU228 rpL35 ribosomal protein L35
MAKIRQKTKRAVAKRFSITKNGKLKRKHAYRSHLALGRSTKAKRHLRKDAIMSTSDTKRY
TQCL
>UU229 rpL20 ribosomal protein L20
MRVKGGSVTRQRRKRWLEKAEGSWGTRNTSYRIARQTVIRAAEYAYRDRRNKKRDFRKLW
ISRINAAVRELGYTYSQFMNALVKANVVTKDGQGLNRKMLSELAINNPEAFNQLVDKVMK
>UU230 rpS10 ribosomal protein S10
MNQELRIRLESYDHRLLDDTVKTIVNISNSTGSKLRGPIPLPTKKEIFTILRSPHVNKSS
REQFERRTHKRLIILENPQPKTMEALKRLSVPFGVEVTFKI
>UU231 rpL3 ribosomal protein L3
MKSLLGTKVGMTQVFTETGKAVAATVIYVEPNKVLAVKTNEKDGYSAIQIGYETVKEKAL
NKPLLGQFKKANSDPKRHIKEFRDVVAEVGAELTVSEFEPGQLVNAQAYTKGHGFTGSIK
RHNFSMGPMGHGAGYPHRYVGSIAKGRGGSQAQRVFKGTKLPGHYGHELVTTKNLLVLDV
KANENLILIKGAIPGPKGSIVLLKSAKKVGHIVSDPQVVNYLANKASSSEANE
>UU232 rpL4 ribosomal protein L4
MAKIKLLSIDGNFAKELEVTSDLFVEVPHKQAMFDSVLAENAAERQGTHSTLTKGEVRGG
GKKPWRQKHTGKARTGSTRNPHWTGGGVVFGPKPNRNYNLKVNAKVRLLAFKSALTIKLN
EGKMLGLVANSDLETPSTKKMVNFINNANLENQKVLLVIVDNFSNIKKSTNNLQKVTTKL
WYQVSVRDLMHANVVVVAEEAFTNYARKVSK
>UU233 rpL23 ribosomal protein L23
MELTRVILHPYTTEKTYSIRNKSEHETLTFIVDKNANKYQIREAFIAIFGLKPLKIRTTN
RRPAKIRTSTARPGYTKAKKIAYVVMPVGVKVAVSKEEVEAANAK
>UU234 rpL2 ribosomal protein L2
MAVKRIKNHSSGKRQTVVVDYKSILTTSKPEKSLLVTLPKKAGRNNQGKITIRHHGGGHK
RKYRIIDFKRNKDNIYGTIKSIEYDPNRTSFISLVVYADGEKRYIIAPKGIKVGDKIISG
NENIDILLGNSLPLEFIPEGTLVHNIELSPNAGGQITRSAGASAQILGFDETKKYILVKL
NSGEVRKFRKECRATIGTVSNDEHILENLGKAGKSRHLGVRPTVRGSAMNPNDHPHGGGE
GRSPVGMDAPRTPWGKRHMGVKTRNNKKSSTSMIVRRRK
>UU235 rpS19 ribosomal protein S19
MSRSLKKGAYADPSLLKKVEAANASVSKKPIKTWSRRSQIFPNFVGLTFEVHNGKTFLKV
YVTEDMIGHKLGEFAPTRNFKNHTEAKR
>UU236 rpL22 ribosomal protein L22
MTNKVIQRNIHISHRKASLVIDLVRNKPVHEAIRILSNTPKKFAPIVLKLLNSAISNVQH
NSKDMDPSKLYIYKIVANQGPTMKRTLPRAKGSADQLFKRTTHLEIVLSDDVNEREKELA
AIKAKKSKKPLAVEPIAKVETKKVAKPSKVEIKPVEKDENVDPELLKREQQVLKVVEKTA
SQKEEETTETIMISTSPKNAQVLFDDLEKNVIFYKTTPINKVLRVLVYVTSPTKKVVGEF
DLESVEIGAISSIWRKYSKQSVISKKEYDAYYEGKDKAHALVSKKAYKYRNPKDLSEYNM
TKGPSGFQYLK
>UU237 rpS3 ribosomal protein S3
MGQKVNPNGLRFGINKQWLSRWVPTDQLQMAKWLVEDDKIRKYLSTKYKNAGIDHVEIER
DQQRVNVYVYAVQSGLLIGTEASEKKLIELAINKIVGRKQLVSLKVVEVQIPELQASLMA
REIADAIENRVSFRIAQKMVIKKVLKAGARGIKTHVSGRLGGVEMAREEGYTQGVMTLHT
LRADIDYSMQEAHTTYGIIGVKVWINRGELFGNKLVNSVAHAANKEFSRSSKPKKGSFNR
SSRSKNTKPAPKQAVSE
>UU238 rpL16 ribosomal protein L16
MLQPKRTKFRKPHKVSYEGKAKGNKQVDFGEFGLMALEGAWIDARQIESARIAISKRLLK
TGKMWIRIFPHMSLTKKPLEVRMGSGKGSPEKWVAVVKAGTVMFEIANVSEELMCEALRA
AGNKLPIKVKIVKKGEAN
>UU239 rpL29 ribosomal protein L29
MSSIAQDLRKKDSLELEKIVIELKAKLLELRFAAANGEAEKLHTAKEIRKTIARALTILN
ERELAEKLNNKEANK
>UU240 rpS17 ribosomal protein S17
MERSRRKVLEGLVVSDKMQKTVVVSVETKSKHPIYRKLVISHKKYHAHNDNDDAKVGDLV
EITETRPLSATKNWRVSKILERAR
>UU241 rpL14 ribosomal protein L14
MIQHMTRLKVADNTGAKEVGVIKVLGGSKKRYASVGDIVVVSVKKATPAGLIAKGQMAKA
VIVRTKKSIRRESGLLIRFDENACVLIKEDKTPRGSRIFGPVAREIRDRGYTKIASLAPE
VL
>UU242 rpL24 ribosomal protein L24
MNRIKKGDTVVVISGKNKNKSGVVIQVNPKEQTALVEGVNKIKRHQKKDQTHEQSGIIEK
EAPIRLCKLALVDPKGKDKGKATKVKYLLKDNKKVRVARKSGSELDVNKK
>UU243 rpL5 ribosomal protein L5
MAFLKDLYKNKVAKDLQKEFAYSSVMQIPKIEKVVINAGIGNAVADKKHLEAAISELTLI
TGQRPVETKAKKSIATFKLRAGQSIGAKVTLRGDRMWAFIETLFNIALPRVRDFKGISNN
SFDNQGNYTLGIKEQIIFPQVVYDDVKSVRGFDVTFVTTAKTAQEAKALLVGLGAPFQKV
RGDK
>UU244 rpS14 ribosomal protein S14
MAKKSLIAKQKKHQKFAVREYTRCVRCGRPHAVNRKFGVCRLCFRDLAYAGAIPGIKKAS
W
>UU245 rpS8 ribosomal protein S8
MYLDPIAELITKINNGRKAHKAEVSFATSKLKTAILELLVKEGYIKSYDIRPTENNKSET
VVKLKYKNQTTSSINGFKQISKPGLRIYSTHLNLPKVLNGLGIAIITTSKGVMSDKQARK
ENVGGEVIAYVW
>UU246 rpL6 ribosomal protein L6
MSRIGNRKLTIPANVNVSVESGKVHIVSQTAKLSVDFPVNLISVDVVDNTVKVSRANDEK
QTKMFHGTVNANIANALVGVTTGWKKELEVKGVGFRAKVEGSKLNLGLGFSHPLLIQIPT
GLKVETPSATEISINGADKAAVGAFAAVVRAYRKPEPYKGKGVMYKGERIVRKAGKTADK
KK
>UU247 rpL18 ribosomal protein L18
MKRINFSRAKQRALRAKRLHVKIRNLQLAANKPVLVITKTNAHIWAQLICYNKNITLASS
SSVQLDLQNGNKDNARLVGVDIAKKALAQGFKQVIFNKNGAKYHGRIKALADAAREAGLE
F
>UU248 rpS5 ribosomal protein S5
MENNVKKETIVDSEKVEKQQLVTAPVVNKKENTEPKAKTFKRETTTSNFEERVVKIKRIS
KTTKGGRMMRFSALVVIGDKNGTVGFGMGKSIEVPDAIKKAIKNANNNLIKVKQTKKGSI
YHDVNGRHGAAKVMLLPAPEGTGIIAGGPVRAVVELAGFTDIYTKSRGANAPMNVIRATI
NGLLQQLTPKEIARLRDKSLREI
>UU249 rpL15 ribosomal protein L15
MQLHNLEYKKGSRNHKEKRVGRGHGSGLGKTSGRGQDGQKARKSGMVRLAFEGGQTPLYR
RVPKVGFNNDRFANKYNVVTLISLVKYETKELTVEFMYANKIAKNEDLPIKVIGNAVLPS
GTVVSAHKFSKGALESISNSKAKAQILE
>UU250 secY preprotein translocase
MTNKQKKKNAFRQLLMIFKNKKVLVALIVTLSILILFRIGSVIPMPYIKLNGNFGNQGSF
FSIINLLGGGGLSQFSLFAIGIGPYITAQIIMQLLSSELVPPLAKLSKSGERGRKKIEVI
TRIITLPLAVMQAVIIINLMTRANGFISIVSNAPFAIGSPLFYVTYIFLMVGGTYISLFL
ADLISKKGVGNGITLLILTGIVASLFNHFIAIFSNLGSLTSSKVSQIIGFILYILFYIMI
LIGVVFVNNSTRKIPVQQTGQALILDHEKLPFLPIKIMTAGVMPVIFASSVLAIPAQVAE
FLDKQSMGYYVIHNYFIVDSWTGLAIYVVLILLFTFFFSYVQLNPPKMAEDIKKAGRFIP
GVQVGMDTEKHITKVIYRVNWIGAPILAFLACLPHLVALVAKTINHGIPVIQPSTIFGGT
SIIIMVTATLELWNAIKSTSTSTSYAYQRKELETSITVSAESDKSSKSQIW
>UU251 adk adenylate kinase
MKILLIGPPGSGKGSVSELLTKNNTLKHVSTGNLFRAILKEDSELARKIKEINVSGGKLV
PDEITNQVAKSAIDELIKNEQSFILDGYPRTINQALALEQYCNLDYIFYLDIDHQELMKR
LTGRWMCPKCAGIYNIHFKKPQVHGLCDNDQATLYQRADDHADAVSIRLDEYDKLTLPLI
KHYETNPRFIKINANQPIEDVYKNINNYLKQNK
>UU252 map methionine aminopeptidase (map)
MVIVKTEKDIAAIKEAVRIWKIAREAIYKQAKAGVSLKELDLLAKEVIEANGGIAAFHNY
LGFKGHICISVNECVIHGVPTDYVLKDGDKVTFDVGVKYDNHYCDAAFTIIINNSNVEAL
KISEICKKSIDEAVAIIKPKVTTHAISNAIQKFIEKNGYFVLRDFAGHGCGNEIHEDPLI
PNYRSLLYRNVTLEENMVICIEPMILSGSNAYYIDPNDQWSVKSKNHQMTCHWEHMILIT
KDGCEVLTD
>UU253 infA translation initiation factor IF-1
MADTEKLKMLGKIVEVLQGGNFRVQLENGITIMSHVSGKMRVNKINILPGDTVDVELSPY
DLTRGRITYRHRDN
>UU254 rpL36 ribosomal protein L36
MKVRASVKAICKDCKIVKRSGVVRVICANSKHKQRQG
>UU255 rpS13 ribosomal protein S13
MARILGVDIPNDKRVVISLTYIFGIGKSTSQQILKLANIDENIRVKDLADEQIAEIRRVA
LNFVKANGEKLQLEGDLRRTVAMDIKRLMEIGSYRGIRHRRGLPVRGQRTKTNARTRKGP
RKTVANKKIETR
>UU256 rpS11 ribosomal protein S11
MAKKKKLSFTNGIAYIHATKNNTIITLADEQGSVLSWASSGSIGYKGTKKKTPYSAGIAA
EAAAKAVIDMGLKSVEVHVNGTGASRDTAIRSLQAAGLEVTKIKDVTPIPHNGCRPPKKP
R
>UU257 rpoA DNA-directed RNA polymerase alpha chain
MRKFLKYQLDVPSINSEDKNRTVVKIAPLEIGFGDTLGNALRRICLSSIPGASMFAVKFG
GYSHEFQPYEGVKEDITHIILNLKNLAIKIDELIYSEDYFNNLLIDKWPKMKINFKGPGV
ITAKDIVCPVGFEIVNQDLYIAEVTKPIDVEIEIFAKTGRGRVDFNTNKDFVSTLHIIAT
DSNYSPVLHYAYNVEMIKDSKSSMSEILTIDIATNGTISGSEAIAIAAKIMQAHLEPIVN
IDKTINEMIIMREREEEEKRQNASISIDDLDLTVRAYNALKQSGINTTAELIELTKSQLE
KIKNLGRKSVTEIIQKLTERSLELKKD
>UU258 rpL17 ribosomal protein L17
MSYINKPGKTRAWRKMVSRQQVSDVISHGSIVTTKTKAKESQRHVDHLITLAKKNTLASR
RAAAAILLGTNQHSADDLLRKLFNELGPKYANRAGGYTRVIKLGNRPGDNTEEAVLQLV
>UU259 unique hypothetical unique hypothetical
MNKQKRKISVLTSISLFLIISLSIGLGLGLIKNNENSITSKVQKSSNFFINDLSKQLFLD
VFNQDKLELNAYMYDQNNVSDQQLLDLKFALTLLNPNRLDINDDDTIAIMKNNAKKIIFQ
SLSNNWYWLFTNLKSLEFSYTPYKPNFYAPYINEKQDFTKSSIFDKVININKPLTNYIKI
KQKLFDKENYRSVDVYYLQFGDHLILRLLKFNKKNHFDVRFDTDLFQFNKPIINLELIAK
EMQTSIDYHREDNFKKDILDYKKNYEDYLYYDEKLNSSIYQQGLDKINKEYYEVNNFNFF
NTKKPLFQKFSYQMFLELKDKLGFKRYVLRNIDQKEVRARDHFNDNEKKQQNKNYFRSFD
KELNYFQKYIDHNLDININKISKEAYITQKIIKNLLLDAFNNNDVQITKYLIQQNDKEYQ
NKLIKQLIEFSNYFKNQKTPRDSNEYKQKLNDYEKIFSQNWYFILMNLKHFELSFNNWFT
LPKQINPITKEMLGPSEKYLKRLKKLKPYEDYYFINNYLEKKQEGDTSMLIGSFKDLYIT
KNQSIFNIKIDFSSSENRLSLNPLIYFFPKTKNKLSVDLITSIFHQAIFHQNKEYYQLFE
TDMIDKYEYGIPAQMLLLWRE
>UU260 unique hypothetical unique hypothetical membrane lipoprotein
MFIFFKKNHLLKLSLFFIPLTLISILITSCSTSNLKKQQILTNNEISFFMDKSQNCYVGL
IVDQTLKNDKKTIFNVSLIDEKNTKLNLLVKDYQIKDNKILIRLPRLIKLNDHLIITSNN
ASFIPIRKIINIDNLIDLNIIRTNNQTQDSWIAFLNNKVINNLLITIFPNKKDRDEYIKS
QQEIKIEYAHEIANWLNYYNTVQNDANKAAVFNENTARSKLNNNLFNNVSLSNPFAYEQA
RKFHNTLFNKNWLWFLFNLKRQIFMLYPDDNLFQESSEETAEGLKDSKINNRSSFYRAQS
NEFIDGLYVVESSNLNKKPEELDEYTDFSKTAKFTLLNNEGFVFTISIEENYDKTKKLIS
RKVSLLPWIKTLPRLMFNDHVIKQEFNLANYTENSYDYNAVNFHSPLEIKVYEDQFGGKA
IRFSFVDIDPN
>UU261 unique hypothetical unique hypothetical
MNNYIQQVIDYVNDKTYKNKTYFIKKYAFAFLTSLIIFIFLLVFGLSNYFNPLVSLVGVV
LIFSVLVVFCIHIKIINNYSLNLLKWLRNQKELSYKYIINILDFILNKQLYLNLTIIEVQ
QICIDLEEFKKTNVI
>UU262 conserved hypothetical hypothetical
MSFKTIAYTQKNIKIIKKSKFITIVEPISDKNEVQSLFKKYKEQYYDATHICFAYVIGRE
FNYMKAYDDGEPNGTAGIPILNIIKIKSLTNVIIFVVRYFGGIKLGTGGLIRAYSQCAKE
IIDNCEIIILQKYFYYKVVYKLKNTKFAKQILTSISYEKLIESYEDDRVILKIRINTKIN
IFMSKIEFIFIKHDY
>UU263 unique hypothetical unique hypothetical membrane lipoprotein
MKINFKRTFLLSFIGVIVTPIPIILSCSLTKIKKEDNKNFFNLYLKIKEEASSKVDFVLK
NNHKYNYLLNKADIINNYINYLVNLNLNENSENELLAFTYYELYKLIKDFNYLLKEKTQE
YESWLIKIDNFVKLIKKRQADFLNFKNKNKIIHDIDHIKNNIEEILTNYNQIPDNENIDD
IKLRYKKMIESYDGLYKKTINDEANKIKNIKSDVKNLKHNYFEKIDNGEEYYKLYNREIM
ELFHEANQLHENISSVLQSILNRKLIENKIDNIKREIQEHKKVSQYIKQNGHKNNQDFWD
TWKEDILGKKFIYQTLMDNTNVAIWYGLALKIEDLAKQKFINTKSLELKQLIEKWKLYGQ
ALIRDSLDAANFSGLFFTIKSKTSMLDNWQPSIDPNSLSKKGKYYLLIKKLKDLTNEIEK
KARNANQKLSRFYDSVVKDDVEQIVPYIKAVGYGFYPQEEFGELMYWSNYYLNQLPDVFQ
YYKEKIIKPIIDQIKSKSDSANDVSKLEELYNFKYHYTNIYEPFNQKRDNFYYYSDYKTD
DKGEKIKNSDEMFILTKQVPNHLKNEYDTARLFFRIERTIGEICKKYALTNPLE
>UU264 pacL cation-transporting P-type ATPase
MSFDPENINPSTGLNDEQVLKSRQIYGFNEIKKKKKSHIITKFLKQFLDFMVILLVIAAA
VTLALVIIKPPHDTAELVVQYVEFGIICFILLLNAIFGTIQEVKAEKNTDALSKLASHQV
KVLRNNQIRIINSNQVVMGDVLILEAGDQVPADALLVNSSSLEVDEAILTGESLPVVKNA
KAIVKKNTVIGDCLNQIFSGTYITNGTAKAIVTNIGMNTEIGKIAKLINDQKTKLTPLQK
KINKLSKIIGLFASILCIAVFIIYIYLIGDGNWNISWHPALIMAISLSIAAIPEGIVAIV
TIVLSFGIKEMAKQNALIKRLPAVETLGSANVICSDKTGTLTQNKMTVTKVFTNKLKITD
LIDNESVFNLIKWATIANNGIKNFNEKKQEYEFIGDPTETCIIEAALKLNIDKYKLDQEF
IRIHEFPFDSTRKLMSVVVKHQSDYYLITKGAIDAIDKIVQNPITKDVYEANDFLSKQAL
RILCVAIKKLSSIPTNFNQDELEKCLEFVGLIGMIDPPRPETQEAVKIAIKAGIRPIMIT
GDHINTASAIAKQVGILNEGQEVLNGNELNMMSDNELINNIDRYSVYARVSPTDKIRIVK
AWQHHDKVVSMTGDGVNDAPALKAADIGCAMGITGTDVSKASSDMILIDDNFATIINAVS
LGRSIMDNIKRIIVLLLITNLSGLVSLIFGIIILGINPMSSLQILWINVIAETLPGIALG
LHLADVNLMRHKPLKKSAPIVNKRMWATIFTNGFFVGLISILLFYLGASSHFNFDFMLMR
NEFKELTNLEKIYQDTWSWFGQNHEISNIIHEKILTIKTAIMAGSSLTFVFMGMSLTFNA
LSLRTNHSVFVNFWENCKYVVYSILISIVMIIVIAYTPHLNQIFNMNPYNINGYEWFNIL
PFVLFAIPLSIFEIIKYFRYLKLRSTFDYKNKTYALLNQEIQSTNLKINNTKISYEKQYY
KALLNNLIIKRKILINKCHKEI
>UU265 conserved hypothetical hypothetical
MNFSSFIFKVSDVFKSVIHEASDVVTKADLDNANAHTHSLAVGLGIGIVLFLIAGLIIGY
FISMKIMKRQLKKNPPISKDTIRMIYQQVGRKPSESQINEIYNRAVKQK
>UU266 conserved hypothetical hypothetical ATP/GTP-binding protein
MAKFIKSAHYFDQYPIDKQFEICVIGRSNVGKSSLINALANKKIARTSNTPGRTQLVNFF
DFNNFRLVDLPGYGFAKVSKEKQTDLAAIIDQYLGYRQNLCAVFQICDINVLTNDDVEMS
RYFENQKYAHFVVLNKLDKVNKSYFNNNKHKIAKFLNISTDRLLCVSAQNNINIITLFAL
MKKVVIQAKQEKILSKKEEKMSSEEEIK
>UU267 valS valyl-tRNA synthetase
MKKKLSKKYSFKEVEANKLLFWQENNLFKAQINSTKKPFTIVLPPPNVTGHLHIGHAYDF
TLSDILMRYKKLKGYDSFIIPGTDHAGIATQTKFEKNLKVNAQTNRFNLGRELFLEKLKI
WKDEQINYIHKQWNALGLGLDYSNYLFTLDPIVVQTVREVFVKMFNEHIIYRDKKLVNWD
IQLKTAISNIEVIHKEVEQKLYYIKYLSQDQKDFVVVATSRPETMFGDKYLVINPKDKRY
FHLHNKIFINPINNIEMTVILDDYIDIEFGTGVMKCTPAHDFNDYELAKKHNLEIINIMN
ADGTLNEKCGEFKGLDRLEARSLIIDKLQKNNHLLKVESYRTSVGFSERTNEIVEPYLSH
QWFIKMDSLIKDTIKMQDDCNNKVDFYPNRFNKTLLTWLKNTEDWCISRQLWWGHQIPVW
YHKKTNQIYCDTIPPKDLENWIQDEDVLDTWFSSGMWPLLTTKWNYNSHFFDRYFPTSLI
VTGMDILFFWVSRMMNFSQYLVEKKPFKDVLIHGLIRDSQGRKMSKSLGNGIDPFDIIDK
YGLDAMRLFFASCTTIGEDLNFSTERLGANWNYLNKIWNIAKYIENLDEINDNLNFEDVD
KFCDVNKWILTELSKLTLEINKNMDKYNLVVATKYLYDFIWNTFASYYLEYTKVLLQDLT
LKNETIKTIRYVFNKILIMLQPFAPNISEEIWLCLNQTNNSILLQEYPIINFEFETIIID
KIAKIILEIRKLRLEENINNRINLCFELISPNDAFYKSKIKLVNLLLILVNAEINEIKKT
SSNNYTYELVIDDFILKTSYEKPIDYVFQMKKASEQLNYLENEIQRATNLLNNSGFINKA
PAQLIIKEKNKLINLKKEHANLLKTLTDLKQKVK
>UU268 spoU rRNA methylase
MLNIVLFEPEIILNTGNIARMCVGFDANLHLVRPYGFILDKKRFHKDFIRASTNHLNALK
LYEYDDFNEFINKNNISGDEIYFFTRYGTKTPCDYQYQNIIQHNVYLVFGKESTGIDHNI
LKKYPHNWIRIPTSINLRSLNIANSVAMGIYEVVRQNNFKDLFKYEPHKKFE
>UU269 conserved hypothetical hypothetical
MRLRNNANAPLYLKSQHEYIINDPHLLKDNLGKIFKNPELPLYIEIGMGKGDFIIENALR
NQQINYLGIEKFPTVIVKAHKKALKHKLDNLAMICFDANKILELLNSESVDKIYLNFSDP
WPKKRHAKKRLTHPCFLEKFAVILKQNALVEFKTDNENLFMYTIYDVLLKDLTKYEILFL
TYNLYTLVNNVELLKNIPTEYEKKFVMQGERIKKVNFRFLKNNQ
>UU270 unique hypothetical unique hypothetical
MINKNKKFHFQYFKKDNDQSISTKETLKRYFNFRSQSVKLIIFNLVLTAFFLALFLIGRF
LTKNLDFLNGFSWQLQMGIFVLAIVCIPNFYYKLMYYIIAPLVMLAIGFSAEPFFGYLMP
HYGFGLILFTDVILIIVKKSCQSIKKQIFLSYLLIFSFSIIGYFIVWMGYSIQGTLFYNT
AFIPSMIYNSLVTFGSMAINFVLYIISIPAIVALKNKYLCKLV
>UU271 unique hypothetical unique hypothetical
MFMFDQIFKKRKRHLNFQIFIFFFVLILITFLILWIISGNVQTIIDFIKKKIYDASPQLK
YLTNIQIKPFKNLEEIFDFIIKNKNLIKDLQNEPEILDVIKNNPQILKTLNDNREFLKQI
VEYKPFAEILSKQPEILKFVQNNKELIKQIQNLPELLDLIKKHQNLIDHLKTNEKYIEVI
KANPQMLKDLYHVDDNLFNIIKTSLENDKENNILMLAIKYSVLINNFTKNLTLQEWKQII
EFYKTVDLNKFIVDDNLFNIIKNNNQLFEVFLNNYDYIKNLEDNQKIIDIIQQNPDLIDD
FKKIDFDLLTQKRNFVRALIKIIDYKQPKEIQFLNKKVFLDFFKNKSEITNALNITSLIG
FVLFIVIYTIFIFASFISHILMLKQIKDFNKIFKEAKLKKIYLISTLLLQFLFLILFIIN
FIVLIILVVDYNKLKAIVLNSGIKRKVEDSDARLHFL
>UU272 hit probable HIT protein
MQDCIFCKILKGEIISKIIDENEFAIAILDIQPASDGHMLIIPKKHYRNFSLTDPIYLDG
MMRLAKNMTFVLEEVFPNVLGFNYLMNSNSSAGQVIMHTHLHIIPKQSNGRGFVFKAIKE
EGDISNIDEIYKKIIIKTQKLKKSRLSKHYMV
>UU273 unique hypothetical unique hypothetical
MEQIRNLIDLQIKLKPIQKAFYDAWSKTFINGIDNNKETHEQNKKIILEIYMILKVFLNK
NRDIISKIPLNQVKKIANDILEKEIILEQPLVDYYYQSSSCFILIPYLIQILYQSYHLNK
PIYKIMCKFIIRNNLALFKEWDLIERQTLEIIKLKTNLIEDNNKAINLFSCEQRELQHNR
FVKLFNNFILVYWTKREVKYIEAIRFLMYFIWIPIIFIVLLILILGLYFGLSNSESLKSS
TQFLLDLFIIN
>UU274 hemN oxygen-independent coproporphyrinogen III oxidase
MIFNKKTKHLYIHIPFCNYICIFSDFKRILKTPQTKKFFKNFLENIKMHINNFKIKQFKT
IYLGGGVPNCLNNQELEILLKTISPYVDDNCEYTIECNPELINQTQINLFKKYKINRISL
NVQSMNNDVLKQMNFIHTNQDSKKAINLLHKNGLYNVSCDFLFCISILTLKDLDDVFNFI
LNHKINHVSFYSLEIKEQSLLKKYHITIDEEKEIEQMNYIINKFAGLNFHRYEVCNWTNN
FRYIAKHNLAYWRTEDWAAIGWGAHGYEKNIVYFFDGSIKNPILIKKVLTKHELYQQILM
MGLRLKDGLNLNKKINYEAYSYFKNQLKHVSINKKNHLLIDDLNLLNLTILDIF
>UU275 unique hypothetical unique hypothetical membrane lipoprotein
MGLKKEKKDRSTIQLLFGTIKKRKIANYLIIAFAFLTFALAIIGSFEAIASKYAIGIGSG
LSLFITIAFSVWRILMIHLEKEWNKSEIIWQSVMGAILVLSIIFWIWATTTTTIQYSSLK
EHLLLLKQQDSRANFVVLTQATVDEFGVALKGGLWAWVITSCIYIFINTFNNMFMKEKNS
K
>UU276 conserved hypothetical hypothetical
MGPIIPNTRLIDFKFDRDLLNSAYTAHYFIKTCKIIELHAPNHSVIMQFTHFSKTPIMVC
GTSEVLALLEFCLSKKELKQLKIYYVPDGHVIKPKEALFVIEGPYEIFGWLENIIDSILA
RRSSIATNCYNVLNLINDEQKVIYMSDRSDDYSLQPYDGYAAAVGGMQYFVTQKQVEFLK
DINYECKVIGSMPHALIQQNNGRIDLACEMFAQTFPSDPLIAVIDYNNNVLNDLEQLRYM
FDRLFAVRIDTAKDLIDESLLSTFNNVGNRDLHGCNPYLIALVREYLDNNGGKHIKIIAS
SGIDLNGIKNFNKHNSAIDFYGIGTYLSHLSVHITADLVCLDNVYGAKVGRKIAKNFSEM
ILY
>UU277 rpS21 ribosomal protein S21
MSRGVSVEGDLEKALKKFKRISNETKKDSKRHEYYLSPRIRRKEKIKEANKYRSF
>UU278 argS arginyl tRNA synthetase
MITQKISEELNKALAKMGIHDTQETKILVDKTKNIKFGDFYTNIAMILSKKNNKSSLEIA
KEIANNFEQDLFLEVNLQPPGFLNFKLKAKDHENLLKQIYYEKDRFGQFSKKNITYNIEY
VSANPTGYLHIAHAANAIYGDILANLLKIYGYDVETEYWINDAGNQIDKLAMSVLVRYLQ
LQNINIQLPADAYHGQEIHLVAQTLYQTYKNQFINVRLNEKYEIDDDIANQEIKNFAVKY
LLNEIKNDLASINTFIDTYTSENWIRNSGRILEVLSKIKPYTYTLDGALWLKTTTFGDDK
DRVLIKSDGSYTYFTPDIAYHDYKFNKTNTTKLIDVWGTDHLGYIARLKAAMNALGYDPN
NLEIVCAQVMKLVKNNQEFKLSKRSGQSLTIKDLVEIIGKDALRWFLGSSSMNSHVIIDV
DIALSKNNNNPLYYVQYAHARANQVLNKQVYELDFKTDLLTETRERELLNQLHFYKQTIA
NAANNREPHRISNYLYDLAQIFHNYYANVKINNDNNKVLSAQRYTLVWCVKQVLANGLAI
MKITPYDQMY
>UU279 pgk phosphoglycerate kinase
MNSLNKKSIKDLDVNGKTIVLHLDLNVVVDYENKRILNDRKLRASLPTINYLINHNAKIV
ILSHLGRIKTLADKQSGKYSLEIIVDELRNRVSKNVNRVVFSPLNYGETVVQMVNDLEER
DILILENTRYCDISDEGEYVGLEWDGSEILGQFWGMLGDIFIDDAYGVAHRQLSSNYQTA
KFAKKSALGFLIVNEINHLDIALEVPKSPYLALIGGNRVADKIAAIEVLCERADQVIIGG
GLVYTFLYAQGYNVGLNLVERNMIDDCNNILEKYGKKILICFDFLCNNDFSDTRPIYRKI
DEGLEGLYGLDIGKRSLKFIKHEIYRSKTILLNGPFGVIENIKNYAQGTTEICKSMAKQT
TRGAYTIICDIDTSSHAEYLGLDKYINFISTGGGASLSYIEEGVLDGLETIDNVPLNVLK
KE
>UU280 celM Endo-1,4-beta-glucanase
MSKFNEKEIRNKAIEYMEIYGMSRHEERVASKLKASLKDAGVDYERDNLGSIIFKKTNSN
KGPKILIATHMDEVGFVVQQILDNGQLLLSMVGGVWPNIAIGSVAKVYVDEQRQYTGVFG
HTSIHILEPEARSKAVPVKELFVDCGFNSKQQAIDLGIEIGTEVYMEGPTLNFYDENYIV
GKAVDNRVSVAVLDLLIHSLKDKVIPNQTYFAATVQEEVGLRGAKTVVSKVKPDIGIVID
TTTSHDTYKCPEGDTKLNDGVCIRIKDGGTLVNPKLVKYFEELAIKHNIPLYKYVARGGG
TDAEELQYGPNGGVLTIGLSIPQRYLHAPIGVATVKDIKAAFDLVREFLEVFDENEFEKV
KFK
>UU281 deoD purine-nucleoside phosphorylase
MTAHNQAKLGEIAKVVLMPGDPMRAKWIAETFLENAILVNEVRGMLCYTGTYKGKKISIM
GHGMGIPSIGIYSYELYKFYEVETIIRVGSTGSYKKDLNVNDVVLVEKSYSDSTFASLIG
AQVGDDKVLLPSREVNNLIKNTAKELNLELSLATCHASDVFYNNDFQTLDEIIHRTKSDC
VDMESFGLFANAQILNKNAATLLTVSDSLITGDALSPAERANTFKKMVTLALESAIKLL
>UU282 hupA DNA-binding protein Hu-alpha (HU-2)
MNAKIKAKTRSQMIDELSKMLNIEKKQTKAFMDTYEAFLILELSRAKEVRLGNIGKFKVS
VRAERKGINPKTGETVIIPEKTIPKFTFTKGIKEIINAGISIDNERVSIDDNDFDDDDEF
VEEYIVSENN
>UU283 spoT/relA ppGpp 3'-pyrophosphohydrolase
MNELVKKKLDDLYDFLKQKKYSSQTIELVHKSFDFANYYHGDQTRKSGEPYIIHPIATVR
ILASWDMDESTLVAGMLHDVLEDTNCPEEVMEKTFGKEVTQLVCFVTKVSLYSKNRRNKV
SHTNLEEKYSIQVFMSMTQDIRAMIIKIADRYHNMQTIQYLRLEKAKRIATETLEIYANI
SGRLGMYRVKTDLLDMSFKILDPQNYQLVNDSINKLVENNQKKWNEILARLKNILIANNI
KAEFEWRLKGIYSTYKKITSGYEVKDIHDIYAIRVILDDVYLCYQTLGLVHMNFTYIINT
FKDYISTPKWNLYQSIHTTISYEGTLVEIQIRTTKMNLFANNGLAAHWKYKEQKDNKTEI
LLTVNNVLLRDFLLSTDKGIKTIKDVTTGTIFDVLILNSNKWITVSNGSTLLDVAYKYDI
NNFFNILAIYRNGERSHFDTHVETGDTIKISYSNGIETIRPNWITLANNDVVKLHINNHL
KKYELNKQITKEQFLANAEFFLEGKIMSEEHAIKRLEKEFQVNSINTFLDNIANTDIDLQ
TKYKVFSENKQVSREAINTIKNQAWKWLADSSYFSGLENLYFTDFEISPCCSKIPGINCV
AKIVRNKVEIHRNDCSKVKNSRSKTIVIEWSKEKLENRPRYFKVNLTLKGNWSESVGNVL
CNTLIRMKANISKVDISKNKTARTHDTFLKIYVKNLDHLQKIILELQAKNVINEWRLI
>UU284 pyrG CTP synthetase
MEIDLMKHIQKTKFIFVTGGVYSSLGKGVSASSIGRILVELGYSVAMQKLDPYLNIDPTY
LSPLQHGEVFVTKDGKEADLDLGTYERFINADLNKYASVTSGKIYYEILTKERENGFDGK
TVQTIPHVTSAVIDYIKKIKDSLKTDFIIVEIGGTIGDIESLPFIEAISQFKTIYGVNNV
MFIHCSPLIYIEKVGELKTKPTQHSVKTLRSLGINLDLLLLRTNQKLDEVTIKKLAWSCG
LDIDMIFAAYDVESVYLLPNVLFEQGIHKTILDFFSLPLKNDNINSWIDFTDKITTFKKH
NLVIGLVGKYVELPDAYKSVLASLELAAIELNIDLKIKYIQPQNLNENNINEELKKINGI
VIPSIAGSIKGWPGALLAASYARKNNIPFLAVGTGVNIGIGEFINNVLKLPIEFINLGNG
DFSFLKDAFVKNEIENYRIGEYCSNIQANTITSQIYLKQNQLNERHRHHFEFNNHYINNY
FLNQNWKIGAISVDNNYIDVLEYTKNHFYVLTIFNPEYTSKPSKANPYFINLLKMSLKIK
ES
>UU285 hisS histidyl-tRNA synthetase
MINYSKPRGTIDLYNKEMNDFKLLENFLLSTTKRYGFQQIKTPVFEFAELFMKSAGESSD
LVSKEMYLFKDKSDRWLALRPEGTAGVIRAVVENKLLLNHPLPLKLMYFEPCFRYERPQA
GRQRQFHQFGVEVLGTKNIYYDFELIALADTILKKLMISNYILEINYISSPHNRSLWVKS
LQEYFHLHRTELTPLSQERITTNPLRILDDKLESQKLVVKQAPKISHFLSNEEKEEFNLI
KKMLDDYNIKYYVNEGLVRGLDYYSGLVFEFISTSPKLLGQSTIIGGGRYGELIKQTGGP
NYEGIGFGIGIERLLIALSETNKNILNTDDDKYLIAFFDKELENEAIKLTQILRINNQLN
VDIILSSTKADKIFKLAQRLNVKKLIILAKKEWSDKKIILKDLLNFKQDLLSLDEIKGIR
>UU286 aspS aspartyl-tRNA synthetase
MKVYCGYIGEEHLEKNVILNGWVKKVRKMGNLVFVDLKDRFGIVQIFATKSDGVFNELTQ
LSREDVINVEGLVLLRKNPNNDLKTGRFEIHVKKILIYSKAKTPPLIIEDETDANEEIRF
RYRYLDLRRDVNLKIFELRSKVYQAFRNYLYSQDFIETETPILAKPTPEGARDFYVPTRT
RKFYALPQSPQTFKQLLMVAGFQKYFQITKCFRDEDLRSDRQPEFTQVDIELSFADEIEI
QTLIENLLKYVFKQTINVDLTTPFMRMSYEQAINDYGSDKPDLRFDLKIKTLNTYFENSK
TLFFQKALLNNQSIRAILVPNINLNKKQVQTLEKFAKDKGAKGLSWISIKDEKIIDGSLL
SIQEDHIIYKTIFKDFNLSTGSILLVADTFDIASQALGLVRINLASILNLKKPNIFKFVW
IIDWPLYEYDNEAQRFVAAHHPFTMPTLETLNTFDVNKKDARGRSYDIVLNGYELGGGSV
RIIDQQIQRRMFKSINMSDEEANLKFGFLLTAFEYGVPPHCGIALGLDRLMMILVNSEYI
RDVVAFPKNNNGVDMMLDAPSNMNDEDLKELGLKIKND
>UU287 unique hypothetical unique hypothetical
MINKKIKINPNITYFKQKISNYHEHLLVWNDLYDKLISLTNNIIVDKNNKNIYHQNDKQI
FDFTLCLSGLLSKTLGLNHKSSSLYLTNDDEVAHRFKIKVLHNYFNLYNIEEFFTFMDNQ
IPLENAKNIARLSLIYDLKQHENILKTISNEGLENIDLEFAFINFLRAKISINFAYSYDI
SEVILLLRTGLDLHFFRKWAF
>UU288 unique hypothetical unique hypothetical
MTVAYHNLDINDPKNVLLATQKFFNHINEIIIDYGLDKRDQWIKKIIPFEE
>UU289 msrA peptide methionine sulfoxide reductase
MIKSIWIAGGCFWGIQKYFDSIIGVNHTVVGYSQGNVINPSYEQVCTQTTNHTETVQIDY
DDRFVSLISILEHLYQIIDPFSLNKQGDDVGSQYRSGIYYVDHDDEFIIKDFLLKKQNQT
PKKIMIEVERLRNFNIAEEYHQKYLDKNPNSYCHVDLSLSKKEFR
>UU290 unique hypothetical unique hypothetical
MAVEKIKISKVKLKIVSALFNLLKTNSFNKIKISQIIEVADVSRPSYYRNFSDKISIINY
FIKNIYNWKVVSKLINNNLNINFDEVGFTKFYEISLQISLEFKEYFLILDKNNFSGLIVD
LTTESGFYAIGNMSNNSIDKYLINYLTGFFCNIRMQWLKNGAKESIHDMAVFLTNVLKDN
VIKKLEKYQSCNNIND
>UU291 bsaA glutathione peroxidase
MERLNMKLSDYPVLDIDKKLFNWSKVKNKLVLIVNVASKCGYAKQYEQLEYLYKKYKNKG
FIIVAFPCRQFMFQEFDDNNKIKEFCSTKYNVTFPIMDLTNVVGSNISPLYKQLITEYPW
SPKAKAVKWNFEKFFVKNDEIIGRFESKCEPNDLEEFIKNNL
>UU292 conserved hypothetical hypothetical
MDKKSKKILGLSVASIIAALAIIAPSTYFGLQKQEEGKKDINLDNVTRKIPGETKDDIKV
EDLNNINDQNTDLKLDFSKVSIKPQTKINYLAIGDSITAGFNSELGWEAPGRYDPITNKI
SGLSFPSFIAQYINKVEPNRLASYENLGITGSRIEDWLYMLGAGSDEYFKNQEYRFFDFS
KQMDQQKDNPFKNRLSKFFKNFGYDSKLTPKNNHEVNINDFNGLKEQIKKANLMTITLGA
NDFLRYLDIPKLVSLTNLKGNDLEIKVKEFENNLQKASLEITKNLKKLIALIRTLNSNVS
ITLVSYPLPLLRLQDVIDSSFKLTNKRRLSDEIINILNSAIKKTYDLNNNINYIDAFDEN
DWKENSFNFAKAIFDIHPTELGYKRMAQDIFLKMSLGQNYAQQKTASIANAIYDAWDSEY
FNKDSDSFKQQIGFANNTNQDLVEKTLGSSKGAAFWAKTALENDEELRKSFSNFKNTSTI
VKDWLISNKRRFGSFVNLITSNLTSLGLDKNGYISQFLSKKDADNTNNLYKLASALASTP
YIDMVISGIQNDLDNLDLDKNNIIGTQNISKKILYDVFRKNIINDQNLYELIKGMFHSQL
FNENKSQIKSLIKALLSDLVSSHKLLEIIFGEFATDNLKNNNEFLKNLLIIQNKLTQTKS
LDNIINVFVDALFDNDNEYLLQGPLSNVLAKIVKTNKALLTTRIDNLFNDLFKDQTTLDA
TYNILIRVLGQNIPDFIKTPQASLIIKKILSKGTNLKLINTLKLNTIDLLTDSKTYAGIF
DSSETSIINLIQKSIDFTSKSFISDVLDLLTSDNVDLNEWKEFIKTILNSSTIKNIFNYG
IVNLVSSNTTPLKTSHFDFNVLLKNLIAVLEEKDWTTNQKTKLKSLLRMSVDELLKNPQT
QNFVTSIEDFIANKLGDLVISANNSLLKSNMSDIWKLIKEVVHDLIHSSESYDLIFSIIN
DFIDHPQNYDNLNNINDLLPLILKSTNKELQDKVDILFKKLINNENIPNLVGTLTTNLIV
KNFFVKELTVDQKQKINNFITNILPTIPNLTLYKEIRKQAFEFLTNNINKILVDPKNTLL
ILNDGINKLLSNILPQLSTLIELIDNDKIKDQDFIDVIKIFIDNLDFNKLFVNIKSNNNQ
TTDSTTLNQFYFKFKLNLEPKKLIFDLIKNLLNSPILKVNDNKNNKIKIESNKAKIKSIL
TTSVTNIFENSNLMNFFNNQLSQLFSSIDLFKNLNLSNQQRLNFAKAIVELLNKEKLLSN
LINVLITNLIDHADEYAEATDLATILSLTIKYNQNELKNAFDKLLIGTLKNDNLQDLILR
IFVKLINPNKSYDSISVVSINKLKTFISKFATGISKLDLYQQLKNSIFTVFSNKTKMQQL
LSNDVSVINKTLLEAFNIDTPEKVLKISSLLDINEIDARDYADIIEIILVEIGFNVTSIQ
NNDVNNNLKTIDKKTNDFAFQILKKALNNGVSDQQLQKIKNVVNYLLDDIVKIHDSSSFL
RIQLEQLSHVLVDKITAVLPKSLTIKHKYTKIFSSILNNQDFLQKAKTLLSTILNELIDH
KDKYKDINSFSELISVFFKNKASDLKTQLKDLLNTILKNQTLITNIGQVIIESFKLENKI
SILDSDLEQNTISFINKIFAHITELPIYTNLVDNFFNFFSEYTKSSDTKTLNFNKFKSSL
FQAIIPKISDFASLLDLFKYNEISEQEWKSAITFFIDYLPINNLINSKILPTNSLLFVRN
ISISKTKPELNKIENIILDLFKALSQKAKTFDNNTLTKAKNIIEFTFNKLLTSNNIKNFI
NNLLSNLSPIRSFLKSINVQDKSKHNLLNM
>UU293 unique hypothetical unique hypothetical
MYNDLLDSLFTKLSDKSILNKLLNDDFLSIGSILKEIFNINQPSQLIKVIDIFSIKDITA
QDYVNVLNVIFNDIGFNNQQTKQNITNDQKYDINIYFEYLKALVEHNFSELTKTKLKEIV
KLFVKDVMNDDHHNHLWKKMTSFISHKLSDLLIKKIQVLTPQKNEYQQLVNNLLNGIDFK
NVVQNLIVEGFAKIIDHQQQLKNSQNFGDLIQKVINIDDVWIKKQLKQLLSAITKDINLT
KATSTTIINSYLNYFEIKNLTEEDKRNLINIFDKILKQIPNLLYLQNIVDQSVDFLKVNI
EALINHQPLKNTTWNDFINKNVTDISALSNLLEIFETNEITNNEWNQLITILINHAPIDK
IEEIIRNITSNSIINNKAQKQDIKKQIDKIYLLIKKVLQTQTLNKSHAKTSVVKINETIK
TLIDSLFANQEIKTLISNTLSNWIFSSNLAKILNVDEDQKNSLIKPVVEFIISSNDLKTI
LKTITNSFILHASELANTNSFEELIVKLISFEQTNLKSNLNNFIQKILQNDKIDELLARV
IFKQISPQKKYDQIQQINKDKVVTFIKKLGDNLTKFDLYNKLLDNLFSSITNQTNLTKLL
SEQQDSVINFIKTIFDFSDPKQIISLIDVLKVNEITSNDYIEVIKSILDEIDFNHFFNQA
VKNSNLSNYPLNKHENDNDSKLDINKYYIYVKTLFAHEMDSTSKEKLKTIIDELTKKIVE
NNNKGLLYNLGNGLGEKLSNLIINTFPGLTNLKQNYKTLVQKVFTNQNLFEQVQNLITYA
INSLIDHKNEYQNCKTFGELLTTYINKNQTQIIDKLKEAINKIISGSSSLIDEISTSFAN
TIKTYFKLENLTVEDINKLKSFINFVIKNIFNLEYVNDGLVKLITTLSSNAIKIVDQNTN
FVTVMQNDVISYLTSPQQIAKLLQIVDLDKNDDILNFLKVILSHLPQNAYTILFGNKINL
ITKNTNQKTNRSVIQKYTILDYVKTILNSSYLKKQDTIVKIKHIFKDLLVTISKSSQLNN
YIGELISNTFAQKLSNLSGVDKQYSESFLKESYKFIISDEKLIKIIDEVVNDLVDHKDEY
LKEITNNNQPSINIILNMLIKRNVDQQKVDFVPFIKRYLVIDSSTQFMAQYLFKTLKLEN
TNDQDVKIVQTFVKELINQIDQLDFVNLFIDKIFTLIKENGLDLFTKEEGIKKVNEAMKT
FGLTETTNLLKIAKLVEPNKIKPQTIGDLINLVFEKSPLAEDFESITQDKNPLYYGLKNL
KEDSLNAVLFASGKKKIGEAAKVSEINMLDAIQHLINKLWSARAEYAKNHPNLEYEQDNP
YMRSLIHLGIVMQWYVHETYFRNVSGGLWWTGSDSLSGEGRVYLLLKADMGSESEKRVRS
MIMGNRGAMLWNTPKEWNYNKNDFLYMITYWKWRTNSRFNDSKEKNKATYIFKALKRGYG
EKVKTMK
>UU294 unique hypothetical unique hypothetical
MIQKAKFYAGYISRLRFIQKLRYEIQNEKKTLNKIIKVVNDADISTLYDFKDKNLTIYTK
TFYFHNYQFVNANKKNYFISKKTIKSVITENLLDIGFTWTIIYNDQTKTYIRPTDFMTKN
FIDYKKNENKIATRSKILYDMIVKNESLNINHSEYESLLVNNEWKRYYENMINIFLYQYY
NEGIKNDIDFLNHFLLKDALK
>UU295 conserved hypothetical hypothetical
MPRKHLIASGINKKQQQQAKIWMKCAKEIKAAAKMGGPNPEANSRLKVAIERALNNNLSR
DSIERNINGASKDIDNLKELTYEGYGPNGLAIIVRALTDNEQRTISAIRGYFSKLQGQIA
KPNSVSMLFNECGQLLINKETKSLDEWFEILIDQSIIDINEDDKIIEILVKPEDFSTVKL
ILEKNNADIKSAEIKLIPNDFISLDEYARERLVRFVNACENDDDISWVITNYEEEL
>UU296 unique hypothetical unique hypothetical
MSNYELRRRIIMSNIDVKTNFWKLNQKNKKILFRVLGYSSLSVTIITPLIYKISYNKQYS
FITKSIRELKTIDTNFVSSYSDFYILQKSSISNDLYNYNLINNYHDFEKLIKNDLNFDKY
NSALIYEKIKVSLLEKYNENFFKNNDLLYVSYNSLDSKYFLTSILSFDYNNLYLPFLNTK
SIFNDEYDNKNFYTDSALSTTKTEVKFFSINKKYNIKLKQIKIYSIETAKDLFLYKNYVR
KNNKPI
>UU297 conserved hypothetical hypothetical
MNNKNNGMHLEVLINKSISLFNLQYQAFFKKRCVDIIIKNIDNSYVQGKIKQKSETDYYG
FYKGDYFDFEAKQTNKNSFLIKQIQPHQLAHLYLIHKNSGFSFLIICFINYNLYFIITFQ
QLINYYQKTKRKSIPFQWFKDQCIELEIIFPGVINFKKMINDLKLKYYDD
>UU298 efp translation elongation factor P
MATIIQAKDLRAGHTFLYKGNIYQVIENSFNKTAMREGIVKCKVKNLRTGAITIEVLTGE
KLEQAVIEKSKMTFSYDDGSGYVFMDNDTYEQISIPYSQLSWEKNFIEEGTEVSVMRYDG
ELMGVSLPDQLVVTIIEAEEAVQGNSVQNATKRAWLESKWEFQVPQFIKSGEKVIINPSN
GQYVGRAK
>UU299 unique hypothetical unique hypothetical
MQYITINNTKSGKILISKSNIKKFIEQKFNLIVNKKFVIKNIDIVQYDESLVDISIIISL
FDIHQKVDLDEVRDVQNHLASFIYSNLGVDTKSVNIGIDL
>UU300 nusB transcription termination factor
MKTQWAKRVKLFQFIYHWLITKKNKPIALKCALVDFDLDLNWINVGEYILDNYEQLTKMI
KPLISKDWTFERLSYVEQALLLSAYGEYLVLKTPKKIIIDQTLITTHNYSNNESYKFINA
ILDQLLN
>UU301 conserved hypothetical hypothetical
MQRYFVSKIKDKKVYFYDSDVHHIKNVMRMRLHDKVIVINKTKAFVAEIINLEPLHATII
KPYTLNCELATKIDLFQASIKPNNFEWIVQKACELGVNSIYQTIFKRTYNHSLIKTNRIL
TIIKEACEQARRNHLVNYYAQFSFNELLKYLRDYDLILIAYENEKQNLLNNAFKEELTYQ
KIALVIGPEGGFEQMEINLLKQFDNAICISLTKTILRSETASLYLLANLVNKLI
>UU302 unique hypothetical unique hypothetical
MKQRLINYIIVLIGILCIVSLVVGFAVWFSPNKNFDTLTQNKIDGNEVKRLYNPNNGIFL
EQLEGFSKYNIAGYVVPIVFVILSFILLFLYYFLNKKSRSKADFPISEKFIITLQLPLFI
>UU303 unique hypothetical unique hypothetical
MQEGDFYATDRDPFLTYWKELKPSFYAKKSVYIAFLTIIIAFAVSIIGFVNYFSLKIALE
QTQKATLEVQKQKEEQKNQLSNGVYFDQDLNLLNEYDKLVLYQKNNLSSIVFLAINDQEQ
ILMQKDQVVVNSLNIEQKVKYREQATRIVFEKQAEHNDHLVTSGNF
>UU304 greA transcription elongation factor
MAKYTISKHRLEELQLELREILDVKWPAITKQLQDAREQGDLSENADYDAAKNEQAALKK
RKDEIEEILENYELIEDVLRSTDEVSIGSTIEIYNYQKDCEEVITLVGSMDSDPFANKIS
IDTPLGKALVKQKKGTEVTVHTLASPYKVKIIKIID
>UU305 conserved hypothetical hypothetical
MQKKYIKNTLGFDTNLFIYQDKKMFNYSIDTILLANFISLSSKTKKILEIGTNNAALSIF
LALRKEDIKIDAIEIQIEAINLALLNVSQNHFEKQINIIHADFNQYWKDFDKSENNKYDA
IICNPPFYKQDKIIPSTKNPLKTLALYEITLNFEQIMQGCAKIIKQKGNLAMVIPTTRLV
DLLEIMRKYQFEPKRIKMIYPRIYEQSNLVLIEARYKSGWGTHFEPNLYLHYEDKQNHQY
TEEVLNWYKPIKFKK
>UU306 nfo endonuclease IV
MDKYNLIIGSHVSLKAKDFFYGSVKEALSYGSNTFMVYTGAPQNTKRQPIKSFKIEEAHN
LLKKHNINLDDLIVHAPYIINPCSSKKNVRELAKEFLIQEIQRTESMGITKLVLHPGSRL
EQNEDIALEQVYTMLNDIFSTINTNVIVCLETMAGKGSEIGVNIKQLKTIIDNVHSKKNI
GVCLDTCHMNDSGLILDYYNFNQYLKEFDAQIGINYIKVLHINDSKNPCGANKDRHENLG
YGTIGFANLINIIYHPLLNNIPKILETPWFNVNDELIPLYKHEIKMIRDCKWYDIKNKLL
SKK
>UU307 conserved hypothetical hypothetical ATP/GTP-binding protein
MNNNQVDDELDLENFNYQKALEIPNIKAINLTEEEFNLYFWDIVEVYRSYLNNLNNQNDS
YYIYQLNRNEYNHLCLVVVKKENKVDKIKRNYILNTIKNMDYNISLADDSQIFSKKTEIL
DANLLAERNKLINFFLEEARKNKKNTLIKNNNQQPKSAFIYGDFSVGKSIITQAYTNTIS
LKYNLKIAYITLNDLFKNVIQFFNYKDTSDLVINELVNLLSNVDVLVIDDFSSVNLNYWS
ISTILMPIIENRLKSTRQTIFISNFSIEQLINSTKNTTNIEEQKTKLRLFNRIEYLTYGN
IFKITGPSVFKVVNNS
>UU308 conserved hypothetical hypothetical
MDIVIKKNCNFVKNDDHLYSFYTPLIGMQAVALYSWFVNRENIFNKKGTINLTHEYLLDE
LNISINTYNELITKLINVDLIKIYSFENNSQQVIEVFRPLKFSEFINIEKFNEELKNNVS
LNHYNVLNLLNKENNIDTNRLIDLSAQFKTNHFNNLENKLDKIKKIILKEYGLSLQIDES
TKLCLINFFKKYKFSIDQMLNLIKNNLINNIDFLTIDLNKLELTIFSNMEFEKNKTKFQY
YNIERDFNIFNKNSNLDRFKNVINDYNNFKPSDFLKHIRKEKLSLKDKEAINLLTYDKSL
SDPIVNVILDFVLFKNLGRLNVKYLKRIKETVLGINIKDEYEMIKFFQNKKNDHKELICE
DSDNANTFKNTNFIEVKFGDL
>UU309 unique hypothetical unique hypothetical
MFEQVFFLASINDKKIIRWLYERYHKIFLKYINEQLNFKFYTLEIEANDLKTIIYEIFLK
IFQVTRIKSLNQFIGFVKRQIYFYLVYLLRKSLSNKNLVNHLNNNNFENYELISTNSDEV
GAELNNRFLIYEFLRSIQKENLFLYHFTILIIKGYNTKEISEILKINSAKIYYYKALLKK
YIKKLL
>UU310 rpS20 ribosomal protein S20
MANIVSNEKTYRHTQKVRKENHAKMSKLRTIVKKTRSSNEQAQLNEAYKVIDTTASKGVI
HKNKANRLKSRTAKAFKTNLEVTA
>UU311 ard1 N-acetyltransferase complex, probable ribosomal protein-alanine-acetyltransferase subunit
MLKNLLIRPADQKDLNDIAIFENRFFLNDCYSMRNLEEIFHNSNYQIIIVEYEQKNIAYL
IYMKSVDFNEILKIGVDENYRNLKIGSLLIDLLKQKKQNILLEVSDLNTNALNFYLKHGF
IKQNIRKRYYANGSDAILMIWKYNQT
>UU312 conserved hypothetical hypothetical
MNSTYQLFIDVTSRKCILAIYKNFKIHTSIIVDTNNNLTDIIVEHLNNLLKITNLQYQDL
EAIYLNTGPGSFTGIRVGAIVAKTICTIFNKIKLFINDSLNIIANGKNDVFVYLDAKGNK
SYVITITNNIQNEYKIITNKELQNELKNTSLTIIDANQIDYHDLIYNLKFDNFKLTNILD
FRLNYVKKPLN
>UU313 rluD pseudouridine synthase (uracil hydrolase)
MKILYSLMSSQRIDKFLVENTNYSRTLIKKMLDQNLILVNDNFISKASYLLKKNDYIQIN
NELPIVQEQKKLLPFVYSLEIIFEDQDLLIVNKPSGMLVHPTSFHEQNTLANALKYYLKT
DNFYITHRLDKNTSGLIIICKNQIALNSLQQQFMQKTIRKSYYAIVHNRFDMQHLHFMIN
EPIGHSYQDKLRMKTGNSKNTKEAISIVKVLEQYKNTALVEVSIITGRTHQIRVHMRYIN
HPVYNDPLYGISKHTTEYEQYLHSFYISFNHPSTNKKVEFKINMPKEFMELIRELKANE
>UU314 lspA conserved hypothetical protein (possible signal peptidase II - lspA)
MLQKIKNSNFYIIIKKFNQSLRKINFFEKIILKINNKSIRDYFLSITSLDVIFYKIINFI
IVALIVLLSGFLVREWAIDLVVKTKETHHGPIFHFTLNNGIALGRINNHSGIVYTLQSIP
IILGFLSFIFLKNSCYYVPLLFLLFGGLGNIIDRSIPEFELFNALPNIFHNSLINPNSVG
GGDDVINGVVDYWKFVNSIINLFDVYIVVGVCVLVVILVIRFIIKWKNDSDNQDIIKKVA
DENDLEINEISNKPFGYDDLKKS
>UU315 ppa inorganic pyrophosphatase
MKLNVTIEIPKNSNIKYEYDRATKEIMVDRILHGSMVYPHNYGFLKEALDYDGDELDVLV
FADQAFQPGIKVPARVLGAMKMIDGGETDTKLLAVIDVDPRYKHINNFKDIPLHWLAEVQ
DFFENYKNLQNKKVKILGFEDEIWAQKEYEECVLLMKEYGHLKKDEFVTKMMKERPEKYI
K
>UU316 unique hypothetical unique hypothetical
MKNFSKNRNINNFKNPLRVIEGIVREIKNNELQIDFVNSHKKGVCKFINLTDYHWNTISS
RFLINSKHLFLVSKFDPIRHVYWLNYKIIHPIEIKNKRRSYPTLSHDRNLRIFLNNLLEK
ENELKN
>UU317 conserved hypothetical hypothetical
MFRNLIKNVYRYLLKSKASFIGLCLLLFVSIFSFSMLTNLSKTLTRSYTNLVNRQKLHDI
TVNESYIEDQKDIKQAQFNKLLEELKVFYAQKGLNFDWTRSNSLIVNSTKDDITYKIVQY
STSKTINTFDKQTSERLIKNSFSDIDLYGILNNAKVDVIDLIKTKTLNASFVINNLKELD
NKQKSNLVKLAKVDNYDVSISQQARLYLLKNIVYGAWPSKTNNLYKKFKKAYEYSLEDKN
YDPLIGNIKLNNKANFDILEAKEISTQFILMLYPSKKGISINGNVNTIVKGHRITFSFEP
AGIPIPVYFDVKSAYALVGLGAFLSNHNKQKYPMYLWQKALVDHEEQQSFEKWFNSLDEK
YIIHIDNTPYLILDSGITPDFMYPIISFTSVIPNPKKEGLVYVNLNGYARIYDAFRSNPI
ENNLQIRITNQKHQSVDISILKKIVKNLNDQIKKDAIMNWPTSLDAAYLKDDTNNHITPS
PLRLVFINKITNTIQTFSVLITLFILILTIFVIVIIINRFLAQNKINIGISIANGVPRWK
IILSFAFIGLIPCVIGGLCGYLTAYFTQNLAINIFSGYWLIPTVLENFNFGALITVIIFP
FLLFFILIVGLGYWSIRKPPIDLMRGTETFKISKIVYVIKFPFKYISGFNKYLITLSFSS
ITRIIIFSIMIALSFGSIMFLTGTRGKIKQTIDATLQTKKYRYGIDLITPTDQGGQYISL
STNQIGSTLNDNDNHELTQKYESSDYKDFINSPLFKNLQNLKLIGAKDDQRRIYDLNYIA
NAFQVKQFLDFNFGIGDVNSGSSSNPWSITKSLIPENNLQILNETYKKWCSKLINDHSIF
SKQLIEKGVNELAYDILNIRNSYDPNEYFNYFTFKSIVDTYLKRFNKSFLDQHVTYEILV
RVHNNLFNYKNIYGKLVFKNNQWIINFKDNNFPIDDQNFVSAIYYKKPNEQNYDLKKYIF
KNDDLIYDEVYFERNSKQNYHKLTYQTFSSYFRARFLKFDPEGDFDYYLPLKYFNATIVR
KELLENAINNEILFKNDENKIIKKINFKSDNDIVVTKINDLTYQVKNIINQQIYLYSPKP
IKRSYRIDPAKATNAIKTGLSIKLDNDFINLVLLTHPSINPSYADVWSGITFNMVGFDYL
TKNDKTQLNEFDEPYIWIDAQINKINNQKYEEAKNPKIIGIIKNSKLVHLLSNKKQINNL
LFNKNDEQVAIINRVAAKYYNLKIGDHFSFVANNQTNRYTKDYIKKQITLKVVGIIDTYQ
GIEIYTGIKNAAEILGMHSSPYADKSLYDEYDGAFNGIFTNKNNPAMLTRIISIYSPSGL
YPISETWKKDAPTINLIKNILSDKYTTYELNNKWDPKSLVLNSRLSLTKALGYKNFDELK
LDARNIYDDNHNYLGLRDEQAQAEWVIDKLISIYGRDTYSSTLNNVEVVDVLFAVLETAS
KTIQTVEIVVIFLILFIIILVLVLISINSLSDTLKVAKLLKNIGYSDLKNAKLFLMAFLP
SLIIGSIISIPLVIVVMQVFSEIIFNSLNVLLTTSFIWWHFLIILLIVAIIFLLMWAIAI
WILRRSNIADASKRN
>UU318 nusA N-utilization substance protein a
MSNSFKSKEFIEYFKDTAKQNEIEFEVLSSIIKEAFEKAYLRTHPGENFETNIDLKQGTI
NCFRNLVVVENEKVHNEDLETCLDDAVEILLDDARKINANAQIGDLIKQHISIDNFKSIE
VGQIGSLLRQKITEIHNKRVADFWKPSLMKMIRAKVAEVNYNKQRNEITGVKVELDDQWK
TLGYLSRKDRIGDEKFKVGETYDFLIKEVKEQSRLWPILLSRTEPELVEEILKREVVDIK
NGNIEIKKIARIAGFKTKVAVSTNLLNIEPVAVVVGNKGLTITSISKQLNNERIDIIRYA
DDKRIFIANAIGLDKLKGLLVQENESGQRSAIAIVSKDDLPSVIGRGGANIRLIAKITEW
NIDVKTIEQAFEENILYEKFDEKIYRSWNIESINKKNVTNDEMLALIDSIEDDKIEQDVQ
LNHPLKQQEKKVVSSNDEDGENDETQLEYLEGFEDFKF
>UU319 unique hypothetical unique hypothetical
MAMKVNERTCVFSKEKYPKDHLVRFVIINGELIFSLNYHRGYYLMIQKNTNIQKVCQFLK
KRFMIKNEEQVYRILEQLIQSLI
>UU320 infB translation initiation factor IF-2
MAKKNIKQKKDNRIAIDVKKHIKKVDVGVFDGTFVFTSPLSISELAPKLNKSPNEIIMRY
FKKGVVYNLNTILDEEQIGELCLEYDLDFKIEKNVNTENLLENIYFDDLEIDLVARAPIV
TIMGHVDHGKTTLLDTIRKSSITASEAGGITQHIGAYQIIKDNRAITFIDTPGHEAFTEM
RARGANLTDIVILVVAADDGIKMQTEEAIDHAKAANVPIIVFVNKMDKYEANPEKVLNQL
SAKEIVAEELGGDVVFVKGSALKNEGISELLDSILLIAELNNYKANPNRLAYGTTIEANL
DKGHGPLATLLVQNGTLRKGDYLVVGSTYGKIRNMFDEYDNEIEIALPSKPVKVSGFEEV
PTAGDKFLALADEKQARAIANDVKQKKMRLERAMLQSSDIRTKIANGELKNINLIIKADV
QGSLEALKGIFSSINIEGVTTTLIRSAIGTISESDVRLAQTSDAIIIGFNVRASRIIKDL
ADSVGVQIMNYDIIYKFKEDLELWMKGTLDPIIIEEVIGEAKVLKLFKHSQVGTICGCRV
INGKIKRNALVRVLRDGIVIYNSKIATLQHNKDSVNEVIADKECGLTIANFNDIKENDII
EVYIKVEKKHDEVK
>UU321 rbfA ribosome binding factor A
MANEVRVARLESLIKDVINNALANEINDKIAKLARVTAVRLSNDLSVAKIFLDAHKRESM
LKVLENVNKVSGLLRSKLAAEWTSYKVPELRFVIDETIDYANHIDELFKKIKQQEN
>UU322 unique hypothetical unique hypothetical membrane lipoprotein
MLIILMNYLKKLNNKKINYPMLKKQNKNKEQHWLEKHLRQKTGLIISWSIIFGVLVLLSI
GFGLILHFFNSNNLSIQLSFIINLNKYLVNITKILDYIGFALIYLPIIFLLGCWITGING
VHESLYYHVFIWLFYFISVILLIITICLSIATHIYY
>UU323 conserved hypothetical hypothetical
MLSFVKELNFEINQKKYFIKIYLQPRIKYIKIKIINHQIVCLINHLKLINIAEEFIKNNK
LKILKIYENDLKKIKYDEQSLDWIILLGIKFTTIKIKNNNFHCQFNFQKQIIYLYDQNQN
LTNTKLLYQKILIYLAEIIFPQIIKNAQNITTLTVKKYVFGFYKSQWGVYNKIKHTIGLS
YFLVHYDQDIINYVVIHELAHIKYQHHQKSFWDFVLKYCKNAKIYNNQLKF
>UU324 lepA GTP-binding membrane protein
MDKKFIRNFSIIAHIDHGKSTLSDRIIEFTNTLSKREMTNQILDSMDIERERGITIKLNA
VQIKYHAKDKHEYLIHLIDTPGHVDFTYEVSRSLAACEGAILVVDAAQGIEAQTLSNVYL
ALENNLEIVPTINKIDLPSADPNRVKKEIEDVIGLDTADVPLISAKTGLNIQDVLEAIIK
HVPPPLDAKDDAKLQALIFDSFYDSYKGVVCLVRVKQGTIKVGDKIRMMANNKDYIVSEL
GIRTPKIVNKTELVAGEVGWVAAAIKTVKDINVGDTITHTNNPADKPLPGYKKILPMVYC
GLYPIDTSQYDDLKEAMAKISLSDAALTYEYETSQALGFGIRCGFLGLLHMDVIRERIAR
EFNIELILTAPSVIYKIELTNNQEISIDSPAKMPEPTSIKLIKEPFVKLAIITPDNYVGA
IMELCQSRRGIYDDLEVIDGTRRKLIYKMPLAEIMYSFFDSLKSITKGYATMDYELIGYQ
AEKLVKIDIMLNGNKVDALSIIAHRDFAYGKSKIICERLKEVIPKHQFEIPIQASIGSKI
IARETIKAVRKDVIAKCYGGDVSRKKKLLEQQKEGKKRLKAIGNVDVPQDAFVKVLSEN
>UU325 conserved hypothetical hypothetical
MDLWKEQDENGISPNVSNERKVVVASNGEKTLYIFIIVISIISIIGWIFLLVWWFNTKNH
LIQTKNSVNEASSSIQVAQTKRFDLLNKMIEQTKSYYKYEEKVLDEITKNRSIQMSNDIN
KNEEVLNKLQNLVNVQFERYPDLKSSNILMELMSTSSYLENEIASSRRAYNSRATDWNIM
IFQFMTVIVAEKLKLETFPIYAANKQERKDVDMKSLSDF
>UU326 unique hypothetical unique hypothetical
MEKTIIQLEFNEEELASIKKIKDKMDPNNNLELNVFLKDLIKDLARDYLNFSNQSFESIA
KQMNDLKDLIGNVANDPSSFDFNSVMNEFQKFSKSQKDEEKEIKNDTEIKTATKPTKKS
>UU327 spoU rRNA methylase
MLKIITSNKNEEIIHFYRLIHDKKYREANKLFIIEGFKLLDEALQNQQTIVSIIINEHVY
NKEFETIFKYTLYDNIQIYKVSGNIIKKLSVNIEPSPILAVVKIKQEMCDINDNILLLDN
IQDPGNLGTILRTCFAFNIKQVIFNNCVDLYNPKTIKASMGAIFKINFLRFNDSKLALNF
LLKNKFYLIATILDKNAISLNEITIKQKYCLMVGNEGHGLVQTFIDHAHIKTMIKMNQTE
SLNVAVAAAIFLYELNK
>UU328 unique hypothetical unique hypothetical
MNLINKELFLITGDNRLKMDQKINEIATSFDELVKINDQEISLISFKNLIEQDDLFNSNK
IYLFKNVNWFENLEHLKNVSDLIDYFFNNHVAIIITIESTKISTAKKIQETIAKFNHQIT
FMTYTNENAMAFLKEELNQRNLSLNKSIMQTIIQKTNFNINFLNNELDKIELINDFLKNH
GMFDINNFICDYGEYQIFSLLNLLYQHKINESINLINKMLIDKIDELTIINMLATIMSTH
YLIKLLHEKKYNKNVISSSLNQKPYIIDLNLKLIRNYSAKFLLKKMYDLLQLEIKVKENK
IDKYFGLINWVLNF
>UU329 unique hypothetical unique hypothetical
MLNAELSSAQKDLYKSIKLYLNTIFLNQKLNYAIKNDNDYRNQLNKVMNIFEYYEDNYEI
ANKNFHSYWQAFKSYVHYEKIVNDYNDFDELKDIVNGLKIYVLNTFQIDLDQESQRIADI
DFKYDEKTQASMGFYTPRNQENNTSTEYEKVSAESISDEDSMNHTYQPTSDFTTANIDNL
TNMVFSARVMNGEIYLYETKPKVIPFLKYVFFAVSLALVFFTTLTYAFLMDFGTHMSSVI
NVNGITHIVRLVSPTFPTQLVISIFIMIYAGINAFKRKISENEKFHFKNFIWIILFGALL
VVALANIFTGNLRFSSSSFDEMFRQAQINDVLANLARNNSFSFDYSYLQSIFYGYSIAQI
LVFVVIILGTILIISTFILNPKRDIQRIKLLLQEIHDDILTGKIDPNTYLRTKNPFRDLF
GF
>UU330 conserved hypothetical hypothetical
MNSRFKFNYDINNKLALSFTKDLIANKKQKNKKKFLLFLFPFYPLKLFKTINLIVVFAVL
VAIRLGMGFLHIKIPGFNMVISFTWMALMVLGWYFGPLIGIFAGFLVDTLAWLISGGIWF
WMYAIQEPIVGFIAGFLGSVATLRKKTKRPIIDLIVNQIFILFFSILTLFMILTLVNDGK
NSLFSILKKRDKEINEDWISIFKYLAIAFLATFVLLVEAFVIIYYLRNRNRSKVQLINFI
YCSLLVIFSTMLFSFALGPYVSVAYLKYIKVPITNYLKYGVNYYLLPRIIKESIKTPIYI
ILLSSIISAFDYVFLNIKQINMHKWKH
>UU331 unique hypothetical unique hypothetical
MSYYYKSKFRITDHALARFRERAEWTDVNIKNLSGTFIIPIINERILGIRPLNSLDNNFH
IYMDPKNKGYYFLVDKYTNTIISYTKRTNKNDFYHIKKIK
>UU332 udk uridine kinase
MNTKSPILILIAGASGSGKTTFANEIIARIPKNTTSVVICQDSYYISNSQLNKKERRLIN
YDHPSSFEWELMREQLSDIKKRKKIKVPIYDYKTEIRLDKTIDISDVDVIVLEGIYAIYD
DVINQIADLKIFIETPKDECLIRRILRDVNERNRSFESVITQWRSTVSPMYDQFVEPSKK
NANVSVLWNEHNRVALHLIHKWINNIH
>UU333 rpL32 ribosomal protein L32
MAVQQRRVSKSRKGMRRSHDHLTISNTVACNECGKALLPHRACRDCKTYRSIKLSIK
>UU334 unique hypothetical unique hypothetical
MMNDSVKQTNNIDENQLKPTTKSFFDDKNNQLTKVLNIPSVVKYTESKIKKNGKNFSINL
IITITTMFIVIGIIITIAIAIGIKLS
>UU335 unique hypothetical unique hypothetical
MFYINLRVKTMMEKLKNNKTLFLNVEQAQKLGINNPLTQEIFLDDQKLKVHLINSIKDEF
YLKKSISKGYAYFNSLEQFKTMELDVLDNYQFAKIAATNLDEYDQLVYTKTRQYLINKEF
WTNDGLDAFIGDDFKRKQLTSKEIVNLKTKYDLWIQELHFNNARISKQIHNLSIHGQNKL
DYEKFYDKKATLESNLDILQILIYLRSSLLELDFDDLFKDDQNKISIRQLLVNDLEYLPF
SFQRYDYESRRNFIRNSRQLVDTSIDFDDLEYDFLHNKKPKQELEKNNESIKIAELKKFE
NSQLSDEQQSNLEKEFYSIGRINCFDEVSENKQELNKEQLVIDKKNGYLKPRSYLRHHET
PFMVDIENRVDFLMAGYEIIKNDDPYAIKQEILKNTILEQQKLVEQDDHDFKVKNDDQEA
NEELLDNTDKLENQDSTSAVEFNDSSEVTQVVKTDENVDNLIKTKQITSFNDLKQEQSSQ
ENIIKNDLSSIQIRLDEIINVHEKDTKLQTELNSIMIDSNEKNIDDSLNNLNEQIRIQDQ
ELESSDNQNVIIEEEINTKNLNNKADVGVMSVEKKYEPEEEMVNFEFEIPENQKESVNQD
VLNSNSIDNFKEEKAKENTFLTPKEIENNDLSSQIELTPADFELKTQEINDETERLLDEL
NNNKPKEKKKFWTWFNSKKR
>UU336 unique hypothetical unique hypothetical
MNKTNQIVDLLTNKQNNSIQRRDNLVFVKNEQEFKDILDSTISLSNVYDPLLGNGCEQEK
IKELTILNNSVDISKIEEYTKTLESKVDDLYNNVSNQLIQDYQKNENTSANNIIMKNEEL
LNSHLKEVEKICEQLIDEWKIEILGEVNFKFQQQLIEIDQKQEHKLKVKSLINEDSFLTK
RQVKNKNKILTEFEKHRSQITQNYLNKRSDILKKEYDELLKDDKLFELSSGDNWNNFKKI
TLFISNEIGIINDLEDLLNHQELIRTRNYTKRAILNQHHINGHFKDEKKYLKSLYDLRVK
FMYGLGSEIVILKFLIEHYKKLNSLRLRLETLNHPLSNYAVYFDILNRIEKQTQLLAKIE
TLKYDNYDFNADVILDDLESNITKINEIKHNSNVLNKTKVIKTIIEPKYELELISKDDKV
DGVKVYVNDQEILSK
>UU337 folD methylenetetrahydrofolate dehydrogenase
MKLKIDFLYEKVLTELLTKKNKTKKRIYVFYDSDLVNFNSAYIQSKLKYAKLFSVKLIIY
DLNAYQIQENHHFLSKLKQANKDFLFFEFPLSKKHLDQNYFQYLTFQNDLDGINSHLFLN
KKQENQIIYHPATINAILTLIKELDVNLNDYRICIIGRSPYLGDYLYKLLNPKNNKINII
HSQTKNPLRIIKESNFIISCVNKAHIFNSNALSDNSYLIDVTTEYINNKLCGSFLINKND
ALNRNIKYTPVPGGIGKLTTLFLFLNYFK
>UU338 unique hypothetical unique hypothetical
MIDKQKIKQLIQNPVYGFFDEFKKNLNSDLDHVILEQLKDQDNNIDKINHLVTDINNLKN
DIKQRKKDEKIKQRTFCNILIAVCFVIIIGLFFLHFYLKNSKFIKNFKKYEIEKNNQINI
CNSQKNKYIYNVLSQINSYKISQEIFAKNGLYLMPEIQYENIKQTDLLISRNAKFVGFFG
GLEVKFKSTDTFLVYYKEFSIKDVVTSGCIQISYRKGDQMVSETIVAHHKEPTPFVDLHS
NFVHKTNYSPNFNFSTYAQTVNSRSKTIFSNLEFSKYYGLGIATQNLEFDTKMLEFFTPF
SQENYENFAKYLKQDDITVPMFTKTATSLIIDDQLLKDNRKPFFINLLTNNSYVKTCDFL
IDTDINADLQTNLNILKYELVKLFEKYILYLTTTSLSSVIAREWYINNDTYKIGDNYDYE
SYYYTNQNQLTPLSVSTKLFLKNQIAFVNDCEVIPFAELVNNQTRFGINKAQFNIKSYHV
YNRVDNVPVYAHGRTHIVPVQYKEYIEYEYPFICLYVLKYKQLTEEIGLKYFTRPFNNIL
LTNFEDHSACSIDEILDFNDNESKNNSDNDFKIYLKELDTIVTNANLNKNEFSFLKDNDG
YFITISNKIELDEETEQELSTWLRKVSL
>UU339 dnaK heat shock protein 70 (hsp70)
MAKEIILGIDLGTTNSCVAVIENKKPIVLENPEGKRTVPSVVSFNGDEVLVGDAAKRKQI
TNPNTISSIKRLMGTKEKVTVLNKDYTPEEISAKILTYIKEYAEKKIGAKVNKAVITVPA
YFDDAQRQATKNAGIIAGLSVERIINEPTAAALAYGIDKLDKEQKILVFDLGGGTFDVSV
LDMADGTFEVLSTSGDNHLGGDDWDQVIINWLLKSIADEFNIDLSKNKMAMQRLKDAAEK
AKIELSGINTTTISLPFIAMDSSGQPINFEKELNRATFDNLTKNLIERLKKPVLDAMKES
KLSLVDIDQVLMVGGSTRMPAVQNLVKELTGKEPNHSLNPDEVVAIGAAIQGGVLAGEID
DILLLDVTPLTLSIETMGGVATPLIPRNTKIPVSKSQIFSTAADNQPSVDIRIVQGERSL
AADNKLLGNFELSGIEPAPRGVPQIEIKFNIDANGIMSVNAKDLKTQKETSITIKDSQGL
SQDEIDKMIKEAEENKEKDAKVKHERELVNRADSLINQLEQVSKTENVPQEQKDVFNKQI
EDLTNARDAQDYVKLEAEVKKVEDLLTNAAKFAQQAQQQNPDNQNNNKDDVTEATVTDDS
TKK
>UU340 conserved hypothetical hypothetical
MYKLIFNLCIYIKNKGKFEYMVENKFLKQIKEGEQIKIEIKGLDKFNNFDEQNYGLNNIS
PQIRWSPVLETASYAVAIIDYEAVGGAPFVHWYALNIFEPELALNVANLGYANLYQGENS
TSKHFSHSILDANYQTDIANNYFPPCPPNKSHKYEIKVYAVHHKLSTNRNNILYLDDFEA
KLNEAKIIATGSTYVCAPQISFEDDKLIIGSLEHKHPYLFANCENEYHVIEDVIVTDINK
NIYSENQLDNFKDLEQAKIKIIDSSDALSYAVIITSNHLFKKFGRPVVNYAHVIEKKTNK
RIKFNNSYKLNHAFSEISPSKYDHLGNELLILEDKDANFESGLFTIHVFGLNKKIKYLNK
IDSVANSISDLFEMISGSVISYKAKLFK
>UU341 unique hypothetical unique hypothetical
MIDRKQIHVKTRLTINELNKFYTLIRVQKQSLKEIEDKIKKLDWINFSEIKNQNLFDEFK
FDYKNMTPYVISQVQDLVSVYDVRQISEIILELNQVNIQIQTKDSEFYIKNNKKLSLISS
EFEDYQLKNYDAYEHFKITMDEPKIHTLNHQMPFDSKLNIKTIIFIVLTSCLLCLLIVII
ICALLIAGVIN
>UU342 cmk cytidylate kinase
MKKYISIAIDGPSGSGKSTAAKELAKKLGFLYINTGLMYRAYAYFLSINKLDINVNEMDC
INAIKNANFIFNGDNVKINDNDVSLILRSNDVAMIASVVSANEKIRDLATNEQRRIASEN
NVVMDGRDIGSIVLTNADLKFYLNTSIQTRAKRRLFQNKDIENLDYESIYNDIKERDHRD
MTRKIAPLKKANDAVEIFNDNMKLDECVQHLYEIYLKKIKKLNF
>UU343 unique hypothetical unique hypothetical
MNFDINLINENDYVFSGYIILKKHNEEIIELLTYLGDDPINDEAKIITLYNNDHIDLKNL
NDGDLIIVKASLIINNKNNKQLLLKDINKLELSIN
>UU344 plsC 1-acyl-sn-glycerol-3-phosphate acyltransferase
MNFLKTLLWFVAYPFVALYIIIQMILAAMMANKYKNDPESVSVNERYKKIMGIIDAILYL
KNIKVDLIGKENVSIKSMLYIGNHKSNGDPIVLLKALYQISPHNVRFVAKIELKKSFLKF
LFNLIDVIYIDRNNLRQSISTINEQVNALKQDYRGLVIFPEGTRNFNHEFNEFKSGALTA
AYNTLSSIQPFVIFNSQGSFEMKNDQKQKLRSNPFKTQHIKVSFLEPIHSFNYININKDI
LMRKIQSNIKKNYDELLKSTIKTN
>UU345 conserved hypothetical hypothetical
MNRMSEKQIQNSLFEYKFIDFNGPLDTLCVLIKQKRLDINNLDILELSKQYVNFVNQLIK
TIDIDILGDHLAMASYLLELKTRMLMPTVDEKQIMSIEEDRQNLIDRLIEYNGYKNLSEH
LKQRFEFRATMMDLPQQDYEQFYLKDAIYKPLPNHLDSMILKNIMDKIIYENELKNYKIN
KIKVHEYDVKQLEQLLLNYLKQSPNQQASMLSFFDIQAVIDKNKRFFAIMFLIILILINR
NEILFEELDNDYLLKINIERVVDDYNSSSVEQAKNLTSNLTKDTIINFKGEDNE
>UU346 conserved hypothetical hypothetical
MNNDKKNKKNLLNNELDLAKYTLHNLSADNNDDENELELDWDGIDDEIIDNNQQIYQKKH
INHKTRLFIEKDDKLNNHEQIESGNEIINQPKALSGQDFLEFVNSKLVQKNNNFKQNSKF
LQNQLTNHELLREKLKPQEDFNKIFKTKDINVTEEIKIKDVKKNSSVSFRNSFNINDLNQ
NQITNIKSIIDSTLFLAGEEGVSLQDLKRTTGLNESSQLKTILNQLQKDYDVDDSGLVLV
QFGEKFKLLTQSKNKDALSKFVTTSFRTPLSQRNLETLAIIAYNQPTTRAKIQAIRDRDP
KPAIDALLKLNLIIEAGRQDTPGHPILYTVSQKFYDLFGIRNLTELPRLNKEINEFSPID
ESTN
>UU347 tig FKBP-type peptidyl-prolyl cis-trans isomerase (trigger factor)
MKLLNKIKNENAIEFQILIEKSEWEKKHKESFEKIAKKTASKLKIPGFRPGKVPVEEAKK
HVNEIEVFETTTNDLIPQVLTFLEQDESFINDDSETVDTPSVDILDFKDGELSLKVVYDL
YPVATIESYNDLILTPIVNEAFEHEVNAEIEHALNSKSQRRVKDDNEFIEKGDEVRFDFK
GMIDSVPFEGGSAKDHLLTIGSNQFIPGFEDQMIGLKKDERKNINVKFPDDYHATDLAGK
AAVFEVFIKEITNVKPQELNDEFAKSFNLPNVNTVQELKDYIHNQIVLAKQEKNSERAWL
EIAQQLLAKAKITPIPQSLIDREVSTLRQQVLSQLSQYKIELKQYLEFSKKSEAQFQEDL
IRQAKETITLALLVDDIAETQNIVVSDEEVKERVAEMAKLYQGEEQAVIEQLSKNPDAVK
EFLLHKKVVNYLIDLNKNNQPKNTTLSSK
>UU348 lon ATP-dependent protease
MKKPILISRAIVVLPYETTTIEVGRPKSIQAIDLAKQSSSKEIIIISQKDIDTDEVVNFD
ELYKVGTLVKIKSIIDNFDEGYSIEVEGLKAVYINNENDVIDAIEYEYEDVITNPILSNK
DEIAINGINSEIFNIINKRSRHKNINFDNMHALISLEKEKFAYLAAATYINDYDNEISEK
TIEDRINILLQPNLLLVHETILHLLFDQLVDKRVIEDEVEKTITDKINNNFQKQQREFYL
REKLKVVKEQLGELSSREEDADKIRAKIEDLELPPNVKERALAELNRFENAMSSNESSVI
KSYLDWLLDLPWTQQGVDNTDLMSVRTHLDDNHYGIEKVKERILEYLALRMRNPNLKGPI
ICLVGPPGVGKTSLVTSIAQALNKKFVKVSLGGVRDESEIRGHRKTYVGAMPGRIIKGMK
KAGVINPLFLLDEIDKMTSDQRGDPAAAMLEVLDPEQNKNFSDNYIEEEYDLSKVMFMAT
ANYYQQIPYALIDRLEVIELSSYTAIEKREIAKSHLLKRIFMDAKLNENELIFTDDALDF
IINHYTKEAGVRELDRQLGHIVRKYIVETYKNKNNQSPLNLKVDEAMIIKYLGKIKFDFN
KKEETTIPGIVNGMAYTAAGGDLLPIEVNHSTNGKGGNVTITGNLEKTMNESVSVALGFV
KANADKYGIDTKKVSFKEIDIHVHVPSGGIPKDGPSAGIAITTAIISSLSQRPVRTTLSM
TGEIMLRGNVGIIGGVKEKVISAYRAGVREIILPIDDERYLEDVPKYILDDIKIHLVKHY
DEVYNIVFGEK
>UU349 rpoD RNA polymerase sigma factor
MSTKQNEPLFVNLEDLKQKVKLSFTEEFSFSYALSELEAGIFESRNLKGADAGDPEEILL
NVVLDVSKKKRSRNEIKFNKLQNYFIHMNLREEHFSEIIDVLEAIGIRVPDYDLVMQSKS
KTNTKKKDEYGIDDTLEISTSKIGFSSTTTEKVDDGIKAYLGVLGESKMLRSDEETEYAK
MVISDDPSLVKIGKNQLYTSNMRLVTSIAKKYLNRGLDLEDLIQEGSSGLLKAIDKFDHE
KGHKFSTYATWWIRQSITRAIADQARQIRIPVHMVETINKLTKAERNLIQELGRDPTAEE
IAQAMNKVSQAKNQKEQLITAQKVVEIKKLNVDPVSLDKQIGHDEESQFSDFISDDEIIS
PEKYTEKKALNDQINEMFEKVLNDNEQRVIKMRYGLLPFERPYTLEEVGEYLGVTRERAR
QIESKAIRKLKHPSKTAKLRSFIGESEN
>UU350 conserved hypothetical hypothetical
MNPKTRIAFIADLINDAQNVVDVGSDHAYLAKILLVNNKAQHVTNIEVNQGPLENGINNL
TKNNLLKRTTNILNDGFKGLILEQTFDYCVIAGMGATSIIEILEQNKNQIKNYILQPNTQ
SYKIRKYLNNHSYQIKVEHIFVEKKIFYEIIICSKTINVPKLIEKDYYISSQMHKDSLNL
YFKFLKRRYEYLKALDISLVSENIVKEYEYIKEFINEKNGY
>UU351 conserved hypothetical hypothetical
MKKMDIKAQDILNFLTKKYDLSKAEAWDKNGLFFDEQQTINNVQIALDITDDVVNDAILN
NANLIISHHPLFTNQDSNDEVNYFVNIDLIEKIKKNKISLIHLHTAFDASANGMSMQMAK
RLGLLNLKQDEQNPYLVVGELKLGVSVDYISRIIKQKFLSPIIKYNNVFRLETNLKKIGI
IGGSGYKFADDAFNRYQLDMLITSDLKYHNWLDAQAKKQNIIDMNHLSESIFIDVIYDEL
TKFYGNDANLNKSLSIIKINYI
>UU352 conserved hypothetical hypothetical
MCISKIDMAKVKKFFKEYLFAKFQCKNRELYRQLKDYDPKDDQKYLKWEHFVEYVEQVLE
ALDKTSAQIIKEIYIQNKRICELPYSYSTYYAYRKKAIIELLAYLDLKI
>UU353 unique hypothetical unique hypothetical membrane lipoprotein
MRESFDAHIKKKSKILFYFMEWWFQTTNYKLNPEISHAKRSLRSWLIEIFFLFCIVALIV
CILAGVARPIIDCVIKSITLSRGQFKGDLIIDGQIIMKNLSPSNINGLTGGSSILNVDQW
ELIPKVWKAYFSSPSVVVLILLVLFFLFFSCLYIYMIKKIRPRTNKMSLEDYLIARMNLI
NSFKFILKRKVLFIEGIKEYNHRFVFNMNADYNLMRIMNYIYSGLAELNIIMVIDMDSDE
KIFELQKVIKQDFDNLDLIIIEKEIAESLKSKYQNGCLNKKTNLININNKEIDQSQQTQD
INIY
>UU354 truB tRNA pseudouridine 55 synthase
MSAISKNIIIINKPIKWTSNDVVQKVKRVIGAKKVGHAGTLDPNASGVLVLGINEGTKLL
TKLILDNKSYIAEIKFGTSTNTYDAAGEIVSSTNRMVTLTEVTKIVKDFYKNDYWQKPPQ
FSALKINGQKAYVLARQKVDFEIAPRLVKIFKYQIMDFNYEKQILKISLHVSKGFYVRSF
AVDLATKINNLAHLLTLIRTQSGPFEIKDAIEIEQVYDYWNNINKYL
>UU355 ribF riboflavin kinase/FAD synthetase
MIIEITSTNIYKIKQQFVINELIIGFFDGIHLGHMNLLSDPNNQTILTFKNIPRKIKKLY
DFNERIQQLEDLGFKRIFIYDIDQNNLSGEEFIDQILKPLTPKKIIVGANFTYGNNFCNA
SSLKQYFNVEIKIITNDVSTTKIKELIINKQVEIANKLLIKPYYRVGNVVRGDQIARNIG
FNTANILCDNNLIDIAEGVYKAQVIFNNKKYDSVVYLGIPKTINTRSFSMIEAHILDFNQ
NIYDERIKIVFLKYLAPNLKFNNIDELITAIKNYIKLVLDKTN
>UU356 unique hypothetical unique hypothetical ATP/GTP-binding protein
MVYFLFKVVVYLIIINRVRTNHFMKMKAKKFLITGLLGVVSLATITTVATACTNGNNQKA
NTVNNKSDLKTNPNINLTQQDVENLEKQRQQWSEDLDVYFNGGLSKSGKNFDRINTLSSN
ATEWFKNHQKLAATRDSGSLVQDDAAYSFGIAPDYVHYKWVSKDGGDVSPSYLKPYWNKN
LTEGRNFSKLDPKTLDDNGIGVLLISDHHYGKWNDNFLSKKTVGGLIMQSRVSGLPSHYP
AVLTPKFLFDPNLNPNLKKYASANYALPNYYSDPLDGIILTGKTLDRIYDAKKFSNVYNA
HVAGKTHFETFTDFAKAMVDETRRGISQWSLKNDKWKDKTVLMVMPNFTPTAKMVDVNFK
PEDLEFLSNVCINEPMYCPTIYSDPNDKYLPGLGAKFPIPVNHISQVQNYIDDYGQIGGK
VLNGTGNPEASKQVGPTLGDAFKDTSDVVVFCYNEYGLLNYKPGTEEGEALVQQFEKNLT
NYVNGLTKETKNQFVPTKVLKEKPVVGKNFFIERKGKFYDACYGFAGQDLVVNTLNKWTR
GANAQNIDLGYPIFNKNTVKHIRAFKDSLGVKVLDKQK
>UU357 fecD citrate-dependent iron transport, membrane-bound protein
MQIKQVNINKKDLSIYKKLIEAKKFVSTQIRRPYMITIIVLTFIILAVGMFFMNVFYEKS
TYFDANYNTHVTYFRTWAKVVADDKSILLYWYPPIVKLFVAISMPVAGYAIQITTQNRLS
SPSTLGYIPVSILAYVAMLMIDQGKSWLVYVFGFIFSSFIILVNYILQRQKSSNRSFKPV
LIGFAISATITAVGLVIAVSRPNILNRVTIWTGELPNVYEWLKLYISMPLILICLFAFLV
LSPKLKIMQRDFALAKSLGIKVNLIFWVVTVLTAIVTIATVNITSPMILLGLIIPNIVRA
TFNKHEPLFVFFVSIVFSLALLEVSLFLSLNYRFGPNFLMAIVSAFVLIFIMRKHG
>UU358 fatC ferrichrome ABC transporter
MKNPSRFIFIIKNNILNTINNASFIENGNFKKKFRVYARKQHLAAWVISIVTILFLSLLV
MFIKINNQGQLLNNRTPLDLFKVNYETILQIWITGASLGASAYMFQRITKNRLVDTSTLG
IGNVCLIGLFFLAISINFENYGSQKLFENLLPFIFIISGVCAGLILYWFSKKRTGFSHTK
LIVSGVFINFIAIALSISLKDNLTLVASNYIDDRLLGNFSNRNSTEKYLSYAVFLFLMIW
CFLRSAKFKVVITDTMIAEQLGLKVKLLNLEMIFISSCLTAVSYIMGGNVLFLGIAAANL
GYAVFGNRFSSSIIFSSFITIIFLIFGQFILDNIVQNLTSLVFDAPIVTPLLVAPIFTFI
ILFKNNI
>UU359 ABC sbp putative ABC substrate-binding protein - iron
MKYKKIWITSIASIAFITTIVSTTTACSKVNNEVKSSNDIFKQILPTKEELTNLIKRRKD
WANDLQVYFEGGKSASGKEFERIQTLATNASIYYQKNQKIAMTRDSGSLCQDDAAYSFGI
APDISNYRWKAGDVEEVVPHYLSYLYNPKLTKGMELKGVKAETLAAENVGTLFIADFKFG
NYKTNFLDKNKIGGIVMQSRSSGLPSKTPALFMPNWLFGKNNPYLETDVNASAGITDFFV
DPYDGLIFTGKTLDRIYDAKKFDNVNKAVIDGKSNFQTFTDYAKAIVSVVRKNVSNWAKQ
HSYWKNKTVVMTMPNVMKGARIIDPNFSKDDLLFLGNIFIPQPVYFPILYADQNDEYTPG
LGAKFPIPKKDINEVQRYVDNWGWIGGAILSDATNPDAAKRVGPTLGEAFEGTVDKVIYS
YNEYLIKGYKPGTAEGEAIIKKFEANLAKYVNSLDINTKNSFNPTRILKEKPVVGKNFFI
ERKGNIYDANYGFIGQKTMVNILNRWMNGENSPEVDLGIPNFTKDNVKHLRAFKDELNVK
NTDE
>UU360 ABC sbp putative ABC substrate-binding protein - iron
MKLKFKKILLSISTSLIILSSIITIAACSNQVKSKTNFSKTTPTLEELTELKKREEAWKA
DLEVYFEGGVSKSGKKFNRIETLSSKASSYYQKNQKIAVTNDSSSLCQDDALYAFGIAPD
YSGFRWKTSELEEVHPHYLNYLYNSKLTKGMNFTGKGALPENFAKLNVGTLFIADFKFNK
YKENFLDKNEIGGVAMQSRSSGLPSKTPALFMPSWLFGKNNPYLETDVNASAGITDFFVD
PYDGLIFTGKTLDRIYDAKKFDNVNKAVIDGKSNFQTFTDYANVAVKAVRKRVSQWAKQN
NKWKDKTTVMISPDVMPNGRIVDPNITKEDLLHLSNFFITQPVYLPILYADQNHPYTPGM
GCKFPIPKKHLEDVQKYIDNWGWIGGAILSSSAENPDAAKRVGPTLGEAFEGTVDKVIYS
YNEYLIKGYKPGTAEGEAVIKKFEANLAKYVNSLDINTKNSFNPTRILKEKPVVGKNFFI
EREGTFCDGCYGFMGQKTIVNILNRWMNGENSPEVDLGTPNFTKDNVKHLRAFRDELNVK
NTDE
>UU361 unique hypothetical unique hypothetical membrane lipoprotein
MKNKYFRKNKFWLLIPISFVSLGSITLVATACVKKNFYPNTFADDQIYITKNNEKTVKFR
ISRNDEENKKYFKDDLKWNTFINKLKKTYINVETVIPKENAKQNIKQQDLCMRALPVQVL
SNNKYVDIYVKIPVLLANTKMLVVGDDLLKSFYFDTDNLIMNAKHFQPIPIKML
>UU362 gapN NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MNYKTLINGAFVDAKEKLPVYNPSNNQIIAYVPNIHNENEINTIFENAHIAYLKFKDTPI
KYRCDLLLKLADKLDEHKQELAQIISTEIAKGLKDSLIEVERSADYLRETVFEYQKLMQK
PIIFDETVHHVKNKVATYYRIPVGVVLAICPFNYPINLLISKLAPALVSGNSLVYKPSTQ
GSLIGIRISELVHEVGFPKGVVNCLTTEARITGDLLVTNKYVKAISFTGGPKVGNHIAEI
TSKISLVLELGGKDPALVLDDADFELAANEIVKGAYGFSGQRCTAIKRVFVSHKNHDLLV
NLINKKVDALTVGLPQQNPIITPLINSNSLKYNLSLVEDAIKKGAIVHQKIVYNEKNNLL
HPLVIDNVTKEMRVAWEEPFGPILPIITYNSIQEAIDLINQSQYGLQACIFTTNYASIEQ
LALQIESGTININKSSSRGPDILPFFGVKDSGFGVQGIVDAILSMTTIKGIIINK
>UU363 asnA aspartate-ammonia ligase
MDQLQKAKINQTQKAIVEIKNSFQKHFAKNLNLSRVTAPLFVEGQSGLNDHLDHKQKAVS
FYAKKLDKTLEIVQSLAKWKRLALLDYGFSLYEGLYTDMNAIRADDDIDEIHSIYVDQWD
WEILINNQDCNLDFLKSIVNKIYSTIRIVQLEIDQLYNPKQIILPDSITFISSQELEDLY
PHLSPSRREYEFAKIHKAIFIYQIGYPLKSGYIQSIRSPEYDNWNLNGDLIVYHKLNDQA
IELSSMGIRVSKQDFIKQTNFANLKNDQENNFYHQMILNNQLPQTIGGGIGQSRLCMFLL
NKKHIGEVQVSVWPNEYKDELLKKGIKLL
>UU364 psgA phosphatidylglycerophosphate synthase
MAKLNFKKNISSSPFFRNIPNIITIFRIFLALICIILLLVDFYTKNLNIVYEVLDANISA
LRLSATIIFIIAAFSDFLDGYIARKYNLVSNLGKILDPISDKILVNGVLICLTLDHTALA
YLTIINILRDIFIDGLRMFASSKKIIIPANIFGKIKSILLFISICFILFLLSLTSSWKNV
YLFNIPLFFATSLSVISGIIYYINFYKGVKKRGSITKS
>UU365 asnS asparaginyl-tRNA synthetase
MQLKIKEIFNQDYVKLEGQKIQIKAWVRSNRDSKKIGFLVLNDGSSLTNLQAVYRVDKID
NYEEIAAARMWAAVVIEGVIKLTPTAKQPLELEVLNAQILKQSDEDFLLSNNDLNLETLR
LNAHLRPRTNLFHAIMKVRATLAFAVHEFMNQNEYSWLAAPLFTGNDAEGAGETFSIQKF
DNEEFFGKQTHLSVTGQLQAEAYAQAFGNVYTFGPTFRAEKSHTNRHLAEFWMIEPEMAF
VDLKGMQDIVEDLVKHVIKAVLEKNQQELEFLAQRNDENLIKKLQKVVESKFERIEYKDA
VKILADAVKNGHQFENNEIFFGMDLGSEHERYMCETYHQGPVFLQNYPKDIKAFYMKLND
DQQTVASTDLLIPGVGELVGGSQREDSYEKLLKRCQELKMPIESLQWYLDLRRFGYYMSS
GFGIGFERLVMYVTGVNNIKDTIPFPRSHGQIEF
>UU366 unique hypothetical unique hypothetical
MEEQMSATNKKYDPQISELLELRDLANKVDNLKRKLKTIEYNHYCEHENYDSDDGETNNV
YEQEVSLNHETQIVKLRVDLNDLTNLSNTKIVEVEKPVYIEKVIEVEKPIEKIVEKIVYV
NQDNQVNKQESIKEEKEPKTPVKSGKYVKYRRLKNNGMSDAGWKIFELVKQTQQDKVAAE
KRFDEQQEEKKRQREQKRLEKQQKLEAKNEQ
>UU367 conserved hypothetical hypothetical
MKTTANKKIKLINIEKLEFEILEPINTNEILVFKDENSTIYESFNQNLEKQRDEFIKKIR
EEEEQNWRNNFLANDRDYNELVKQRYDLEKQRDELKEKLKNEGNKAIAHFKDSDEYKNLI
KAQEKINSLNKTIESNEQSYKKEIENIELKLKSQFDEETKSLKNTIAKQEIKLDNAEKMA
IINFKESNEYQKIIKDKIDLDIEIEKLKFAIQAHEDNMKAAKENWESKKIVEIKELESKK
DKEIHKLTESIEQLKREKSSNVKLVGEELEQWLKNKFDETYSFSCPDMTFTKINEAIDGK
KADFLLEFFDFGKEMSNDDKKLIFSATIEAKTEFFDNQKGTKNSAHYKKLDQDRINQKSE
YAILVTELEPEDHFVIKKINEYKNMFAVRPQYFIPLVDMIRNFATLKAKINSQIIRYEDR
AKIEENLDELKKDIVDNTLKYINDKTKKIIDDSKAIIKKAESIEESAEDIINKKLNTLKK
KINELTIRKIDPNKLLLEVSDDENDEE
>UU368 deoA thymidine phosphorylase
MLNVVEIISKKKNNIELSEQEIKFVYDGFVNKTIPDYQMAAFLMAVNFCGYSENEQYYAT
KAMVESGKLLDLRVENKIVVDKHSSGGVGDKVSIILTPLLSALGLYVGKMSGRGLGHTGG
TVDKLESLNLNLDFDLKTYMNQLKDNGLLLTGQSDDMVVADKYIYALRDVTATSDVFDLM
IGSIMAKKLALITDYIFLDVKVGEGAFCKNVAQAESLATKMLKLSKKFNRNTIIHLTNMD
QPLGKAIGNAIEIKESMDYLLGKPVPQDLYDLINQFALDILIDTKFAKNKEDAQSKIDNV
IKNGLAYQKFVNWVKWYKGDYISLENDTYFNPKYKLEILAKQDGYLDFKSTKELGMIAVD
LKAGRKVKTDQLDFQAGIYLNKKNNDFVKTNEVIATLYASEPINDEVVNKYHNNVVYLKT
PKQIAPSIIKVMR
>UU369 alaS alanyl-tRNA synthetase
MLKLSTNEIRKKWIEFFESKDHLFIEPKSLIPKNDPTLLWINSGVSTLKDYFSGKVKPPH
KRLVNSQKAIRTNDIFNVGLTSRHHTFFEMLGNFSIGDYFKKEAIDWAYEFLINVLKIDV
KKLWVTVFEDDQFTNDEWIKLGIIKEQIIKCNRDRNFWDVGNGPCGPCTEIHYDRGERFD
PNKIGSKLILEDIENDRYVEIWNIVFSQFNNDGHNNYTELLQKNIDTGAGLERIACISQD
VPTNFDSDVFMRITKSVEQFSEYKYDMNEYFHPNVTQNKINFAYKVIADHMRATVFAIAD
GAIPSNKERGYILRRLIRRTMVLVRRLNINNLLWVDAVVDAIASTMGDFYTYLKDEKTLT
KIKMILNKEVQLFEKTLQLGLNIFENSIRNQELDKEITFKLVDTYGFPIELIKEICEQRN
VKVDLEAFDAMFKHHQLISKANKANLKVMESQNESLMQLDVDSTFHYEIFRWENAKIITL
FNEDFELVDGLDHEDGYVVFDNTCFYATSGGQQHDTGYIIKNDQQFFVDDVFKAPNRQHV
HHVKNASLSMNEHVILQINEQDRKSITANHTAEHLLHYCLKHVLSPDIKQEGAAKYPHKV
TFDFTYHAQPTKAQLDKLENVLNEMVQSNFDVQELHMDLDEAKAVGAAAYFEDVYKKLKG
KLRVIKMGPSIELCGGTHAHHTSEIERIKIVECASKGAGSWRITMVTGHDNLAKYIHDLY
VDYLNEINHLKVNLDINDHKLNDLYNAFANWKNLSIDDYDLLNEKFAELKQSLINFKIEF
DKQNAKQAIIDIKNTFNTQLTNKRVHVFKNTDNKNIFNALNELINENQDTLFISFNLDDN
KIQYLLAINEKFATTNQINLNKYIKELNTISNGKGGGKPYFVQGGTSEQEKLDELLTVVD
KWVINA
>UU370 conserved hypothetical hypothetical
MRKLALDLGTKSCGFAISDLLGIIASGLDNFIYEENDFTAVLAKIDEIMINYHHEIDTIV
LGYPTNVYDGSKNERTYLIESFYALLKQHFLNHEKIKIVYEDERFSTKIATQRLKNSCVK
AAKIKKVKDKMSAVVILESYLSKNHFN
>UU371 leuS leucyl-tRNA synthetase
MYNHNKIEKKWQKYWLDNKTFKFVDNPNNPKKFYVLDMFPYPSGKGLHVGHPKGYTATDV
ISRFKRLNGYDVLHPIGWDAFGLPAEQYALETNNHPHTFTQQNIKIFRKQLQMIGFDFDY
DKEVDTTDPQFYQWTQWIFVQLYKHNLAEIQDIDVNWCENLGTVLSNEEVVLNDKNERVS
ERGGHPVVRKPMKQWVLKIVDYADKLLDGLNEVEFSESLKSLQRNWIGKSIGTSVQFKIK
DSLLTLDVFTTRIDTIYGVQYLVVAPEHPILKSITSEQQINVVQSYIEQTKKISDLDRIA
DTNKTGVFSGAYAINPINQEIIPIWVSDYVLMNFATGAVMGVPAHDERDYAFAKKYALPI
KSVIDTKQKLPYAGDGLHINSAMINGLNIKQSQNVLNDYLIKNHLGKKVANYKLRNWIFS
RQRYWGEPFPVLFDENNQIKIIEDLPVLLPNLNEFKPSKTGESPLANAQEWLYVEIDGKK
YRRETNTMPQWAGSSWYFLAYILKNEDGSYTPLNSEEAKKRFAKWLPVDVYIGGQEHAVL
HLLYSRFWHRFLYDIGVVPTKEPFYKVINQGMILGENNEKMSKSKGNVINPDDIIASHGA
DTLRIYEMFMGPLTASLPWNPDGLDAMRKWLDRVYRLYHNLSELEVVEDLNKLNEEIIIA
YHTLIKNYTKAINEQAFNIAISEMMVFVNVLYKNKVINYELLDNFLILLSCYAPHLAEEL
YSLNHSESVCLQKMPIYDEQKIIAQNITIPIQINGKLKHTINVLRDTNAEELVNLALACE
QVKQEIGDQPIKKQIVVVNKIINFVI
>UU372 tnp integrase-recombinase protein
MNKLGLLCEIRRSKRKREIKNVNATFKNLANRDYDGQMNDIYATDVTYIPSPTDVIENHV
YLSVLLHHKTKKIVSWNLSKYNDTNLVLKHFKLTKFPKKFIVHSDHGYQYSSKEFLDYID
SINGTISMSRVGNSLDNREVEYFFSILKTEIFSNFFQKAKSLTFNELQIEIDKFINLYNN
ERFIKKFDLKTPQQMWDVYMNNKSIWV
>UU373 unique hypothetical unique hypothetical
MSREQLEYLITDIFYEEILKRNNSKNLEEVVEKN
>UU374 unique hypothetical unique hypothetical
MGRQLREDEWLSIFFWYEQYLNYDISKEFLSYKYCEISNGRQLNKYSLKLIKTKYKLYNL
GMNINSQTGKATKKR
>UU375 MBA multiple banded antigen
MKLLKNKKFWAMTLGVTLVGAGIVAIAASCSNSTVKSKLSNQFAKSTDGKSFYAVYEIEN
FKDLSNDDKKSLSNIEFNAALTSAENKTESTLEKGHLVGEKIYVKLPREPKPNEQLTIIS
KSGLIKTSGLLISDNLNYQTEKVNFETTQPGKEQPAGKEQPAGKEQPAGKEQPAGKEQPA
GKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPA
GKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPA
GKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPA
GKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKEQPAGKETTGK
>UU376 unique hypothetical unique hypothetical
MNFEAASAPSQQPSPTPAPKTEEPKENGGSEQQADQPENSKKDDVVASGVKISEVKNNTA
TIEVTFSKFELADANKKDFVLEVIKKADTNPIQASDLKYDEASKTLSGKLSGLNSNVDYE
ISKLTLNGKEVKFNEEELLKSYVKNAKLFMTFNKENKKINVKLQNFDILNSLEENQPILT
FDIEIKKDSSLQVVHKSLTKNQLSNLNGLEIDLKDKMNGNNANYDVKLTNAKLLNVNIET
QK
>UU377 polC DNA polymerase III alpha chain 1
METKNALFKKIVKISDQLLNKISIKKLTKDKKNNLFVYFDEFVDVTIIDELHQLSKTTLM
HDLQIWYINNLKEVDHKKILTFFKKISEQNANLIFLEQINDLNTKIEYNSNLNSLILKIN
DKLIYDHFIANKLEILNILKVWSLPYSNFEIHFENLSSLLNEKHEQAVNEIISHHIQQQK
HLEQQISQQQNFYNNQKANFNYYKNPSNKTITKLIDINPLMNNAKIRAYVFLKKIDILKS
GAIAYKLNVIDDSETLTIMTYLPSGEHPLKKFLDELKIDQLIEAEIDIVLDNMSKSGQVP
IGKIKKICCVEDKHVKKQITPRLELNFHTKMSSLDAIISTQELIDFAVKNQLKTIGITDR
NVVQAYPEIAKFSKKQDLKIIYGLETEELEDQIPLVLNVRDQNLDNATYVIFDIETTGLF
PNFDEIIEFGAVIMQNNKQIGEKIQFFIKPIQQINENVTNLTNISQEMVNNAIDEKTALL
KIKEIFDDHILVAHNGINFDINFINQRLLKWGLEPLKNPSIDTLMISRAINPFKSHRLGA
ICKKYEVDYNDESAHRADYDAIVLADVFKVMKNNLFNDFGITNLSEINTKLQTTMLKNRS
FGNWINLYIKNQANVKDMYELVSISHTDMYYTRPTITTSFLANKKDKLIISNSIHESDLI
NALYSKNDEEIKRLIQRYDFITLPSLGSQKHLVYAKKITIENVQKAFKKLIYLALELNKI
IIYSSSPYYFFKDDKKFYDVYVNTKGLEGKAHRFANEVYVPDLEYIDQKNAIDELAYLED
EKLINLIINENPVHINSWFDDSIQPLKEGLYAPKMEGVDQKTIDYVYHTAKKIYGENLPT
IVEQRIKKELNSIIKHGFSVVYWISHLLVEKSMQDGYGVGSRGSVGSSLVATFLNITDVN
PLTPHYLCPNCKKCEFITNADDGFDLAPKSCEQCQTPMLTDGHNIPFETFLGFDGDKVPD
IDLNFSGVYQAVAHNFIKSIFGETHSYRAGTIGTMAQTSAENTVKKYFENRFNENKIIRD
STVSLYVQKCIDSKRTTGQHPGGIIIVPKEYSIWDFSPYNFPANDINETWKTTHFAFEYL
HDSLLKFDILGHDNPTILKLLKDYTGIDERDVPMYDPLVMKSFSDISALNIKPSDVLNET
TGAISIPEFGTRFVRGMLVDTKPKSFADLIRISGLSHGESVWLGNAQSLIKSGKLLKDVI
ACRDDIMTYLIRQNVEPKTAFLIMEDVRKGKKIKPEHQIILKELKVPEWYIESANKIKYM
FPKAHATAYVMHAWKFAWYKIYYPLEYYAAFFSVRADNFDLFVINQGKEFIEKTYNDIEQ
RSKSRDPQKKVSSRELALQPIYEIVIELLARGFKISNISIEQSQATSYVIDKENNAIIPP
FIAIQGLGETVANSIIEARNQKVFSTIEDLKNRTKISRTDLKNLRVLGVLDHLSETEQLT
LF
>UU378 unique hypothetical unique hypothetical membrane lipoprotein
MKKINKKILFSSLLFGTVAIGTVAVATACSDNKKTKKTINTGTTQPGSSTGTTSKSLTQE
KVLRNEIISEILNAKSKKPDRDKMWVNWWNSSFEQARKLAREMDKAVDLTKSSNFKKLIA
DGKYKSTFSAQIEDIITKVKHDIKMYAESPFWKKWRDEKKTVITLVNNNAPREDLGAMNV
TSIDLPADFPIIYSKPDYDGIPGLGARFPTPKSKVAPEKLLDDGFSFGDIIVEDGSDTQK
ANLPGQLIESFEKTADKVIYLYYDSGLPEAFKNNQRQPEKIKQFEDWMKSQNANDFVAKR
MLKNPNNKDDLIVMPMSSLWYASYGILGVNYSLHALSEAFGMPKSELDALKAKEEFKVPK
QLVTLVNQATDLKEDKQTIKDECDPFKSHRDPNHKIDWKVWATNSQVLDIAITLGLKPDL
LVNGELSTSGHEENQLALYLSDYINGQLKDCRTITPNDGIRWETTSLTKIKDLNVNLILA
GIHGEAATKMFGALMKEHKEIANFAITNRRFNDETRKVVAPQDRDKYSQNAALVDWEDYL
KTKDLH
>UU379 conserved hypothetical hypothetical
MSKNPYVINEWFMANVIHNIKELQTLTINKKIKIKDFDYLSYLPLVKDDPLASYFKSIYE
QEVKRTKLVLAHNDFSINNILANECENLFILIDFEYSSRNLKDWDLFNFLRDLNDVQLNF
GISFIKEKLGYDECLIYKYLFLTSYYGFLWATNAFLKTNELKIKIYGENAYQKADFYLQK
LNK
>UU379.1 unique hypothetical unique hypothetical
MKNWAKSLLIDFINIDFHNFKSIQIVLDAWTNQVFEVVDIINLSWYIRIKIKKGNTLEHY
LFTKFFKGYFYYDQQSHHLISQKINVKKPLCN
>UU380 conserved hypothetical hypothetical
MKKTLVLYARVCPTKSFHTQQIFEAFQKQTNFVCVNLDANQPFDVSKEQEFILGFDRIIL
LFTLNWYNIPWSLSRYFIEVWRTFPFSLENKEVYKIITTGANQDFYEKKDPNINNISVEE
YLNNVNGMLKKLRASIQKSFYYYGAINQDQMRLNQFVNELIKYFKNQN
>UU381 uvrC excinuclease ABC subunit c
MNDLLKNKLKLIPHKPGCYLWKDQFNQIIYIGKAKDLYNRTHSYFNGCKDNKTSKLVNNI
NDLEYIVVNNVNEALILENNLIKTHLPKYNILLKDGSNYPYIMITNEQYPRLKYVRTYDK
NKGIYFGPLADSTNKYQLFNLLNSIFPFNKCNHQPYKKCIYYDLHQCINQVQQSTYQEAI
SEVKEIFKGNLDHILMILQTKEQHAVTKLDFENAQKYAEQQKALTSIINSGLVQLDNNES
FDIIGFYEKNNYLVIIIFNYVKGKLLNKSADTFAIYDYEINELITSFLMQYYSQNKISSK
IIVSLDDDNLLALSQRFHTKFINAQTKFHKRILKLALDNAILYFESNIKNVINKQNELDD
ALNQLKQILKLPDLNIIECFDNSNINLSLPIAGMIVYQNGKLNNKLNRKYNLMTTKNASD
YHFMIEVITRRYQRLVSQHQKLPNLIVVDGGKLQVNAALYALAQLQINIPLIGLKKDQKH
KTDAIVLTNGDEIVLDRKSILYKFLANMQNDVHNYAISFLRDKHTKSIFNSLLDNVQGLG
KKRFNELLKYYDSINDLKSASDQELLQFLPKNVLVNLREKLNKI
>UU382 gpsA NAD+ dependent glycerol-3-phosphate dehydrogenase
MSKILIVGSGAFGSALTQVLVSNSHIVDVYGINENELNDLKENQKNKKYFQDQKLDLPIN
NTYLDINLALQNQYDFIIIAIPSFAIKNFVDNIKIFNLSKTIVVNAAKGLNLETKSSWCD
YIKQNLKIKALVGLVGPSFAIDVFLKKPTVVNLVGNNSNALIKVKEEFENNWFKCILSKQ
FDAANYISCFKNALAIGCGIIYGLQNSNNSLVAFLTKGINEMQLILEKIFHKKVNPLEYF
FIGDTILTCTDQKSRNFSFGLLIAQQGVQEALVNKQQTIEGLNNIKVIYEIIKTNQISAP
LFQNLYKVIINALNPQDLFDKSFC
>UU383 conserved hypothetical hypothetical ATP/GTP-binding protein
MRTIAIVGKPNVGKSSLFNRILMRRKSIVDDQPGVTRDRIYDIGNWLTRSFMLIDTGGII
SSKDTYQDNINEQVLFAINEANTIIFLVSAKDGINNDDKKIAKMLKEKAKDKKIILVINK
IESEKYYLNEGELYSFGFGKFFKISAEHGIGMGDLLDELVKDMPIQNNLEKQERFKFCII
GRPNVGKSSLTNTILGEQRVIVNAEAGSTRDSIDNDFNYYNKKYTIIDTAGIRRKGKIVE
SVEKYAVLRTKKAIERSQLILLVLDGSEPFKEQDEVVGGLAYNANIPTIIIVNKWDNIIN
KNSHTMEMVKKQIRSQFKYLSWAPIVFVSALDNKRIHTIFEAIEFVREQAMRKIATSLLN
DVVIKANAFQEPPPFKGGRISISYIVQVQSQIPTFVLKCNNPKFLHFSYARYIENEIRKA
FGFDSVPITLYWQDKNKKLRGE
>UU384 conserved hypothetical hypothetical membrane lipoprotein
MINNLFKTKNYYISFLILATSIACCFYYNNFWILIVNICQFYWLYSIKFNYKIIILIIIF
SALCIILCLLIHKDFNIHFLVINIEKKYNYSLRTQILIYLSKKYSNENTLMLIKLMIFNE
KINSDFKQILYDLNIAHLFIVSGLHLNLFILIINKIFSKRWPKTSFLIGILFLLFYGYLL
EFSIGFIRVFIMHILSIKFFQKISKMDKLAISGMLIGCLSIYNLSILSFIFAYLALFCIY
LINIFIKNNSVLKNIYINLYILSITFVISINLNQKINFLSIVFGYVMNLPILFVYQILFW
LMFIPHFELILDLFTNTLVKSIYFISEIDASILIKAYVKIVTIFYTTIWITTSLWIYYKK
ILKKV
>UU385 conserved hypothetical hypothetical
MFIGTYNHSIDSKNRMLVPSKVKATLGEAIFVYLSLGFDGNIDMRLESEFNQFVNNINNL
LIGSKEARNLTRLILSQTYKIEIDSASRILIPQNLIDKAKIKKDIYIIGTNDRYEIWAKE
VYDDFSLNQESTLSDLAEKLLINGI
>UU386 conserved hypothetical hypothetical
MEFNQHITVLLNETIELLNIKPDGIYVDCTFGRGGHSQLILKKLSKKGKLICLDQDQEAI
NFANNLFKNNTNVIVIKTNFKNLKSALSAHKIFYVDGFIFDLGLSSPQLDDPKRGFSYHK
NAWLDMRMDQSQNLNAHYIVNNYSFAKLVSIFKRYGEIKYPKIIADAIVKERSIKEINTT
LELVEIIKKYSPKKNLFEKKHPARLFFQAIRIEVNDELNILEKAFNDAISMLNPLGVVAI
ISFHSLEDKIVKKVFNNYAKIKLPKEVPINNYVNKYSLLNQKIMPSTQELNDNNRSRSSI
LRGLIRNY
>UU387 unique hypothetical unique hypothetical
MNKPMCLLRLDNYYFTLLVFIYNDVTKVNDLIFIKSIPNNNQNNYESSNFLQTDLKIQLN
TLINCFKKELHINFIDEIIVSYGFSSFQTTHTTFYNYNEFMKLRSNFNNEHSELLSSDQK
SYIAVDFGISHYSKENSYKLISYYILKYDYQLIIDLCQSFNLKIKQFIVSQAHLNGLKFD
NEDNKTSLLLELENFKINFRTYNEYNLISNVISETKNHFCLADIITQTAQSLNINPKKIE
SYFNDINYNNKKVIEINIDPKELFTYSFICGADIENTFLKIFKEHFEKSILSQFDHPLLD
FNPKNLAFLFINTPFNNLNKIFYYFFSSYFKEVKIEVFQNKFFIYSNCYEYSNSQALAKQ
DFYNVHNMKNFDSFSNENILTKMHDQTINIKNF
>UU388 unique hypothetical unique hypothetical
MALSKHSIGLIKNLKNKGLTIKNKEKFISFLFNYGVIRVIDGYSFFLKKDNQYVKGLKSK
DLINFVLLDRKIANLMGDCIMLFEQQLNAIVVQNFLKINNLNSKYVIDMRTDPFIKFESP
KHYEILSENIYTYANSSNLLSQFNTNAQEIPLINLALSWTLNTTIGFYRAVDNNVQISVL
EYFQLNHITPLEFIDILHIIKHFRNSISHNDMVITNSFNDNVGAFAKSLKLKSIKKVVGF
LDVAAFLTAFTNDKFHVLNGNLHIKILQAIKKAKFKGVVLEHINNLLGVED
>UU389 conserved hypothetical hypothetical ATP/GTP-binding protein
MQDQGVNNKAIKQKVLNLLSTDTRDSCIRTRLTKYHLDISHTFNKYELQDFIEGKINILK
IRNFININTFENDVKNINSMDELIDYLQDFNLKLKDLLSTRKINEWSQDFVFYKNERIAD
MIKAIESQPKKFEYLSREARNIYAQTGVWPLYIAKNFLIGTTPKASNINAPLIFVDVEIK
KYNGEIFLKRKNTNFIVNEKILSFLKNDYKNNIVSLNEIKNFSYLEIQTLIKKIILKDHL
ESIINNNEFLNLKQNEINEQFNNFFLYDAYVLGIFEPHGGAIKNDLEVIISNNIDPFDEE
INNVNQQIYYKNYHFLAEENKLPLIQINRPLNIFQKYAIHSGLVKNTLIYGPPGTGKSEV
IASIIANVINDLKSILIISEKKAALDVLHERLAKINFFTLFIYDTNNDDQFYNNIFNLIE
KIGGLRFIENQDLNQFNDFKYKNNIISNIYYKKIHELKKEIINITSLIKNLHNEKDNNDN
NFANYLYWLSRFNEVEIRFINDPLLINEINNLIENYSYNFDEIITHVKASYDFFKKYNYE
FSKNNFLKFKEESEQLNKLQIDFNLITKSLYQSQTFLPRIKLLESFLVKNNMTLTSLIYD
DVNLLSNTYVEANEFYTNFNHLLKDDFKKFIEDNIKSHSLFFSHLNTLKNNEWTYAFEQY
LLINNPFAKKGLFKKIKGDEKKLWKQLDLLKIYINNPFLSKFSFDFLEDLIKQPIEIFNV
ENLVYLNNKHLLNKAYVKDLYENAFDKNLSYELIYGLKDLKLNSEQYDIIKNLIKYQNEV
LVNYQFIKNTDFFNLCKKLRDANIQFSKNADEIIYNNYLDYLQIKLVTAPKQIQTKIKEI
AQICRLAKKPNIVKFILKYYEILRFLFPIWISKPELVSEMLPLISKSFDYGIFDEASQMF
LERSYPSIYRCNINIVAGDDKQLCPTNFFINRQENENDEFELADVDVAESLLDRAKTALW
SEYLLKNHYRSNREDLISFSNDNIYNGDLHFASKNGLFDPGMEIIDVEGVFENENVIEAQ
KIMEVLKERAANYQKIIVITFNIKQSELIENLILQTFSFNDVVYQRFENDEIIVTNLENV
QGNEADLVILSVTYAKNKEGILRNNYGPLMKKGGANRLNVAITRAADKMIVVKSIKAVDM
MVNINNDNIRTFKNFIGYCDEIVHLTNQNKFNDCSHFDEEFLTSLEKTILKILKDYKKTN
QQILYKLKIGNFKITFALYNEEKQKIDLLIFIEEFNEWKSYNLLEIYDQFNFLMDRGYKT
IVINDYEICLNYNQVKNNIIKLID
>UU390 unique hypothetical unique hypothetical
MNLKSFEFLKGDAIVDNQIKKAINTSLIKASFSCAIMCILVLIFGFLMRKYLFYFSDASS
LIISSRLIFQIITIIVATLSIVYFIVHLIIYFRQRNNFLAPKFAWSIILYLLDGITMCFM
ISYVAAIVGLDLTLIAIGISLSIIVAMGILGFIMNHKIAFKLGIANIVLFTIATIGSIIL
LIVFFTTRYNHTGFNKGVIIADIVLSIIWLLALSIGFASTIYIIKVMAEHHNLDNKKIMR
DFTTWNSYLLFASFNRILLYVIRLFLLFKRV
>UU391 clpB ATP-dependent serine proteinase - heat shock protein
MEFKQKNSNNPLEEFGRNLNKEILDNKIDPIIGRDEEIRRTIEILSRKTKNNPVLIGEPG
VGKTAIVEGLAYRIVHKDVPSNLLDKTIIELSLSSLIAGASYQGQFEERINSILKEVKKA
DGNIILFIDEIHQIVGMGRNQGSNMDVANILKPMMARGEIKLIGATTLDEYRLYIEKDQA
LERRFTKVLVNKPTIQETLTIMRGLKPRWEAFHGIKIHDNALIAAVNLSERYINDRNLPD
KAIDLIDEAAAKIKTQINSQPIYLDEIKRDLQHLQTEKAALEPEKDEKSIKRLNEILEKI
KLKQDEFNNLNDLYLKEKKQIDDLKNLRQKIERIQHDIEFYQSEGKYEKASRLLYSDLPL
FEKQREELENKINENNNQKMIIDSLTENEIADVIARATGIPLSHLLADEKTKLLSLNKRI
ASHVIGQDEAVKLISDAVIRGRAGINNPNQPIGSFLFLGPTGVGKTELAKTLAKELFNSE
KALIRFDMSEYMEKHSVSKLVGAPPGYIGYENAGVLTESVKRKPYSILLFDEIEKAHPDI
LNILLQILDEGSIKDAKNNEINFKNTIIIMTSNIGAEALLENNKTKALLDLQKTFKPEIL
NRISEIIFFNKLSKEIIFKISENLLKELENLLAKQDYLIKFDDNIAQIMVEDAYSSNYGA
RPLKRWITKHLENEIAKLIIENRITKNINYKINYDRELDQVLIK
>UU392 unique hypothetical unique hypothetical
MLKNYFQSSWLYTTFLSRLVLFKKSTYFLVGISLFVNLIFIIINGLNIANNIKTYLILFY
LFTSINSLLTIVFSTIKAINLFKDLKDEGIEILVFSKSISRKNIIFTKIGFLILNIVFWS
LITYILNIIFYVVNIKNNNGINFFYLYAFFNYYFCGLIFASIAALIVSRWSNKVAMIIPI
SCFLPFLIAGGVANLYSTSKINQVAKYMNINYDKYDSNTILDVEKFYLNNHNDEVYLITK
NLNNPQFSKRQNYFLKAAFDHAKNASTFFHVLSWLSVPYQLNNSFYKNDIDPFSVNSQHE
NYLDKYFNYHGLESKLYDYKLNKHPHLPQFNINENQKEYFVPGALKNTSQFPTLENRNLI
YARENVDRFDVNFIEDDNLFSSTNDFVGELKWAVIRNTLESKVFNNFAKKFYDNFDEDID
KPQIIAAYNDVINEQSSINFSTIVDENSILFAKKINNYYVKNLVEKKIYFIVALMYYLYF
NEERWNLLEKLLKNDKVINFYRPSSIRINVNNYAYDIGGIGSYELMKKVVNNKTLYRYQL
QKSNNYVFQTAKEVYSIKRADQIVNKNYYWLIWILFSTILIISLALIYLKRDYK
>UU393 acpS holo-acyl carrier protein synthase
MKLVHGIDIIEWNREELNNPLFAKRILIDNELEYYFQLNSSREKKRYLASVFACKEAVMK
ALKLKYGYGDILILKTENQRQVYLNKILIKELELSISYTETYIVASVVGLINNMN
>UU394 unique hypothetical unique hypothetical
MVNDNKINEYKNKKFVANKVGYDPESVDVFLDELINELEIFINEHKNAILKIEELNEYKR
KFEKEREYTTSLNNFIDLLEKVVDKKSTFDVWEKRPVRK
>UU395 unique hypothetical unique hypothetical
MQRIINKNMIYGGFMPLVSGALGFWNKMLFGTIIANTAISMIGGITNIVMASSSQQNHDS
QDIDSIKIETINVDMSTIVGPKIPYMNIYYLNS
>UU396 unique hypothetical unique hypothetical
MQKISDNFKKVYYGGFSTSNSFNYMWNNALISSMLGQTVVGFLGMISQLVYAFNPQPKFN
PQQMIDNSVARTYARIAQKPMNSTISLGTPFF
>UU397 rnhB ribonuclease HII
MAIVSVKLTSNQVDKFLILWRPYLVHNNHNYAKYTFKIDGTLIIIYNTNTCTINTHDINS
FLNTFLKREDLTLFNVIKQQVNTKKNNQNVMSQSEIYESAQVIIGSDEVGVGDLFGGIVV
CAVSLKKSDFKKINHLKIIDSKKLNDQQMQEIYQQIKNQISYTIVSYNPKEYNELIKEYN
NAHILKTILHYKALQSEIHKHAKYSIFSVVDAFSSLKNWNQYLQKVNFQPYEPNLLIPKA
ESIYTSVALASIIARVMFLKMIAIIEEQFNVKIPLGSSNPLVNDVASNIFQKFGLKILKQ
VAKEHFSNFQQIIKNK
>UU398 unique hypothetical unique hypothetical
MKFKKFDSKKSILRFLQVDETKREINLSFNDTTDFIFFLKEIAEDPNIAKKNAKKLTSLY
IEISNKLGNDDNTDLSVYETKCNNLIEACVIDEAIYLVNMAKNIVIFLAHNKLDLLQKDF
FDKLLLIESHFNFDQNLTYSYIKNSSIALLIFHLKQFINIYDEFLNNFENVINHSLENSI
STKNKLTQQINHFNTIKRRPS
>UU399 hmuU hemin permease
MKMKFNFFKDKQNILGQNHILELNKKSFIPYHFKPLLITITLLIALLVVIILIFSVTLSN
KLGFSELAKVIWQEVVQLIITGVALGVSSYVLQRITRNRFADVSIMGIGTINLILLCALS
IPVDFTSANELSILQKKEPWIFMFMSCCLMVLYFFVSRQKENFNYKKLILIGVILTFFLI
AIAQSIRGWLNYHANDYVVGHIVGSVQKAPLNSLIIAASFVILGLLWLLFNSYKLNIIAT
NQQVAKQLGIKINFQIFIALIFVGIMVGASYSISGDFVYVGLLAGNAAMRRRNNSFTYGI
LNSGIYGMLSTLITYWIGISLIGMSVYHVGAILPLLIGPYFIYKVLRS
>UU400 fatD ferrichrome ABC transporter (permease)
MFKNKSLKFKNKLDWKTHFRRLITSLLIILSICVLICYCLFDGKELMNFKNVGEEINEGS
APYIRKFIATPIAIFLSALTLSFSGYSMQVVSRNPLASPTTLGYLPAAILGLAISKLAIN
QILYLPFIIGIVFASCLIVINFFLVKGNALEASFKPILVGFAIGGIITGINVLLEDLVKD
INIKITGFVEPPINFQWQQLCIGGPLIIISSLANLFMAPYYTIIAKDYLLAKSLGIKVNL
IFWLTAFFAVVATVSSIILIGVLTLLGMIAPHVARILNPKGNSFKQLLLSFVISLLLLTS
SRWLINVYNQFDINLFSAIAALPVFAYIFVSKQYRRNVE
>UU401 ABC sbp putative ABC substrate-binding protein - iron
MKLFVKTKQYYFKNEDNKNMFKKNKKSLAVLLVGFSTVLISSIAVAATACARKDNNVKEE
GKTTLNKLISKKAPKQNATKSSEKYILSDVNNSSTFFNSLTDPYKCFEMFAKSLDDAGYE
ITSHEPLKNSGKTSFLEYAKELNNKIREYVRKVANLPTIKKLRDNNTTVLWAESTQSFNS
SDASKLDLYYFQQEDLFPLLYSQPDDSNVPGFGLRFPKPKNHNADKYFDNWHGIGASQNN
ASKNDYDWMLSMQEAFYGTADYVFFNYDSNNLEGNEDGEILKSNFEKFFKKTVNNNKIIP
VDFQFEYSSIWGPIGTVRLVQSLAKRLGVSDSELASVSLDWTMPSKQTLKHIRPKNSNND
HNKFAIWFYNLWDHCVALGIQPDYASFVKEKGKTYTKLPGFLADLVDETKTEFKDFTGDA
QKVAGMNLYALGGNNSHINRSFKTLIGNAIPKAVPTERGDSNNSRSPINFEFYDRTTNTL
QSVEGTKVVSWTDPAKENKQK
>UU402 trmU tRNA-(5-methylaminomethyl-2-thiouridylate) methyltransferase
MEVKVKKRVVVGLSGGVDSSVSALLLKQEGYEVIGLFMSNWDTIANFENNHEFNKTHQGC
ESELDYQDAQAVAQKIGIPLYRVEFIKEYWDNVFEYFLSEYQKNRTPNPDILCNQFIKFD
SFLNYAKNELQADYIAMGHYARVKHDRNSSFLLKAIDTNKDQTYFLCNLNQNQLQNVLFP
IGHLTKLQVRAIAKKHGLITANKKDSTGICFIGERNFKTFLQNYIPNQPGQIINIVNNQI
IGHHIGTMYYTIGQRKGLNLGGMNERMFVCDKDIDKKIIYVAPSSFEKQYLISTQALIEN
INFIEPYNPQIPIMVRFRHRQDLIIVNDFLPIKNTKNVLINYESARAITPGQYAVFYQND
HCIGGGIVSKTNIGHQKVDFLVYKS
>UU403 conserved hypothetical hypothetical
MKKAILISISSLIGISAIVATSTFLSLSAKTNIYAKLIKSSDLNQSLNYTNLSDANIGIK
EMLLGTNKINNGNYVLYIGTQSNLDNLNFVYDNQTNHINSISDLKYNDNLKFNGSLAKSI
NNVKNYADKGVYEHVPEFYSFIDLMDTNVFKQKQDYENLIKQNKSSTIKEDQNWANNAPT
DYSFDVNKKYKDKSGREVYFRNDTQAVKFREILNFLKKYLSKEKLIELSTSQTPGIVLFY
SQDNLSKGPQVYASSKIYDKSKNERKESYVSGDNVYNSSRFEFGGDLNAAIYSVYGKK
>UU404 tnp integrase-recombinase protein
MDKKNIFTILEKLVKKYKYLHKPILDDYISTFTRTFLEYILTIEMKYHLNYERFERYLSS
NSKNYRNGFSKKQLYMNDLKVSINIPRDRNGAFESKIISKYQVDISHFEYRLLSLGINNL
QLNEYEKILEDIYNIYNDKMVDKLCNEIALKIFDYLENKKQELNNIDVDQIFIDGFNLSS
NKWLTIVITKDLEKRLTILGFWVINNLEDKWWNDIIIKISKYHPQVINYKVIFKDNDELL
MSLKNHTSNNFERARFVFINKSILNQKN
>UU405 conserved hypothetical hypothetical
MDQVYNIVMAYILTLIISPLYSYLIGSLNASIILSLVFKKQDVRLFASKNAGMTNMIRVH
GKKLGILTLFLDIIKPITTVSLTYIIYKYALDAPFDLSNGFNQAILVYFGGIFTIIGHCY
PIFFKFQGGKGVACYGGFLITVDPIVALIGIITLLVILLITKYMSLSAMITATFTCFLVL
VPGINYIPYYNQNFTTYFFDLNYVIKGIWYVWFFLLVSASLLIYRHKTNILSIATKQERK
TILFHTKSKDNLSDVNK
>UU405.1 conserved hypothetical hypothetical
MINNKKFINKTFDNTNQIRLQNNLKTYAPKFLNLIIINNIFVLIMIISLCIFFSDPHFLY
RNDVISNQYRQFIFTYQQTAIAIVLYVLAWYIMVNFFFFGYLLEYVKLNKFETFNFALAS
ILFNPYAYVIIVKNWTSWSFYWQRSFYHVLSENNKIEFNIKNSKTIFALVFLIIAIPFII
FSSIDYVPKNPGRLIIFNKNSLGEKVIYTNNVWFHNMHYFTSQGNWMCIGIAFLYFINPK
ARCTKNNRVLLIVLSYILIISSIWLCVLFPMFSRQSTWVWFNNMVGFYNHLITPISFTIF
AYYCIIKNKYAIHIKYFYAWKGFMFYVVIYAMYALFLPLLANVTVYGAITNIWPSANGNP
IFVTMLFALIGYQILVFSINWTILKFINKYKNNKILIG
>UU406 grpE heat shock protein
MSKNNENIKHQNNDKVNNQVDKKETKNHNKQEFKYKELYEHELKKNKELQNINTLLKDKN
QQLEEQISQLNQDFIKQLETKAKQAQQILEQKVNELEARHEAKVNDAVFKIFKFKMEPLL
DAINHFTKIVNQNYDDPKIQAFIEGFKMFSQNMIDGLDNLKITKISPQVNDSLNDEIMEV
FEVVENTNKPSMHVVEVISDGFKYNDKVIKFAVVKVAK
>UU407 dnaJ heat shock protein
MAKRDYYEILGVSKSATPEEIKAAFRKLAKEHHPDRNKSADDTLFKEINEAYEVLSDSKK
RAQYDQFGHDGPQGFSSASGFSGFSGGFGGVDFDINDIFGSFFNNASSSHNSSNQYETYD
IHLRLHLDFMEAVNGISKNINYDRKITCHKCQGTGAKDPKDVKICTKCHGRGTSIENVHS
LFGTIQQEVECHECEGTGKVASSKCEQCYGKKVINERVNLTVEIPAGTREGEKLLVSKKG
NIVNNQEFDLYLHISVKPSKYFALDGLDIYSETYIDPIKAIVGGIIEVVTINGIKTIEIP
SNTPEGKKFRISGSGIVNKKSNIFGKKNGDFYTTIRYAKPVELSKDEIAYLKNISTRTNQ
NVEYYKNKVLKEISK
>UU408 unique hypothetical unique hypothetical
MSKIVDNIDINALRINHYEEWEQNHIIKVINAYRHHESKKEKFKMIHELIKNHQMHLTKL
IPLFDVSISGYYKWLEDLKIDQVCPIKKRNMDLIEKICKSHKHYIGCRKIQKILETQYNV
KLNYKTINLYMNKMDLCKPCHHEHHEKKE
>UU409 conserved hypothetical hypothetical membrane lipoprotein
MSANYFLIGLTIFCITCIGLANFLIKPIQIKKHNWLTWNYFINTKWIINTLISISFLIYF
CCLRWAPNIHVFFINHIEIINVLRDKFSDDIDLYEASITISRTFLLDWCPCFSVLISCVA
IFDKKQIIINHLGFLCFCFGLLTIIGGLIGDEPIRWNRLITYIFIGDKPNPIYFSLHFYL
CLFGFYLFVNTRKTIKIYWIYIIIHIILITYIIYVNVMILIFNIKNNASGFSFGDWYSPI
YAQYGTVAQFLQLNYRLNALIMCLFMYAIFIVGYLIRYHLQKIYINKYNIKYSQERNYFA
YVKNCR
>UU410 ileS isoleucyl-tRNA synthetase
MKDYKSTLNMPTTGFEMRANLNVKEPKIQQFWVEHQIYEKLLTKNKDKKPFILHDGPPYA
NGNIHIGHALNKILKDFVVSYHNMNNYYSPYIPGWDTHGLPIEVALSKKIKLSNLSVNER
REQCKKYALEQVNNQIQQFLRLGMISDFKQRYLTLDHNYEIDQLKLFTYMLKKGFIYQDF
KPVFWSWSSQTALAESEIEYADRQSSAIYVKMKVVDHNDLFTDKPTSLVIWTTTPWTLPA
NLAIAIHPELVYSLIEYKNENYIIAKPLVETFVKKVGFEDYKWIKDFKANTLEKIKYISP
ISKKHAFVIMDEYVSANDGTGLVHNAPAFGLEDYYACKKYGIETVVMIDQFGKYNALVND
LELENMFYEDANQVILNRLMNEHLLIHHEVITHSVAHDWRTKKPVMYRATKQWFVSIEKI
LPNILQTLNNDVKSTSFRGIERMHEMIVNRKEWCISRQRVWGVPIPMIFDENHNAIMDHE
LVENIINVLNEKGVNAWFDLDVNAFLTPKYLSMKNKTFYKEKDIMDVWFDSGSSYNILGH
YNLNYPADVYLEGYDQYRGWFNSSLITGTILNNRAPYKYLVAHGMVLDGEGYKMSKSKGN
VVDPLDVCKIYGADVLRLWIANSDYQNDTRISEEILKQNAEIYRRIRNTLFKYSLSILND
FEPSVDFSFNVRQEEQFVLNEFNELHIKVIKAYENFDYQTVVKLFNKFILDLSSWYFENI
KDDMYCLAINDPIRKQIQSAVYWILKNSLIDLTPIIPHTTEEAYSFLKDANKKESIRLED
FYDQSQFQFKKGIAHVKAFFSIKDQIFNELENARKNNILKKNNEAFVTIAKNLILDDYLI
NNPKLLAKWFGVAKIEFANNTNVANANFKKCLRCWNHFPDEEMYNDELSMNCYKVINKIK
>UU411 gcp sialoglycoprotease
MNDNYLILSIESSCDETSLALFENNKLIAHKISSSASIQSLHGGVVPELASRYHEQNINH
LFNEILNETKINPLTITHVAYTAMPGLPGCLHVGKVFAKQLAVLINAELVPINHLHAHVF
SASINQNLTFPFLGLVVSGGESCIYLVNDYDEIKVLNQTHDDAIGECYDKIARVLGWKYP
GGPIIDKNYQENLATLEFIKSQPAAKDFSFSGLKTAVINYIHNAKQKKISFDPVVVASSF
QKFAINEIIKKIKYYLNLYKLNHLAIGGGVSANSLLRKKIQSLDVISYIPEMIYTGDNAA
MIGAYAYALIKNHKKSILIK
>UU412 metK S-adenosylmethionine synthetase
MKYKKIITSESVGAGHPDKICDQISDAILDECLAQDKNSRVACEVLACNRLIVIAGEITT
HAYVDVVKTAWEIIKPLGYNENDFTIISNVNKQSVDIAQSVNKANKDLIGAGDQGIVFGY
ACDETPQYMPLTTVLAHELLKEIEKQRRNKEFVKIQADMKSQVSIDYSNCTPVIETMLVS
IQHDEDYNIEYFNKKVSTIMDQIAIKYGLNTDFKKIINSSGRFVIGGPIGDTGLTGRKII
VDTYGGIGHHGGGAFSGKDPTKVDRSASYFARWIAKNVVAAKLAKQCEIQLAFAIGEPQP
VAMFVNTFKTNLVDEKKIFEAINKSFNFDIKTFINDLELWTTKYLPVATYGHFGRDDLNL
SWEKLNKVQDLIKYSK
>UU413 fpg formamidopyrimidine-DNA glycosylase
MPELPEVQTIVDYLNHHVLDIFIKKTIVHLPKILKNKTPQEFEKLLINHKIVKIKRLGKY
LLFFLSNNLVLSVHLRMEGKFYYQAKEEWFNLAHTHIIIEFNNGMQLRYNDTRQFGTFHI
YEQQSFLDSKELKKIALDPLDNNFSAQYLYEKLKKSNKAIKTALLDQSVVSGIGNIYADE
ILFAAKIFPTILAKNLTLKNYEKITKEAQRILLLSIKNKGTTIHTYKFGNDETGLFQKML
LVHTHAKEPCQICGTIIQKTKVNGRGTYYCPNCQN
>UU414 polA DNA polymerase I: 5'-3' exonuclease domain
MKKAIVIDGNSLIYRAFHATYKQAEWAVEKQLMPTNAIKLVASMIFKILNQEQFTYGLIA
MDASKQTFRAQEYAAYKATRKPMDAKLIVQLPYLKKLFVAMGFRIISQPGIEADDFVGSF
SNLMNKFDVDTTIYSSDRDMLQLINKNTKLKLLKTGTSVMQEINLTNFSLLNNGILPYQI
IEYKGLVGDSSDNLIGVKGIGPKTAINLLLKYDNIENIYTNLEKIAPSVKNKLIEHKDMA
FLSKKLAAIQTDLLFDEKLENFVLKPYNTQELDELFTSLKINNMQNYYK
>UU415 dnaE DNA polymerase III alpha chain 2
MFINLNVHSHYSLLNSTLSIDDLIKYALDNKQPYVCLTDLNNMYGCIEFYDKAKAHNLTP
IIGLEFEYQNATLVAYAKNYNGYLKLIKWSSWIMTSKEFEIQDDFDDLIIVCKKGTIVFK
SPNFYQTHDQNAPNAIALQSVFYANKNDKIVFLAMLAIKNDLKLEDFKNCCDFDNNHFLN
DNLAQSFFSPIALNNLNKVLNELKVQIHDLPINIPVYDKQNSIISSEILKQLCISGLKKR
LNANDGQVNKIYVQRLKYELDVINEKQFDDYFLIVYDFINFAKSNGIIVGPGRGSAAGSL
VAYCLHITDIDPIKHNLIFERFLNPTRKSMPDIDTDIMDEKRDLVIEYLFEKYGNDHVAY
ILTFQRLKAKMAIRDVGRILGIDLKVIDKICKNIKPEYDEDLDLAIKKNTILKEMYLLHK
ELFEISKKLINAPRQIGTHAAGIILSDSLISNIIPIQLGINDRPLSQYSMEYLERFGLIK
MDLLGLKNLTIIDNVLKMIYENQNKKIDLFNINYNDKFVFEDLAKARTNGIFQLESPGMK
KVLLKVKPQNIEDISIVSALFRPGPQQNIKTFVERRFKREEFSYWNEATRKILEPTYGII
VYQEQVIELVKTIANFDIATSDNFRRAISKKDEKILIQLKDDFINGALNNNYKQPLVNQI
FEYIFSFAHYGFNHSHSLAYSYISYWLAYLKHYYTLEFLSVLLSHTSASKDKLLSYLNEA
KEFNISIKGPDIQYFSNDFVIDTQKQIIRFGFKTIKGFGDELLKKIKSALQKSTLSDYIS
YIDALKKGNVSLKNIEILIRVGTFDSFGINRLFLLNNLNEIFEKTGLNGHFFDLNLVGLD
YAKDMSVNDRYLDDEIQYLGIDLNSLNYANYKTEIDYNKLKYTIKDFYEINTNYETNILA
QVLNIKQSKTKNGNDIFYLETLIDNKKQTLTIFQNSKYLIDEISIGGIYVFGVKLLNHFN
FIVNIKQRI
>UU416 unique hypothetical unique hypothetical
MSDKKSDFEKLFERSKVQETSIFDINDIDEQKPYEEHSIEELSYILEYEKIDKKTREKIK
KIIKEKQQNL
>UU417 conserved hypothetical hypothetical
MQKDLLTKLIEQTYGFNKITIFVHTNPDCDALGSAFALARILKLNTFGTRVKIVGVNALN
PNDFKNFFTFDPNEVDDEFIKDSIAFIVDTANQERVLSQKHRLAKKTILVDHHVKTITYT
DLEYINDQSIAACEMIAYSLMHTNLNFDLKTLNYLLLGITTDSNRLMYDKVSDFTYEIMS
WFFKNNVKHYQIYQQLYERNLNDILFDNELVKTIKTQGQVAYLNIDPQWNQKYHFTRWGD
KVYLLSNIKNYPIWFIVYFDENTNTYKVSLRSNKYKVRLVASQFNGGGHDLAAGCSLTNI
DQLENLLSALDALIKNKIVVD
>UU418 thiI thiamin biosynthesis protein
MKPIIYIKYGELTLKGKNRTQFIKVLVHNIKQILIQYQNLTYCVGYDNLKIINLENYNLK
QIIDDLKEVYGIAFICIAYQVDKELSEIQLACKEFINDYEQTFKIEARRSDKSFKYNSME
IKQMCAAYLLQNSPLLKVDVHRPQLLINIEIKYDCAIVYGHKIMGAKGLPVGINGKALVL
LSGGIDSPVASRLIMKRGISIDFITFITPPHTSQKALDKTIALAKQITLDNKLTKANLYV
CNFTKLQDEIAHISKESYRITLMRRYFMRIAKRLAISVKANALVTGEALGQVASQTLNSM
QTISSVLDNFLVLRPLIAYDKEEIISLAKRFNTYELSILPYDDSCSLFAPKNPTTNPNVQ
TAAKLEEESLVLDAIYELVYTKEITKINLS
>UU419 conserved hypothetical hypothetical
MPFIKTPNKDFGLVDNQIVLSSDYKKRYQRYFAKITGSRLGSILNIGDFTNPVRTWAMMV
KIYNEPIDPIYAQAGVVIEPKIKDYVETVLKVKYKQYEPAQIGYDVFKDNQIFGGIPDGE
PIDENGQLLYPNQPMLEIKTTSIDSFSFKTIDYVLVLQKDEHNHPIIKKKGDKRAKWFNN
DESEVIISDEYQLQLGLYCYLRKISKGIFAIAFLTSEDYINPQAFDINKNEIILVNYELD
LNEFEKVISKAKTWYEEYIIKGISPKLTKEDLEWYKVWINKYETNNLY
>UU420 conserved hypothetical hypothetical
MKTINLKKEFNQYCISLKTQDLIKQYFNDEKLKEKLLKNRLIGLISLIIIFIIGVGILIL
GAFINKGNGANLNNGAITCVIIGIFFLLCLLIPYTIVANQNKKIMHKYIEYHFNEVNVGQ
LIKKISTFFQEFRLLTEGFLNFKQSNQVIDINYCNEKYSLIYSFQQKPQVWLIKSTNGNK
ISSKEWDLKGNYDLKIYELEKWNAGFSKFYLENNIESIAFQIESKLSTIINDFEELWIKG
GGFLNEEY
>UU421 hrcA heat-inducible transcription repressor
MKNTKTSQEQVIELKLSDRQKKVLKSIVDEYTISATPVSSKLLVQKEFKDQSSATIRNEM
MFLEKNGLIEKQHISGGRVPSLKGYDFYNKNLINKNNNVSDNFKMRLHKILSKRYSNIDE
ILNAAVSIINETTQLPAVVTKTSSDELLKRIDLVKINDNSALVLIVTSSENILTHSIKLD
KNTKFNDLQTCFSVLDERLVDTKLSLISSKLDLIVDIVRNKLEEVEYYFSKIVHRVFDFY
AYKPNIDSKTYGVKYLTKHSEFEDQQKLNDLLNLLEDSTIWQQIALNKKTDGLAKIMLGN
EIGHEHLAIATTQINLANTNHQITVVGPTRMDYAKIKALLDFLKIEIEKILGSTNEH
>UU422 unique hypothetical unique hypothetical
MNIKKIKREFNTHYELIKKEIKNLNEYKKELEFLIATIYFNSKMVFKEISLDSWKKFSDY
VYRFFLIINKNNQSQNFDLDCWYLEIKELIKVLNISNFLLNKQLEQIYLKYIIFYWYNIN
IPINYEIDDFNIICLRNKAFVDCMQILQEYYHINVDILINLVIKQIR
>UU423 conserved hypothetical hypothetical
MQEKKQTKNENFQDLDQLKIGDELMVHAYKLNGWLYRSWNNPKVVYIDDQLLILSSTNTL
VITSEEKSVRNFPSFTNKMSYWFFFKNEWFNLIATVENDGIKFYINVASPFIYEEQAVKY
YDFDLDFKISSDDKWKEVDVNEFIENAKKYHYSEDLIQKILSVETKIENYIKEGYFRKLV
TRQLLIKLHVLDDIDDFKTNFNKHTNEWNYNLKKHFNKKNGLHHFKNKKGNVKDNE
>UU424 unique hypothetical unique hypothetical
MVCIILKIKKGMLKIMNNNKSYIKKYFDDILIQAKQVLKKHDYAYAYDLISNEFNNPLID
LKTLQEFEAFAIEIKKSAELNFIDENEAKLAKTDFYCKIHDPKTTYVSLAYLETFLMRFI
NEMDELDITFLNSLLTNKLINGSTKLDILDLLATNNIDQNFNFYNKYLKQTKNVNPVNFN
NHYQEIDQIQNYLNKYLAKNPSLLHLANKLLMMYITYYFPFKFAHNHNLIAKTIIDYVKN
AMENHVCQYSEEQKAIVACINKILEEEQV
>UU424.1 unique hypothetical unique hypothetical
MSFLASISPIIALNCCKYANDAFHSLMWKVGFLFFAESRICFYRSVACCSLNSNEFFVIH
VLLLQAVATIVVWIIIIVNDNDENKIFYLFF
>UU425 unique hypothetical unique hypothetical
MATSNDLLIYSNLKQTPKYQIDNKKLKEDFVKNNNWLSENVDYHLSIFKDIKYDFYLSHW
CYQYWIDQNRLDVILKLIYNANKIILYPNGNAELYYVANYYAQAIKNLIREDPHLSKQKI
NDHLNNFINMKSFLEAKNYFSSQLNNNKDWLTVFVLNKLFKIFTIGESWVDSKYFSFNKE
LMPKSYKIRTNYASVLNSLNLSLDAKNQFKKKILSTLLEYTIKHF
>UU426 unique hypothetical unique hypothetical
MGSSLFKNNVLKDRKIAKQELQQWALKIKNKYPNANYFFKLHPIYNQNQVLDYIQEITNG
IFKPIILDAKTPWENILLKDYLSIKNNKAVLFKNKNTPNFSLWGFQPTTSALLTSFDFIR
NNTKLTNDEAQSIIGFDNFLLGKNYDILRRDYEPNKDYTNENLQILERIYGQLIFAKILK
KFF
>UU427 unique hypothetical unique hypothetical
MVKSQKVIDVLNTHYNLNLELGSIYAQYAHIADDQFSMPFLAKFIADLSNDKLGVHKNLI
SEYARKVEIPLHTKFSVDVNFKPANPKELIKHILDTELKVRKHVANMAKVCLEENDFETF
SFVKWFVDDGIKDFDDVRTIHDFFENATNNLQVEYAIRKYLKQMKVEEEK
>UU428 ureD urease complex component
MILNKEKIKNYAAYLYIKVAYDQAHSKMAHTVYFTNFYRSSKPLFLDEEDPINPCFQTIS
MGGGYVSGEIYRSDFEINDDARCIITTQSSAKAYKTVDGKTSEQHTNITLGKNSILEYIS
DNVIVYEDGKFAQFNNFKMDSSATLIYTECFGPGWSPHGSAYQYEKMYLNTKIYYDDKLV
LFDNLKFQPRKNDESAFGIMDGYHYCGTMIVINQQVIEDDVIKIRDLVKEKYPDMDMIFG
VSRMDIPGLGLRVLANTYYHVEKINAVAHDYFRRKLFNKKPLILRKP
>UU429 ureG urease complex component
MKRPLIIGVGGPVGAGKTMLIERLTRYLSTKGYSMAAITNDIYTKEDARILLNTSVLPAD
RIAGVETGGCPHTAIREDASMNFAAIEEMCDKHPDLQLLFLESGGDNLSATFSPDLVDFS
IYIIDVAQGEKIPRKGGQGMIKSDLFIINKVDLAPYVGANVEVMKADTLKSRGNKDFFVT
NLKTDEGLKSVADWIEKRLQLALLEE
>UU430 ureF urease complex component
MKEKKLNLKKHLNTVVTLNSDYLNLLDLMQITNANFPIGTFSHSFGVETYIRKDIVFDGE
SLIKALLLYMNEQLLHGDLLAIYQIFKLLPKQKINAIWEIDQMINFQGLARETREGQRRI
GQQMVKIYNELFNCELLVEYAERIKNKKSYGNPAVAFALLAMHLKIDLKTALYTHLYSTV
AALTQNCVRAIPLGQVKGQKIIYQLKHVYFDDIVNKVFTLDFKTDFCKNIPGLEIAQMEH
EDTPVRLFMS
>UU431 ureE urease complex component
MTVFKEILDNIANIKNVESYQIENIHLTSDDVLKRVIIISSDQNVEYGIRLEEDKKLMDG
DILYKDDYKLVVIRLELSDVLIITAHTIGEMAKIAHNLGNRHMPAQFTETQMIVPYDYLV
EEYLQDNKALYERKKIKLKEAFKHCSDAK
>UU432 ureC urease complex component
MFKISRKNYSDLYGITTGDSVRLGDTNLWVKVEKDLTTYGEESVFGGGKTLREGMGMNST
MKLDDKLGNAEVMDLVITNALIVDYTGIYKADIGIKNGKIAAIGKSGNPHLTDNVDMIVG
ISTEISAGEGKIYTAGGLDTHVHWLEPEIVPVALDGGITTVIAGGTGMNDGTKATTVSPG
KFWVKSALQAADGLSINAGFLAKGQGMEDPIFEQIAAGACGLKIHEDWGATGNAIDLALT
VADKTDVAVAIHTDTLNEAGFVEHTIAAMKGRTIHAYHTEGAGGGHAPDILETVKYAHIL
PASTNPTIPYTVNTIAEHLDMLMVCHHLNPKVPEDVAFADSRIRSQTIAAEDLLHDMGAI
SIMSSDTLAMGRIGEVATRTWQMAHKMKAQFGSLKGDSEFSDNNRVKRYISKYTINPAIA
HGVDSYIGSLEVGKLADIVAWEPKFFGAKPYYVVKMGVIARCVAGDPNASIPTCEPVIMR
DQFGTYGRLLTNTSVSFVSKIGLENGIKEEYKLEKELLPVKNCRSVNKKSMKWNSATPNL
EVDPQTFDAAVDFNDLENWLEQSASELAKKLKKTSSGKYILDAEPLTEAPLAQRYFLF
>UU433 ureB urease complex component
MSGSSSQFSPGKLVPGAINFASGEIVMNEGREAKVISIKNTGDRPIQVGSHFHLFEVNSA
LVFFDEKGNEDKERKVAYGRRFDIPSGTAIRFEPGDKKEVSIIDLAGTREVWGVNGLVNG
KLKK
>UU434 ureA urease complex component
MNLSLREVQKLLITVAADVARRRLARGLKLNYSEAVALITDHVMEGARDGKLVADLMQSA
REVLRVDQVMEGVDTMVSIIQVEVTFPDGTKLVSVHDPIYK
>UU435 fhuC ferrichrome transport ATP-binding protein
MSFFKKKNDLQKEEHKHVSVVDMNEILSYEDSEEFKNDEIDSNEPIFKLNNVSLGYGKKM
IIKNLTATIHRNDFVVVLGPNGSGKSTLIKGLCRINNPSSGYIMYRDKLISRPLLPFLWL
EKAWSSIVNIFTKDRKEVIETIDWHIQNYKKIHAYKSKELALNLAYVPQLAVFPEATSIY
DFVKMGRFPSSNALGINTNTEREKQIIDEALKNVGIYEFRHKNLEDLSGGQKQKALIALA
LAQDTETIVLDEPTNHLDIRSQLEIIELLHKLHHEMKKTIVLVIHDINNGLKYAHKVMIM
KNGEMVRYGKLKETIDHEILLDVFGVESIIVKNESTYPQVSVTDFSLPKDYKINEIKENE
KTNSIYNDGDEVEIENELEKEVDKTKK
>UU436 hlyA hemolysin
MNQRLDHYLKNTNQCETRSKAIDLIKRGRVFVNNFQVLKPSFLVKQTDSVEIKNDEMYFV
SKGGYKLLKIIKEINLIIKNFVIADLGSSTGGFTDCCLQLGAKKIYAIDVGVDLLHPSLK
KSYKIINYEKTNVKNLDKSYFLEDLDLIVGDLSFISLEQIFPIIKKISSPKTLLLLLIKP
QFELGKDVASKYKGLIQNQKLQQLAINKIINLAKNYDFECKHLTPTDIFDEKKQNQEYMI
FLQKHEK
>UU437 conserved hypothetical hypothetical
MHLDIDAFYATVSELLHPEYKNFPIAVGSLNSRTGIISSPNYLARSYGVKAAMPIFLAKE
LCPNLIILPSEHNIYQSYSKHFFQIINKYTNKIEITSIDECFIDATDLVKKYHNNIRLLA
TKIQKEIKNKLNLSISIGISYNKTIAKMATELNKPSGISIIDENKIINLIYELNINKIPY
IGEIKSQELYAINIFKIKELIATENKQKISLVLGSIYQNLVNDLKGLSKIKIIDEDIYKT
ISHSKTFNEDLNDFYEISNEMNDLILTVTNRLKKCNLMTNNISIYIKYPSFKTKIKQKQL
TYYTDDYQTIFLAIKNLFKIMYKDETIRLIGISLNKLVKKENVKKQLFLFD
>UU438 ruvB holliday junction DNA helicase (fragment)
MIANNAKGIPRLANRLLKRVVDFKINGFNDIKSIFKKIQIYEFGLDEQDINYLNVLYRQD
NEIGLKSIAQILRLDQYTIETKIEPYLIQHHFINKNLRGRKITIEGIDF
>UU439 unique hypothetical unique hypothetical
MIYKEIVRNIIKHPLILPDGKHYHLHKILTSKDELRKGEVTLVAENGKEYTVDLSAFVDL
LVDGDCIFDDNHSLVALYFDDAK
>UU440 unique hypothetical unique hypothetical membrane lipoprotein
MNKRHLVTHSLKKKLFIKTSLLSLFLIAPLIIGCTTNKSKSNNSNKLSKQIEIKENKQQE
KPKTKELSPIIDIPKNDYYKVLYANNIKSFVYDGKVWDDQKQTYDLEFVNKLLAYIDQHI
SNLVDFELVKNNQNKPWFKWLIDYYMFLNVTYFIDNKPKFLANSIKYISLRDPEHYFDEA
TRIFKKYYHPNKLSSNNKDYFYSWYNFIYFAHINHYYNARELYKYYNQKFNLDLPSKYIN
HSYPISRIYKNDRYYFSNVNRILFKIKTYDKTRINTLFLAFKKLNQSNDENKNLIIKYLK
QENLIDQNYEITNKLDFNIFLEKSFLNNKEYSSTKNELKRFFENINDQLNKFNLFVNAYW
YDNKYYSISTSNTKLMNDKIRFSIINMLWRDYDITDYIKAKKDELIETNPINSHYEDRYL
NLLKQLYENEWQISINKDKNNEEINQLKTKNESLKTRMQNIKNEFLQYLVKMGIIDDAKE
LADFSVSEFYLWSTYLSTK
>UU441 unique hypothetical unique hypothetical
MIVKIEKVHLYSLDINAKDETSENSHIKIWKELDWLIQNDVKIINHSYGWSPNDFLNIGF
YNFINGKEINDDKDFKRELKKYIDTLNKDDIVNNTINKYKFKNYIYDFISYYFDIINIFS
AGNSYNDEIRYRNKNGHILEINWFDISKYSFMDRFNQNSIYVGSTNKNNEKVSNFSDRHH
LNDVKNKYGDLLMPFLVAPGEGIYDTSIITKFIKNKGDKNINLGTSFSAPIVTGAISLLQ
SYYMVNNANKTIPLTHIRSILAASSIPLKNNENYDFYKNSFSHLYGAGHLDFKRAIEAYK
NAKQTKILTKHKDKQLVKEMDISIDNDQTNFNFALSWLFKPTSNSFSKKHDYNSVYNEYK
KLTYFKNDNYDIYLVKNEDLKNIDYQNFDNFGEILRTINIYRSESDSNVELIRAPNLNKG
EYKILVYQKGEVRNEQTSFSYTFIKEKAIH
>UU442 unique hypothetical unique hypothetical
MKFKKKAILLSTISLSSMVLGSFSLLAKNKSQQTISSKLNQQVNLVDNQNQNKISYSVIE
IDESNKDYFKDKLIIRLIFNTTKASKTEIFEQHLKIKTWIKNAKISGVDQYNEFDYLPFM
DLIIFNNKLDLKQLESLSNSDFINQVIINKIKFILFNKKIDQKPMAVFGECKNLVLKNEW
GFDQDVGEFCQIDSSSGTSFEPVYSKDLLELREEFIENVEDRLSDEFFADFYDNTNLFEQ
TPTPNDHLLIKTNPIKDDFESLLSKKSGLQYKIMRLVYQHEHGKVIKTLPVNALTFLNHE
DLKFEELYSGNYRFTGIEYWDKENKIWVFEELINHNEQYYQMQVVFNNNITVHDLISKVY
FDAHFNKPQEESTSQSLTLSLNPNFNNINKDESIEIKLMNLNDRENWESPSLFTRY
>UU443 unique hypothetical unique hypothetical membrane lipoprotein
MKHKKYKWIWLKLSMISAIPLLATIITACAKVDTKQKAKEELQSSLNKAVLLKEIVDQSS
YEDFKKIYNQTLKSNLENINKLSEQKLKQEQQTIKNLITQVSVLNELDSIKNMSDLIDVV
ELENTKKQLQDFLNQYEKLLNQASVDTTIIDKLKSDAHQKRLHTKALIQKTILDLANKIK
NLIKTSGSNKNIVEIESDIQKLVNNNTKANFKKLYEDFKLIYTKLNDINDLINKELKALP
FIKKLDDIVNVINTIYQQNYSFLWFDQLKLTNLKQNLNKNITNIVNVKKSLDIEQIKSLT
NKLLNDLQNYLQGLNTIALDSENSINKLISIIQSLKPDDYNPYYSIEKQQNIQKDKNNSS
KATYNGLENQIENLQSIISLFSFNTNSLTIDSANNLNNELTKKFEDANTKISSIVDQIKQ
TILSNFKKTYLFKDFIKHLKEFNTKVNSENDQAKKTNKTQTIQDVLNSYKNDPWINTKVS
LKLSANQTLTIDNLENIDLAYSNDFLLKPKELINYLKLDNNQERVFTKDIENFSVKIFTI
VDKKLYIPEAKELIEESKKITETKNGKTNNESKVERLKKFTKFVEQGINNNNVSSYTLDL
YNKKLKKLIEEVKKIQNGTSQKIENNSK
>UU444 unique hypothetical unique hypothetical
MKNQKDFYFYGASSNAVLNKKVNFDLLKNTSINKTLEQLVANKVKFIIDIKHLLDLLL
>UU445 unique hypothetical unique hypothetical
MYWYVIIKKYLDQFEQLYKNSLEQMKKDNHELLFKLQNNKNLPNQNEIFIPIEKYKKCEN
MLDLNICDKYAYKDLKEQNHYFDSSTESKFANRFLSLSNDNDKIKNNVELWTKNPVFHGL
KYQYFNEDGQISNSYPDFILK
>UU446 hsdS type I restriction enzyme S protein (fragment)
MINLNIITRDNYYYEKIGNNKPKKLENLPFNIPNNWIWVKLNNISNVISGYSFKSSKYTS
SGIRIIRISDFDSKEVDNNEPIFYEYNEKFNSYKIENNDIILVMTGGTVGKNIIIKKAND
YYLNQRVARIRTFNVNYNYIYYLINTTYI
>UU447 hsdS type I restriction enzyme S protein (fragment)
MPPLDEQQRIVDKINLLEFFIKQYDEIEQKLSKLENEFPEKLKKSVLQYAMQGKLIKQDP
NDDSIKDLLKQIHKEKQKLYKEGKLKKKDLEESIIYKSDDKSYYENIGNNEPKKLENLPF
NINV
>UU448 ruvB holliday junction DNA helicase
MKTNYEFRPQYLKDFIGKEQLKNNLKVYLTASKRLENSFDHTLLHGLSGTGKTTLALIIA
NEMNVNCHITQGNLLNKPIDIINLLSLIKENDVVFIDEIHACGLGAFETLYSVLEDFCID
INIGKDFNSKMTRLKIPHFTLIGATTIFGKIPKSLEERFGHIFHLNEYEPSEISAIILKN
NQMHFQIDLNEEEIDLIANNAKGIPRLANRLLKRVVDFKINGFNDIKNIFKKIQIYEFGL
DEQDINYLNVLYRQDNEIGLKSIAQILRLDQYTIETKIEPYLIQHHFINKNLRGRKITIE
GIDFLKNNQLIK
>UU449 ruvA holliday-junction binding protein
MNYLIFKVIYANANIVVGEHNFIGYQIRIPKDYELEINKFCKLYLYEYISIMPNKNLIIK
DLYGFRTYNERLLFIDLISINSIGPKTAINILKYDIDTIIDAIATKNIDYLITIKGINQR
NANLICDQLNYKYINKVNDKNNWAKELSIGLENLGYTKKDIEYAITKVKINSQQDIDISE
IISSAIKEISLRHEN
>UU450 conserved hypothetical hypothetical
MDNNINEKTSFWTKKNICFLIIGLIVCLLMIIISILFILDIDFQNLFIKINHSLKTIKLA
ILWLLILISFIFFRAFMFIVIAVIDTYKNQIKIAWWKWILYSFSLIFLNAVTPFSVGSEP
FSIYFLNKNGYHNLKKVSALLLVSSTFYELGQVIVTVPSFIYINYELITYAVNNKTSLPF
YYYLAVVGIIADLCMTAIYFVLGFSKKLHFRSVLIYNWVKKLFKLKYLTKIELIQKNNQN
ISFKAFYLYYFKTLRVSLLAFVIGVVYNIGIYALMYISYRLVEPKPHNIFFDLFNYTNIA
VTATNFVPLPGSEGSIQFMLRVFLTNDQNQIRYAMNWLSTQDINNIIFIWRMFSIYLGSL
IGMFGFGYFLIFDLYKFIKKAKVDKKR
>UU451 unique hypothetical unique hypothetical
MGLFSKKNKLNQKLTEDKNINITDVLDNNKDIYQLYDETIVTKKVKVRCKNCGVFMWVDY
TKTIKSLRNLALTNIQQEQIPVMDEPQILQDCNDLSSAPVNNQEDDIVNEHESTPIEPLH
EEVEPEPIKNENQSNEEFIQENIVAPVDEVDNSVKEHTPFTPVSFEFEEPVFENIYSNQK
VYAENLFLESLFSEKESLINDDQNDFSWLSKYVSVWNKRDEAELAQLVYDECLLAPQSSV
FPNNEYFIEEEYEHIDPDNHHNKHKAQRHHRGHDLIVKKNGKEQIEKAIDDVLPINNGLD
KKQQLLLKTVLIEEEFQSDPISKKTWWETESANKSSKK
>UU452 proS prolyl aminoacyl-tRNA synthetase
MSKKLEKITTRKENFADWYTSIVNNAKLIQYTDIKGMMVFQPNAWAIWEAIKNQIDVEFK
KHGVRNLAMPTLIPLSEFQKEKDHIEGFAPELFMVNQIGDKKLDNSYAIRPTSEILFCNY
FKNIVNSYNDLPIKNNQWCSVMRAEKTTRPFLRNAEFHWQELHAIFASENEADSFAKVIL
DVYTDFVQNYLCIPVIKGLKTPWERFAGAQKTYTIEAMMQDGQALQSATSHYLGQFFAKA
YDIKFQGQDNQMHYVHQMSAGLSTRIIGALIMVHADDQGLILPPDIAFNQIAILTIFSNK
NPQLLKISQQICEQLNNYRLFEDHSDKGIGYKLAQQEIEGTPICILVGAKELVNQQVVIV
RRDTHEKINVDLTDLKLIIPKLLADIKRNIYEKAKKDLEDSIVFVNNIEELKQVIAQNKM
AKAFFDGTKEDDEQIKLLTNASTRCIFDETQNGQCFYTNKKTNKLTLFARAY
>UU453 conserved hypothetical hypothetical
MASYNINDNLLLRKIIMQHYEHPKNKVCFVQDEINYLSYHNTTEGCGDDITVYVKLNHQK
IIDVVFLGTGCAISISSTDIICELVKNLDLNNALLLINNYLNMIEGLDYNKDIMQELIAF
YNVKKQMNRIRCARIGASALKMCLKQFTDKHKTIV
>UU454 nifS nitrogen fixation protein - class-V pyridoxal-phosphate aminotransferase
MNDYKQFFPWFKNNKDVIYLDSSATSLKPQVVIDAIVDYYTKYSTNPHNTDSNFTFHTHE
IMNETRANVAKFINANFDEIIFTSGATESLNLIANGLRPHLKKGDEIILTYIEHASNLLP
WYKLRDDLGVKIIFANQKNQFPQLSDFLKVISPKTKVVSFASGGNLIGNVLDENLIIKNI
KKIKPDVLVCVDATQSIQHRMFDVKKCKSDFMVFSAHKLLGPTGIGVAYIKNDLIKKMQP
LKYGGGMNFSIDLNSYQLYDNYMKFEGGTPHVAGFYGFNAALKFLMDIGYNKIHEHELKI
TKYARDQLALIPEIKTYVQDATSSTITFSYNGVFCQDFANYLGSKNIIVRSGLSCAKIIN
NVIQTECAIRASFYIYNDFNDVDRLIKAIKEYQKGDELNGIL
>UU455 unique hypothetical unique hypothetical
MEFDMKFKKILLTSTLSVLGVISIASLATNCSQTKTKINQYKITINKLDSLNLTSNLTTK
QALKDVLFSKEGQNEFLLSNVKKVVYDWAKNNNDPKLAHDVSEYNTQLDEQLKRIKENVK
KSYPNDWQSVLQSELYDTEGGSEKSWKEAKLIDQAYKSITSSIFDDNDNWISVLNDQNQL
IDAYSNDATKLLENESTFKSTKIGDRNKIVAKTNNFLQKGYANLFNFLIDDYIKYNLPLS
FANIEFKYDDLKNQNIYNKDFFTKIPTSGTSPNFPWFDPKPTDNKSTNTTTNYLEVAKLL
KENKYLDSKDDTNNIDKKFNNNNDINKYLSLNDFITQDNTNLTLSVGLLAKFLSLFGNEN
FGIYQLDNLDENNILNNFISKNQSNANTNNVDLFYPLVKKDKTAFLNDFKDVKAIRQIND
LKNGYTLLRNENSVDLWGINNFKRLQQAAKIGLNALLTELKNDFLYNGALYLNSRKSNSV
KKQGYDIKAKIKDYFNNNKERLLALYIATHQNDSDFLFKSNLKNDSKVFAFDQRTINIIK
ENNEIHLLNYYDNLIDKLNDKLIKFNKKTFIIPSVDSLYDNGINTPIYLIKDQNQQISLF
QTLKIKLVGNKNLIDENQKLSTMINDYVENFDIKKHLVANNKNSQSIVFDDYVINKVFSK
GINSVFANIIKQEQIKKSVAKFFEFNDFNFKNNFLENQELLAAFNQIIKNTSVLETTQTN
NFSNFDNLKKVYEQALKLWNDNYTKNGPFNQLSINYQKYQALFETLAIINYLLDFKDGKP
TYQNLINYLLKKTANHQPLFIGWKALNDVTKIPNFGKDSKEDFSFKKYQINLYNGLDLYQ
LKKADVYEIDQNSQEVKFKKTFIDALTYTNDKNYWNSTVNKDGSVYNNFIGLIDQNNQKD
KLGKAFEKIDLFDKLVYANNPSKQFKGALYGYGSRELLIKTLDGFVSYHDYQTLAQLLYD
LNFNAEANAEFKTILDNQKQIIPGNQKDSKIKNIDLATNEIKTIMIKGINKIPQTAFQRL
DLDLVYNKLDKNATPLVNKEDNANLKYILLVSQFNANDVQNLVINNQLNQSATGYLGLSK
SQFYNLLFDLALNDQTLKIEAFSQIENEHKIKVYDKRLANNSNLKGWIINNL
>UU456 rpe d-ribulose-5-phosphate 3 epimerase
MNKQLVPSLLAFDKKYPYEQLKIFKKHHLQTIHYDVMDLTYVNNTAFETEHLEWLLKNDF
LVHIHLMVINPLEKIKQYFIYKPTRISFHFEMNDYQTNLLIINEIKKHHVLAGIAIHPCL
SLNDYASYLKEVDYITFMSVIPGKGGQIFLEESLLKLKKLYEYKIKNNFKFKIEIDGGIT
LEVIKKINIPIDFFVSGSYLVKNIEKLEQTVNEFNQLVN
>UU457 pheT phenylalanine-tRNA synthetase beta chain
MILSLNLLHKISPKLKKIPLNELCAALMDLGCEVETINSIKPSTNLVFAKVLEKTRHPNA
NHLNLVKVKANQKVYEIVCGANNFSVHNWVVLAKLNAELANGLKITPRELRGYVSNGMLC
AYSEINPQATSFLTSTDLDGILVLDDNYDHYKTPNQIFNLDDVILDLSIPSNRNDLNGYF
WIAKELCAYFDFEYVVDATINHRPHKEIIDVRILSDDVNSYGIIEVKNIQNYILKWNTKS
ILINNQIKVLNNFADNMNFLTLLTANPLHAFDARKISGQIVVKNAEEDAILLGLDQKEYL
IKKGDLIIVDDQKILALAGIIGSNDSKIDATSTTAYIECANFNPMLIANTARRLKINTAA
AMRFSKPLTNYVTKVTLKKLLANFKSDAKLIYYFKHSVHNVIKNKINQVSDFVGAEIDLD
TAQTFLKRLGYKINKSNLITPSHRYDVLNEFDVYEDIMKKISIQEIKPQPISFDILNFEN
NLAYDFEKKVSDFLVDQGLFECKTYNLKNQTQAHEFNFFNFKQAYEINNPTSNMRSHLKL
NNLNSLLEVLEYNQNQKNELENIFEISKINPVDSSQQTVLSIILCKPLINSKINDSLIVN
NFVTTKALLHALLTKLNIDYAYDKNHVVNELYDNNQLALINANKQVFGFIGQLKNQVKKT
YGLSNDIFIINLNLTSYLNQKQVITKVIKPSMYHDVIRDISVKLASDVDLNNIIANIKKI
KNIRKVEISDLYIKDDGIIYTFKYYINDHLSNLSSEQIIIIEQEVNNYLKQF
>UU458 pheS phenylalanine-tRNA synthetase alpha chain
MDVINLIKNLKQILRTANNERHLIELKNIFVKQHLLPLYDELKKSANKKEMGLLINNFKQ
QIEFVTDQILKELNDKDDQVDLKKWTNKTLFAPFINNGHHHILNSIIDDIASFFKKLNFE
IVSGSEVVSPIYNFDHLNIDENHPARASADSFFINSIKMLRTHCTTTTAQFLENNVNKDI
RIMSFGNVYRKDDDDATHSHQFNQVDFVWVKEGLTVANLKWLIDSLIKYLFGQNLKTRYR
LSFFPFTEPSFEVDVQCFKCDLKGCAVCKKSTWIEIMGTGMLHENVLKAANINDIRTGMA
FGVGIDRIAMLKYEIDDIRYLYSNNFKFNAQIK
>UU459 unique hypothetical unique hypothetical
MNNKKGKKFYDFLKTIEGFKIITIISYVFVAILLAILIWSAVRLSYYIKDYYARIDEYNE
WKQNIIKIFKTKNFHLDSPYNQIKIFKYGSILGISSFLIIIININIFAYWSYSNVYIPEL
KDKKLVKNWFRNFQKNNKEDQKVIKDQQEDTKKESE
>UU460 nadE NH(3)-dependent NAD(+) synthetase
MNNDLIKYLQWLKNDFIKFLNDAQTNNVILGISGGIDSTLTLAILNDLKKEYDLNIYAYF
LDIHNSSLDYECINELKNIYPNIEVINLVDIYDSYCKMINKKTNDKYVLYNLKPKIRTNY
LYAMANAYKGVVVSNLNYDEYILGFFTKYGDSAADYYMLIGLLKKHIYELGAYYHLPNKI
LNRAPTPANEDDEHKTDESFFGFTYNDLDQFLLYRKINPKIVSMIKKRYETNAHKHFVFD
KKKLFLNYKLGNKHE
>UU461 obg GTP-binding protein
MAFIDKCKIVLIAGNGGDGIVSWRRETHVPEGGPAGGNGGNGGSIWFVGNHNETSLEFLK
YKKIIRAKHGEKGDIKNQHGANAEDVFINVPLGTVVYNPITNEILADINIDQQKYLVAQG
GLGGHGNTHFKSPFNKAPNLYELGELGENVEVLLELKTIADIGIIGLPNAGKSTLISTFT
NAKPKTANYMFTTLNPVLGTIYRDQNRIIFADIPGLIEGAHTGVGLGHDFLKHIERCFLL
IHLISLDPNDNPDIINAYETIVNELKQYKQNLVNKPIVLVANKIDQIGALENLQILKEYL
KNNQEIKIISALTNLHVDNMLDDVIKIYFAQKKIYEQRLKEQLPVDQILKWTSDIPKSKE
LDKTIEIIKVDDHIFEVFGEYLKYWAHRIPLKTQDNLIRFNQKLQSINFNQQLLQAGAVA
GDSIKIYDITLEFEE
>UU462 unique hypothetical unique hypothetical
MNLRHSKTTWFRKPFETNTRFKSPLLYKFLITSFFVVIPMIVFFILYGEINLLGFNGIIG
VNGRWYGKGFKLDENQQWIVGVKDFYHWNPIVYDQLKPKPGPLMIERMQKLVNEITNQYN
HGVEFGTNIISSYPVWVAMFSTLGLAVIVCIIFAFSTPKIRWDILTPVVSCWFGMFILII
SGFIPSQIWGYLVRFLILVVAFILPIFIMTKITNAIMNRSKHFETYAADLYNELKDSEQY
YNEFNKKRLELKKRNKANERIKYKVEDDQKGK
>UU463 fmt methionyl-tRNA formyltransferase
MKYKVMFFGTPEIAKIVLETLFNMHEVDLIAVVSQPDAHFDRKKNVIYSPVKQFCLDHNI
KLFQPEKIKEIEEEIRILGPDIIITCAFGQFINQGIIDIPKYKIVNIHASLLPKLRGGAP
IHYAILNGELKTGITLMHTIKKMDAGNILFQRSLEINDCTTTKSLTLELANLSALMIKEH
FLELVKPNLVGIQQDENSVSFAYNIQKDQNIINFDQPAFFINRFVNAMYDKPIAIMQYNG
VSIKVYQVKITNQKSCQKPGTIMIFKNQLFVSTQDFDIELLLIQLPNKKPLSPKVLLNGK
NPFIN
>UU464 conserved hypothetical hypothetical
MLDNQEIIESILQADSAKGGNGNFLMILIIIIPIVLVVVFIMRKKRKQNGENQTSVNNKD
KSDTNEVWTTIKKYLRSIDDKGKEVIDSYVVKRAEPHNLVQMTKQQRIDYKNEQKAIKAL
KTTNPEQYKIEMERIKKEKRAKPKELYVVLFTTRNAKTLIIDEPRAIECEVRLVKINKKE
NRREIDVVRALDYEEEMLWIEPIKAKDDEIYNKRLEADKKKQQKAAQRRQKQLEKQKNKT
N
>UU465 def polypeptide deformylase
MYNIKFLDLLNSNLKPNPQWIFKDPHPILREVTQDIEGNELSKDDIYYLKKMVRYIDVCY
HNQAKKYKIRSGIAIAANQVGWNKRATYIHFNDEAKEHHYLLINPHIIKRSSEIAYLNPG
EGCLSVDDDRSGYVIRNKKVHVKAYDLISEQFIDQEFSGIIAICIQHEIGHLDAGLYYDN
INQQQPFYADPSWTKIGR
>UU466 parE/gyrB topoisomerase IV subunit B
MANKYDGNAIKILEGLEAVRKRPGMYIGSTSSTGLHHLIWEIVDNSIDEVMNANAKNINV
ILHEDNSISVLDDGRGIPVDINSQTKISTVETVLTVLHAGGKFDESAYKTAGGLHGVGSS
VVNALSSWLICEVYRDQKIYQAKFINGGHINQSLKVIGTTKKTGTLIHFLPDPLIFKNLV
FNPNIIKERLHESTFLIKDLKIIFEDKINKKKYEFINNQGLIDFIKFINEAKKTFSDVIY
FRSNINKIDVEIAFQYSDQNNEIMVSFANSVKTSEGGVHENAFKNALTSVVNNYARKHNL
LKEKDKNLEGDDIREGLSSVISLRIPESLISYEGQTKNKLFTPEANEAVKKTIEDNFSFW
LEENKTQALDLVNRAILARDAKLAAKRAREETKKVKKIKEERGMGGKLTPAQSKDPVLNE
LFLVEGDSAGGSAKLGRNKKYQAILPLRGKVLNVLKARLVDVLKNEEIASIFTCLGTGIG
AEFDLKKLKYHKIIIMTDADTDGSHIQVLLLTLFYRFMRPLIENGNIYIALPPLYKLTNK
NNKKFFYAWDDVELDQLKKEQKNYEIQRYKGLGEMNADQLFETTMDPNNRLLLKININDI
LQAERQINTLMGNDVSIRKQWIDNNIDFSVIDELQINNEESK
>UU467 parC/gyrA topoisomerase IV subunit A
MSVNHQKIINTPLDNIVGESYAKYAKYIIQDRALPDIRDGLKPVQRRILYAMSELGIFYD
KPYKKSARTVGEVIGKYHPHGDSSIYEAMVRMSQDWKNNLCLLDMHGNKGSIDGDNAAAM
RYTEARLSKIASVMLANLKKDVVKFSPNFDDSEKEPSILPSLFPNLLINGATGIASGYAT
NIPPHNPNEVFDALIYRIDHPDCSVEKLIEICPAPDFPTGGEIHDLNGCANAHKTGEGKF
IIRACIDFKINDNKINQIIISSIPYETNKALIIKEIEDIIYNKEVAGLIEVRDESDAKGI
SIIIDTKKDINLENVKNYLYKKTNLEISYNTKFIAIVHRTPTLVNLSTYLDAQINHSLDV
INKVDLYDLNKILLRIEIVEGLIKCVDLIDEIIKIIRASESRQDAKNTLIQVFNFTNNQA
EAIIMMRLHNLTRTDIFDLKNEWQTLQDEAKTLQERINSLQVRKNYLKQKMIEFKKTFGF
ERKTKLFDELVKVEINEDQMIEKQNLNLVISRDGYIKTVSKKSFESSKYDELGLKTNDIL
FYHNIINSHDKILIITSKAKLINLVAHKITSMRWKDVGEHLNNYVKFDANEKVIAVYIWN
EQFKIDEYQLVLASRLNLIKRIELSELDINKNSKQISIMKLNDNDNLISANLIKKGHNQF
IIAISKLGLALLFLVHEINCLNRLAKGIKIMKLKPNDEVSAILITPNNGYNVQLFLERGS
KCFNISELKLSKRAATPTNLYPITKKVQNVLAAFLVAHENVFYLLDQQQKINPYYLSNPK
PTKLDTKISIYENDQMITDVVKDCFLSDEAISDFKKINMYANEFDNEMLKINKNHDDSQL
ELIDEEEEKK
>UU468 conserved hypothetical hypothetical ATP/GTP-binding protein
MITNKKCKGCGAFLNDQINTIGYTPKINETKTNLCQRCFKLIHYNKLEKVSTNLNQSIKE
TINTLNFSNLQIFAVLDILDLEHTIIDELKEYQNKIIFLVNKIDLLPQRYNSELVNENVV
KTLINHGFIDPKIIYVSTHSNTSLKKVMDYIKNATNKKQKSIFFGKSNVGKSSLINALLA
LNKIKTKLTISSYTNTTINLNKINIQEHQILDAPGVCFDENILNYVRDEDNKSIMISYGA
KAINYQINPQQALMISGLVGIQYLKGQKTTFTLYVSSQLDIHRCKLENFIMNFNKRYLLA
KFNYLNQDLEFVDHLITLNKDQKTNICIAGLGLLVINAHAEQICIRLPKSVGLKVAKYAI
I
>UU469 conserved hypothetical hypothetical
MKIILFCGAFDMVHNAHIAMAKQAMKLVNADKLIFLPSNFKFFKAINKNDNLEYEKTKLT
PGHHRIAMLKIATKNLVNIEVSDYELKQINKSYTINTIEHFKQIYGSEHEYYFIMGSDNL
ERFKQWKDWERILKEVKIICFKRGDVCVKKSCPQKSCECESFNFFEHEILLVNDFNYNIS
STEIKKRHNLTSGIDPAVLDYINEHGLYALWLLEKHLISYDNFNNLEKKVARINHCRRVA
QMCVDLMNVYDKKLIDQAYCAGIYHDILKCLDEQESVAYFNEHKSELNIGDDFISWRILH
SYLGAHLLQTQYGFKNQLILNAIRRHTRPFDFIKDYSELTTLDKILYCADKLEPNRREEI
DQINIDYYRKLVFEDLDKAFIEVYQYQQRQRK
>UU470 pfs purine nucleoside phosphorylase
MIGLIVALNSEIKTFFKQIKKKVYQINNIDFYLCTHQNIEFVLVFTDVGKTNASFITALL
INNFKPKVILNVGSCGALNDQLQVLDIAIIDQCQYLDVNVSAFGYLKNQIPRLDNFLF
>UU471 unique hypothetical unique hypothetical
MELAAIAHVCTRMLTPLVSIKLVSDHITLPNSNQEQFNKNLSLIDKWFNEHLPSIIEAIL
EIY
>UU472 unique hypothetical unique hypothetical
MIYKEIVRNIIKHPLILPEGKHYHLHKILTSKDELRKGEVSLVAENGKEYTVDLSAFVDL
LVDGDCIIDDNHSLVALYFDESK
>UU473 unique hypothetical unique hypothetical
MKSNNKNYKFLNIKKRKYRIFFMLCSLNLIWAGVIIAIVLRLKNIDKRFSENDHKIARPT
WEYDNDGNLEIHTQLANDLNDDLKQKALNNANVKGIVVDQNGVEHEIDVSIDANGKVIIP
TKDLVNNDPTKPNIYTLKKVVLKQHNQPNIDLISEEQLSGDNHISFKKPTVVAQINDNND
YIMHFTNPNLVNKKIKLTFKVDDQDDHTKTIEAIIGLDGKAIFKTSDDAIFAPDHKYTLT
KIEANNKKVANIDEIPLKNRIVDKNPIKRINLTQLKVAKDLILWNNTNQNQFITATFKNI
NNDFDDYIVKLIYEYNYRGEMKEIASQPFKLEKNKTTYNNILLPISIPNRLYHFKKVVIQ
KLNQPNKSIDLDHDPNLKSFFIVGPGKTDFAWKKPNDDQITYDGLKRLNIEITSQDYALQ
NGKKVMVWFKSDAEPNNDSLKFIGELSQTNANGTAAVINNLNNLYGMKEQTEYYIYKIQF
IDELEYSKLPPNRNNIVYEYNKNIARNYAFRTKTAPLILEKIEKDDNGSIGGQNFYFYLN
KASDDPSTIKQVTIYCRDNNNELYTSDDQEIDSVDLVYHSWIHDLKWNREYVFDHAEIQT
TYPDDPEYGGETNDLEIKRGLTFKFYTPPSKTEIQWKHPIKITNNGAILDIQLQSKDRAF
EDKQKYRVTLVEAENQNNAVVGDFLLAGTSINKNDSPIGDNNDKNKDIATLSCNFENKLK
KGTKYLLKEVRFIANPNEEISAKPTRAARPFNNDNIIYSLNLRINDPYDFTTLKN
>UU474 unique hypothetical unique hypothetical
MKVNKIIMKKRVNKIYKHNMFILLATLNLVWAGVITGIVLRLKSKDYSKHTILKKYYSFD
KNGNLILKGYLKPHDNTNYVFGIFSDESNQEHKIQALVNDKKGFEFNTKSLPLNHSYKLK
KVTSINDYNHVLLTNDDLVSQQKICFSKPVDAKVNFINNKKVYQVKLNTLLKNTLIQLTL
KDLEHNVYKITAKSNDMGEVSFDVSQLKNNNLYEVIALQTQDQTKIVNVNEIEYNNKIIN
NLNIDELNTPYQYSKNGHLNLIAKIPLRYANEQVYGVFEDQNNQKHLIPAVNKNDGTIMF
DTQVLTKNPNKKYHLQKVVLAKNQNQILIHNFDLVSNQKQDIFLKEYKVISISALENDAD
KTKREINLKLSNIKNDWVNKQIKVIYSSSDGSDVQTQPLVLEKNQTNYVLKLNNLKANRL
YTLKAVELINNNGKTNLPLDTNLTNSFMVERTSAVLATSISEISNRLGTALTNAQVKITL
KDVDNVLLANQKAIINYGNNQKSEATVIVNNGVKYLIATLTKLTLNTPTIIKSITFEQKP
TCAIENIGLDKTNNIIYQNTHEAAIPLVINNNFEINGPLASSHESLKSINASDAKKVNAI
NLTLDFNTNEHIYKNLFFKLKYVPIDDQGNENIYDASEAIYSDVLSANNIIANKIQFSLG
NLQTNRKYKLKTIYYLTSKTTPLDDHNVVMIKPNVKSEIIVAPNDSTIVKYGNWNQDSIT
NGSKAIFKINCNDGDILSEDLSATLVYESNDPHDLQSYTTKLKKVNNDWVIDFNLNNLKP
QTTYHLKSITIAKPNKAYTNLKIQSLPQVDIKTQLPNLILHDLKATSAVLKWDSTNNGKN
NHQTIQATFSHVSANYDNLNVKLVYEYNYRGDIKAVESDLITLKKDQNVYQINLPISVPN
RKYTFKKVLIQERNNLNNYVDLNKKINLTDSFVVSPGKTTFEWTQPTSDQISQTTLKALK
IKILSEDKTLDNNVKVIVWFKSHTDSNDALKWTRGTWEVNSDGSEAIINQLNNLSGFKAG
TQYYLYKIAFVDNLQYGNTQANDNKVIYEWKANDTKEYEFTMKNAPTILQSIKFENCDAN
GVINNEAEGIAEFSMTTNKVNDDFANRKVKFIYHDNNNVAYETDGFPLSRSETSLHFSLS
NIPNNRDYTFDHAEIETSPNSNKYEIWHSQNKIISKFKLKPAQTSVKYIDKQERNNNNVD
FELHLGSRDCAFENNQKYRVTLVSVDALQTEISKEFLLSDVKLDYQDGNIGILKCHFDNL
IPNTGYTLKEIKFLANPNEQQSAKPHKVIKPFNDDNNVIIDKNYSWKWYIYPS
>UU475 unique hypothetical unique hypothetical
MKHKKYKSIWLKLSMISAIPLLATIITTCAKVDTKQKAKEELQSSLNKAVLLKEIVDQSS
YEDFKKIYNQTLKSNLENINKLSEQKLKQEQQTIKNLITQVSVLNELDSIKNMSDLIDVV
ELENTKKQLQDFLNQYEKLLNQASVDTTIIDKLKSDAHQKRLDTKALIQKTILDLANKIK
SLIKTSGLNKNIVELENDIQKLVNNDTKANFKKLYEDFKLIYTKLNDINDLINKELKALP
FIKKLDDIVNVINTIYEQNHHFLWFDQTKLTNLRQILIKNINHVLNVKKTLEIKEIKTLT
NQLLVDLQNYLEGLKMIALESENSVNKLISIIESLQPDDYNPYYSIEKQENKQKDENNSQ
ATYNGLEHQIKSLKSIINLFDFNITNLSIDAIYNLNDELIKKFQKANSQINDVVIKIKQT
ILSNFKQIYLFKYFIKHLKEFNIELNNENDPIKKANRIQTIQEVLKSYEKDLFLNTKINL
KLAPNEVLTVNNLEKIDLTYASDSLQKPQELIAYLELNNNQEREFSKELENLSVRVFTII
DKKLYIPKAKELIDESKKIIQTKNEHTNNKAKLQRLEKFTSFVEQGISNENVSSYTLNLY
IQRLTKLIEEIKKPQH
>UU476 unique hypothetical unique hypothetical ATP/GTP-binding protein
MKLTKSQQKAVSQLVNCYLESVNNNKKEIIDFQAPTGSGKTFIITNTINEIIKTNKANGS
PQKLIFVIATLSSADLPFQLEQNMNEYKYYINGLFDVELKESPSSKSAKKDSSYNILAEE
NKVIIFGSSSFGKGRIITEEGILDAFLDEIKSQGYTLVYIRDEAHHGGNVNKTKIFEDFD
EKIHKNSFKKEETRFEYKIQEAASFIIKMTATPKGIHKLVFIDEKDLMDDDTKLLKDEHV
YNLEIKELKEENIDDELLLTTACEQFLKIKEQYSKAKELKNIRPAMLIQVENEPNKEPQK
SEFLDKIEKIIKILEKHNLSWVKYFSNDKEVQTNILINKKNNKISLKEISKKTSNVDVIL
FKIGPATGWNIPRACMLVQLRNVSSKNLSVQTIGRIKRFPNPSFDKNEISYNSISNQYFI
YSNIISEDKIRQTLILKDKYKNDRFFYGEINQEKINNYLNGETYKEEIVEKFEDSISNFE
YYVNEEYRENFVKNQYLEGETSKIEGKTRVYTKIKNSIELELYIIEQLRKYKHLFPQKII
DFLETKFNEWEKRWKLNISINMYWYVIIKEYLDQIEKIYKNSLEQMKKDNHELLFKLQNN
KNLPNQNEIFIPIEKYKKCENMLDLNVCDKYAYKDLKEQNHYFDSLTESKFANRFLSLSN
DNDKIKNNVELWTKNPVFHGLKYQYFNEDGQISNSYPDFILKIKTHDQKDHYLYIEVKNL
YSDYDYEKTKLLIESYQRYIENKNNNDNLILDELDKAEITILVCYINMKNQKDFYFYGAS
SNDVLNKKVNFDLLKKTSINKTPEQLVANKAKFIIDIKHLLDFLL
>UU477 mod adenine specific DNA methyltransferase
MMNERLKLAKNLLKNDGVIFVSIDDNEQAYLKVLMDEIFGEENFVTNFIWQKKSGGGLNK
LIYEGHEYILCYSKNNYNFCLSEKNKKMSGFIKYKDKNNNSFFINSDIIRNNFGKKDNKF
EHRNKAYEDLSKEDKEKWNLKLDNKNYILVPFKKEPGKHLVAKIFNDERKTTYSIIKLPF
TFVSGIWTKDGNNEVDSLNIDFQNPKPIQLIMHLLDLHSNKNARVLDFFAGSGTTGHAVL
ELNKEDGGNRTFTLITNNENQIGTNVCYERLYRINNGIGTKNEIDFDWVSKNKPYLNKLN
VYDLKYFDTNPIEVDNSKIKKVFAKMLVDFNNTSQSSLFENNQRELLINLSTLKPIEKKE
>UU478 unique hypothetical unique hypothetical
MIKDLNSYLKDIDEMSKSSLNEDQKQLIKKILEKTDPQDLDNVFQLLIQRVKIGFSFDVA
PSVHQTQIAILAKNEQLSFMNDAHNLFKNDTNSLIIGENYDVLKNLLVLERERERD
>UU479 unique hypothetical unique hypothetical
MKMKNNKKILWKKHIKIASFLICLNLCWSAVIVGIVLRLYDKENSIIFVDQNNDSYWLKI
HNKKDLKTEINTHLPQGNVYRLQKNKLSNSIIGLTLSKIDKTNEYSNTGDIVIKVNLKNK
AKKNPQIMGVFVDEKHQYHYIQPTIKDKVAYFNTSKLANNHDYRLVKILDKTDYNHVLIQ
QNELAIEHQIMISKPPKTASFINQNNQKIYRINVGKWLFNSSLSLQLKDLNNQIYSIDAK
VDVEGNVDFDVSKLANNNFYELVNIYKNNTHPLVKVINPVNIAYHNKTINNLNVNSLNQP
YQYTKNGDINLIAKVAPYYVNQQVYGIFKDQNHKLHKLLAKVDNDGQICFDIGKLVKPNQ
YRLEKIVSASDENIEFVHNFDLSSNQKQTLNRPNIVVNYLKNGDYTINFNDANLINKKIE
LRFKIDNTNEIKTIQAIVDVNKKITLKTNDNTLFAPNHKYTLIGIVDNKLTVNNNIANLD
DILEINKVIIKKPLVKVLTSSLVEEPRSPNSINSTNIKFEISDEANVLNTNMSATINYDD
NKITKAHVVAENNKKYLTARLDNLELNKTSFINKIEFDQKPPKAIVNIGYLDTNIIYDDT
KEEKNQPLTINNNFALLPLENQEDYFQRKNEANIKLKVELKANSNILKNLTFAATFKYKD
NKIVKKIKTNAISCTPIKNEINKWMIEFNLKFDDIKTATLYELDNIYYLDKNNPNNLDEK
HKLNQITYNFELQNPLSIALVEKYLKNTLDVDKKTNHPVCEVKLFILNVKYPWLVNKKAR
FVFSYTTVDGTKKEFMAYSNDIGSSDQIINRENLLFKLKNRMYVKIPLPIANREYNFERI
EVLNDDNTWTIFNQSSITIRCRPSQNTILTTASDFNENKENKYIKNISPTQVNLNLELIS
HDQAFHDGLVANLELIDDKGNIKGPYQITLSKTDKEFDGLIKNHIDPNKHQELQTGLTSW
LISENKINNLEPNTKYYINRIYFSEKPNYLTYKWNFANNNNEIYNRNQAKKDNPQHNDYS
FTTTN
>UU480 conserved hypothetical hypothetical ATP/GTP-binding protein
MIKKHIKKIVIGALSTLAFITTTVVATACAKHNNSVTKNNEPNVNVKDEISSSNSELNDS
HYYWKAPKSDTSEGFQTIHKSMVEDGKRAFLLPGFSQSNYLQDAIKNAKFDKNAVGFLLD
TVYNANNDPSLFDGANRVASVYFKVDDAAFLGGIAAAYMLNANQNIFATDGQLNWGGYVA
LNAKNTTNYLAGFALGIEWANKHLANKKVLQEGSSESKTWIKVNEVQASQSSAGGFDENN
ENAKRILKELISKKADLILPVAITQMSLAVNEAISTTSHKVAIIGVDTEQENDKTINKEA
NTFKNTNISGNKNGVIRFSIVKRLGVAIEKLLENAVNGTQFQGHVNKIGDEIDVHDKYKL
GVNTVGSLVDGVVGISESAYHYLIDAFNLAQTDETNKVSTYDQLVQKIIQDPLFKSLNQD
PKIDGYINPKNLANARGNEGELINGKTISPEANGGTIYKATNGSYYYYPVAKSTYTAQNA
STIFKEIWDKAKNDDDKRRLVGLILSFAGANVKDGGYSEISYDGMLGFYAKHGIKIPKL
>UU481 unique hypothetical unique hypothetical
MFNDLSINGVSHKFGINPYNTNLSIDYSNWVTNLTENSATINVKVNSTDQVFENNQIVEA
TFVSTSNPSEIKKIDGVLSEVSANKNSAKIKWNLTDLKPETEYRFTSAKFKNKPDLAKWM
LTINKNNVIYGGNLDTKFKTLVDKLKLLKLESNNDIYYNIQENAVNPNRVIGTIKAEFSR
INSNYINKKIKLVYEDNNHQEWETNELTLSNNKTSYNFDISKLTPNRKYSFKKILISNNN
IFEELLNSNNIADSFIYHHAPTAVTFKTEGDENQLWKSNIGITTAKFRLGLESLDKILEN
GDKIVVTFANKKYPNNQDKMKVYTMSIIDSRNDGLYANIKHDLVNLDEGSEYYIKEIRMI
KKPNKAYEDVNGNKIISPINDAQRRTLENTNFKTNWAIYNAKKYGNWDQPTINSAKYAFE
ITTTNDGTMLNTNSKFQLVFKKVSDSTKTFIQTINLVRKDNKWILEGEISNLEPNTEYIL
STIKLSRPTGNDLFDTELNTNINIIEQNQNKILTKGIDPYIESITYEKTNDLRRRIIKLK
IKDIKDYNDGDRLVLEYRYNNSTSKKEVSLTLNKNQEDYSVNIENLTYNREYTLKNIIKI
NHNTNNITSIDISKLNDKTFVVEPSVTKLTNFKNITNFDEKKQIWSRIMEFNITNDDEWF
SQSLLNSYKIRAIVENLSTNKIDDNPIIKIVNDNGKPKLQIHINNININDQNNEYKLRIV
KFENKPNSYLYKNINNDWDNIFYDTNKNGSVIYKSSNTSNYAGIVDITNVDHNIYTTNNT
SYTYVSFSGSVRKLIFNNMNNQNDSIFGEVMYKNLDNGQIYNTTVGIIENNVNKNYNTPG
QFQLLLDKMPKSSRYQFYGIKYWRANDKKDNAKIALVPNDKKTKIIWL
>UU482 unique hypothetical unique hypothetical
MNNKKSKKIQTIKNDNNKKSRKQRLFLLLATLNLAWAGAIIGIVLHSKNNNELSNNDFYS
FNDDGDLIIKGQLPKTYINKDVYGVFVDENNQEYKIKTQIDSYAKFEFDTKYLPKTGKYK
LNRIIDLNNNIVRENEKLKPEQKIEVLKPVPTNVYEDQKNEKHIQLKVNKILANKILVAK
FVNQNNEVYSIEAHVGLDQKIDIDTSSLKDGNVYYLKDLILKDSNPLTKVVNVNDIDEQF
KKIDKTHTYDNEGNLVLKVDLTNKTKNQALPTAVFKDENNKEYLIPALSVKNNVGYFNTK
KLPLNHKYELNRIVNNNELNDVLVPNNELMLEHKVSVNKPTKAKVNFIDNKKVYEVDLGV
QLKNTPLELTLEDLNHQTYKINAKTDEKGRAVFDISSLGDNNLYEVIGIKKTNEVDVVNL
KQIPYHNRSINNLNSNALNTPYQYTKNGDINLIAKVAPYYVNQQVYGIFKDQNNQEHQIL
AKVKKDGTIAFDTGALNNNSNYSLDKIVSVSNPQNVLVSNFDLTSKQKQLIKKPAANASV
DSTKKTQILENLNNDLINQKLVATFVDNNDKEYKVVANVDQNNKIIFDSNDLPKGYIYHL
AKVENNDLNKVINLNDFELKDKIIDKRDLNLLDSHPDFTYDNDGNLEIHTQLANDLNDDL
KQKALNNANVKGIVVDQDGIEHEIDVSIDANGKVIIPTKNLANNDPTKPNIYTLKKVVLK
QNNQPNIDLISEEQLSGDNHISFKKPTITAKTKENDDYEISFSNPSLANKKIKLTFKTDD
NNTNTKTVEASIGLDGKAIFKTSDDAIFAPDHKYTLTKIEADNKKVANIDEISPLDRIVN
KQKNGNVNADNKHEFKIPDQKNKDLTAVYKDKNNNEIHVPIKTDDKGKVIVNPNNNLFDP
NKIYDFDKIVDLNEYPNKTILDRNSINKDVSAINDGVDQARKLVLKAPAVSNVTVNAINF
QVNLFDLNKLSYNRQFALTIAKVNDLNDTQKYIATYDPKTNNYKLNFDFTHLDANTKYKV
VDVELLELNNKEKPIKLIKDDVLNFEFTTSSATTINPPIWTKFDVVVKTNNDTTITFEID
DKDNILKNDQKIYAQLALMDDDLLDTDVINPLVNFSKTNKIASINGLDLKGNSKYSIKNL
YYLNDQNQKVYLFKNDVTKYEQHFITNPHKINLSFNKSAVEQDIFADHANLFIDYKDYDQ
KLRINEDVKIYYQNIDNTKNELQIGYGKVVANNKIKFNLVGLKEKTTYVIKKLEALNKSA
SSIVNSEFDLLDPNTNFSTSNKNTTLVGLNSIDNWNNDQTPIINAKINIGDDFQDNQQVK
LIYVSNDNKEIKSKAVTLIKGQRNYQFEFSNLIKNRLYTFSKIVYETNNQTLHKLDTLTH
QFSINPSNNAVSLKNNTNIEITKRILVNNDQSLISAKIEVDDIDNVLNTADKPNIVYQLE
NSNDANNNLKLATNAQVVVENNKKFLKFDLVSLKINQNYVIKEISFNSKPTNAYFNFTNN
KTNNIVYSYDEQNKISLSNNINPTSYKPQTINKNDKSVNIDVDLQVDKQLLANQYLRLKL
KQLNDNKTVWTDPILFNNNAKISFKLSNLIHNRAYELEGLYYFDDQNSVNDMTNNQISFN
SKIHKPKIEFEPSLTTINYDTNNAIKTVSAHNAQVHFKLKTNDEALENDQIVEAVFAPTN
NLNDQKVVEAKLNNVTNSFNEGELEFNLSGLREETTYRLIKVTFKNKPNKAYELLNKNGV
IFEYKNGSQAYEFTTQKFEHKVIDVVSSTSTNTTQQEITVKIDGIQRAWNNKKLELVYES
NILGDPEIKTTVDNNNNSVHLSFDKKEYNLVLNNLKPGRRYSLKKINIKEVDNGQDHEFV
KEINVNNSFDVNLQSEITASSVEEINDRAPDKLNQTTIKINLKDDNDILKTNDIATITYD
NEQKVDAIVKTNAQNQKYLEAIITNLVFNKNVIIKKIEFKNLSQTFIKVGKNNTNVIYDE
SNLNKLIINNDFQIIGPLSTDVNSTQNIVANNKHVISSTLDFKVNPHISKNLKFKLKFQN
INGEVVYSPILTNSSIIVNNNKNVINFTLDNLKSNQLYRLVDVYYIDDNNDTINDKNKVP
KANNVTRIIDIAPGKTTISKSNNTWNTTSTSSQFEFVINSDDGNEVLDNLEATISFKKGQ
TLLTPVKVNIIKQNNKYLIKGQITNLEPENRYVLESILLAKPNKTKKPLVVEILNKDDIS
FQTQAGNYKVIQIKSQNPSTVDTKQRIKLKLDGIQNAWNEKQLEITYSANDNSTKTAIIK
LEKNKLEYEFELTNLEKNRTYTFTKIELINDNNTKTPFNKSDSIQDKFIVLSNNQVGVGN
IIEIQDRDVNHLNSAKIRFELNDLDNVLSNDEQATITYNNNQTTSAKVITDQNQKYLEAT
FSNLVLNKDTIINKIEFNTKPKNASKNIGINDTNVIYDATNLIINNDLKITGPLHTLKEF
EANNKTNISVSLELDTNNHISKNLYFIAKFDSNDGQSVLTNPIAADKIVTNNNNNKKELT
FNLTNLTSNRQYIFKGLYYVNSSNQTNIDENNKFEKNSNVDYKITVKPTITTIQKNGNWT
FPQPNAQKFKFNINSDENVDFSTDLDATITFSDQHDTKKTITTKLKQKDNQWYIEDTISD
LAYNDTYKLDDISITKPMNAFANLKIQIENKEQISFTTQSGPTQLVSITSHDLMWNDQPN
ASNQQTITAKVSGVNDLYNNRKIKLVYEYRSNNQKSLVESNELTLQKDQTQYIFTLPISV
ANRQYSFKEIKIKTSNNNFETLNNSTNVTNSFNVNASKTQIVIDNTNLATNITSTSATIT
YKLKSKDHVFQVGDSIITYLKSNDDERQEISYTKTITSISSDGSEATVSFNTDQTLKEEA
NYKLIKVGFVRKPTLAYTNINNDANNVIFEDNNSNYNFKTLIVDHKVTNVSSNDSINTTT
QTVNIDIDGIQRTWINKKIQLVYTSNDGEEILSDQKTLLWANNHYSFELSNLKHNRKYTL
KEVRIINDDNKTSIIFHLKNGIADWFIVNKTQSISISSIIEPIARAKNNLQSTQIRFILN
DPDNVLSNEEEAIINYGENLSVKAKVKIVGSQKYLETTFNNLALNQDTIINSITFINKPI
KAATNIGIDNSNKIYNNTNNINPLKIDNNFSVIGPVQSDTNKRITLEYNNKTNVKVNLEL
KANDNILQNLYFIATFKDQNNETVKSSIVSYSSIKKEGKKQIIELRIPNLKSNRLYHFDN
LYYLLNQDDKDLIDNNKLIRSNNVVNEIEVKPGNTTFKKNNVEWQINSNSVNFKLQVESD
DEDILDNNVMADVIFSSKSNQNDTKFVNNVKLKKEGNIWFIEGIVNNLKPETEYELKSIV
LTKPLNANSNLKTINPTNISFKTKPGNYGIINIESNQTLTNSQNVNVTIDGIRSEWFNKE
AKLVYISNTNDEVEAKVNLEENKLNYVFNFNNLKYNRKYTLKSIKWFDGQNWIDFPNKQN
LQNSFIIKGKTPISVNKLNEISDRVINNLNVAKIQFSLNDPEDVLSNNEIAEITYDTNKK
TNAKVITVNNEKYLEVSLSNLEFNHDTIINKIEFITRPNKAVDSVGINNSNKIYELTNLI
EETRKLKINNDFRISGPLSSNNLHLEIKNYNDKESINSSIEFTINKHIAKNLKFKLKFRN
EFGHEVYSELIDGNNINKTGKQEVLFSVKGLKSNQLYKLVDVYYLDNIHQNIDETRKIFK
DHNVSKEIEINPGVTMISKHGNWKSPTDTTANFEFKIETQDDNDVLNNIDATVKFKDEHN
NIKQKIVRIIKENNDWLIKGQIDNLNPETKYKLENIELSKPLKTHTNLSVSINDKENISL
ITETGNPVLKVIQTQNDTINDTQQTINVTLSGVNSKYNGRQIKVVYKDNNNVIYESSLIT
LQKGKNDYQLLLSNLNSNREYRFEKIEINHISNTNNFEDLEKLNGVSNTFITQTKNTTVQ
WNDSSATIVGTRGVNFNFKIKSEDKILENNQQVVAWFAPKETIRDTNTWLQYTRPLKDVT
SDFKEGTWAHDLSNSVNFKEETTYKLVKIQFVNKPTKAKNNINNSENNVILDNTNSINSN
YEFTTKVGDHKLINITSSNNVNTNSQTINFTLSGVKKSWVGKKIKLSYKSNDTSESIHTN
EVLIESNKTQYNILLNNLKRNRTYTLIDVKLIDNNNVSDFPKEGNLTNSFITTRTSAINV
LNIEEISNRASTNLKSTIIKINLNDPDNVLRDKDQATIVYGNNKQAMGFITVSGNIKYLT
ATLVDLNFNDKVNIVNISFNNKPSIAAENIGIDKSNNIIYNNDSIPKLEINNDIIVNGPI
NKEIVVKNANQKNNIDVDLGLQINPKIAHNLRFIAKFKSTNNDIIETNVINGSSLVNNDG
KTSIRFTLNNLKANKLYSLVDVYYLVNNNSNTIVESNKLPKLNNINYQIKINKSHTIISK
NGEWSNPSDTSAEFNFLLKTDDNDGELDANATATVTFNKNGGTLKQVNVNLLKENGKWLI
KGKINNLEPNSTYVLNSINITKPSNVYEDLDVSIENKRNISFTTQFGPSILNELLSTNEI
NVDSQTINATFSGVNDQYNGRRVKLIYRDQNNELYESNIVNLKKGMQKYNFTLSGLIANR
NYTFIKIQINDDKNNSQYIDLKKQNTVNNSFKRNPSTTSIEWSTPLNITYNSAELNIKLK
SVESNIWN
>UU483 MBA paralog MBA N-terminal paralog
MKLIKKKLLFLFTAALVPIVATALASCSNKSKLNVNVLMKDIIHTKSDHYYVVYEVNELN
TSQGIYKNLTLNTNLFNPLLNKKVDRLENIHPLIINNKIYLRLARKPKINDHFITNFSND
AFPALHLIFDHNLNFIEQDINEDLNLQPSLPNTPKIDHLEINNISFTNIKQNQVDIKIKL
KTVSFKDDAIHNFSLKIIKKTNHQIITSDAVFNKQKNEIDATVYNLTSDCEYLLDKLNFN
NQKIQLTSIPNHTFKTLDDSDNLLKNLEITKINDNGANLTLNFKELKIKDDSDEALNNIH
ISLAYNRVYKKGQLELNKKHFFIDKLNKRIIVYVDELERGTHYDIKQIKINDQVLNLNNQ
THDFTTKGDYAKVEAIDYETAVDKITKAVTIKVKLSEDLAFYNPNIHNFKFLIRKENDQN
PIEFSEVKYDEQERLLTAVINGLDVDKTYEIDNILLNGKPVSFPNDDDYAGGYYGPINKT
FKIRPDRSSIEIFKDKSFYNSYYSAFNSWFWYLSVSKKDDNERSKEVKKDYKEHLFISDI
TKNSAIINIKCEKLLLRKENSLKPKIKLRYHPLNNPNEWAYKEFSFEDKNCFMSIDEDQK
TIKIKLLNLDNHINYEFVSFILEDVDGNYHSDNFNVNVYIGDFFDSHPFHLDLSFLKFKT
NEFKKAVFSFTNTKSTSTDLNVDLQDNQYADSIEHKIKYTLEDENHNKYKFVKNLSKSET
TQLNATKNIILHLFALDKNQTFKLISFEIDDDNYLTNNITVKTLNESSPHLLLNLEFNDI
KNTNSTLKLTLNQAVINMPKRVDVILKNKKTNKLLYLFKTDFYFDKKTHQISTKLDNLNI
NTDYEISELFIDKQQINLKNINNKTFKTLDYGFDQFYLDKIDHEINQQQKNIKFKLHFSD
FIFKDKNAHKMSLVLEDENNQQECIDLNAHNQLKIDYEHQTIEFELKYLKPDIKYRINSI
QLNDKNLDLTWVDNQRYFNFPGILNPNLKWKVDNIKYEVNGSDPKINITFDQDIFLSNLS
QDKECNIELNYVYNNSDGDTLESKIVAKINKNNNKSVEITLTNENCYWLNDLKDICSNLD
SNQISTQFLKSIKINGHKIPKVN
>UU484 ackA acetate kinase
MMLIINIGSSSWKFCLFDMNLKQIFSGKIRLDVSPHQLKYIFDKNEYVYLLDDDHNNHVD
LIIKFLINKKIIKKLEDITYFGIRAVYVKNFYGASAFLNNEIYNDLNQHTDLCPIHNQNT
IMLINDIKHLNTSAKIIIIFDNWFHRSINKNKYTIAIDQTIAIKHKIRKYGFHGISFSYS
NKIMQNYLGKQDVNLIILHLGSGSSVCAIKNGKSFDTSMSYSPLSGIIMNTRSGDIDPSV
LLTLKKVKNQSLKQLILFLNQQSGLYGLTKHHSISEVANNLHNKNNELALEMYTDSIVDY
FIKYLNHLQKIDAIVFSGGISEFEHLVLEKIISKIHLINLEINDHLILTNTLNKISTSKS
QIPIYLCLVNEEHEIAYEMLNLINKTK
>UU485 unique hypothetical unique hypothetical membrane lipoprotein
MITKKHLTKIITILTCSTLIIGLSCLIGACTKSKSKVDDKQVLFKIKKFKTTTNSIELFL
EGSAVLASHSYSVVLKEKATGDLKTINNLKLVKDNDLNKLIINELKPNMGYELVDLLINN
QKQLITKLDFITSTLTQENVDQFSIKKIDWKNITNNSADLNLEFTKYFLANENQNIFEIS
LLNLQTQQITKFKFNYQPNSPSITFNFTQLENNAKYQIHRIVLNNKELVFSNQNLVLSNT
NKQNSNPIIKDLNITKIEKEIYDTSAKLIFYFKDNKLGDLNNQKFVLKLVSAHQPSNTFS
FENYVYNNSKKTLSFNLTGLQTSTKYSLNSLTLNGQPISLANLDLNILTSTKLTTVQRLE
NLEHESSDFWFNDENLSVKIKLYFENNVNYLKNKYLKLVYMDNANNIIVSKPVLFDPTKK
EYEFSFDKVLSNRKYTFSKLVFDDLQDFSEKQALEVNTQGLNGSFNTPQAKIKIKKISYS
STDKSAKLEFHLEDDFDLVDGDKVSVKYRLKPSSNSIDTTNNTVEGLVHNHILNVTINDL
ESNKSYEVIDFVINDYKNKQLLNKPEFLKKNTNHHNHPFNIPLDFDTKNSDYKTKFNVNE
ISKSYNKETKLTTIKLKFDNIPTNPTSSNNFTFTIKKRTGYTTNLISPKTLEYDVNKKTL
IAKFENIEDQIVYDFVDVKVNNQNIEFNKSLDKYFSIIHSADYHE
>UU486 mnuA membrane nuclease A - hypothetical
MKNNKSRKWVITISLTLLIILIASAVIGVVFYLKNKKKNDTSVNNDSYIIQNNNNSLKEQ
PNSTRSFLNQKTICVGHWNVLNQGGINQLKNEALAKVILKSNVDVIALTEINSAKNNEHD
DLPMRAILKELNLHKNQFDQTANWNYVLSKNLFSKGNESQTERIGFFYKANIIKPVQEYI
YKNNDNKDILFEQYFKNWNDNTKITYSRPPYAYEFQTLDNKFNFTIVASHLDSPGANEHK
TSKHDHTYGNKNLKINIKQGSKELNEAYQLGNVMDYIDRLDGNNDDLIFVGDTNIKTKNE
LGAFASLYKRNYLSNFKDDNENNKTTLAKTYLKYAQHYDKIFTSPSIKVLNTYKYDLWSV
SLTNTLLDKNWKLAFLKTYFRSLSNQQMQNIVDNWDEIAKSNDVYIKKATSIISDHTLVA
VNIKIDENDIIDEN
>UU487 MBA paralog MBA N-terminal paralog
MRLKNKNKYWNLLIASLISIPIISTISACSFSETRYKLKVLDYFLKTENDDYYIAYEFNK
LTNEDMQKMPKVIFSTSIINSSNQKIAFYVDIKPIIINNRIYIRLPQRPKPNEKIIINSS
QEFVGVQVIQTNKMLTRSINFNFNKEDHLIKVVDQSARFTNIKKTEVEFEIKLLNLNLND
IKDKNIEIELTNKKTNKTFKLHFLKYQFNHLTQQNKKPVLTITANLNADANNQLDDGEYF
ISKLVLDQKKLEINQSVYKPSGLQLDGSINNQRPTYLLIPSVFSKWTKINVLDTKVIKND
GIPQQLQLSYDHFINPYNFKDNMLSADIELISTKNNKTIILKSLKFNHDKNNIVFDLVNN
LELQTLILKTPFFKIKSLTIMNDKQTLPLSIREKQLDLTNKHLSKIIKFTFDDTDPQNML
MKFQLDSDSPIVQNTKKVLLTIKKINTDQQEDIKTFSFDILENKITTGSFYDVKNKYFLL
NLNKTLNAKSIGQILENDSNYIITKLTVVNNEASINEIPIEIDDLQNKQFTLKFAEYQSN
VIKFNAKNDPELHLNIKHFKQLNLTKINKIKLTLKDGKQIIFNRLNNEFSFQQAGFKLKI
NQNTFPNYLKQHQYVIKSISLINDDQSVIELLSKHNHEAIFEIPITASLDTWEYDKIHNI
LKIKMKLDSLSLHQSLNPSDYALNFYNLDTNIINRKFTLSPQTVLSSKVNNSNVIELIYD
LDNDENIYGGLEPESTYQISSLMINAKPVIINTSITMVQTNASASKVEKIVASYDSVTKK
TKISLQFSNNWWYNKNADHKLFAIISSLKPKNNKNANWTFSLSRTFSNPEAINSNKDKDF
VLDKATKTLTYVINYANIDYKDQNDHESFDWYYDDLVLNKVTIIYNDLTTNDISPFSKDD
QNLTIKLPNKINS
>UU488 apt adenine phosphoribosyltransferase
MINIDYIKSKIRDVPDFPKKGIVFKDITPLFLEPKIIEKIVDDFADFAKSLNIDAIIGAE
SRGFLFAAPLSIKLNKPFILVRKPNKLPNDVYSAEYTLEYGSSRVEMHKDALKPNQRVLI
VDDLLATGGTVAAIENLVRQAKGIVAGSVYLIRLGFLKGEEKLSGKVHALINY
>UU489 unique hypothetical unique hypothetical membrane lipoprotein
MSFKTKIKFKQKWKKVLAFFGISTLTIAAIVGTGIGAANYANKNIKTGDFGDKISARTQV
LLNDFQTEAEQLNLLKTTANLSQKHLQALGVNNVSAKYAIYERINKNTKKHEKFGEIVYQ
FYPTNSKLDIVNFLTKTKPYEKINSKIQLLSLFTTANRLELQNISSLFSPKPELSQNRDF
DNTNWLTLNNDPKKISVKTTNNGQQVEILLPKTSFDHQKFNLDFFAKEFDANFNFNPMGN
KTRAQAVATFDRTKQKRKAPVNSWLLWVNRDGLIARFNMLLTLAHAQKQKYVDPKSWDYV
DTVYKNLNTNSEEKAFVDWLAKQDFDKYFINTNSIIEPINVQTDQLLNIIRAFYQSSSHK
VKIKNANNQDETQNFKDNEMFYSWNINKLSLVRGFVYAIDYNNFFNYFLAPKKDDKLTPA
QQSIVKYTSDKLVLNKDNTTQSFINTAHNLKQYYLPTYFAQSVFSENNIKKDYAKTFYDL
LNNFSTKPSNLKRAVIKTINPMDAILIGIAVLILIIAIIISLLYKIPGLIYSLLMAFSFV
ISLLLIKSSNLGFSTETYSALIIGICWPLLNLVDFNNHIKHLIQQKFSYKNALRISLNKT
IVNQGMFYLLMIFISLVFMYFGKNNISIFGFNLILITFSCLLISYILFIVMMYMLWSLAH
HLPKLHLWRKYLVATNAINQNRFDDKFEWNDQQKYQRLIFKIMNQKVYRISFLIFIFILA
FIGLFILGFIVPNHSFSFGSVYELIMKSDLKDFNSHEFKTILDYKINDGVVSMQFDAKKP
NVLSEIDLISLNHRFSDAIVYRSSQYHLINNITNSIAAYFIIFAIILIWSSIWLKPQSII
PIIINLICTSLISFGIAGLLRLFNNQISIIAINTSFVLMTSFSLHICLNLKRTLDLMKHV
TKKQLQFQIQDSLIKYFNTYNIIYIVILFALLWLMIFTPFVLISFNAIILFSLISTHYLS
IIIIHYLWMKMVYISKGLLAKDDNADNVYDKFDEQEIMNINKF
>UU490 conserved hypothetical hypothetical
MHFLITNEVKKIFNDKLYSQRFKQITDLVSTKLNIDKKRFFECHFVDEKTIQEINKNYRN
KDYITDVISFAFDDGEIITPLLGEMYICYQKVVDQASQFAHSFERELCFLFTHGLLHLLG
YDHIKIEDEKIMFALQDEILNELKITRNINGARND
>UU491 era GTP-binding protein
MVLEMIKKYGIVAIVGKPNVGKSTLINAIMKKKVSIISNKPQTTRNAVKEIYEDDESAII
FTDTPGFHEPSNKLDLFLNHEIEISYKEANVILFVTTMDKELDANDFEIINLIKEANKEN
IILVISKAEMAKNQDQIDERIHFLKKHIAFKDVVQISALHVINIDKLINTIKNYLHKDVV
TDYFRQKAEKEDKFVITEIIREQCLLNLNHEVPHGVGVEIDESKYNQEANHWIIKASIII
EKNSHKPIIIGQNGTMIKKISMGARKQLHEIYDCHISLTIFVKVENNWRDNNNIIKSLGY
KIKK
>UU492 conserved hypothetical hypothetical
MAEIITRGYLVARQDYDVFDEILTFINEYGNRFIMFAPGTKRITSKNARALFFGNFLEIQ
FFYARNDTKLSKLKKVISLDQIDYKYENTYSMLILSELMTKVVNFNVEFYQFYQLILEYI
ILEYNDYYISCFLLVKFLIMNGVNFNFQACVHCNSSKNIKTFSLADHGLICINCESKIIN
KIDYEPKALQLWQKLYFATQIKKDEDKDNEIIYKGLLKILNSVLYDQLGIYLTIIKNI
>UU493 glyS glycyl-tRNA synthetase
MRYKFKTQEDLVNHLKSVGFVFANSEIYNGLANAWDYGPLGVLLKNNLKNLWWKEFVTKQ
KNIVGLDSAIILNPLVWKASGHLDNFSDPLIDCKSCKTRYRADKLIESFNKDIHIAENST
NEEFMKVLNDHKIFCPTCKQFNWTDIRHFNLMFKTHQGVIEDPKNIVYLRPETAQGIFVN
FKNVQRSMRLHLPFGIAQIGKSFRNEITPGNFIFRTREFEQMEIEFFLKEEIAYDVFDKY
LNQIQNWLVTCCGLDLNNLRKHEHPKEELSHYSKKTIDFEYNFLHGFSELYGIAYRTNYD
LSVHMNLSKKDLTYFDEETKQKYIPHVIEPSVGVERLLYAILTEATFIEKLANDEDRILM
NLKYDLAPYKIAVMPLVNKLKEKAEAVYNKILDLNISVTFDNSGSIGKRYRRQDAIGTIY
CITIDYDSFGDEHDPTFTIRERNTMAQKRIKLSELSLYLSQKAHEDFQKQCQK
>UU494 dnaG DNA primase
MSKITNNVFLTIRNAINISDVIQNYIKVIKKGNNYWAICPFHNDTNESLSINDKKQIFKC
FACNHAGDVIKFVAEYKKISYALAAQEIVQLMNLDLNLLNHLQKISPQEIKKNKVFDLNK
QIQKWFINFLNNKNNIHVIDYLTKRNLNKNDLAYFKIGYAPNNDELLNLIKSNYNNLIQE
NDEFELNKLIENSFLVIDKNGNYHDFFNDRIIFSIYDHLNNVVGFSGRIITNEKTPKYLN
TKTTAVFKKDEVLYNFHNVITIENNHQLFIVEGFMDVITIHKSNKPNVVATMGVELTNKH
LELIKSYGIKDLILCFDNDQAGFLATKKQIMKLINSPFNIFIVNHKDNDCKDMDEYANKH
GYSATSKLLDQQLHISEFLLLEISNTNKSTPSLKHSYKQECFTIIKKYGDIFYVDKYVDF
MKQTFSIEENLLKKVIEELLINKQCNSIQNKKNIQSYQKQTQLTNKLTTSNPKVILTKID
KHFNHLVVIILMNRVFLNRLDTQVRNRLTKEQSLVINIIEDFYLYHFKINNILKNTDSFI
EFINKNYSKYTNVINQLTKMVQIIKYNPKFDNIVAFELAKNNFIYEWLNNQIKRLKLINL
NLNMNNNQEQIINNEKLIKQYNDEKILLDNLINASLFHKNQ
>UU495 unique hypothetical unique hypothetical membrane lipoprotein
MMVKKVINVADLDQKQIIVNKLNIGKIVNNQLVFDVPKNVEEGEDVFVNYQDVDGNLIKI
PAIVNNKHQLQIDLSNNPNFTKDKIYHFDSISIEDEYHIPKETIISSDDVDNSVKTLNNE
VDLGRKIIVKNPSVIQNKPTTLILTVNDPNKLALNERLKLTLALKNDPKHCVSAYGLIDY
KNNSLVFDFNHLQTDTAYYIKNLVFKNNNLNLTDLNAEAHSQTKINIIKDQVIGYTFRIF
STNTLVLEDYHQYDTDPNATKLNLNISTTNKHPKTITYRLLDENNNALEPDLVANLNYDL
VKKNYVAHLQNLKGNSKYLLLGFNDENNNKIHYSTPIKTPLIFGTTPHATIVNFDVNNPK
QIIKSQDARIAIDFVDQDQKLRIGNPVELTYLNKNNQQVYKTIGYVKGINKTNKSGTLEF
ELNNLVSNNNYELLELKALGLANDAYQKVVFAPFDQKHNQFSTKLIGTYIESISSNEVIK
KDENKLDVNVKIVFSQKDKTLNNVWAQLVYISKDNEVCLSQPLLLNVGNSNYKFTLTNNK
PNGFLSNRVYKFVKLIYAQDQNDLQSTDAVIKNSTDLSHGFKTEPTGIISLKNNSLQVIK
RTDDSIRLSIPLVDNDHVLVDSDGSSFTIKISDLDDPNNLFDADNQKIVIDQNGNRNLEF
DVPNVSLNHKYHINNITLINKPINAAFNQNENHEQVYELNNSQPQLSEFGNELLVNTYNY
EPNITDVKTNVLNYKVKLTLKRSLNLMNEYYLKLKYIDNNGDVVWSDPVSINNVNNEYEF
NLPDKNALKSNRIYKFDGLYYFKDVNTVKITSANKVNMNNITPLQIQTASKINLNSPKVT
INNITPASADLYLPLVSTDDIFAKDQVIDVTIGNKDNTKNDLMFTSNLEYDDITKTWGVK
IHANNLSPEVNYQIKSVKFRQKPVLGAFNVNNSDDNHVLIDSQKTPGFSTPKASFDLVSV
TASDVVDANVKTNSVHIVINNDGTSLNNCKAKIVYNDGEHDLVSNNFVVLNYGVNEYDFN
LDDLKHNRIYSFKKLIYTEPNQNDYKFSFLNNQKITNTFKTASVNEQLTIDTKLVRKPDS
NLNKINLKLQINDPNDFLEQDSILEITFHDEKDKTTHNVIGKINVDANNNKTLEFSVENT
NTFKIQPNHKYIVDNINYATKNKIQPANAISNNSNKNSIYDASSNPSKILSFTNELFVNN
INVNQPNTNLNPTASIDVELKSSQNLLKDQYLRALYIDNNHQKIWSDYASVNNVDLAHIN
LNFNHLTPNRKYNFAGIYYFNDQNQNNDETQGKKIFVKEHSKTYDFSTLASTTQLLEFKT
HNVDEDQFNYDFNINNDDQVLEPGMLVELCFENLVDKNQPVLKTQTTLVKKDEHSFSASG
VITNLLADHTYRLTSVSLKQKPQLANVNINNNNNNEILLNNIEDNQKTIHTLSKSIVNEI
SNLADAYPKNNNGIYDVKFNINIIKNNNKLNNKYVKVVFEDNEHQLISTNDLLVNKLDQT
NLISLQNFSFSNLKPNHLYRLLKVVYGDEQNFDAINEQKNILALNPSLVNSSFSTTPAKI
KVSKNAIDVWQNQALIKLILDDSDNQLHSGDEININYRIKGTQNIISTPATISDQDKRYT
KCMATNLIAGLDYEIVSVTIKNQKTKNVSPIIFELPSGPIGFYTLAPVFKITSLSMDPVY
HENKNTADLKINLRIENIGASLFNKDIKFIFKRKNDGKQISFIHKVTSANDANYEWEFKD
LLRNREYTLERVVYLKNKDFNQSNVSESDYIDLWIYENLNKTFKLLPTKPLGIIGAPIKE
ISDNGAKVQLKFAINDFDDVLKENQTFKFNIQPNENNGANLNEISEHEGKVEIIDGQKFF
VANLNNIKVNKEYKVYKIYFDENQDVGNGVYKINFKNDYKEPNNVVYDASVNTTQTYVFT
NKFAIASFSNNLTDVDVANKQNISINLDSRVETIQGYHFKAKYISNDNRVVWTNTIPAPT
NIGNNKNNIALNFELNQNQLISNRLYTFAALYYSKDVNVDENHANMVVIKNNVNPQTIST
KPSSTYVDLKAQNADENKITLSLLLHSNDQIFEDKNNHLKIAKISIDELDAHDQIINSTT
HDYDLTLEKENNEWLLKTQLINLKPNTKYRVKKVWFTSKPSDTIYNGVNKDNIVYPINNH
NTNIDLKTLEKSTLNSVKPTKTNFNKNESIKLMVGFNKTGSSLENKYAKLVYKDNNNQQI
ESDPVLLNSDTTTKPFNKEFSFNNNQTSLVANRDFEFVKLIISDTADFKNANTLDLTPNF
NKDDAKFSIEPTPISVNNVIQSGSNTYDEIHLSFDYDDQDHNLVDNDQITITYRKKGEQA
WTSSKAGEVSVKNHKINVTLKDLTPNTTYEIGAISTTHVHSPNVKTSPIQYNETTKKQLE
KLDLTTKVAHNFIKDFKLASNSKLVNGVYECAKDENVKFSVGLHKEGHELEGYEIYAKFV
DKTNPNKPAIEIKSSNNINSNSNQVYEFELLKSQITPNHQYELSEICAIKNKGANNEIKK
DLNENHLSLALGLAPNKMDVQKPTITITKVQDNQSVSAHVKYIINDPDGILNSTDCSKEL
LNVKYALFNQTQNANLINNITIKYDQQNKQFYCEFDIDNLTLNQDYGIFEISFANKPIHA
AFAKINDTQHPLALLSTNNQDINQKIALDCEVNKVTINKQDLDYDQNTKISWPIELSSNL
LNNKYIRVKYSVSGHKFKQDDQFSSAFKITNNKASVEIGHDKLIANKAYEIQAIYFSDQN
NDFACTNTNQIPINSSITNKKIVINPSATTISSHEVKNITSTSADINCSISTNDGDIFKP
NSQIIGHFAKGDDLTKTFVANGVVANVNNQTKLSFTLNNLEPNTKYILVSVEFKQQPNNA
YKHINNKYNDQFYSNDQTHSIIFTTSTPIFEINSIKTIKNTYASNKEEIKVNAKFNKIDP
YLNAKKLKLVYQSQNNNETFETQPLLVSTNTHDYVFSFDKNASNSIIGNREYHLDKILYL
NEHNQWCELNKNNLVDQFNVEPTPISIAKIVEDDSKRTQNDVKFRIYFNDLNQDQIFNDN
DNVNVKLVYPNTNNVWVSHDWPIHFDQQENKWYTEVWLSVGSLNNQEFEVGAVSVNKKPA
KAKFDIHKTNHGYDNFIYNKDIKNQNYLVGNIFKVNSINVAHPSTPTDSNTTVHVKMQNN
MKSAFKGKYLALKYKRNDTNELVWSSTKIKIDENIHDDLDFTFTNLAKNHIYSYVGVYCV
DDQNKEVFVANNITNLNPPQIKVLTNAINTISYINANDKISNLSDNTAKLKLTLNDPDHI
FKVGDELDLVFNTKINPTTPKQKNIHVSVKEIQNNEVILNDVDLSGLSENTEYELKTVSL
NQENWSQKETYISSKPHFEINNVHFATIKHLFINKIEINKKAQENSYTLKLTLDGDYSEF
IKQGYLRLLLVNNKNEEFNYTKSHKDTDKNQDNNAVKYFTFDLNNLTWGMQYTIKWVGLA
KNNVSDNTDFKKYKLEKGYLTKKTDDLDQFTVRASKPLKIKQVNVSEIKAHHAKLNLKLE
DQDSVLKNLNYELELRFGVKNNQSSNSWITKKLKTKIVNNEIVLDEIVFDNLTEDMQYEL
KDAKLIFNEEELKKFNKVTAVDNLNVDSDQIVFKTMKSAYVETATINFVNNTPNATIDLK
LNGDLSVFSKSQYIRFEWKLNNSDPNTKPLYYTIPISSLDLNNLNWKKDFGSDLLWNSSY
TLRIGYGDDNKATDDSKWTWLALEKTAKGNIKTPNAQRISINQMQTPTNYSLLTQEVNEN
GNKVKKALGALDLCFELNDPSNILTNQDQFSIKYAMLNNLKQSVSASAHVEIKENKKIVK
FHISGIDLNQDYKVCELMLLTKPARMGENINNNDKNNYSSIYQNSTNDDNQYKFKILLEN
NDLSTKERPSKTGDVVNNKGKVDITITQAPKLLANKWISAAYVDNNGETKWTKPRLITTN
DNNQILYQAEIDNLTTNRYYNLNGLYFGNQQSDFEQGNATYLLSLYPANLLVPTDGVRIQ
NIKTPATTDAATVWFQLESKDQVFDKQVLHIQITPFNEDINKKDIPAENIPVFERTYTLN
GNSNSAIVLLSLNNLEPNIKYKITKMWFEQKPTKAYANLNSKANNNVIYENTNDKTQPNI
SFKTKTVEPKIISLVKKDQTNDGISFDLKLQHDGTYIGKPFRLIYESSKRKSDVWDEKNN
NWESNDKQLIYSEPINFKAGQKDYLVQIIKDHNEYFKGNREYKILGIEWADPSFSQDKHH
KKLISKDTDSEAFKNVNSNALSFSTDATTIKWYVATPKIVYNKNHKKMTFQIRYDDPDDS
LFMGQRIGIEKILLPNKRKQIPLNPPLVGEVDNKKKIIEFNIDNNDDHFKPGNLYQLISI
DLVYEPKTLSHKDLNKLMYENPQTKMYKDKVTFELDNSQYSSIKIEENQNPYEVKSVKNK
LDNKNLTLKSTVTFNNKDEHLYNKYMFALFTNTKTNAEVWSKPIQLNTNNYSKLEFDLPN
NGALEENSEYQFLGVYYNEKQTHPNKNEIEKQIYMIDNLKIINIDNRITKTIKTGIHIDV
NEVQNLAQFKDGISKQFKLVGKNDSTVLNQILNGDFSINIEYKRKDQPDNEASFSTGACK
LFKKNNNDPFWYFNADFNNLNFNQDYYIKSISFVNKGINRIIGSINNADNQIIYTTNNYN
SSKYHIKTVGAQIEFDQTTVVKNDIVFTKGDSGGYPASVVNFKLKGKEANTFVEGQTYNV
VLSTWDDPFNTRDYENKIDNHLNYDIKKDYVIVSIVAHNNCLEFKNIQLIPNQNYNIVKV
LHYQASNTISAKDMGYSLKNAFSTKSVDWKVWKFGHGRNNFTWRYQVALSLKGPFTGFGG
YRKTIFDLGLAKSLGVYARIYQHNTNNLAFKGYDIDGINEGEDTSLLTDFERASRPTSAN
VLSSSCTLANYLRRNSDSLKNTIDIGKVWYEPRINPNLPNSSNATYYSGEPKASIFKIDD
QHKHYTDSFGTTNNDAMDTNNENQF
>UU496 unique hypothetical unique hypothetical
MNNKNKKRNAKIATGLTISSLIWAGVITGIVLRFANQHSNQIFSKYYEYTKDGNLIIKVR
LFTRDNDINQKIYAIFKDKLGKETSVLITRNKEVARIDTTSLGLNNSWVLDRIVDENNNT
LINNNELVWQQKILVDRPNVFKVNFNKEGDKFFEIKLNHELSNQYLTAHFINQNNAKYIQ
NIQVDHNGNVIVGTKQLPLGNFYKFVGLTLKEDNKNTKIVNLDEISEPIRGIDKTRSFDD
QGNVIINARVSQNLANQNINALFEDEKHQLHTLKAIVGTDGLVRLLTKDLENHHDYKLIQ
IVDKDNHDVIKPNKLDAAHQNIVHKPNKIKIETDKNGLQKALHIQVDSSLNDRLLTLSFE
NENHDKTNIIAKVNNGEITVDLNNLKDGHLYKLDNISINNTSPAKRVANLDDLNESAKTI
NKLNTNALNDPYHYDDKGNLIFNAKVDSKQFANDQVEAVFIDEKNNEHKVLTKVDLNGNI
VINTSDLNLNHTYKLKHVISLEEPETNVLNDYELAINQKTKFSKPAAIVGALEDNNYKIQ
LLNPDLANKSVVLTFEDENHHPYQLTGKLNDQQELILRTNDDHLLPNNHTYTLTKITNVN
NQPIVNVNDLDRKDRLLEKVDVNKLQQLNTYTYDDLGNLIIDINDNLNKITTQDAVAHFI
DENNKDYFVPTKVDLNKNKISINTKDLDANHHYQLLNIVDKNKHEQILLNSNEINPLNRI
SIIKPLAIIKQDANKNLNLLTFDKNLFNRSLDATFIDENQKEYHVKAKTIIDSLGQTRFI
TSDEVLPNHHKYQLIALKYDGQKSN
>UU497 unique hypothetical unique hypothetical
MKKNTHKKLLPLISIFVLIPLSSLVVMCSKTKTKIVKEQKQITASSLRSTDIDLTSINLE
IYFAKFDVNDILVKKFSIELEDDKGNKINVDINPEYNKNLQMLSFKLENLKPNTTYKITK
FNITGHEVDLTQIKDSLFTTKAENLLPDIPNLPNSVGIEIKDIKTNSLSNDATKVNVNVN
LEINQSTLENQYARLVYKSNDNSWKLSNTLKIAEIKNSNFVLDGLISNRKYLFKELIIGS
QSDLNLTNAQTKITTNNELSFTTAPKPVEIKSVLIDTKFDNHPSSLINLKFNDSENNLKE
NDILKIKYKKVGPNEVIFEKTVRLANNFELLFEIENTKKNEKYEILSLESNTKHGYNVAP
SIFNFISNDLRTFEIKG
>UU498 rpS4 ribosomal protein S4
MSRYTGSIYKKSRRLGFSLLENNKEFNSGKKRTYGPGQHGNKKVKLSNYGQQLVEKQKLM
FLYGLNDRQFRRLYRVALGRPGVLTLNLLQVLESRLDSLVYRAGFAPTRRAARQLVNHSH
VLVNNKKVNIPSALVEVGSTIALKAKSLEIPLIKNTLNKPADFIELIDKEKKVAKLARLP
ERNELPADVNEAYVVEWYNRLM
>UU499 unique hypothetical unique hypothetical
MSLIYLLIGFILLFLLIYSTFALLDIWTLRKYNTFRQNFFNFDQLVNTKFNDIYTHTDNI
YARTSKQKITIINKYLIAINNELDFHKKSLIKLQDYLENHKLFSYLSLIKFIKANEIKIK
NNVDEFVDLIQSFWNDFIIIDQQERKIEDTHKKLDLMYKDLISKYSIPNLNYQKAINWTT
DSFNNLIETKISMNYSKYNYFLVQLIHRIKNKVHLLKNIIVVLNSIKIIEEANKNSLQKV
QEITFLTDDKIKELRQFNHDFNDFINNQLADFIYNSKFVNLNNLYLNSYYQQALNWLNIS
SQNNIGGAVFDKYKKRFYDDFSFINSTIIKVNNILEKIKSTSKNYQLNQLNQLILDLDQA
NQKIINSKIDKNDIKQNIDFIISTQLFYDNLKNLLFYLNDLNVKLANWNHHWNTLVKKTI
TIYNKKIELESYIKNKDIFFNLSNEIFLDDFEYIENIFQKINASNSFDPQILTNHELIIH
QLNLINERFDYLIEYINQTQLWMPKIYDLLYNKINYYGINYEWIKKEFQNLNWNNVPQAS
KLLNEFIDNIIIADHALKRLKFN
>UU500 conserved hypothetical hypothetical
MKILAIGDIFSKQGRKAVANELPKLKQEYQIDFVIANAENTTHGRGLCWKHYEELLGYGI
DCITMGNHTWDHPDIFEILTTKTNIIRPYNIINTHQYHLVGSGSRVFYCNKKMIRVTNLL
GNSIDMKGLQTNPFESLDKIIAFNEAPIHIVDFHAETTSEKNALFLDFKSKLSLVYGTHT
HIPTNDARIVDHTAFQTDLGMCGAANSVIGANPSSIIQRFRDPNKRFILEPSDEKYVFCA
SLVEIDDETNFPTNITPIVIYEK
>UU501 uvrD DNA helicase II
MGLGIDYSRLNQEQKEAVTADLGPQLVIAGAGTGKTSVLTLRIAYLITEKNIHPSRILGF
TFTNKAADEMKERVGKTIGVSIPYLSTFHSMCVKILQQDIHYLNYHNNIKIIDTDDQEVL
LKEIFDQLNIEKKSQVIKKIIKTISKVKNKFFDQNDMLNEKNHKYLELVDLNDAQRLVDI
YKIYCDRCFKLNYVDFDDLINLTHKLFIEFPEVLEKWQNKFDYILVDEFQDTNKIQYDLI
SLLATKHQNLFVVGDPDQMIYSFRGAEQWIINNFSQNFKNTKVTILKTNYRSTQPILNTA
NRLIDANNNNYKKNLTAFNTNDNNLPIYLRGQNPIDEANWIARKIRELLEEGTPANQIAV
LFRSNHYSRTIEQSMMRESIPYTILGSKKFYERAEIKDMIAYLKVVNDLDELSFLRIINT
PRRAIGPTTFEHVKHYAINNNLFLFEALAEVEKNHLINNTQKKNILNFVNLIKEIRDEME
DLKIHEILELIYKKVNYEAYLLENEKAEDKIDNVYELKRAMKMYVDRHPDDTINDYLNSI
ALYLNKDGKDSKENVLLMTVHNSKGLEYENVFVAGMNEGLLPSDRAINDDPIKGVEEERR
IAYVALTRAKKNLYISSACCYDPLARRQVFESRFINEIGFNNLKIINSSFKNNKPEDMPL
KSFLKQQEERSWFDSKQKQKEVEDNFYQTMKNDFEIGERIVHTSFGDGVIIGIDGDILTI
AFSKYRQPKQINFNHKTIVRRIG
>UU502 unique hypothetical unique hypothetical membrane lipoprotein
MSDKSTLKQENTIEYPVVGALRRASASVLDYIFISIIAFLLSLLVFINSNFKISDIFVNN
DELAPEPWRLFLMGIIAFFVYSTYYIIIPLFCKSYTLFRWAFSIRMISLVKQNDKKILFI
ALIKHSLLTWLIFTIINLLAMGFCFVFADASFKSIQAMNETELKEYYHQIKDLKAYVQSI
LSLKINDNFTNTTTMAILSILVKSLYSIMGLVSCIIVIHMFMNSKKRALHDQVAKVVLLW
MHYEKPKQAPKHKTKREVEIQKIDNLIQELDKI
>UU503 epsG glycosyltransferase
MLLTIAFYLSKTTHYLKKNFNYFLDLLNQNQKNIELIIIDDASDYNLFKTLKPLIENTNA
KIKYFYLNETQGNAYAYNLATKYAHGKYIWYLGGHVELNLDASSLLFSVLEKDYDVISFN
LNDNVNQNPSLVFDSLNKEILVGLWESVSNKIIALDFIRKNKLAFYNDKWYPALFIYDLF
TKFNSWRNVNINFISNNSGEVGYNVYDLLQQINELYIRFSNDDLLDLYKDELCYWITGIC
FHSFLKKIYELYTININSKKQIKERTMIISHALSNAKKYLEIYFANFENNLYVRKFKINI
LKYYLKSKQGLN
>UU504 unique hypothetical unique hypothetical
MKKKVIKMINNSPNINYYLQDKKYIPKYAYYVNKKQKPIELFARYKGRPALFIRENTMIN
TSLNSNVLNLDFEFEVAGDFKLPINYFFMDIKSDIGEFRNLEVYETKHSLYEIGGVIYDL
YTYKTNLKINLNQAGFVNKNTLSKKINFAFFLRINDDKRIHEQINYTCEKSLFFEAVQKE
FQDLNFDYFYKNTFLLNKHEKVNPTNFWETIPLFWIQDKELDNEIKIKNNKRYIFNTKFS
LNDDNSWNNRPTKETFELIKYSLEYVNLAKENKKIEWIEDYQNINITYDYYQRPIDFLLK
MKTKFLYDFKNDQLSINNNYGFNGIWLPNKQIAKLKITVINNYLTPQKFVINQLINIEND
FNSINKQKISVQKAIIENYENFKSLEN
>UU505 unique hypothetical unique hypothetical
MKILNHLKINWRSHKIKVIVGGIISLLIVITAIILGVILSTQNTNKISKKEPLTQIEDNI
NNKKQDAHKVNENITIIDKKGGIIHKKTDITKINQINQQKEILKDYLKNKEEKNKDQINN
TNENLNKPIINVKNVDDKNKQENSTKLKNNDFISNNDKNNKINENNNISYEEKPFKLKRF
NIINVIAKNKDLYQLLDFKTYFSNENINNDIKFNEKLFIKNIYEIVKSAISSFQEFCNIM
QYIKIDIKYKFNKDAKNIIVIANWLFDNYNIKNETRYYEEFVLSIN
>UU506 acpP acyl carrier protein
MSINIKDLIMKIAKENKIALNMDNLNIELKSLGIDSLSAMNLIMKIEDQIGVQLPDEKLL
KIKNLRDLINAFEDVLK
>UU507 ampL cytosol aminopeptidase (leucine aminopeptidase)
MTLNEKKEFVYELKAVEKNHNLKGFEENTTEHVVFGGLYQKQQYLILTPDFDSNELSRSL
ISFLEKSPKSVSVDLNSFLSLVPESRHASLLNVVISALEYVEVTPFSLKSKIETKNIHNL
VVDQKYHDLINKLHVIAQSQTITRTLQDTPANLMTPGDFEERIKELFKDLPEVKVSVLYR
KDLEAKGMNAHVGVGKAAVSDKAQPRLVVVEYNNNPETNEKYAFVGKGVCFDSGGYNVKT
GSHMRWMKFDMSGSAIVSMTVRALALNKEKVNVVAVCPLVLNLLAPEGQKPDDIVKSYNG
KTIELDNTDAEGRLILADALTYAVRDLKASKLFDVATLTGAMIYALGDTYSGVWATNNDI
WNEVVVAADYAGELVWRLPFHNDFLKMLNSNVADIANSVSDPRGGSSRAACFLKEFTEGV
PYAHFDIAITADVGHKGTGVMLRTFYRIAQNQKFN
>UU508 ftsK cell division protein
MVSDNKNTLNKETISFYSYDNQLDAQKTESNGKEQEKSNLKTKKFKVQKNYFFNKKKLIG
ICFFILSFLILILAFLKAPYTGAILDNVLEFFFGWVKYYVYVILLLFLIVFYIKKVRRRL
FSKWMIVFYIITLILFALIIGAVGYGIITNSLTYKFIINTNQQMINKEILNLHKDNFEYI
SLVNLHSKKLHLCEWWAYSWSQEFLKAIDEKHYYYTSVFAYGGIIGYANLDLYRANAWIF
TIVIMFMVLVLISFILITFGTKSHLGLKFKKWLVNKIITNINNYHKKDYQLSEQNFFEEK
LGEDHHNIDKQLEQKEVIQEQNLQIKNFNDRQTNSSCITKNDKLKTTILEPIVNDINQFR
ENPSTIKNNKYNFYPRIDIIDGKSQDYLHELKSKGENLKLIIDKFLENNQLEYHFNAINP
YFSNVEIVYQFTRSSLNNFLKNFLNLMKQAVNDTDDYEINIYNDNDFLIIQAKVKDLNPQ
INIKDILTNLEYNDKLCLGIGKLKERKVVWLEDTQAGSILIHGSQQFSGKSMLISNIIIS
ALYTKSPNELELFIINNGSKSLKEFAKLKHTKKSVDHDDFENVINLLREIMNDINKQNTL
FADNNVDNLDEYNLKNQNQKLPKKLIIISEYVEIVSSQFNTRFDTLIRNIANIAKKHGIV
LIISSNITNESTVSFKNVFDYTIVLKLNNPYESILLTDRNWCNNLVGFGDMLLIRNFDNL
PLRLQTAKITNEQFANIINEINSADYDIDEYRHETRLTSRTQNFFNK
>UU509 conserved hypothetical hypothetical ATP/GTP-binding protein
MAKINFLSLGGQDERGKSCFVLEVNDDIFIFNAGAKIPTSDVFGVNMIVCDYSYLEKNAK
RVKGIFIGTPTFNNVMGIKLLLGQVGYKIPIYTSPIGAIVIKKIFEQKVNNKKIEPNIIE
LDPISDKKIGSIYVTSFKVSNSMPHSYGFVLKTSDGAIVYVDEFIISNDKNKTFDSQINL
LNNITKNNTLALIVGMGQAGNPYFTAPNHKNKAFYEAALQNTKNRLIVGCYSNDAYSIFT
LATIAKQQNRPFIVYSNNFINTFIGVLKLKLFNSKNLISLPVSEINNSKNAIIVVIENQD
TLFSKLNKILHNEDKYVNLSSDDQLILGVVITPGFEMLAAELSDEVGRLDIPYKALPKTV
LPMTQSDEDLKHLINFLQPKFLIPINGLYKTEVKFSSTVTTSWIKSDQIISVSNGELFTI
EDKVLNPKPQIIELEDKYISSFDALDVGANILFERSQMGENGVINLIVIFDKQFQKLFNY
VEFDYCGVVNNDAQIKEIEETFKKRMGECLVYDERKRLILKDTKANLKRLLTKLFEKKFN
KRPLVLPTVVDCYKTK
>UU510 ABC ABC Transporter
MKIVQQTSDNECGVCVINMLANYYHNKTIDKNIILQKANLTKNGLSLQELENLANEFNLD
AQSFECSFEELIDEKINDYFIALINKNGLNHFVIVKNYNKNFFRIYDPENKIYELNNEEF
KKIFLNIIVRVSKNHQIFDLPIFKESYLKNIKLSSLIIILFIELLNIPLNIFLSKIVNLL
IDLVLIDTQIKNLTYLFIVFSLFYISNAFKDLLITIYINKISNNIFSNINNKIVNNLANK
SIIFFNKTNLGELSSIQIHLNNIIHFLLVSRIKLLVNTLFAICIICLLGLQNWSLLLISL
GFSLLNFIIGLINWKYFKIHSLKIINIENSLFIKYQNFIKLINLEYNIDKYNNYINSYKK
QFDELIIFKNKITIFKSNVNFYLSIINNIGLLILLTYLIINTNYDYKVISVITYIVFLHQ
NLNNLFFGIFNFFNELLNFKNGKQIVEKILYIDNYEEHDGIQINKITSCKITENQKEFEF
SKSCLIIGKSGVGKTTLLKNFLNFNNKNLFFNNLNVNNINLNQLKELIIYHPTNPLINDF
DINWFIDKNEEIINALKIVIFITKIDWSLNNNFEHNINLSTGQQQILAFLNLLKYKNKLL
LLDEPLAHVDNDNKKIILNSILPIILKNNFVIYVSHDHYLKKYFDQIINLNDEKMDKY
>UU510.1 unique hypothetical unique hypothetical
MMKKWISISLLGFLLSLLIAIGVMFGFKNKKYFKTTLNIQTKLSIITKNNYEKIKTKKQL
EIKIKNLTYYVKFKFLKQTHDYCLIKIFLSLKTDQKMIDISIYTNTQPLIESIINNFKLY
N
>UU511 cdsA CDP-diglyceride synthetase
MISVNKINEKTKNTFFKRFYSSIFIFLYLLIYFVLALLADRNYNWTPLINNLYIQQGIAI
VLLIWLLPLICIGSYEMNKVIFDNNKITLIILTIVFNICIYTTTISYFIYQYEFLNIKYL
LTINYHYVIKLFGACLGCSYFVTLVILFFFLAFLKKINFKNCLYTILIFSFLSGFFIGLL
YFTFIRSWITSLLLMMIVFLSDTFAYVGGVLFGKTKLAPKISPNKTVEGLIFGLVIATIV
IMLIIFGLSYVPIKPKNGIVLKSQNVLYNIFGLDFSSSNEKNLTLHKQALWWICTIVAFL
FLSLISTSGDLVFSAIKRNYHTKDYSNLIPGHGGLLDRIDSHSFVISIMFIFTLLITGSL
QDENLFPNIQKFFIQLIV
>UU512 frr ribosome releasing factor
MNFKIYETKIREEFELVLKWMHNEFIKLRTGRATPAILDGILVNYYGSMMPINQLANISV
PEPRVLAIKPYDRSSIKDIATAINASNLGVNPQVDVDIIRLTFAAPTEEVRKNLVKKAKQ
VGEEAKIRVRHIRQEAQDLFKKDSTTIEDDKKFFQTELDNLTKELNKEIETVVSHKEKDI
MTV
>UU513 pyrH uridylate kinase
MRKQRIVIKISGACLKQNDSSIIDFIKINDLAEQIEKISKKYIVSIVLGGGNIWRGSIAK
ELDMDRNLADNMGMMATIINGLALENALNHLNVNTIVLSAIKCDKLVHESSANNIKKAIE
KEQVMIFVAGTGFPYFTTDSCAAIRAAETESSIILMGKNGVDGVYDSDPKINPNAQFYEH
ITFNMALTQNLKVMDATALALCQENNINLLVFNIDKPNAIVDVLEKKNKYTIVSK
>UU514 tsf protein chain elongation factor EF-ts
MTKAELVKELRIRTQASMSECIKALDASENDIEKAIVWLRENGAIKAANKLKNAATDGVV
LAKKINNKAILIEVNCQTDFVAKNENFLAYANQILEEALAKVENKEDFDKLIINGKPIAE
SGLDLTAYIGEKIVFRRGEILKANDDQTLGVYTHNNNRVAAIILVDGKVEDEVVRNVAMH
AAAMRPRYLNEKVVDKLWLAKEREIIVNQLEHEGKPAAFAAKIIDGRLNKILKENCLVDQ
SYFKQPELTIEKYLKNNNAVAVGYFSYEVGEGIEKAPQMSFADEVAAQMKK
>UU515 ABC transporter hypothetical ferrichrome ABC transporter
MNKIKNAKSSFLYFKKMHNLKSFNKKRNRLKGIQIIFIVFLIIFCSLFFLIDLFFTGNHL
NVIKRMFENSSLSNSTYIFVPVANIITGFSLGIGSISIQITSKNILAGPSTLGFTPMAIL
ASTISFIITSSGIFSTILIYCLGLIFSFIIIGVNFILVRNNFLENSFKPILVAFGIGALV
TGINIVLIATHDNLKIVGWWRFITINNTLINNYRMIVSSVLMIISTIILLFLSPYLNIIR
KDYILAKSLGIKVNLIYWLVAICVVTITISSSILLGIIALLGVIVGIIIQTIFKKTHVLL
LMILAGLFGSGILSFSSYINEYIPSAREMIICVFAIPVFAYILSKRKGFIK
>UU516 fatC ferric anguibactin transport system permerase protein
MINLNTWNKTHSFKNPLKYQNKIAYLKTMITVIISIVVFIITLAWTYDFNFKQDNIALAY
IIMQIFLSGFILGFCAYLIQKLTKNRFSDTSIMGISSVNILGVIIIAFQVDFNNFSADKL
STLEHTEPIIFFIAPIILCMLYYFTCKEQSSFNYKKMLISGVIVNFLSVALGASIAKNLP
KLANAYVSRYTYGSIEPQQESFFIALVLIIIGLLIVLFNFKKIQIVSSNQDLANQLGINV
KLTSGLLLVAICLMVGASYSLNGNLIFIGLMAGNMGSVISNNRFKSAAISSGCCGSLIYM
LSFLLFIKILNFDSQWLNLAIPLIISPYFIYIIVKKNKSDL
>UU517 ABC sbp putative ABC substrate-binding protein - iron
MKKWKLVRTSGLILITGISIPVITTSCSLIDLFKSNNEKQNEFTHGKLKSNLDYNVSTAY
LNKRSIALKFTIPLDKNQAINIFGTGWIFDFQEDPFTKNIRTYYLATNIHVINLISAAKQ
NASLTLGQYDLESQSQDTRAFFNENLSFKSAKKTYNPQYYVNYNPVGTFSILPVGLKNQL
KNYGIKNPAALASLNNLTTAVDLAIIKITPDILQKNNIDALRNFDKEVGIGFGNTISNHQ
RFYAAGYPHDEKYSRWNQYSNQPDELFNSFSTSNYRKDNPINFSYNEEYMTVSNRNTIGK
NNPTKYEAYDYATKNFDLHSGASGSPIIDDNNNYVGIYWGGFKIQEGLKTTFYGNFSPLF
VHKDNGLSQDLLAYYLAYTANETTYLDTNFNTNLRYSALSKENKEIYDKFVQSLEKQFLS
DDNQYGDKNILSLKTVDGYSKNKQDLINTLYNFIFKDINSPSFNEKYTHENLKLKDIIDV
KVEWNRNKNIDLRITFITKRPLNFNVNHIVNFNTSFTFFKEISKPNENNNWIDQLL
>UU518 conserved hypothetical hypothetical
MASEDKVVYYLSPNEDKGWKIFKKGGERATKLFSTKKEALEYIKTLGRNQNAVVYIQTKD
GKFQDVRNYRDK
>UU519 unique hypothetical unique hypothetical
MTSSIEKTPLVIKRHVFKKHYGIFTTLWEVIKDSSSFIASSLFSSLALLLITIIIALHNF
SGAFAATSVSYIVVFQFSFIQLGGNIGVVLALWAKKLYDGSKHKFVPSHSTTNLASFYAF
SFGLIMLGVYLATSYTYNLYANIHENTLFAQLFGEQYIWSSLGIIVLAPVHNYFLISIWT
NDRRKILLTIILDFATWTICLVTSFLLGKYSILAYSGYGLGLSIGYIISTIAISIIKFSK
DWRISKLGLSLNLLKISIKQIWNQTLISIFSSIIKMFVLLALYHLINQKMTNSVPLNLQT
GRILWYHAMLFIQGIGLGFTDYLFYIFQKQTIRDRRYHSRQLFICVFGLLFVYLMIAAII
FGFSIKPLSVVYAKEQNEAYINLDAEIPDHFYMSIRQGILNNPRLVYFLGAQAHIDPRLI
LAHLTNHNPEVWKVVIKQLITPIWAAGPNFKYLYGIDNPITTSFVQISAEVVKKLLIGDN
TYIHLTIFAIFYSLSLTLMRYRDLIAKKQQSPFPTLLLQVLVIAFVVGFGVDYQSSVKFA
GLLAWSMPLSISSAVILIISLLMFTIVYYKYLNKNDYKDNQITNQYSFKWIRHILWK
>UU520 unique hypothetical unique hypothetical
MVFLYKRGRFNLEEQKQMKVIKKSDSYFKKNLTVFRTLLELLKESSPFIAASVFTGLSLI
LIVVIVAHHKDIGAYAATSISYLTIFQLSFLQLGTTFGIVFAIWSKRSFKDGKYKFEPTN
DTVNAASFYSFIFGLVVLLIYFTTSYIYNHFANDHQNTVINQSVGSAYIVSGLAVVGLAP
LRNYLLMLIRSTKSINVLLAIVLDFCTWTTALIAAFLLGSYSVLNYWGYGLGMSIGFVFW
TIIIGMTTIEKAQIVLRPLYISKRLFVLSIKLLWIQTILSSLKSVGKMFILLITFVVINS
RVVGSSLLDFQSTRILMYQSMIFIQMLNLGLSDFLFYLYQKQEVRDCRYHSRQLFFWVFI
LGILFALITSVIFGFSVKQLVQLYTSEQSPSYIFLEKQVPEHFYQSLRKILINDEKLLDI
ITSHVNIGRQEVVNALSSNDKNIWLPMAQKVIDPIWKLGDKFETIYQMKNPFTHRFVDIS
ASNIYSYLIKNNAYILLSFFCTFFSFSSILSRYVGLIARRQRPPYVMIVIQLVMVAFTSG
FGLTHQSDPHFIGLMAWSFPLFISSIFILGYSTYKILRIYRKYLKNHKYNDEKLSIMPKK
QLEQQIKVRQN
>UU521 pepF oligoendopeptidase F - zinc metalloprotease
MNDINDKKYDWDIDSLLKGKKLDILFNEFVESNNELIKAFEKWINSLNDFINFHEVSEKN
LLISNRINNYVSNKLQTNLIDNEMLAWSQKIEHEQHRVAKIFINFENLAIKNKDLINSYL
KNSSLIKYQLEYEELWRYEKHILNEQQQKVVTAISRFSSSFGDIFDVLLDSDMQYQDGIN
YKKQKVCFKNQTDLYVASKSNDRALRKSAYESHFKAIYDLRNTFSKLLYYEYVKQNELAK
LHNFKDYISADAFSDKVDKNFINHIYTQTKKFAKGINRYTKYRTLFLKQQYQLTKVEPWD
KNLDIIDKKNMFSIESAKNLTLEALALLGSEYINVVQRAFNEQWISWMPNNNKISGAYSI
SNTKGLDKIFILMNYDETYNSILTLVHELGHSVHTYFANQSQEVYNEYETFYAEIASITN
EILMNYHLLKKYENDDLMRLYILDEMISGFIATTTRQAIFSNFEWVANEWINQGEEFSWN
KIVLAYLEINHDYTGYKYNKNKISKYDEANALILINIPHFYTGNFYVYKYVIGQICGLIN
AIRIFNNKANAKEKYFCFFKSGGSLSPLETINILDIKINENDVWEEVNIIFNSWIDDYIK
IIKKFLINKKI
>UU522 tuf translation elongation factor tu (EF-tu)
MAKAKFERTKPHVNIGTIGHVDHGKTTLTAAISTVLAKKGQAIAQSYADVDKTPEERERG
ITINASHVEYETKTRHYAHVDCPGHADYVKNMITGAAQMDGAILVIAASDGVMAQTKEHI
LLARQVGVPKIVVFLNKCDFMTDPDMQDLVEMEVRELLSKYGFDGDNTPVIRGSGLKALE
GDPVWEAKIDELMDAVDSWIPLPERSTDKPFLLAIEDVFTISGRGTVVTGRVERGVLKVN
DEVEIVGLKDTQKTVVTGIEMFRKSLDQAEAGDNAGILLRGIKKEDVERGQVLVKPGSIK
PHRTFTAKVYILKKEEGGRHTPIVSGYRPQFYFRTTDVTGAISLPAGVDLVMPGDDVEMT
VELIAPVAIEDGSKFSIREGGKTVGHGSVIKTSN
>UU523 fusA translation elongation factor G
MSKELKLFRNFGIMAHIDAGKTTTSERILYHTGKNHKIGETHDGAATMDWMAQEKERGIT
ITSAATYAKWKGHSLNLIDTPGHVDFTVEVERSLRVLDGAVAVLDGQNGVEPQTETVWRQ
ATKYNVPRIVFVNKMDKTGADFYYSIETMKNRLGVKATAIQIPIGAEADFVGSIDLIEMK
AYIYDGKADEEYKIEDIPADYLTKAQVMRSQMIDDVAVFDDEVMEKYLSGEELSHEDIKK
CIRKGVISTELYPVLCGTAFKNKGVKKLLDAVVDFLPSPIDVPPIKGVDDHGNPIEYHND
PNEPFAALAFKVATDPFVGRLTYIRVYSGKLDKGTYIYNATKDKKERISRLVKMHSNNRD
EIDSISAGDICAVIGLKDTTTGDTICDEKKPVILEQMVFAEPVISLSVEPKTKADQEKMS
LALSKLAEEDPTFRTYTNEETGQTIIAGMGELHLDVLVDRMRREFNVQVNVGAPQVSYRE
TFTEVADAEGKYIKQSGGRGQYGHVWIKFEPNHDKGFEFVDNIVGGKVPKEYIKEVENGL
IEALTSGPIAGYQTIDVKATIFDGSYHDVDSSGMAYKIAASLAFKEAAKVCKPVLLEPIM
SVDVTTPDDYFGTVMGDISKRRGVIEGQEQRGNAQAIKAKVPLSEMFGYATDLRSNTQGR
GQYIMQFSHYAQAPKSVTEEVMVARAKK
>UU524 rpS7 ribosomal protein S7
MRKLKPQKRQVLADPVYNSRLVTKLINAIMYDGKKGLAQSIIYSAFEIVEQKTGKPALEV
FNKAIDNVMPIIELKVRRVGGSNFQVPTEVTPERRQTLGLRWITLYARLRHEHTMIEKLA
HEIIDASNNVGAAIKKKEDTHKMAEANKAFAHLRW
>UU525 rpS12 ribosomal protein S12
MPTIAQLIRNKRAPKVKKTKSPALLFTYNSLHKKTTKNPSPLKSGVCTRVGTMTPKKPNS
ALRKYAKVRLSNGFEVLAYIPGEGHNLQEHSVVVIRGGRVKDLPGVRYHIVRGAGDASGV
EKRRQQRSLYGAKRPKKEASK
>UU526 MBA paralog MBA N-terminal paralog
MKLLKNKKFWAISLGSIIVSTSIIATATACTNSNIESTVSSSFVRTQNGVYAIYEITNWT
KLDDNQKKSLQNLNFKTSVIDKDNNAEFTSSTGILRDGRVYVKLAREPKKDDRVIIKPDD
ANLKKGAVYVTTLNISNIELNDGPKVQISHSNEKNEIKSYNSAESIIYNQRWLANIWNTL
SAEKDGMLLTEYNSAKHQFDAMIKQSDFDTSKVKVEKDSNGNITKVTVSNPESNKAIPVV
FMDIDETILNNYANQNYQLLNNKAYNPKDWDAFVNDKVSKRLAGAFEFIKYVWEHGGVVM
FNSNREQENQVDPTIENLVSEGLERSLLPKWIFWMQGVDFSSDKPWANIKKDAQGKRVKS
TKEDRMNAMNKRTQGYDLSEFGSGNAVVLKTVMRIGDNFDDFNDNASKGKLNSERVALLK
EYGKLFGNFDINNKGVKYEKNQNGQMVKSDETWSESYVLIGGNSSYGGFEAGIAKGYYGL
GKEGQAKALKDYIKQLYWEPKSK
>UU527 conserved hypothetical hypothetical
MAKLKFWKISTSINTFIKYLICNENNVKKIFSNEKLHLDTNDQEWKILINDKNQKKVEFS
FKRSSYELIRVLYYLQIIVDSDKNKTINTYKNDTLKDYIFTFNVSDNTEKSINKHITNVF
VNKFLRNLDLNDFFQNETIDQKNKDFVLTIFLSLLHYKKHNDYLTKKELFEYYYEPKQND
SNFKHFKQYKEFVENYFKDQIISNELITKFENYWAKTNDENKANPNNQTNINKTKNKPDF
LRTAKTQQEKDNKKFNFEEYSDSCELVTNWKLPLISNDNSIEVTKLDGTKKLASDNGDAY
IFNLVWLIKFLNKNETIKMSIPVFQRNYVWTIDNIEKLLEDINDISNKQNNENHFLGSII
SVLVKEESIDNIQIIDGQQRLTTLFLITKAFIIFLYNNREEITKFTNEQIKQLSHLKDIF
FNREFIIDRFSRIGGNPDYEALKQILSNDELDNKNNHIFMNLKDIVEWFEEKPKEFKEWA
NFANALFNNLILNLVILKNVDEFKTFESLNTNAKKLNAIELLKNKFCWYENFKESIFKNK
EEFQQKYNDLITKKFLLKKDENIIEVKRFNEFVDSLSALNLCKDEDLKRFEKNDKDDEYY
NKSWFFIIEIINKKFTLKNNWKACLKYFSKYIDIYNDLTIKDKFTNNNCNFYLISDYLLI
LTNKKKKNYIPLLVYLLEKIFTEDVLYDFDNNGNFDKSKLRINIEEYVSVIANFSLRNVL
LNTRGQSILNSVIKLIKLIDNDINKNNINSIKNINLSKKFLDVFNSNNQMEIKNIKNFYN
KMLDEKVSDIHLAYLIRFETYLTFFLDDTQINKNKDTKVFFYPPSNADNEKADLTIEHMY
SQSLKDERFNIVKNNIGNLIPLTKEYNSALNNKEFKDKKQRYKNAPIIQNLWLYKGLNEE
QITKLYNEFTKINEKLKSNKIDVNEDVFKEALMSLKLSDKEELQPEQIKKRTQAIALVLS
IALFNEDWDVE
>UU528 dcm cytosine-specific methyltransferase
MTGEQLIKSVGNKGIDLLTYSFPCQDLSTAGSFSKKAFGMKKGSGTRSGLLWEIERILFD
LQKLNQLPQFLLLENVNNMLSKQHKLDYDMWTKSLKQLGYSTCTFQLNALDYGSAQRRKR
VYAISILNYDGLIDSNGNILDLEAPIFDGKQKQLKDVLKTNYKIEKYYQEAYLAQPNRTF
SRIKYVIPKYDLLNPNCYCTSTITTRQDRFPNGGYINLKNTILGDDYREKDHNNLPKKAN
FRLLTNREAYLLMGFNEKDFEAIQAKGISKAKMYQQAGNSIVVDVMVYLMKLIQERFNK
>UU529 codV integrase-recombinase protein
MKKFINYLKNVKGYSDGTIAIYQKYVKVLIDNNLDYLKAIKKYEHNANVTKRVVLSAFKA
YLKFINHKDAILIVMPKKEIKVKEFLTWDNFLKIINNINQATFLGFQKYLILRILFETGI
RSCELLKLEIKDIYENKLKIHGKGKKERFVYLSNDLQNNIKKYIGQIKTKYLFNFSYKNL
YQKVTRIKTNIRLTPHILRRSFANHCINNGINIYDLSLVMGHNNINSTSLYLNKESKLVE
LDHLFDNKKVN
>UU530 cpsG phosphomannomutase
MENTNKIFNCWLNSPKIPQVIKEEYKNKTQKEIDHIFDENYRFKFGTSGVRCIYEEGTRY
LNAITYTQLTLGFIEYLETKKNFNKIIVIGRDNRFGSRENLKLVAEIFSSFDYTVYINED
YGMLSTPITSFLINQLQAGAGIMITASHNPKNYNGFKVYNANGAQPLVDDTNLIESLMPS
YTEALDFNFEFKQDNIRFLTKEQIQSYFDAVKAQLINTDPNIKKPFKIVFSGHHGTTTKD
MIPFLESLGYDMVSVSEQNFEDPNFNDDPSSNPEEQCSFDLSVEYADNTNAEIMIASDPD
GDRMAIAVRHENYWKFLTGNQTGVLIAHYLLEHKKFTKPTYIISTFISTRYPELFAKNFD
CDVLYVDVGFKNHGNLIANRKKTHNLVVGFEEAIGSLPSDINNDKDSYQTASILLEMINY
YYEQKLDLFTVLKKEIFAKYGNWYSKTTQFVIDGDNWKQKALIILNNLRNFEFKTVTQYT
IHNIIFHEQGSYLEWKLDEYSTIKFRLSGTEPKFKVYIDLYDFSKDQKRDFYQELKIKAE
DILDFLKNYLGL
>UU531 cdd cytidine deaminase
MKYNDIYMGLLELLKKSYSPYSNYPVAAYVDTDLGFISGVNVENGSFGLTSCAERNAIFN
AIANGAKTFKTVYIITKNNGDIASPCGACRQVIFEFFKKDAKIVVFNNDGTYKEYNVEQL
LPFGWDPNISL
>UU532 pepP XAA-PRO aminopeptidase
MSDFKLQQVLKTIKEHEAQGADGMILFSNYNRYWFLEFASSDGFVFINKDGKAIYLVDAR
YYTAASETVKNAKVILLARTPQKSTFDLLKDAMVELNITNALVEADYVTLDVHEMLKKLV
KNTTPFTSATLRAIKTEKELEYLQKAADIAALTCNWIREQDIIGRTELEIATLVSKHMLE
LGGELNSFDPIIASGPNGGSPHHHPGNRVIEDGDMVTVDIGCTYKGYCSDITRSFIVGNK
ANPQMQEIYDKVLESQTAGINLLSTKVTGQEVDKVCRDIVDNSKFKGYFTHGTGHGVGLQ
VHELPNTNAGNPNKLPLNAVVTVEPGIYIPNVGGVRIEDTIVVKDGQALVLTRLAYK
>UU533 rpL33 ribosomal protein L33
MAIKRGVRLQCNESKSINYITTKNAKNNPDRLSLNKFCPKCRKVTTHVEIKKK
>UU534 thrS threonyl-tRNA synthetase
MYKFDQKLNHSAAHLLAMALTKFYPNLSLAIGPTIDEGFYYDFNLNDPNTSITPLDLLKI
EKEMKKITTQALTFDYEQVTYEKAKELFKHNKYKLDIIEQNKNNSLSIYHSGKWFDLCKG
PHVQNTKEIKAIKLLNIAGSYWRGDANNDQLIRIYGVAFSDQDQLDAYLKDLQERKERDH
RKIGKDLNLFTFNNLAGQGLPIWLPNGTIIKNQVQKFINEVEFQFNFDTVITPILGSIDL
YKTSGHWDHYKDNIFSPVQIDNEILVLRPMTCPHHTLVYSNELRSYRSLPIRLSEHSILH
RYESSGGLTGFERVREMILEDCHVFCRFDQIEHEVINAFKMIQEAQEGLGIKTFEIHLSL
NDPNDKEKYYDDPQMWEQSQNVLRKMLKDHNIPYKEMVGEAAFYGPKIDFQVKTVLNRII
TVSTIQLDFLLPNRFNLTYINESNEQSVPVMIHIGIIGTYERLLAILLEQTKGILPLWLS
PIQVVIIPVNENLHTDYVKELNIKLRKHLIRSNVDLRNERLSKKIREAQIQKIPYQIVIG
DEEIKNNKMVTYRCYGSEKTTTVSITDFINMLENKIRLKK
>UU535 conserved hypothetical hypothetical
MKKSFLIMTDSSTTLDREWAKNNDVMILPLSILRSDHTLIVDDGIESKPERIYEDIDNGY
TFQTSCTPYGVLIEAIEQKLQEYEKIIFIGISSGFSSQFNNAKNLEKEYQDKLFVVDTED
FGYSLEHLVYKIKAMLSNNISFGDILKMINKHHDYTSSFLACENITGLVRSGRIPKIIGT
MLKLSKVTPIIKAEWKNHRAGMALNIRSAPHKILENINHVFDNQLNNHTIEKVCILQAGL
SSERIDELKNDVINHFHVDKEKIVIRSGPPIFLVYVWKGALGIQVIANIPKKHVEKKH
>UU536 hisT pseudouridylate synthase I
MNYKISLRYDGSLFYGWARQPQKRTVQGDLEEIFKSIFKINNIRIIGSGRTDKGVHAYEQ
TFSVKHSALKYDSHIIYQALCSRTSSDIQILEVQKVDDSFHAQYNATSKTYQYVINDYEF
DLFRNNYELFVNQKINDQKILEALELFVGEHDFKSFSTSELTMTIRRINWVKIKRDTHLI
IYINANGFLKNMVRMIVASCLDYAFNKISLAKIHELLIYPKKGASIKLAPACGLYLYKVY
Y
>UU537 conserved hypothetical hypothetical
MSANAYVFRRSPIHRLNPAIKFISFILLIAMIFLPLGFFAQMIIGIFILIVFFVAKLPKR
TLWNVFKSVVMLFIILLLINWMTYKDPIAIYNVTDQAKVILGNNSWINGPINRNLSFNLF
YNDISSTHPQNLVSNIWGGEIKNYISPEIIKKLIDKPDYNVAKFLNENNVTVKKLESTFN
ALNQDVRLNNFYPIYGNSTLKSGKLEVPLSHLSYYMSTNLWKINGIKYQGLILSGVGDQL
GKAQTALFYTRSPFALSPIAIQLAVYISIKIFLMITLSSILTATTSSIELTNGLEDLLSP
FKILRLPVAEASMMISIALRFIPSLLDESKRILNAQASRGVDFNNGGPIQKLKSLISLVV
PLFSIAFKKAEDLANAMEARSYNPRYARTRYRTFPLNLADYALFGILCILVGFLISLAVI
KFYFTPFGVFEASALFAK
>UU538 ABC ABC Transporter
MQKLMDYFFKRKLKVPRPISNDISVRVKNLYAVYDEKQENQLVALNNISYDFKKNKIYFI
IGNSGSGKSTLVTHFNGLMISRYGFVQVGDIVSGDHFDFERQLLGVIDSYDKKIINLLWR
NQLDQWTFLVLFSNEVNIQQARILFEANFKQKPISLKFIKTKNNHELITNPYVRENTKIA
VVRVDKNVILEINDKMNYEELQRFEFIKKEIKTNYHLSKKIKRFKELRRRVGFVFQFPEY
QLFKDTIEKDIMFGPVNLGVKKSEAKKRAKFYLNKLGLGDDYLERSPFGLSGGQKRRVAI
AGILAIQNDILVFDEPTAGLDPAGEHEMMQIILDAKANNKTVFVITHTMEHVLEVADEVI
VMDEGEIIKTGTPYEIFFDQHIINSTSIQVPRVIAVINELIKKDLKYEILKQKQPRTIEE
LADAIIEFKKGEK
>UU539 ABC ABC transporter
MSHNDKNTHNYQISSLDKIINDSSVAIEFENVYFAYTEERMILKNVSFTINDNEYVCVIG
HNGSGKSTISKVLTGLLKPKSGVIKLFGIEISAANLKYLRNNIGIVFQNPDNQFVGITAE
DDIAFGLENRKVPPNKMWDIINDAAVATGIEDLLKKESLELSGGQKQRVAIASVLAINPK
VIIFDESTSMLDPKGKNELKELMVSLRDVAKKTIISITHDMEEVVKADKVIVMSNGEVQY
IGTPQEIFANEERLLKMQLDIPFTLKLAKTLKEKGLKIDLTLNNEELIEKICKN
>UU540 rpL1 ribosomal protein L1
MAKISKKLFAAYEGIDKQKAYPLFDAIKLAQEKSITKFDGSINIAIKLNLDTTKVEQQLR
GSISLPNGNGKNVRVLVLSEDITKEEAASVGADYFGGADYIQNIEKMLNQIDVIITNQKM
MPLLAKLGKVLGPRGLMPNPKIGTVTNDVLKAVEEFKRGRIEYRTDTYGNIHMSIGRVSF
ETTKIEENANALLNLIKSKKPATVKGQYIQNIAVSPTMGPGIKVVINNN
>UU541 rpL11 ribosomal protein L11
MAPKKKEVTRIAKLNLIGGQAKPGPALASVGINMAEFTKSFNDKTKDQNGKVIPVIITAY
KDKSFDYVIKTTPVTFLLKDIAKIKSGAKDPKKQTVATISKEQALEIARYKLIDMTAYDE
EAALRMIAGSAKQMGIVIEGVSAYKEKKGN
>UU542 unique hypothetical unique hypothetical
MKKMFLLMKNMMRLFFKNKTLVTQLSILMIVSTVVIVATTITVQRLQKSQSDIKKIGLQS
DFLIDTKEQDNINFNEIDVSNNLVKHNEKLIQLATFNQNILKNSNNYLQLVDNAFHNHNL
FWPTNVNNQKIDVLNLEGNIDWNKINQLKLQTVFWFENNKENNQNFANNYDDLVYEYHNS
KNQLVGFQNLDGGHILFKTPALKSANGNYETTFKINAAIVQKNKPFKSFFNFDKYKELGF
KNKSYFTNPVLIKNIDLYSKQVVQTLNDRSNQSIDFKDYQSTFQAIVDTLETNTINKDFY
SVNLHVDFNTLSTKYLLFANYLKNEGIDKNRYINELKIDNYKQKYLDLFQNQVLIPKELI
DDPKKIEEVQKIIAKAKALLIAKIREETNIFYENSQKSALENKNKIRDYEMQLKQINIAL
QNSNYSNNELIQLKNEQKVLAANLDQAKFKHFLYNDLIKQDFRSILNNYNIYYRKHESAI
YNDVKSDSNFIVTNASNPTYTQNGLIAPRNQWIDNMVQINEKNKNSQNPNKKFKRIFIND
DNSNKINNFYDLYSNYIKVIQILKNSYEKDPDTDKDLLVEERDYTPWINTSLINIYQLPQ
FFNILFNQSEWLLSIQYLKEMSDYKKYLLQIFEPYQDKEWIFNLKHKDWQDGEQVVAIYK
NADSNSDQKEYYFNGYVKNQRAYINVKYNKNLPTRLKLINIIKQNQINQKNNLVNVLDQD
LNDYAKIINFKKGIKDINTNQQSVYDQWALNNPQDYAMFKIWLSKIIKRYYFLRFSNHLM
DIQFKHKTFYQKLCYCRLQLILLIVVQI
>UU543 conserved hypothetical hypothetical
MINQTIVKFTLPNGRKKRIAKDYYSWINYVVSPANKIEINGQFFFIIGAVDSPEFLFPAI
NDSDILINKQKSTVLYVNDSGFAKLKTISASVPILEYYTLKVNTNDLNLLQKNNVYNEIK
SELLDSKKGNIYKRTDKDNPYPIYVKRTFFLTQLRNLIIAIALSLIVLILLLGIYFVTSS
IKNMINKNKVMFGAMQAQGVSRWQVWFSFAPFYTIPSLIVLIIGYSISYEIQPLIMRLFS
SYWLIPIPDQFVSVGWIFAIPIALTLILGFICWVLIYYILKHSTAETMKGDAGFKINKFI
IKTKAIFLKFGAIRVLKATYVVANLARMLILLVIASSFSIIASIIATTKNNFSQSASITN
AKREYQYAVDLYSPTEQGGFYYISKFDEMGVSNEYAPLKQIVKNVKIVIKIKNLVNKKVN
VVYINNQTKQKVIIEALINDKGIITFKTNQLVKGSFQFEGIYEQETNRVLINSQNLNPSL
LNIDNRKIGHFIYSNQKQYIYLLKSYFNDNDVILDYVDANNQHTYLKAKTLGQYLVFDPS
QLKQKQKYQLVNVINHKGNTWVDLNNISNDLKNLDYSKNGRYLYDYYGRLPYLYFNHLPQ
NLINQKVYLTYTINQNDEFRIYGIVNKEKEVVFDLTKLKINTQQSYQLRDMRIANSDLLI
YDNKQHEFNNNILYFDNNYYGLNNNNQKQINIDYLTPNRNLYLTLKAMGNEFVNKKKIPF
IMTKAMASLVEPDTAILDYNELEKGYVYQISTATLEGSDTNLYLDNVNSIDKTKDNGLPY
SSLKYNNAMREIKNLGTDHPVYGKMLSNVYYPSISTQPEILQNIRFFDSKVISKSSLDGN
ISVKATDVNIEFNPWVFAKTFLPITAIARSELNEKHLLDEAFKTFGYEIINGKKINKLYD
VPNFEDNGIIHQISLWTKNGLPPKSENDENAFFIKQNGQWKINEKPGVLTEQGAAEFLPE
FLRLITQMYTFKTTRYLQYKAGLKFVNIEDEKVQQPYTYLLGKMQTKTKRFANEIKILGI
NYEKNKFINGKPSPTTQLSLINDQGVNLIDLIKNDDPNNEIHNIIINKVVAQKYHLKIND
VFEYQINNHIKRLSNKFNNTPENYKTKFKVVGINDSLMDEQLIINQKVANKLIGFDDYRR
RIQIENGYPIIEEREFNGFFTKEKEPIFFNNMASFYSPTGLSPAIDSWPQNLLENIGGNV
QSINIYWIFYYSWDLANSILNASFDKNKITWEPFSEINLDKLLKKIGKIFGKEANLPSFK
AVDANIENEIFASVVDKTSFTLLLNIITAIIPSLVIIIILVASTLANESRRLIAIMKVLG
MRDFRNVNNFMFIYPIVWLLNILIATPLSFGIIHIYKLAIFAAFNIVLVASIPWWIFVIS
YGFVGIVLLFAWLQMLYKTKKLNLPKALNQFNN
>UU544 gatB glutamyl-tRNA amidotransferase subunit B
MQNFEVIIGIEVHTALNTKTKMFSNAATSHKSIPNTLINEIDLALPGTLPTVNQEVVHKG
LFLANALHMRTNHQFIAFDRKHYYYLDLPKGYQITQNYFPIGQNGYIQIIDEYNNLKRIR
IKQIHLEEDTAKQTNIGNQIYLDYNRAGWPLIEIVSEADLRSAQETVLFLEELRKILLFN
DISDAKMEDGSLRVDVNVSIRPQGAKKFGTKVEIKNINSISNVAKAIDYEIRRQLNLILL
NQNVEQQTRRFDDNTNTTVFMRSKNDAINYRYIREANIAPIHLSDDYVKKMFLTKSCSIN
DLRQQLAQKGLVSSAIEQLLSDGPLFKAFKYVDKIVNNPLSVYKWLCLEFIGLINKNTQN
IEEITPELLQKIARMILLFDQTLINGKQTKIILEKIYLTNKDPQILIKELGFEQITNENE
ITKLWHQILAKNQEMLLQYNERPDRVEKFFMGEIMKLTKAQANPTISFNVLKKILQK
>UU545 gatA glutamyl-tRNA amidotransferase subunit A
MKNKTILALHNQIKKREVKIYDLIKKSIDHDLKIKNLNATLANNYEQALKQAAFLDEKIS
SDNLEIDYLFGIPYSLKDNISTKNIITTGGSLFLKNYNPPYDATVKTLLDQKQAILLNKS
NLDEFGLGGTGTDSAFGPVINPLNPKHVSGGSSSGSAVLVQQGVVPFAIATDTGDSVRRP
ASIMGIVGFKPSYGLISRYGVYPFAPSLDHVGIFTNNIFDTQIVFNALAKRDFKDFTSLS
FKTQSLSMLKTKNKYKIGVLKPSFDLLASKYQQELTNLIVKLNDEHEIINVDYDINLLKA
ISPVYKLIAFSEAYSSYSNFTNITFGKHDIDYDNYEDLIIKTRTLYLGTQLKQRFMIGAY
VTQESQFETLLVAAKKMRTLIVDQAKNLFKNCDLILNLAVHDISETIDDVNNQKPTTNLV
EDVMQIANFGGFPSIVIPFLTTKLGNLGLNLWADYLNDNKLLNGAYLINNLLGNEEK
>UU546 unique hypothetical unique hypothetical
MSYNLQKLMSSCMFILTDDEIKQVENRLNNLFNEIKVFELFNLQNITPFEIINKSFDNFL
REDEINSCVGNNSEEVLNNCLKVIDHYGVLKNEK
>UU547 conserved hypothetical hypothetical
MSVLHTTNTSQGNGINSWQSILIFLAFLIVFIIFTVIKKIYYSIRFQKRFYIIPKTSVKG
ISNIAMVISISVAVIILLTVLSANTASVIFRAWPGTRVTLEGILIKIGGLLFGPILGIFI
GAMTDLLSVAMTAGVFHYGYLIAAMAYGLIGGLIRIILTTSKKKDLPFAIYSSMATILIG
VGIALFLYFAPGIGDKGFNIQLFGFDIKIARTLMIGIILGFFLLSIIVVWFSLLIKYWFN
KKNKAKTKTNWFIIFAPVLVTILLTEAVVNVLMMPSFDAELSSLKYTQWLSIRAVLFIPM
VVLNLLIIYPIFKIVVPLIRYDYEDDIVEDKHIPIHVD
>UU548 ung uracil-DNA glycosylase
MKWKEFIINETKQSYLKNIIKKINNIENHQVVFPLKKQRFRCFDFFDIEQTKVVILGQDP
YHTPKIANGLCFSVDLGNNLPGSLINIFKALEYDLQIKRTNPDLSDWAKQGVLLLNTVLT
VNAHQPNSHKNFGYEELIKNVFNELRKQKHVVYLLWGKQAMSYINLIDQKQNLILCASHP
SPLSAHRGFLTCKHFSKCNDYLIKHLRTPIKW
>UU549 unique hypothetical unique hypothetical membrane lipoprotein
MKKNKSKKLIFSILGISFIGLTPIVAASCSAAAHPQVNVHYVSANATTNNIGKIKIRAFE
GKNQKHEMIFENQNLLDDVYYAAGDLTYTSVKDNKRFDKNNKEIDQFGYLVPKKEVWTKS
LSSSTKLTPIDLSILQNELIRLIGNKLNFDSTSKYANNLEILDQTKKQTVFNQKLYSSDE
LTKINKVSELINSLVISDGLYTYITSMTDQLIKWLAEHAFNNHSNKDFELFKGLKNEVAK
EFLLALVQGVGAGKHTYKLALYNFSFDWEYVDAITGLSINKPNFGVKVNDELLVNPSLKN
VLVRLKNIKLQYAWYNSSNKKAGSFMEASSNGSQLNALSSINAALSSVDKKTYAEIHDDH
KPEIRNLVYEIPLKDMVVNFAPSTMRSANINQKATQTLQENFLKIKNQKTGLTETEKKRT
TVYNEYYTGTLSKIHAFSILGRDLKQELKNEAKVNKKEYVEDKKLEDWQYYEHDRGLNGV
YPYAFLGEKKINELKIDDFIKSRKFVEAIKASNNSRTILPVTNPENNQILSKQSYSQLAM
IALENKDANIHNLTSFKAAKNNFRKYLFNLNEIKSVNVNYSKWNEKNS
>UU550 dnaB replicative DNA helicase
MPTKDLNDAILDLFCLIINNNDFWKDVVLRLEVKDFPEKIQQNIFNTIANLNEQKYKINE
SNILNALANYVIIDEQDQNYLLHKNYLLQILDRTDYLVDLKDCIEIIKNASIKNKLDVFA
NEILATQISLINAKDQFKEMHEKFLEILASRTEDTIENMELIANRYFEKLNKIGNSGIIP
GVIKTKYDNIDKFTNGYKPGELVVIAARPGIGKTTFCLNVMVNNVNEIIEYNENIQPNQK
EKIIVMFSLEITKEQILQKFISIKTGISNREVIENKYRITKGYDTRSFAMQAINDIKSWP
IFIDDRPNISIVDIEAKLYDLKKRYDIALVVLDYLQLVSGGNANKNMTRTQEVGRVSSAL
KIIAKEINAPVIAIAQLSRKAEERDVSNNVNMKNNPLVKTIDNSPKLSDLRESGSIEQDA
DVVAFLHWDRKQRNFMQNDNQETRMRDDLIEAKFIVEKNRNGSTGETDIIFSKLNSKFIR
ATTSKE
>UU551 rpL9 ribosomal protein L9
MKVILLEDIASLGKKNEIIDVSDGYAKNFLIRQKKAVALTNKSQEVLNKDLAILEAQEQQ
AILDATLLKDKLEQKPLQFFLKTNNLQTFGSISNKQIIDEINKEQKFITKHMITKPHALG
IGEHIVEILLHKKVTAKLHVIVSKE
>UU552 rpS18 ribosomal protein S18
MAKVTNNRNRKPRKKVCILSAKGIEHVDYKDVELLQRFINNNNKIASRRVTGASARMQRR
IANAIKRARFVGLLPYVKE
>UU553 ssb single-strand binding protein
MNKVILIGNLVRDPEARQIPSGRLVTNFTIAVNDNTPNANANFIRCVAWNNQANFLTTYL
KKGDAIAIEGRIVSRSYVDNNGKTNYVTEVYADQVQSLSRRNQSPSDNNKVNVDTMMESY
TGINTDAAFSSNKPQTTLSSTTSNLNKNNDEEDEITSWINLDDDLE
>UU554 rpS6 ribosomal protein S6
MAKYEIMLVVRGDLDQEQANKVANELKATLKNTEVKENNYDGVQQLAYEINKLKTAYRYV
YNFETTDVSLINEFRRLAIINKNVLRHIIINLEKDYGYKATVNTKKVQRNEKRAEVYARQ
KEEAERRAVERQAAYEAMKAEREAAGLPVKEFVKNTNSKR
>UU555 conserved hypothetical hypothetical
MVLIEKINEQDINTVVAYVVAFRKKLYPKVDHNNLPKELVNFKQTYIINPLGIWFSVFLE
DTHELVGTISCHEYDYRYNNLFYLDRSTKTSEVGKLYIDPLIRRQGIATRLFNALKDQAK
KQGIKCFYLHTHHHLPGAREFWLKMGFKIQKEMTLEDDGQDIIHMTLEL
>UU556 unique hypothetical unique hypothetical
MDLIFKRLKFISIQNWVLLLFAAALFVCVGAWIGHELVRHNLFDAYTLNHEKELINMLNP
KDLEVYLSQKEQIRLSIGFFGLFLVLWTLTYLISLVVNIRILIKYLNDFNENKTKVKKAL
IISLIPFIHYVSSILLTVVYDKVFNWNRKKSHTLQEEYISAY
>UU557 unique hypothetical unique hypothetical membrane lipoprotein
MKKINKKIIFLSIGIVGLIPVAAIIASCARTKTTKEQNKISPYLEDGSNFGLAMDAINTL
NYVKFASLRKIVFSLVDGLIKEAPSTNSTIGNLLGISKLFLNQYKNPVDAGFNNMTDAQL
EGMRISPSYVDLSSFGINSGALAPTVSEDDPTWVFYNNSNNRIVATKFTTNFGASKWSDG
KEVNAQDFIDAIQYILDLNTGSQLRSHLLRFNIKGTNAFNDAQEEYIRKHGVPYKNPFGR
APYILNKQTGQWEEDPNFVPYQNQTFDKNGHPVDDLEIAAIKKAAYEIGLSTGQAYTNIS
NKELKEALKLPENKDFKFHESKTLTIFNPKYDHKKPDKNTPEKIVINLIENPSFNHRQKL
ASDDLQTLANSKDLFKFKSLPTSRFDLLMEFETYAPKPSFSVLLTDILGNQALLPVNRRF
IETHGGIEKFGSTLENFVWSGPFNIADVVLGPQGYMTLEKNKDYFSANWTISDKIKIYFN
SKNEVTSLWFEQGMISSTTVPPSYQLKFWAQSKMRDLMKKQAGAGTVAMQFNLDRQSRYD
SYQEYLKNPNKDIPILDPDLRRAIAFAINRENILKLSGWTSSFPVTTWTSFQRIKDSKGR
NLEYWFDNKRFDSEYIDTIKDEKTHETRKQNRSFLIQNNDFSDHVAAKNSTFENINRKDT
GFDPQVAKFYLDKYKKKHPDKKQVVLKFVYPTEPADIGKAVIAIKDLIDRNLNGYVKLEL
QALPPNTFVTFANSGKFDISYQNFDKYAGSTYDSALGLFLTPDGIDLKNNKSSGYELNPT
GSWTPKNFFDRYKNKAELDYALKRLHISEEDADIIRELVTPTNIKTSEVYNPQHLTNRAD
LRKLKLKDKAIPMFDVNYSEYDAKIIHDLEHQINKLNQKIKNEPTSSSKSTWEKEANNLQ
NEIDTMQEREFYLSEEFLNKHDPKRENKPFLLVLQNNVTGQFTTLQIQPVIDKKTNQYVQ
ATKEDYAKYYNKENIDEINFKKRFKYKFSIKKLPIGSYQVINLSYINDLKPLLSKYLRNE
NNEISDKVNNEIYMTKLETVVDQRKRIIDFFSGNRPGWEDDDSIFRTILNLEKILRDEAA
IVPIMEIDTNWTISSLGGMKNNFTYYLQFAYDYRRPPRPGLPTSPQAEGDN
>UU558 unique hypothetical unique hypothetical
MKKRLKLSAKIAIAFASVGAFAGAVVGFMKLYAVSTGGLGRQTLQVNSSFDTTIPNRQVD
RALLMDQFGKPVADYDFKAKKGNNTQVTLLIDFGKYKKGQKISYLEFLDNFVNLNNNNLP
NLRLEVGPIVFNNNYINSISPDEFIEFTNWFFKNVSWGPDLLTLKEFKLSRGIQQNGNAI
TLGLHSGTRERTVIEFFPDAFFGSLPIYNINAGPGNAYDSLARQVNKDAMTLEELEEYHQ
KIPLMISAYNSHSFGGVKLIDVLKNAKNTYLFNADKYFDLTKDPLNFPNLKNLKASDRTL
NYLFYAQNEQQAKQKVQAYLNELQFVKGLIPKDKKFNPKIDVKMDEINKIKINEFLEFNA
SASSPFGGSLDLESIGKSSGNQNYLLIDATIGGQQQKIKYYMFKDEFTTKSSSNDEFIQN
DNSILASSLREIITKNFNDYIDQKQNFKNVYDVESTFKNKQFYIYDIDGNGKNPHFYKSK
ESLLESELVNYDEKKVSLVTITKTKVEGLNKLILTTKDDKDLILESPKNNPKGYNYDSSF
DDAFNTLKVAANYFDVFTPRLIKQGSKFVNGKIIKTYTIYVDAYSGLLDKVLNKNRHLLQ
KINGIHTEVVQDKYGKNTYKVVNGEYEGIYVTDRIPYLSLVAQSDPAFKTTGINYLKYVS
THEYGHHQTLQDMKDISDSNDSVIGGGIDSRSGVSDESYVNGKALQDYLNARSSGITFRK
TDVDYNPTKDGSFFNFSLNNDPKNPVWETQKDIFGSVNADDPKAFFYNKKRRFLQKYDEL
FEAAKLRNVKPYDLFIMNSFDHESATVNPSFGPDIKDPSRLKAEYYFYNDQNSQEQKNDN
FKFGSVIEKPGLSKYDGILKDGMGTPIKFSKDGRAIVYKLHKKKHPYKKDDIEILIKTKN
NTPVIDLSTCLKSDGTINTRKLNEKVREIQDSINSLIVKNYYNGGWDENGNFDTSMFNLK
TYFDHPMFTSNEKRKWAERITDAMFKYPDFNISKSLKLDEKANASSVPYYKKVLSQIIGE
DITNKTFDQFKYALLTLQYNASKIWDNKSKEEVSKLDPELIEIKKYYDKQFDRFGVKNVN
VVAQTTLFNYFDAGIEGNNGYKYFVKPKEKELYQNILRTKTKESVESIIGIRPSYLTQNK
ITSYEQLFNKSMINLNEFGTIKLIVDRGDGKDNKHLKKLDELTEKEIYPLMILTPAEAQA
INFDYLKSNNGSFTPLTLENNGSKFYTIKFKDIPSLIEFMSVDPAKYTIVENALSSSHEN
VRKWDYEYLKERYDVDKFFNEVIKKQEAYKNLTLEEFKQNLTGLLFDGFTESNDIFKFYK
SKDFNPSELDKYKQVFDGKLGLYGFRSFGNKYERPGSPYGEPLDTYNFAGNPQNVWKAKP
NQKNVRTVDSIIKGIQLEIERKHRENNTLNFGQLLQYAFGFTIYTDIPGGSKDIYGWLGS
FFGISQSSEIPNADGTVVSSDYVTLNKKRVQEKLNEIFGDYVFNIAEVLTRDYVQTVFIP
SQNELDNLPNYISGLSDFNTGNEYVFSGDNTKQWNERLIPVNNFLSVSNTIALNTLFATN
NYEKIQNVLANQALNVYQKNQQLFDDYLTKPQELESNFNKVKESFLSNANFLALTKTHDS
DVLNNLNSYSFLTRLSPKSNSYIGKTRLTNNGFFKDRWLRKIIDWEIYDDNREPIKDDHL
NILELDNKTKVTDRARAMWLYILRSKGIGDRTLAQIYRNKEKDSILMYGFFKKEYKDKVK
KIAIKNKNNGKIEYIDVHTDNTNNLFYLKRQSDINSKWTLEDEGYVSWTSDYAILSNFTN
QLIGYDSINAKGSEFEIYFVDKDLKEVMDLSDPKNPKSLMTLGSRKYVAENGKSYTVSPV
YARNENTKDKNRTIIRISNQFSV
>UU559 oppF oligopeptide transport system permease protein
MSDTNQKKAFFNHKKRFCLPDKITIRPVTEGLIERLNANPEKKRLVQVRHLDVTYGHGFK
KFRAVKDISFNIYQGEVLGLVGESGSGKSTTGSALIGLARHSFGDIIIDGIKLPKQGEKV
TKELTDFMVNNVQMIFQDPSNSLNPYVNIETVVSEGLNNIKDLKKSFLRLIYKDYLRGLK
KELKAKNFLNNEQVQIFLEKAQDLKFDYLNETAQQELIQLFNELELNHLSLDNNDEKLQK
AFNDINTWKSKTRTDITRHLILDVLKSVGLDETVLRRYPLEFSGGQQQRIGISRAVALRP
KLLIADEPISALDVSIQAQVVNIFKELKTKYDLTILFIAHDLRMVEYISDRIAVMNKGVL
LEIGPTKEIVNNFLHPYTRSLMEAVPSIDSEKKSLLGYVYDANMHEYTPTKQPKWIHLGN
DHYILGTDEEIANWKAGKY
>UU560 oppD oligopeptide transport system permease protein
MKQKNNRYTYINYLRSQRAFIQTLKPQILKLTSNNVCLNEQEVDLEPQLNNLEDINIQLT
NEKVNIQDIVTLEEEINVKDNNQNQNLNEEILATTLINEQASGINEISEQKETTIANKKH
KKQTMAFKAANSRKNFDFEKFEKNVKYKSFKDGTVKKIAAEIENVRLTFTNPSKPNDRAL
VLRNTSVQFYEGEVHAIIGESGSGKSVITSLLYGLAGKNANVEEGKILLYNNEVQDFSFK
DWEKSRYLGKVISAVFQNPMSTLNPTMKIGKQIMEGMLINGIVKTRKEAYNKSIEYLKLT
KINNPEEIMELYPHELSGGMIQRVVIASIVSLHPKILVLDEPTTALDPTVQALVLDVIRE
LQEKFKMCIIFITHDLGVVASIANYISIMYAGQIIEEGQRDEILWYPQHPYTWGLIMSMP
DVNKGDRLATIKGSVPSRLNDIVGDAFAIRNDYALTRDFEHEPEMYHVSETHRVKSALLD
ERAEKYTPPQIILDKWNNFKKRQENN
>UU561 oppC oligopeptide transport system permease protein
MAKFGEYLKQKSKSITSSFIDELTSDAPNKFLQPFQHQQWKIIGHLIEFRDNAYMGGRPR
PFREFANRYGRSFSGLIGLAIIIILFILAIIIPFTTGSPTELRPNKRYLDYFTDGFIFGT
DNNGRDLWAMLWWGLRYSLGIAIIVTAIELVVGVTLGILMGYFEMFDKIMTFIIKILTNV
PTIIILMILTIILKPSFGVMIFAISFSGWIAMANQMRSQVKRARSFLWVAASKTLGTKAW
KIILNFLPILIPMMITQLVFSIPGAILAESSLAFIGLSLPNTPTLGNLIADGSSIITLYP
RFTLIPSFLLVCLVASIQLVGGATQDALRRQR
>UU562 oppB oligopeptide transport system permease protein
MNQKNSFEANSSQNNYGELPILNQKKRVNYSFSNNFIIFGGGRSLKTAADRDRVVDPLID
FFTFDSKFMTFIIKSLKLIAEFFLLAWIVITITFFLINSVPGESALTIGITSPEAKKAIL
AQYGLDRPIGVRYVNYLANIFRGEFGVSTSIRPGVEINSFIWSRYLVSFAVGIFSVLLTL
VIGIPLGIFVGRKPGGILDSVSTVIISVISAVPSLVFGLILLLIGKEVGLPFTFDINNFV
TYILPGLALSLGSIIVYVQYIKVEMNRELNSMHAKFAYLKGATVNRFVWLHALKPSLFPI
ATFFPFVILGSFVGALFIEQIFQIPGSGSLFFEAIISKDYNVILLLVIIYSLITIIGYTI
RDALYQIIDPRIRRGGK
>UU563 unique hypothetical unique hypothetical
MSIKKQSFPNRLLNYKSIIVLIALLILMVISHLIVELIKDYHQYRMNVFIAYTCIFMVVF
LYIIFSRQVYRRRWAVKLRKYNEYKLSSWEMKLVDRFYINAKYELRSIDYATIRLNILIT
IIILPSFIYALACMIAYIIKTTQSIT
>UU564 unique hypothetical unique hypothetical membrane lipoprotein
MKTKSNLKARLIIFISILLTTIISLVLLTSCSTKKSKKVTINQDTQIKFQSITNNNINLA
NEKQILNQSQNKETKIFLNLYESLKDYFDQTIKRSLYLYYSYNFALLNLYNAKYHVKLND
FSLIYNTDKNSNNGTFDINYKLGLVIDDIGDINIQTKPQFYEPIPPDKKVRNDDYHFTKK
IKRFWFGSKKAIIDYFNEAISMQINYSNVKIYHSIIKYPDSKEHYEGYTITGGSLYRWVK
QAIPTDDNQNKVRYMISKINDLNIDNDVKLFNLNDLVLKQIFIVDRPAQTSIKPERDLVY
TNIWNNKLDDFYFSPIAFLAPTFIKKNGKKITPFNLKTNKEYLDNLYENLLIQGQKNNNA
LIKGMYVIYSMYSYFDLTLEPKKPGSIHHCHADGFCH
>UU564.1 unique hypothetical unique hypothetical
MLWDYFLFSYILALKSYVKEPTLPLIYFDLLKIHFVNNASTLINFNCINIHLINNRNANN
NKTRAKNTFAIKNANGMIKKFILIII
>UU565 conserved hypothetical hypothetical
MSNNEEKTHHKNKIKKIFNWTNKTKEVLRTENNLLKQISNEATIQQSVQIEKIRYKAGLL
KFAALYSTKKIFLRYLIIVIFSLLASLLVLLLVHNTGIYSAGIMGTSQGIARILQSIMIS
NHSSPKEAKLAYDIMFWLFAIFVNIPLLIFSYKKIGKHFTLMTLTYIITVQVFGFALSQI
PNVEKIMIFGDNRLSYPPINLFFTNGILDEKIVKNIETGVLNYSNITNSKIADEFMHYVQ
ANPNATIGDLFHLNQSLTYRQSLYEFAKPLYIFHDLIINKVQILSWVDPDQASKIPSILI
YAVIYPIFDGIFLSIVYIAGGSSGGTDIISFWYSKKYGKPTGSILTYFNVATLIIGIVLG
SFIPAGMINSRYWDAQYFFSPNMVASILASIVLGIVFNIYFPKHKSLKIQVYSKNVNAII
ENLRANDFNNSITLNSLSDSLTLRTNYSLEIISPYIELPSLIHLVRDIDKNCLIVIYPII
DIDGEMVVKKSTIS
>UU566 rpL19 ribosomal protein L19
MALFKINKGEIMNFVNSTQLKTDIPNFDSGDTIIVHNRIVEGKKSRIQKFEGVVLRRRGS
GSSETVIVRKESSGIGVEQSFNIHSPLVEKIEVIKYGKVRRAYISYMRNRSGKSARIKEL
NKQ
>UU567 trmD tRNA (guanine-N1)-methyltransferase
MKISILSLFPELYETWIKHSIISNAIKNNQVIIEVIDFRLYTNDKHKKVDDYQYGGGAGM
VLRIEPIVAAIRAIRSSNSYVILTTPKGQVFNQELANNFVSKYDHIIIIAGHYEGFDERI
NYYIDAQYSIGDFVLTGGELPSMVISDAVIRLLDGVISPSSLETESFNNYLLDYPVYTRP
LVFEGHKVPDILLSGHHKNIADFRKQQQETITKKNRPDLYQKYLNNKK
>UU568 rpS16 ribosomal protein S16
MKILVKIRLTRVGTHKKPFFRIVVMDAKTKANGAYIENLGHYDPVLGQVVLKKEAILAQL
QNGAQPSETVKNILSQEGIWKEFIALKDANKKRKAALSKAK
>UU569 conserved hypothetical hypothetical
MQYKMLVIDLDGTLLTKTKNISKANLQGLKKYISLGGKVVLSTGRSLENTLKIVHLIHDQ
IKELIQYISCFNGSYIYDVINEKVLFESTINKDIVNEIYKFSLKHGLGFWPYNQRFMQTH
FLDVYNINYKFLLQLHHTKRKVCLNPIFNKNDKFYKINILPSNFVKKLKHEVIDQLIKEF
SDQVNISFTSKYIVEVTNKNINKASSLRFIANLYQINLDKVATIGDSPNDIPMFKISGLA
AAARTKSKTIIEHVDVIINYKNNSNSVALFINNYLLK
>UU570 conserved hypothetical hypothetical
MENTKKSPTYVYALGGLEEIGKNTYVVEHEDEIILIDAGIKFANASLPGFDGTVANFDYL
IKNNHKIHSLVVTHGHEDHIGGIPHILRHVKIKTIYAPTLAAKLIERRLSEYKDIKPPRI
IVFEDESMYKTKYFEVDFYRVCHSIPDSFGICVKTPNGYIVTTGDFRFDFATAGDETNLA
KISQISNRGISVLMCESTSAEIPGFSESERYVIDNIRDYMVNIKGRTFISTFASNLGRVE
EIIAIAVGLNKKICIIGKSMEANIKTSRKLGYLNVPESSFITHKELPFYKDHEIVVILTG
SQGEKMAALNVMANNNHSKITLKPSDTIILSSNPIPGNYAQVEAMVNKLYKLGLTVYENS
PNKKIHASGHATRSEHQLMIKAINPSYLFPIHGEYKMFRALKQNAVDQGFDKDHVIIAPN
GQKLQLLDGVLSHTNIYVDAEPKFINGYEISSKISKLLSERVVLSSDGILNLVLNADFKK
AKLNSAVSISTRGCFFAKESTNLINKISNVAKSSLEEALAKKEFDEKKLKEIVSGNVKSI
VWKWRKKNPIINVTIINNDLVEQFRKDNNYVEFIKQAEVEEIEQEVDIDDLISNGL
>UU571 conserved hypothetical hypothetical ATP/GTP-binding protein
MKKAIKQKLMNLVNLNPHDSIILTRLSSSRNIDLFKYIKKEDLISFVNGEISYVELNVGK
NLNLFEESLKNALNIGEFLEILVNYNVNLADNKINLLQRDFHANKKKIIPLAIEQLLAFR
KKFISINRLAKNYFEDTTVWPLYFTFNFLKGKLLPNDPFKSPLTLFKVEIREEADKIFIA
KIQDEPIVNEKIQIFLKKGYQDFKVETTELLTNYELSSTIKMIEDMTGQKININENEFVP
FMNENETQILDRYTTFEIEPSAVLGLFEPDGGALKADLHKIIEMDVDPFESENDGLNKPV
EYYEDKVIKEQMVVEIGRPLNIFQKYAVASSLSQNTLIYGPPGTGKSEVIANIIFNVLLK
GKSSLLVSEKRAALDVLTERIGSLSQFALYVYDLTNKETFFEKISNLNDLLGTQWYREQS
RSTKIKEIEPIKFTPEESMFFKNYEDWNSELLQLVKKHWSIEDYNDGIYKMDYADYVATK
NELGEQIVKEWLTPQQFNEENEKRTTLFEEISTIFNEYNLLKIEDLFTAYLRFTSFIKKY
KLTDNYSSIEILKHLKMITNKIQTNDELVTKFLMHANRITKDIDNYYNFLAEHNLESNTI
FMNKSIRDKRIFIDKIGDYLKFRKDVIDKDFSLQSKTTQELNEIIDLCDNFFTKHKKLLA
KNEWFSFLIKNKDRISAFLSIYNNASDENKQIIFAEFISNGTIITNADPSDESSLSLKEI
KTRNRDSQEVIELFIDFLNNIEYLSKPKMDQIASYREFINQDVDFLSKLHTLAEIYTPTM
QDIIREWSWLSLPYIKTLYLEPLILFDLEKIGKIMKHVSTLITHDQFKKLKVIVLWDEIT
HIIPMFSETKGRLLQDIIIQLRRESMRSAKIVGEIVFKKYINNLRNYLTKLPQQEKDEIT
NALRIASSRSWPSISRYLSKYYTALKRLFPIWVARPDNVASLIPLVENEFDYGIFDEASQ
MTIERSYPIVYRCKTKVVSGDDKQLKPTSFFINKLADSDFEIDDFDKVDSLLERAKTSWW
NEYHLKNHYRSDSKELIEFSNKYIYNNNLEVATRQGAFEKGIDVINVNGVWEKGNPLEAE
QTIATLIDNWKKYEKILIVTFNAIQASLVENLLFERMNIFEKGLCDKIENNEIVITNLEN
VQGNEGDLVILSIAYGPNPEGNLRNNFGPLNAKGGMNRLNVAITRARKKMIVIKSLYGHQ
IQVSNLNNQNALTFKRFIEYVDRINGQLSINDSLESLEQQTYLEFDNDLVKEIYSELTKK
LSNKYQIFPNWNIGTKKIDLVIIKKETKEIVKTILLETWKENRSVQIMFEDIDRQYFLED
RSYSTYRIKEYEWYIDKHKIVSRINDSLSSNNNNNKIDYVLWQQNNF
>UU572 unique hypothetical unique hypothetical
MRNNLSDLEIEKLTKTLVSKNKRVVALYGVPENTSYKLMNDLISLMDVEIPNWSSISSAT
EDQCINDIKNFLLSNASLENFKNLPSNNPLINWWKRRRLNTVVKKIEEINSAFADREITS
RSKIFLMPVLTAFSTLGTTLAVPLISVTFLRGDAIINLWGKDGYIAFLSLLFSLVVAVII
SAFVALFSSLKNNKRNYIVSNMTKGLKRIYDKYFIESNSQEKINAKVTFYSRFLERSKFV
VQNNYTFFYDVVDINSDQYPKILKYFKTLNQLNNTVIFDASGFKYLDERKIFRNIIDLEK
TNVVRLDRYKTKTSGRRLMSFIFYQLSIIANVNTRKLLQKFPFFVNSLYRFLDYSEKNTE
LLTLLLDIKKHASKTEIPLNDESQLFFVDFFTFVVFKALDELGFETLMNDLTVYGRPSEI
TKKNITYNSLKLDYIINRNARNFGQQALLFNLLDYFDETVNKNIFNELGNSNKNMIFSKN
HQLNLANEALSKKGFTKREIDLNNHWYDALYSNLHDDEDMFVKIIEIKDNVDILNVLDEL
FVRAQNDGVKNLLIYVFNVKMLYSLIDNEYELVNESII
>UU573 kch potassium channel protein
MTNDERKEFIRKNKIIYFNRIRYFFYEWTDMKAYQRMLVPETFFSFFYQLFVLMIAFCSV
TIIIYNQIELKQANEEHIDFIAKYFEVYYAFNIFFIIDYLIRISYADYTYNSISRLKAFL
IAPFRFVNLLDLVSFVAIVIIYNTGLLDFVAKMNETTSYSQKFDYYYQIINNNAYMNVVP
CMFLIKILGAHSKIIKNVILSSEVNFFWQIFKRRWRVLLSSFLILVLFTFLLSFIIYRIE
QNYYEIKHILPGNPLYKLKNFGETLWFSMGTITTIAYGDVTPVSPAGKVFAVILGVIGVT
YYGFLTSLFASALISVINEFGKRRDSRRLLEFQNENERLLHEFSEQIKVDIVQELIKNNV
IQDPEEIKRIEDLQNQEREALKMKAKRRKKIYFSDDLFDDTKRISVSNVKVRSASNVTKV
LGRSSTKK
>UU574 conserved hypothetical hypothetical
MITDKLIKELNEITRLYYKNDRNQFKKSLINIWSKTMGYTPNLQDPKTYNEKLLYMYLNT
DQSKILEIVDKISFKKWLIKHRLYQYQVPTLAIFNRQNQITLLDLNKFPKPYIIKLNNST
ENEDLYIIRETTSQAELTQIITHFNNILLNKKINHPRNFYETWCYSQIKPQVLIEPLLGK
QTLVADYKIFCFAQEQFCLYMNKDEIEKNNWNWDFLKSNIFDLKNNKSILNHEIINFDFS
EIKDVCQKIYEVLKNDFKHFRIDFYYVDHRLYIGEITFNTSNAFFTFWDDPQWKQKDIEW
GKYWK
>UU575 conserved hypothetical hypothetical
MYTKLTWNNYEFVEQIKEDINPGQQISTLTLLLWTYYGYDIYFEYLKDKNIVLFYAQANE
ELKIIEQNKIATQFIGKFFIIFAYFDAKKYDWTTLIPIALEALKTNFKKEFLLAINGIQD
ENYLNNLSQFNFELIYSWYSNFIYETQSLKYFCGKILQKKRNNLNFFIKNFKNDYEIIKY
NPKFHLHEVCTFLKEWDVKNFINSKRMLVNSNSDLLLNTQTNPYFMGSLLIKKSINKIVG
FTLVYTRPNIAEILIEQTDREIRGMYQYLLSQNLIINNINNWLIDRQDGAWSDNISASKL
SYAPKIITKRVNVLIKE
>UU576 rpS9 ribosomal protein S9
MQKSNIVEYKGLGRRKSSIARVKLVPGSGKVLVNDRQPENYFPNKLVIQDMMQPLVLTKT
AETYDVYVKVIGGGFNGQAGAIRLGITRALIQTREDLKTDLRKAGLVTRDSRVKERKKFG
LYGARRAPQFTKR
>UU577 rpL13 ribosomal protein L13
MQKSSMLKKEVAIARRQWYLVDATDLVLGRLSVKVADILRGKNKVDYTPNVDAGDYVVVI
NSDKVVLTGQKALRENWYNHSHYIGGLRTRSGEEMISKYSDELIRRSVKGMLPKNKLAKQ
ILNKLFIYKNDKHPHEAQQPTILELKLK
>UU578 unique hypothetical unique hypothetical membrane lipoprotein
MKRKNKIITSSLALLFTGVIATISIAACSKQNNQKTKNFNSQEQANKIIEAILNKKEGKD
NFIDWVHWWNSPFQQARKLAKDLDKYIDLTKSKNFKSMIDKNEYKSTFSAQIENVIRIIK
DDIKMYANSPFWKKWRQQKKTALFLINYAPIQKDDSQINAPGILLPAEYPLLYSKPDFEE
LPGFGAFFPTPKSMDAVDLLDTWKSFGSLISSKGNSVEKSVLASKLQNSFAKTADKVVYI
YDDAIVPNIYDKNGNRNLKITQEFANWMINQNYKGYLAREFLKINQKNDLIPLPMSIVWH
ASYGIIGMHRMLYTLSKAFGMPKDELEHLKAQEKFKIPTLKKLLTNDELELKNGIQTIKT
GIDSPFKYHRDQNRDDWKIWATNSQVLDICIALGLKPDLLVKGELSTSVHEDPNLAYYLN
DVIKNQLSDIEQISIKKNHINWTATNYEPIKNLNVNLILMGVHGLIKNSAFKKMMDEGKQ
IKNWAFTDRRFSDETRQYVKKGEEDLYSQNASILGWDEFLKTKNNQ
>UU579 conserved hypothetical hypothetical membrane lipoprotein
MKISVKKTKQIGLFTSIAIMISSVVGIGIFFKNGSIFRFNNFNEIGIIISWVVASLIAFF
TALSFAYITFSKKSGSGIAGIIDELKAPKCARFISVLQTFFYNGILMPSISFFAAESLLM
TIIPKNSSSPQIYQIFILAIGLFLFFLLLNFISFKFSSILQNIATIIKFIPIIAIAIIGI
TYGINNAQNSLFNHNNPKHANFSLLGILASLPSILFSFDSFLGISSLQHKIKNAQKNVPI
TLIVGMFLVAIVYILITIGQVFVGEGYAYGVINKVFKNNINLLKIITIIVNVFITISIIG
VLNSFVIFSIHNAQYVINEKIIFWWSWIQRVQSKHFKEAQGLISVLFIFFTWITIFMIIS
IPLNTDAYIDLLSNYPIVFFFAVYGLIIAFAFYKKVKTKQKIKGIKKQYYTSDVTKRPKW
FFNYQNSSLKNKNILNKELKIANNWILSVWIIGITSCLFVFLYQFLYGYTIYAWLDPYNL
KLYTFGLFYANNVSVIPWIVSLLFFVMLIFFIGFPFLNDAILNLNHKKVNKQQKVFV
>UU580 unique hypothetical unique hypothetical
MVNDKKQKSNKYLTYQDQEYERNLLLEKERKQQKKILAQQAYQQLDLNKKLIKKAKNDQK
LILRLLKEDKSISKTQFNTHRLELKNTIDQMVDEYYELLEQYSVDFEKISFKLKRWLYGI
NKEIRRTTWASKRSVIISLIIVIVIVLILAAIFFGIDTGFYKLSAK
>UU581 nusG transcription antitermination factor
MAYKIKDLDSKLLSDLKIDFNHRHQWYIVTVVSGNEQKVIENIKDKLNGYGYGDKLSDLK
IIKEKIKEVKIYEPSEAPRSMKNRANTKWETIVVDGATKYRCTKIKEGNKFNGYIFLKAE
MTDQIWFLIRNTQMVTGLVGSSGKNVKPIPVPEDKILKLIADNDAKRALISLNEKVDHEE
NIEVIELHEDENFTNFEVDQEVKIIADTFFGEIAKIAKIDQNKKIATVEFEFFGRINTLD
LNFNDIQLYDEESDKLEN
>UU582 deaD ATP-dependent RNA helicase
MKFNSNYQKWILDSLINQKIFEPTPIQLKTMPLIAKRENIIGVAPTGTGKTLAFVLPILN
NLDLSQKLQVIIITPTRELARQIFSKIIVFKKHQPLLQVKMLIGGESIDQQINSQLNKSQ
LLIATPTRLKQILTRQILDLHHVNALVFDEADMLMDLGFISDLEFINSQFTNKDVQKISF
SATLHEMLSIQLKKYFKNTKIINISNSIYENKKITHYVIHNHDKWHSLSIIMKTIKPYLC
IIFANTKKEVEAIYQYLIQQNKNVCILHGSLLQRERKNNYRDIKNNKFQYVVASDIASRG
LDIDGVSHIINWNLPTENEWYIHRAGRSGRGKYSGESYVLYDQKEHDKLLNLSKKGIVFH
HKFIKENELFDKEFLFKKKNQFKDLKTQNEIQKIISTTSTKIKPGYKKKIKEAIQKINQK
NKRSHIEKKMNAHRIRGYKLKNS
>UU583 dinF DNA damage inducible protein - MATE transporter family
MRFDFFKKSQKIKPNWFINQFGDKIFMKTAAKLFFPAILEVIILSSVNYFDSLFIALFTP
ENMGTAAKTATVLATQLMFLPTIFFYSIVAAAGILAAQYYGKKDYLKFKETINFMLLFSF
IVVMIFIVIYMAAPLQMIQLYSGNNLDVSASEEAKRIYDLTNHWAASYLRWQSLTLIPYM
FSFSLATAYRQHNNAIMPLISSSIAVTVNVILDPILIKYCAVTPFEAILFVAIATIVARS
IDALIMLILTLFRKQYPYYFLNYLKLSKKVVKLIFIHGWQVLLNEILFSVGTTIILMFYT
RYSQDHRDAISTVALIIQFTNLIWPGAASTVAVLVLANLGANKHDLAKENTRKLINWGMI
VGISLGIILLVLSSFVNKLLNPPLDYTEQGLKHAAYTATIAMYLEWIVIMVVLTQGPYSV
IYFCIRGGGSRWLLTIDCLSTFIWLIIMGCITHINVPEDYNDRLHVVLLFFIMESQNISK
LIMAIIIFKKTKWAQNLVDEEKEITNEINDDKKEKNKQIIKLENKLMDTDIEAR
>UU584 dinF DNA damage inducible protein - MATE transporter family
MSYQIGFKQKKLSFLNFKKIFGDKQFIKKALKLFFPAIIQNIIITAIAYVDNFFLATYTP
QSQGLDAKTATILATQLLYLPTIFTVAVCYACSVYSSQYLGNKNYHKFKETTNYMILGSV
ILNIPFLIIYLTFPHWSITIYAGSINNFSKDMSMVTSNELTNFKKVNEWASMYLQYAMIG
QVFYAFSYPFAIAHRQDARPAIPLLGSIAALCLNCILDPVLMILVAKTPKQAILLAAFST
IASRGFDLLIVLLCVCIFKKRATYVINYWNLTWRLLKNIFKRGWFIAINEIIFSISVILL
TLFLYKYHPDIRSSISTALLIAQFTKLIWPGMNTIVAVLVLSYLGKNEINTAKQNSRYTV
AWSLIIASILAIILFILSLFINPLLNPPLSNSLLDIKDAKKVAKLATQLEWVLVVEIIIL
GPYAAMNNCIRGAGVIYGAINDTMVMIIWVMMFALISTFAYNPKIPHLLTFALLESNWLL
KMILVSILFTKVNWAKNLIGSNQFEIRKNSFKFRFNYNKK
>UU585 deoC deoxyribose-phosphate aldolase
MNKYNIYVDHTLLKADASLEEIHKLCEEAEENEFYSVCINPCFVKVAKHYLLETSVKICT
VIGFPLGANTIETKVFETKNAIDLGADEIDMVININQLINGNREYCLNEINQIKEVCGDK
ILKVIVETAFLNREQKEFAAKIILESNADFIKTSTGFAKEGAKLEDIILWKRILGDVKQI
KASGGIKNFEDFKSFIEAGATRIGTSSAIKILNNH
>UU586 tktA transketolase I
MNRYVNAMRSLALQAINKAKQGHSGMSISAAPIVYTLYKGLMTISKSHPKWFNRDRLVLS
AGHGSMALYPVFYFSSLLTLDDIKNFRNDNYLTPGHPEVLANNYIDASTGPLGQGVANAV
GMAITESYLRTEFATLKGVIDHYTYCIVGDGDLQEGICYEAMSIAGKLKLSKLIILHDSN
DYQLDSAVSDVNIEDLKMRVESMGWNYLKTDNNPENIFKAIAEAKWKKNVKPTFIEVKTI
IGEGTSFENSNEAHAAAISNDELEKFSKRFHIKTNNFEFHQEIFDHFFFNVVARGESAYN
QWQQLVDQYMQTNPEQMQRLLNYINGNYEDLNKLLDENKITNLNDSTRSYLKQYFNQLKD
LKSALVLSADLAKSTFTKIGEGAFNDNHKNPYIKFGIREFAMAGAMNGISLHQGVKAIGG
TFLAFSDYMKPAIRLAAISNLANLFIFSHDSYAVGGDGPTHQPVDQLPMLRAIPNVEVIR
PADHYEVKYALSYSFKQKQKPICLITSRQTIKQINDQKPQDFSKGAYIINSPFSFCKDVD
YTIIASGSEVSLANDAAKELFEKHKLKIKVISAFNLNLFLRQKPEDIKSLLASKNGLLAI
EASSEMLWWKLSIYTNKFIQIAANQFGRSADGDKLMNEFGFSVKNIINQLLNQ
>UU587 ptsH phosphohistidinoprotein-hexose phosphotransferase
MISKEFTIVAELSAFIKAITYFVNAASDFSSSITIKANGRQADAKSIINIMALGIKQGTK
IELSAVGNDANKAINKLEEILIEQKLI
>UU588 cls cardiolipin synthase
MKKRILAKFIITFICVLLIINICLISIYFHHRPTVIVTDILISFYILNTSIGLYILSSRH
RQDRSKKSWLFIFLFLPIVSIIFFWIFGSRPFKDKKINDIITNRRALFKFEDYEFYHSFQ
NMIINNNGLNLIRKIGQYNYQLFRTPIYCDNQITIIKETNEMYEQTIKLIRKAKKTIYLQ
YYIIENGRWLQSLVKELIKKSNDGIKIYILYDPIGSLNKFPKKYRQQLINNGIEIACFKA
RADYKFRSTINFRSHRKYLIIDGEVAISGGSNIGDSYLNIDPKVGHWVDLNYILTGGIVH
TILLEFIHDWYYYTPFSKKNNFNVVVDSMHPQPYLCQGKDDLINNSIKNKTITTLLHTGP
DQSTSSLNEILVMAIANAKKSITIFTPYLFPTEDILIGLKAAANTGIKVKIILPGRVDSW
SFIISMNRLSYESLIKSGVQIYEYSGFLHTKAILIDDDISLLGSYNLDNRALVINYESLL
TIYSIQVNHDINEIFNQYLRNSQLINLEDLDNKFTFNELVQTVFINIFQLLL
>UU589 trx thioredoxin
MLIKLESNQNLNELLKENHSKPILIDFYADWCPPCRMLIPVLDSIEKKHGDEFTIIKINV
DHFPELSTQYQVKSIPALFYLKNGDIKATSLGFIDENSLVNKLRSI
>UU590 topA DNA topoisomerase I
MQKDLIVVESPNKIKSIQSYLGDSYNVIATCGHLRELAKKSGYDPKTYDLKWEIIKTTNK
KLSKKQQIKTIIDLAKKSNNIYLATDPDREGEAISWHVYDLLPKKDKERVKRITFNEITQ
KAILKSIDEKHDIDFNLVDSQFARRILDRVIGYKLSGLVKKNLHGLSAGRVQSIALLFVV
ERELERRSFVKEEWYQIEGIIEKNIFVSLRKIPYDVELYNQKDNSDSDLKFLHKKDAQRV
IDDLSDIFKVYSIDDLKITKGDVQLPLTTDKLLQIASNNFGWSANKTTLIAQQMFEGLEI
NNQQLALITYPRTDSERLSDDFLQEANAFIENNFGKEYLENFKNKKINRKEVNIQDAHEA
IRPVDINLKPEEIKDYVSLDIYKLYNLVWNKTLSALMKVPTFNKQVIRFINNEYKFYTAY
KTIRTLGYWILDFYKKQRDELEFQPPIINVGDEFKKEKIDLIQKETTPPPYYTEASLIAA
LKNAGVGRPSTYATMATIGTTRGYINKDKSKLIPTELGIKVIQELKEAFPKVISIKFTSE
MEERLDVIANGKLFWKDLVSTFIPIFEEEVKQAYTKIEKVPDEKINRLCPICAHDLLIKR
SRMNTRFIACSNFPTCRFTESLEKPEILNELCPNCSKSLVKRKNRKNKYFIGCTGYPECN
FIRNLDESNNDKNDFNQ
>UU591 unique hypothetical unique hypothetical
MIPLNYLTHYFSLKYKGDWSKIYLALINHEDQNEYLFLEKEDYEKVKAIDLTDEKYPNKY
KKINQPPFILYYSTTVEWLDKKNIWLIDYENAISNYDILTLIKAGYGFVIYYDSVVLDTL
INRLISLKARICIITDEGIYSSKNIKYLSYCNVSVISEIPKDYNSNKITQDLKRLACASS
DHILCVNELYQIDDYLFNKYKDCQLDLVLLDKKLAKQNTIYPKYINRIYQFIKNSKLIN
>UU592 conserved hypothetical hypothetical ATP/GTP-binding protein
MDIINKKINWFPGHMKKATDEILKNLKNVDFFIQLVDARCPLTSSNIELLKEVSSKPVIN
LANKADLSDWKKNFDNNFLLISTKKRNDKNKIIQHLYQLFDQKIKIYQKKGLINPKFVGM
IIGLPNIGKSSLINFLAPKKVLKVENRPGVTKTQCIRQINQHFYLIDTPGIFLKNIQNER
DSFVLTLINCVKKEVLELESIVHFAYDFYLKNYRNELFIKYKMNKVLNFDDFIHHICELY
NYKLTNNEFDHVRAYENLFNDFSNGLICKVNYD
>UU593 unique hypothetical unique hypothetical
MKIVLEELKDYLIGKLYFKYKFIGVFISIFLAGWLISFITNLILALNYGYNEKLLNYKKY
LDFTILTCISFLMLFITIIYLLWINCHNSTARYLILKINKYPPKKPIKNLPFIFFRLAYY
TFNIRQKIQYQQKQIYKYLISFNEYV
>UU594 tdk thymidine kinase
MAKVNAFSKKIGWIELITGPMFAGKTAELIRRLHRLEYADVKYLVFKPKIDTRSIRNIQS
RTGTSLPSVEVESAPEILNYIMSNSFNDETKVIGIDEVQFFDDRICEVANILAENGFVVI
ISGLDKNFKGEPFGPIAKLFTYADKITKLTAICNECGAEATHSLRKIDGKHADYNDDIVK
IGCQEFYSAVCRHHHKVPNRPYLNSNSEEFIKFFKNKKRNKNI
>UU595 gtp1 GTP-binding protein
MSLSAGLVGLPNVGKSTLFNTITNSRVEAANYPFATIEPNIGIVNINDPRLKRLASLVVP
DKIVPTTFKFVDIAGLVKGASQGEGLGNQFLNNIRDVDAICHVVRCFDDKSITHVHNKID
ALSDIHVINYELILSDLDIIEKRISRIKKKADSGDKDARREYLILFNIEEALKKGQLASS
VKLTKEELKIINSFNLITLKPILYIANISENEISNPDLNKEYLKVKKYAQDNDARCVALS
AKIEYEISILDEESKSIFIQDLGIKTTGLDEIVKQTYDLLNLKTYFTYGKQEVRAWTFIN
GMSAPECAGIIHSDFEKGFIKAEIMHYDDLISLGSEQAVKEAGKIRMEGKSYLMKDGDIC
NFRFNVTK
>UU596 tsr fructose-bisphosphate aldolase
MSPLVNAKKMIQNAYENHYAVAAININNLEWIKAALLAAQETNSPLLLATSEGAVKYMGG
YDNCYAMVVNLIKQMNIKTPVCLHLDHGTYEGCIKAINAGYSSIMYDGSKLSIEENIKNT
KELLTITKLKGVSVEVEVGSIGGTEDGITSEGELANIDDCYQMCLLDIDMLACGIGNIHG
IYPKNWKGLNFNLLKEINNKVNKPIVLHGGSGISDEQILKAINLGVAKININTECQIAFS
NALQDHLTKAGDLILSKQYDPRKILAYGVDAIKNTIIDKFTKFNSLNKIK
>UU597 rpoE DNA-directed RNA polymerase delta subunit
MSRQLVDIAYNAIKNNKIYNKKPFTFDDIINEIVKNSNVNLVEVNSQLGVLYTTLIQDTR
FISIGDLEWNLRERLSLDEITKINNAMYEVGLYKDSDREEDEHEIVKNDKLTQSKEQEES
DEVSSLSDFVGYEDEDEEFKNNNTSNKDEIEDEEELEEEE
>UU598 conserved hypothetical hypothetical
MVKNFFIKDPIHGLITFDEQYEWAYELIKTKEFWRLNNIKQLGSSWSIFPSATHTRFTHC
IGVFQVTRKLLDSLKFIKSDTHDLINNKKIVCAAALLHDIGHGPFSHTFEYATNYNHEKI
GQMIITNPKSEINKILIKHNINPVDVANIIDHKSKKMWMQQVISSQIDADRLDYLPRDSH
FTGTKYGNIDYDNIFKKAIVFNDQLCFSKHSWNALENILISRWSMFENVYLNKTPTTYDI
LMKKTLARVHFLYQKQKKYIFKNSQLLTILKPWLDNESWDITTVQNLDDYSFTALMRSFA
NEHDFILKTLATNWLQNKDFVTFEYEYGKDKSKDQKIIHKKYFYETITSNKQIYDFNEPV
FLYTENKNNDIKLLKLEDKSLIIAALKSIKQPRIKKWIFYYKPLK
>UU599 gltX glutamyl-tRNA synthetase
MKIRTRYAPSPTGYLHIGGARTALFNYLLAKAYGGDFIIRIEDTDIERNVEGGINSQLDF
LAWMGIIPDESIRNPKAFGPYIQSEKLKHYEKLALDLVDQKKAYFCFCSKEQLDADRELA
EKSHQTPKYKRHCLNLDKKTIESNLLQNKEYTIRLKINENMEYSWDDLIRGKISIPGSAL
TDPVILKSNKIAMYNFAVVIDDYEMQISHVIRGEEHISNTPYQLAIAQALNYDITKIKYG
HLSIIVDETGKKLSKRNLSLKQFVSDYEKDGYWPHAITNFVALLGWSPKNNDEIMSLETM
IKNFDINNLSKSPAFFDINKMNWFSTQYFNNITQEEFINFIKKHSLTKELVLNDYTFINK
CLLFKSHIINLKQLIDLVIEQFNCDKKVLASDVDYIKKNQLITVVRVFYEQLIINDEFNE
EFIKEIIKKVQIITNNKGANLYMPIRIATTFSSHGPELAKTICYLGREKVLKNLINILKI
LD
>UU600 conserved hypothetical hypothetical
MKVKSFAKIDLGYSVYKKQKNFTKHDFESIFILVENIYDDIEITKIEKNIDDVHYYNETN
EIYVYSRLVHKTLEWIRHTYHIKNHYRINIKKRIPIGAGLGGGSSNAAAIMKYILEFEGI
KEINYKDVVNKLGADIPFFLSGYKTAYISDYGSVLEDLTGQFKLNYEVYLMNVNVNTKIV
FEKFDDNSWHVIKNNFKTIIKNLKENIVVNIHNDLQEYCFELYPNIKYKYNELLSDGFYT
ILSGAGSSFIRIKLKNKEDLIINEN
>UU601 ksgA dimethyladenosine transferase
MGQNFLLSNNIKNKIVDVANINKDDLILEIGPGWGAITEILVQKTNILIAIELDKRLYAH
LKTYIKTSNFHIINNDVLCVDLDNLILDYNNTQKIQKIKVVANLPYAISSKIVLKIIQSK
LINDAYIMVQKEMAERIGAKVNTRGYNAFTVLVQLFCKTKILFEVNAKEFHPQPKVQSAV
IHLENLHNSVNFNIEELGKFLRICFLNKRKKLKNNLSNIYDIKIINQMFIDYNLDMNLRA
ENIEPKMFLKLFNYLNR
>UU602 conserved hypothetical hypothetical membrane lipoprotein
MSSVDKQNLTNRMRISVSHFAGASNANSIKKERKKKIFNVLLKVFKIIVYAFFLGIGLYG
CFQNMANHWTINSTIVGNGFELGFHVDPILGANDIRFDLIYSGTGPWYPMSDFSFDYGPF
YALFVWPIAQILLHFMYATRDWPAGLNAILGLIIILLIIRVITMLISARATIQTERISEI
QGKIAEINAKYKDAKDMQSRQKKQMETKELYQKHNVKPLAPFESMIITLPIFLIIYRVVT
ILRPLKFISIFYIWDLSATPISEIFSNFTTSGWPYIFFLLIIIPVQILSQKIPQLLARKR
NRNATTVGAKNKQQLKRVRMTQNIIAIVLAVVVAISASGIGLYWFFNAIFTILQSYIIHV
IIMKRRSNSATRIESKLAKLGIS
>UU603 rnpA ribonuclease p - protein component
MANFISLKKNEDILDTIKKQQKIHSNQIVVYFRKTNLKNVRLAISISKKKFKLATQRNRI
RRLIKAWFIAADIPIKSYDIVVLVKPSFIDGSFVLNCNNLKIILQRIINKEKR
>UU604 rpL34 ribosomal protein L34
MKRTFQPNNRKRAKVHGFRARMKTKNGRNVLARRRLKGRHSLTVSSEK